WO2021193708A1 - Compound, liquid crystal composition, and liquid crystal display element - Google Patents
Compound, liquid crystal composition, and liquid crystal display element Download PDFInfo
- Publication number
- WO2021193708A1 WO2021193708A1 PCT/JP2021/012218 JP2021012218W WO2021193708A1 WO 2021193708 A1 WO2021193708 A1 WO 2021193708A1 JP 2021012218 W JP2021012218 W JP 2021012218W WO 2021193708 A1 WO2021193708 A1 WO 2021193708A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diyl
- hydrogen
- formula
- fluorine
- carbons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/10—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
- C09K19/12—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/10—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
- C09K19/14—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/10—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
- C09K19/14—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
- C09K19/16—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon double bonds, e.g. stilbenes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/10—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
- C09K19/14—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain
- C09K19/18—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/10—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
- C09K19/20—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/08—Non-steroidal liquid crystal compounds containing at least two non-condensed rings
- C09K19/30—Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/32—Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/42—Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
Definitions
- the present invention relates to a liquid crystal compound having a carbazole ring, a liquid crystal composition, and a liquid crystal display element. More specifically, the present invention relates to a liquid crystal compound having a carbazole ring and having a negative dielectric anisotropy, a liquid crystal composition containing the same, and a liquid crystal display element containing the composition.
- the classification based on the operation mode of the liquid crystal molecule is PC (phase change), TN (twisted nematic), STN (super twisted nematic), ECB (electrically controlled birefringence), OCB (optically compensated bend), IPS. (In-plane switching), VA (vertical alignment), FFS (fringe field switching), FPA (field-induced photo-reactive alignment) and other modes.
- the classifications based on the drive method of the element are PM (passive matrix) and AM (active matrix). PM is classified into static, multiplex, etc., and AM is classified into TFT (thin film transistor), MIM (metal insulator metal), and the like.
- a liquid crystal composition is enclosed in this element.
- the physical characteristics of this composition are related to the properties of the device. Examples of physical properties in the composition are stability to heat and light, temperature range of nematic phase, viscosity, optical anisotropy, dielectric anisotropy, specific resistance, elastic constant and the like.
- the composition is prepared by mixing many liquid crystal compounds. The physical characteristics required for the compound are high stability to the environment such as water, air, heat and light, wide temperature range of liquid crystal phase, small viscosity, appropriate optical anisotropy, large dielectric anisotropy, appropriate elastic constant. , Good compatibility with other liquid crystal compounds, etc. Compounds with a high upper temperature limit of the nematic phase are preferred.
- Compounds having a low lower limit temperature in the liquid crystal phase such as the nematic phase and the smectic phase are preferable. Compounds with low viscosities contribute to the short response time of the device.
- the appropriate value of optical anisotropy depends on the type of operating mode of the device. In order to drive the device at a low voltage, a compound having a large positive or negative dielectric anisotropy is preferable. In order to prepare the composition, a compound having good compatibility with other liquid crystal compounds is preferable. Since the device may be used at a temperature below freezing, a compound having good compatibility at a low temperature is preferable.
- Patent Document 1 discloses compounds having numbers 53, 54, and 56 in Table 4 on page 41, and compounds having numbers 125 and 127 in Table 8 on page 45.
- Patent Document 2 discloses the II-a compound of Example 3 on page 10, and the III-a compound of Example 7 on page 14.
- the first challenge is high stability to heat and light, high transparency (or high upper limit temperature of nematic phase), lower lower limit temperature of liquid crystal phase, small viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal compound that satisfies at least one of physical characteristics such as anisotropy, an appropriate elastic constant, and good compatibility with other liquid crystal compounds. It is to provide a compound having a negatively large dielectric anisotropy as compared with a similar compound.
- the second challenge is that it contains this compound and has high stability to heat and light, high upper limit temperature of nematic phase, lower lower limit temperature of nematic phase, small viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal composition that satisfies at least one of physical characteristics such as anisotropy, a large specific resistance, and an appropriate elastic constant. The challenge is to provide a liquid crystal composition having an appropriate balance with respect to at least two physical characteristics.
- a third challenge is a liquid crystal display that contains this composition and has a wide temperature range in which the device can be used, a short response time, a large voltage retention rate, a low threshold voltage, a large contrast ratio, a small flicker rate, and a long life. It is to provide an element.
- the present invention relates to a compound represented by the formula (1), a liquid crystal composition containing this compound, and a liquid crystal display element containing this liquid crystal composition.
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon
- Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl,
- At least one hydrogen may be replaced with fluorine or chlorine;
- L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C ⁇ N,;
- L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C ⁇ N,
- L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2
- the first advantages are high stability to heat and light, high transparency (or high upper limit temperature of nematic phase), lower lower limit temperature of liquid crystal phase, low viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal compound that satisfies at least one of physical characteristics such as anisotropy, an appropriate elastic constant, and good compatibility with other liquid crystal compounds. It is to provide a compound having a negatively large dielectric anisotropy as compared with a similar compound.
- the second advantage is that it contains this compound and has high stability to heat and light, high upper limit temperature of nematic phase, lower lower limit temperature of nematic phase, small viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal composition that satisfies at least one of physical characteristics such as anisotropy, a large specific resistance, and an appropriate elastic constant. This advantage is to provide a liquid crystal composition having an appropriate balance with respect to at least two physical characteristics.
- the third advantage is that the liquid crystal display contains this composition and has a wide temperature range in which the device can be used, a short response time, a large voltage retention rate, a low threshold voltage, a large contrast ratio, a small flicker rate, and a long life. It is to provide an element.
- liquid crystal compound liquid crystal composition
- liquid crystal display element may be abbreviated as “compound”, “composition”, and “element”, respectively.
- the “liquid crystal compound” is a compound having a liquid crystal phase such as a nematic phase or a smectic phase, and a compound having no liquid crystal phase but adjusting the physical properties of a composition such as an upper limit temperature, a lower limit temperature, a viscosity, and a dielectric constant anisotropy.
- Liquid crystal display element is a general term for a liquid crystal display panel and a liquid crystal display module.
- polymerizable compound is a compound added for the purpose of forming a polymer in the composition. Liquid crystal compounds with alkenyl are not polymerizable in that sense.
- the liquid crystal composition is prepared by mixing a plurality of liquid crystal compounds. Additives are added to this composition for the purpose of further adjusting the physical characteristics. Additives such as polymerizable compounds, polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, UV absorbers, light stabilizers, heat stabilizers, dyes, and defoamers are added as needed. NS.
- the liquid crystal compounds and additives are mixed in such a procedure. The ratio (content) of the liquid crystal compound is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additive even when the additive is added.
- the ratio (addition amount) of the additive is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additive. That is, the ratio of the liquid crystal compound or the additive is calculated based on the total weight of the liquid crystal compound. Parts per million by weight (ppm) may also be used.
- the proportions of polymerization initiators and polymerization inhibitors are exceptionally expressed based on the weight of the polymerizable compound.
- the “transparency point” is the transition temperature between the liquid crystal phase and the isotropic phase in the liquid crystal compound.
- the “lower limit temperature of the liquid crystal phase” is the transition temperature of the solid-liquid crystal phase (smetic phase, nematic phase, etc.) in the liquid crystal compound.
- the “upper limit temperature of the nematic phase” is the transition temperature of the nematic phase-isotropic phase in the mixture of the liquid crystal compound and the mother liquid crystal or the liquid crystal composition, and may be abbreviated as the “upper limit temperature”.
- the “lower limit temperature of the nematic phase” may be abbreviated as the "lower limit temperature”.
- the expression “increase the dielectric anisotropy” means that when the composition has a positive dielectric anisotropy, its value increases positively, and the composition has a negative dielectric anisotropy. When it is a thing, it means that its value increases negatively.
- “Large voltage retention” means that the element has a large voltage retention not only at room temperature but also at a temperature close to the upper limit temperature at the initial stage, and after long-term use, it has a large voltage not only at room temperature but also at a temperature close to the upper limit temperature. It means having a retention rate.
- the characteristics of the composition or device may be examined before and after the aging test (including the accelerated deterioration test).
- the compound represented by the formula (1) may be abbreviated as the compound (1).
- At least one compound selected from the group of compounds represented by the formula (1) may be abbreviated as the compound (1).
- “Compound (1)” means one compound represented by the formula (1), a mixture of two compounds, or a mixture of three or more compounds. These rules also apply to compounds represented by other formulas.
- symbols such as A 1 , B 1 , and C 1 enclosed in hexagons correspond to rings such as ring A 1 , ring B 1 , and ring C 1, respectively.
- the hexagon represents a six-membered ring such as cyclohexane or benzene.
- the hexagon may represent a fused ring such as naphthalene or a crosslinked ring such as adamantane.
- R 11 In the chemical formulas of the component compounds, with symbols of terminal groups R 11 to a plurality of compounds.
- two groups represented by any two R 11 may be may be the same or different.
- R 11 of compound (2) is ethyl and R 11 of compound (3) is ethyl.
- R 11 of compound (2) is ethyl and R 11 of compound (3) is propyl.
- This rule also applies to symbols such as R 12 , R 13 , and Z 11.
- i when i is 2, two rings E 1 is present.
- the two two wherein the ring E 1 represents the compound may be the same or different.
- i is greater than 2
- This rule also applies to other symbols.
- At least one'A' means that the number of'A's is arbitrary.
- the expression “at least one'A'may be replaced by'B'” is that when the number of'A's is 1, the position of the'A'is arbitrary and the number of'A's is 2. When more than one, it means that their positions can be selected without limitation. This rule also applies to the expression “at least one'A' has been replaced by a'B'".
- the expression "at least one'A' may be replaced by'B','C',or'D'" is any'if any'A' is replaced by a'B'.
- Alkyl such as in, -CH 2 methyl moiety (-CH 2 -H) - by is replaced by -O- is not preferred also be the -O-H.
- R 11 and R 12 are independently alkyls with 1 to 10 carbons or alkenyl with 2 to 10 carbons, in which at least one -CH 2- is replaced with -O-. Often, in these groups, at least one hydrogen may be replaced by fluorine.
- in these groups may be interpreted literally.
- these groups means alkyl, alkenyl, alkoxy, alkenyloxy and the like. That is, “these groups” refers to all of the groups described prior to the term “in these groups”. This common-sense interpretation also applies to the terms “in these monovalent groups” and “in these divalent groups”. For example, “these monovalent groups” refers to all of the groups described prior to the term “in these monovalent groups”.
- Halogen means fluorine, chlorine, bromine, and iodine. Preferred halogens are fluorine and chlorine. A more preferred halogen is fluorine.
- the alkyl of the liquid crystal compound is linear or branched and does not contain cyclic alkyl. Linear alkyl is generally preferred over branched alkyl. The same applies to terminal groups such as alkoxy and alkenyl.
- the configuration for 1,4-cyclohexylene is preferably trans over cis in order to raise the upper temperature limit.
- 2-Fluoro-1,4-phenylene means the following two divalent groups.
- fluorine may be left-facing (L) or right-facing (R). This rule also applies to asymmetric divalent groups generated by removing two hydrogens from the ring, such as tetrahydropyran-2,5-diyl.
- the present invention includes the following items.
- Item 1 A compound represented by the formula (1).
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon
- Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, Fran-2,5-diyl, thiophene-2,4-diyl,
- At least one hydrogen is fluorine, chlorine, -C ⁇ N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2.
- At least one hydrogen may be replaced with fluorine or chlorine;
- L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C ⁇ N,;
- L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C ⁇ N,
- L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2
- Item 2. The compound according to Item 1, represented by the formulas (1-1) to (1-13).
- R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms.
- R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C ⁇ N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
- Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-.
- Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl,
- At least one hydrogen may be replaced with fluorine or chlorine;
- L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ⁇ N, and at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C ⁇ N,;
- R 1 does not become hydrogen
- R 2 does not become hydrogen.
- R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms
- Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene
- Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diy
- Item 4. The compound according to Item 1, which is represented by the formulas (1-14) to (1-26).
- R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms.
- R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C ⁇ N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
- Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-.
- Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl,
- Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH.
- At least one hydrogen may be replaced with fluorine or chlorine;
- L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ⁇ N.
- At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ⁇ N;
- formula (1-14) formula (1-16), formula (1-18), formula (1-20), formula (1-22), formula (1-24), and formula (1-26).
- R 1 does not become hydrogen
- formulas (1-14) to (1-18) formula (1-21), formula (1-22), formula (1-25), and formula (1).
- R 2 does not become hydrogen.
- R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms
- Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene
- Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diy
- At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ⁇ N;
- R 1 does not become hydrogen
- formulas (1-14) to (1-18) formula (1-21), formula (1-22), formula (1-25), and formula (1).
- Item 4 The compound according to Item 4, wherein R 2 does not become hydrogen in ⁇ 26).
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms
- Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH).
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 10 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms
- L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4.
- X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms
- Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH).
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms
- L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and at least one of L 5 and L 6
- Item 10. The compound according to any one of Items 1 to 3, 6 and 7, represented by the formula (1-1-1) or the formulas (1-3-1) to (1-3-6).
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms
- Item 11 Item 2. The item 1, 4, 5, 8 and 9, which is represented by the formula (1-14-1) or the formula (1-16-1) to the formula (1-16-6). Compound.
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms
- L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 or -OCF 3 Is;
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms
- L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, -CF 3 , or -OCF 3 , and at least two of L 1 , L 2 , L 3 , and L 4 are , Fluorine, -CF 3 , or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4 is hydrogen
- X 1 and X 2 are independently hydrogen or fluorine.
- R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons.
- Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms
- L 5 and L 6 are independently hydrogen, fluorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, -CF 3 or -OCF 3 .
- X 1 and X 2 are independently hydrogen or fluorine.
- Item 14 The compound according to any one of Items 1 to 3, 6, 7, 10, and 12, represented by the formulas (1-1-1-1) to (1-1-1-7).
- R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons.
- Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms.
- Item 15 The item according to any one of Items 1, 4, 5, 8, 9, 11, and 13, which is represented by the formula (1-14-1-1) or the formula (1-14-1-2). Compound.
- R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons.
- Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms.
- Item 16 A liquid crystal composition containing at least one of the compounds according to any one of Items 1 to 15.
- Item 17 The liquid crystal composition according to Item 16, which contains at least one compound selected from the group of compounds represented by the formulas (2) to (4).
- R 11 and R 12 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 11 and R 12, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
- Ring B 1 , Ring B 2 , Ring B 3 and Ring B 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro- 1,4-phenylene, or pyrimidine-2,5-diyl;
- Item 18. The liquid crystal composition according to Item 16 or 17, further containing at least one compound selected from the group of compounds represented by formulas (5) to (13).
- R 13 and R 14 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 13 and R 14, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
- R 15 is hydrogen, fluorine, alkenyl alkyl carbon atoms or 2 to 10 from 10 1 carbon atoms, in the R 15, at least one -CH 2 - may be replaced by -O-, at least One hydrogen may be replaced by fluorine;
- Ring C 1 , Ring C 2 , Ring C 3 , and Ring C 4 may independently replace 1,4-cyclohexylene, 1,4-cyclohexenylene, and at least one hydrogen with fluorine 1, 4-Phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6-diyl;
- Ring C 5 and ring C 6 are each independently 1,4-cyclohexylene, 1, 1,4
- Item 19 The liquid crystal composition according to any one of Items 16 to 18, further containing at least one compound selected from the group of compounds represented by the formulas (21) to (23).
- R 16 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 16, at least one -CH 2 - may be replaced by -O-, at least one hydrogen , May be replaced with fluorine;
- X 11 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 ;
- Ring D 1 , Ring D 2 , and Ring D 3 are independently 1,4-cyclohexylene, 1,4-phenylene, where at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl.
- Item 20 The liquid crystal composition according to any one of Items 16 to 19, further containing at least one compound selected from the group of compounds represented by the formula (24).
- R 17 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 17, at least one -CH 2 - may be replaced by -O-, at least one hydrogen May be replaced with fluorine;
- X 12 is -C ⁇ N or -C ⁇ C-C ⁇ N;
- Ring E 1 is 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl.
- Z 21 is a single bond, -COO-, -CH 2 O-, -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , or -C ⁇ C-;
- L 15 and L 16 are independently hydrogen or fluorine; i is 1, 2, 3, or 4.
- Item 21 A liquid crystal display device containing the liquid crystal composition according to any one of Items 16 to 20.
- the present invention also includes the following items.
- the present invention also includes the following items.
- C One selected from the group of polymerizable compounds, polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, UV absorbers, light stabilizers, heat stabilizers, dyes, and defoamers.
- the composition described above further comprising two or at least three additives.
- D The upper limit temperature of the nematic phase is 70 ° C. or higher, the optical anisotropy at a wavelength of 589 nm (measured at 25 ° C.) is 0.08 or higher, and the dielectric anisotropy at a frequency of 1 kHz (measured at 25 ° C.). ) Is -2 or less, the above composition.
- the present invention also includes the following items.
- E A device containing the above composition and having a mode of PC, TN, STN, ECB, OCB, IPS, VA, FFS, FPA, or PSA.
- F AM device containing the above composition.
- G A transmissive device containing the above composition.
- H Use of the above composition as a composition having a nematic phase.
- I Use as an optically active composition by adding an optically active compound to the above composition.
- Compound (1) is characterized by having a divalent group represented by the following formula.
- X is hydrogen or a substituent.
- This compound is extremely physically and chemically stable under the conditions in which the device is normally used, and has good compatibility with other liquid crystal compounds. Compositions containing this compound are stable under the conditions in which the device is commonly used. This composition has a negatively large dielectric anisotropy. This compound has the general physical properties required for the components of the composition, the appropriate optical anisotropy, and the appropriate dielectric anisotropy.
- a preferred embodiment of side groups L 1, L 2, L 3 , L, 4, L 5 and L 6 are as follows. This example also applies to the sub-formula of compound (1).
- the physical properties can be arbitrarily adjusted by appropriately combining these groups. Because large difference is not in the physical properties of the compound, the compound (1) is, 2 H (deuterium), an isotope such as 13 C may contain more than the amount of natural abundance.
- the definition of the symbol of compound (1) is as described in Item 1.
- One hydrogen may be replaced with fluorine or chlorine.
- R 1 or R 2 are alkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, alkylthio, alkylthioalkoxy, acyl, acylalkyl, acyloxy, acyloxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkenyl, alkenyloxy, alkenyloxyalkyl, alkoxy. Alkoxy, alkynyl, and alkynyloxy.
- at least one hydrogen may be replaced with fluorine or chlorine.
- This example contains a group in which at least two hydrogens have been replaced with both fluorine and chlorine.
- R 1 or R 2 Groups in which at least one hydrogen is replaced with fluorine alone are even more preferred.
- R 1 or R 2 a straight chain is preferable to a branched chain. Even if R 1 or R 2 is a branched chain, it is preferable when it is optically active. More preferred R 1 or R 2 are alkyl, alkoxy, alkoxyalkyl, alkenyl, monofluoroalkyl, polyfluoroalkyl, monofluoroalkoxy, and polyfluoroalkoxy.
- R 2 may be fluorine, chlorine, -C ⁇ N, or -C ⁇ C-C ⁇ N in addition to the above groups.
- Trans-configuration is preferred for alkenyl such as 1-propenyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 3-pentenyl, 3-hexenyl.
- the cis configuration is preferred for alkenyl such as 2-butenyl, 2-pentenyl, 2-hexenyl.
- R 1 or R 2 are methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, methoxymethyl.
- Methoxyethyl methoxypropyl, ethoxymethyl, ethoxyethyl, ethoxypropyl, propoxymethyl, propoxyethyl, butoxymethyl, butoxyethyl, pentoxymethyl, pentoxyethyl, vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-Buthenyl, 3-Butenyl, 1-Pentenyl, 2-Pentenyl, 3-Pentenyl, 4-Pentenyl, 1-Hexenyl, 2-Hexenyl, 3-Hexenyl, 4-Hexenyl, 5-Hexenyl, 1-Heptenyl, 2 -Heptenyl, 3-heptenyl, 4-heptenyl, 5-heptenyl, 6-heptenyl, 2-propenyloxy, 2-butenyloxy, 2-pentenyloxy, 2-hexenyloxy, and 1-propynyl.
- R 1 or R 2 is 2-fluoroethyl, 3-fluoropropyl, 2,2,2-trifluoroethyl, 2-fluorovinyl, 2,2-difluorovinyl, 2-fluoro-2-vinyl, 3-Fluoro-1-propenyl, 3,3,3-trifluoro-1-propenyl, 4-fluoro-1-propenyl, and 4,4-difluoro-3-butenyl.
- R 2 is, in addition to the above groups, fluorine, chlorine, -C ⁇ N, -CF 3 , -CHF 2 , -CH 2 F, -CF 2 CF 3 , -CF 2 CHF 2 , -CF. 2 CH 2 F, -CF 2 CF 2 CF 3 , -CF 2 CHFCF 3 , -CHFCF 2 CF 3 , -OCF 3 , -OCHF 2 , -OCH 2 F, -OCF 2 CF 3 , -OCF 2 CHF 2 , It may be -OCF 2 CH 2 F, -OCF 2 CF 2 CF 3 , -OCF 2 CHFCF 3 , and -OCHFCF 2 CF 3.
- R 1 or R 2 are ethyl, propyl, butyl, pentyl, hexyl, heptyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, methoxymethyl, ethoxymethyl, ethoxyethyl, propoxymethyl, propoxyethyl, Butoxymethyl, pentoxymethyl, vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2 -Hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 2-propenyloxy, 2-butenyloxy, and 2-pentenyloxy.
- R 2 is, -OCF 3, -OCHF 2, -OCH 2 F, -OCF 2 CF 3, -OCF 2 CHF 2, -OCF 2 CH 2 F, -OCF 2 CF 2 CF 3, - OCF 2 CHFCF 3 , -OCHFCF 2 CF 3 , fluorine, chlorine, and -C ⁇ N.
- R 1 or R 2 are ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, methoxymethyl, ethoxymethyl, propoxymethyl, butoxymethyl, vinyl, 1-propenyl, 3 -Butenyl, and 3-pentenyl.
- the most preferred R 2 is, -OCF 3, -OCHF 2, -CF 3, -CHF 2, -CH 2 F, -OCF 2 CHF 2, -OCF 2 CHFCF 3, fluorine, and -C ⁇ N be.
- Ra is hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms.
- Ras are methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, sec-butyl, pentane-2-yl, hexane-2-yl, pentane-3-yl, hexane-3-yl, tert-butyl. , Tert-pentyl, 3-methylpentane-3-yl, and 3-ethylpentane-3-yl. More preferred Ra are methyl, ethyl, propyl, butyl, isopropyl, sec-butyl, and tert-butyl. Particularly preferred Ra are methyl, ethyl, propyl, and isopropyl. The most preferred Ra are methyl and ethyl.
- An example of a preferred ring A 1 or ring A 2 is a divalent group represented by the following formulas (25-1) to (25-27).
- a more preferable example is a divalent group represented by the formulas (25-1) to (25-17).
- Particularly preferred examples are divalent groups represented by formulas (25-1) to (25-3) and formulas (25-13) to formulas (25-17).
- the most preferable example is a divalent group represented by the formulas (25-1) to (25-3).
- ring N 1 and ring N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4. -Tetrahydronaphthalene-2,6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran -2,5-diyl, dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4- Diyl, furan-2,5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofur
- At least one hydrogen is fluorine, chlorine, -C ⁇ N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2.
- a preferred example of “may be replaced by F” is a divalent group represented by the following formulas (26-1) to (26-71). More preferred examples are equations (26-1) to (26-4), equations (26-6), equations (26-10) to (26-15), and equations (26-54) to (26). It is a divalent group represented by -59).
- More preferred ring N 1 or ring N 2 is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,3-dioxane-2,5-diyl, 1,4-phenylene, 2-fluoro-1, 4-Phenylene, 2,3-difluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, 2,3,5-trifluoro-1 , 4-Phenylene, pyridine-2,5-diyl, 3-fluoropyridine-2,5-diyl, pyrimidine-2,5-diyl, pyridazine-2,5-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, and naphthalene-2,6-diyl.
- Particularly preferred ring N 1 or ring N 2 is 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-. Difluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, pyridine-2,5-diyl, and pyrimidine-2,5-diyl. ..
- the most preferred ring N 1 or ring N 2 is 1,4-cyclohexylene and 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene.
- Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, in Z 1 , Z 2 , Z 3 , and Z 4 .
- At least one -CH 2- may be replaced with -O-, -S-, -CO-, or -SiH 2-
- at least one- (CH 2 ) 2 -is -CH CH.
- -Or -C ⁇ C- may be replaced, and at least one hydrogen may be replaced with fluorine or chlorine.
- the most preferred Z 1 , Z 2 , Z 3 or Z 4 are single bonds, -CH 2 O- or -OCH 2- .
- L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently contain hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, and -OCF. 3, -OCHF 2, a -OCH 2 F or -C ⁇ N,.
- L 1 , L 2 , L 3 , and L 4 when both L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH. 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ⁇ N, and at least one of L 1 , L 2 , L 3 , and L 4 may be hydrogen. More preferred L 1 , L 2 , L 3 and L 4 are fluorine or -CF 3 . Particularly preferred L 1 , L 2 , L 3 and L 4 are fluorine.
- L 5 and L 6 when L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH. 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ⁇ N, and at least one of L 5 and L 6 may be hydrogen. More preferred L 5 and L 6 are fluorine or -CF 3 . Particularly preferred L 5 and L 6 are fluorine.
- l and o are independently 0, or 1 and m, and n are independently 0, 1, or 2, and the sum of l, m, n, and o. Is an integer from 0 to 4.
- Compound (1) has five rings from one part. These rings include fused rings and crosslinked 6-membered rings in addition to the usual 6-membered rings. When the compound (1) has one or two rings, the compatibility with other liquid crystal compounds is good and the viscosity is low. When compound (1) has three or four rings, the upper limit temperature is high. When compound (1) has four rings, the temperature range of the liquid crystal phase is wide.
- terminal group By appropriately selecting the terminal group, ring and bonding group of compound (1), it is possible to arbitrarily adjust physical properties such as optical anisotropy and dielectric anisotropy.
- the effects of the types of terminal groups R 1 and R 2 , rings A 1 and A 2 , binding groups Z 1 , Z 2 , Z 3 and Z 4 on the physical properties of compound (1) will be described below.
- Ring A 1 or ring A 2 may have at least one hydrogen substituted with fluorine or chlorine 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, or pyridazine-3. When it is 6,6-diyl, the optical anisotropy is large. When the ring is 1,4-cyclohexylene, 1,4-cyclohexenylene or 1,3-dioxane-2,5-diyl, the optical anisotropy is small.
- the upper limit temperature is high, the optical anisotropy is small, and the viscosity is small.
- the optical anisotropy is relatively large and the orientation parameter is large.
- the optical anisotropy is large, the temperature range of the liquid crystal phase is wide, and the upper limit temperature is high.
- the temperature range of the liquid crystal phase is wide, and the elastic constant ratio K 33 / K 11 (K 33 : bend elastic constant, K 11 : spray elastic constant) is large.
- the bonding group is ⁇ C ⁇ C ⁇ , the optical anisotropy is large.
- compound (1) When compound (1) has one or two rings, the viscosity is low. When compound (1) has four or five rings, the upper limit temperature is high. As described above, a compound having the required physical properties can be obtained by appropriately selecting the type of terminal group, ring, and bonding group, and the number of rings. Therefore, compound (1) is useful as a component of compositions used in devices having modes such as PC, TN, STN, ECB, OCB, IPS, and VA.
- this compound is when both L 5 and L 6 are hydrogen, and when L 1 , L 2 , L 3 or L 4 is fluorine, chlorine, -CF 3 , or -CHF 2. preferable. This compound is even more preferred when both L 5 and L 6 are hydrogen and when L 1 , L 2 , L 3 or L 4 is fluorine or chlorine. This compound is most preferred when both L 5 and L 6 are hydrogen and when L 1 , L 2 , L 3 or L 4 is fluorine.
- Preferred examples of the compound (1) are the compounds (1-1) to (1-26) described in Items 2 and 4.
- a more preferable example is the compound represented by the lower formula in Items 6 and 8.
- Compound (1) is suitable for devices having modes such as VA, IPS, and PSA.
- MSG 1 (or MSG 2 ) is a monovalent organic group having at least one ring.
- the monovalent organic groups represented by the plurality of MSG 1 (or MSG 2 ) used in the scheme may be the same or different.
- Compounds (1A) to (1J) correspond to compound (1).
- Decahydronaphthalen-2,6-dione (64) is a starting material for compounds having decahydronaphthalen-2,6-diyl.
- This compound (64) is obtained by catalytically reducing diol (63) with ruthenium oxide in the presence of ruthenium oxide and further oxidizing with chromium oxide according to the method described in JP-A-2000-239564.
- This compound is converted to compound (1) by a usual method.
- the structural unit of 2,3- (bistrifluoromethyl) phenylene is synthesized by the method described in Org. Lett., 2000, 2 (21), 3345.
- Aniline (66) is synthesized by reacting furan (65) with 1,1,1,4,4,4-hexafluoro-2-butin at a high temperature in a Diels-Alder type reaction. This compound is subjected to a Sandmeyer-type reaction according to the method described in Org. Synth. Coll., Vol. 2, 1943, 355 to obtain an iodide (67). This compound is converted to compound (1) by a usual method.
- the structural unit of 2-difluoromethyl-3-fluorophenylene is synthesized by the following method.
- the hydroxyl group of compound (68) is protected with an appropriate protecting group to obtain compound (69).
- P means protecting group.
- Compound (69) is reacted with s-butyllithium followed by N, N-dimethylformamide (DMF) to give aldehyde (70).
- This compound is fluorinated with diethylaminosulfur trifluoride (DAST) and subsequently deprotected to give phenol (71).
- DAST diethylaminosulfur trifluoride
- Compound (s-1) is synthesized according to the method described in JP-A-2011-136924. Compound (s-1) is reduced with a reducing agent such as sodium borohydride to obtain compound (s-2). This compound is halogenated with triphenylphosphine and carbon tetrahalogenate, and treated with a dehalogenating agent such as diazabicycloundecene (DBU) to obtain the target compound (1a).
- a reducing agent such as sodium borohydride
- DBU diazabicycloundecene
- compound (1b) The synthesis scheme of compound (1b) is as described above.
- Compound (s-4) is obtained by reacting compound (s-3) with aldehyde (17) in the presence of a Lewis acid such as boron trifluoride diethyl ether complex, and then hydrogenating the compound (s-3). This compound is reduced with a reducing agent such as lithium aluminum hydride to obtain compound (s-5).
- Compound (1b) is obtained by halogenating this compound with triphenylphosphine and carbon tetrahalogenate and treating it with a dehalogenating agent such as diazabicycloundecene (DBU).
- DBU diazabicycloundecene
- the liquid crystal composition of the present invention contains at least one compound (1) as a component (a).
- the composition may contain two or more compounds (1).
- the component of the composition may be only compound (1).
- the composition preferably contains at least one of the compound (1) in the range of 1% by weight to 99% by weight in order to exhibit good physical properties.
- the preferable content of the compound (1) is in the range of 5% by weight to 60% by weight.
- the preferable content of the compound (1) is 30% by weight or less.
- This composition contains compound (1) as component (a).
- the composition preferably further contains a liquid crystal compound selected from the components (b) to (e) shown in Table 1.
- a liquid crystal compound selected from the components (b) to (e) shown in Table 1.
- This composition may contain liquid crystalline compounds different from compounds (1) to (13) and (21) to (24). This composition does not have to contain such a liquid crystal compound.
- Component (b) is a compound having two terminal groups such as alkyl.
- Preferred examples of the component (b) include compounds (2-1) to (2-11), compounds (3-1) to (3-19), and compounds (4-1) to (4-7). be able to.
- R 11 and R 12 are independently alkyls with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, and in these R 11 and R 12 , at least one -CH 2- It may be replaced with —O—, and at least one hydrogen may be replaced with fluorine.
- Component (b) has a small dielectric anisotropy. Component (b) is close to neutral. Compound (2) has the effect of lowering the viscosity or adjusting the optical anisotropy. Compounds (3) and (4) have the effect of widening the temperature range of the nematic phase or adjusting the optical anisotropy by raising the upper limit temperature.
- the content of the component (b) is preferably 30% by weight or more, more preferably 40% by weight or more, based on the weight of the liquid crystal composition. be.
- the component (c) is a compound (5) to (13). These compounds have phenylene in which the lateral position is replaced by two halogens, such as 2,3-difluoro-1,4-phenylene.
- Preferred examples of the component (c) include compounds (5-1) to (5-9), compounds (6-1) to (6-19), compounds (7-1) and (7-2), compounds ( 8-1) to (8-3), compounds (9-1) to (9-3), compounds (10-1) to (10-11), compounds (11-1) to (11-3), Compounds (12-1) to (12-3), and compound (13-1) can be mentioned.
- R 13 and R 14 are independently alkyls with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, and in these R 13 and R 14 , at least one -CH 2- may be replaced by -O-, at least one hydrogen may be replaced by fluorine, R 15 is hydrogen, fluorine, alkenyl alkyl or 2 to 10 carbon atoms from 10 1 carbon atoms, In this R 15 , at least one -CH 2- may be replaced by -O-, and in this R 15 , at least one hydrogen may be replaced by fluorine.
- Component (c) has a large negative dielectric anisotropy.
- Ingredient (c) is used when preparing compositions for modes such as IPS, VA, PSA.
- the content of the component (c) is increased, the dielectric anisotropy of the composition becomes negatively large, but the viscosity becomes large. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content is preferably small.
- the dielectric anisotropy is about ⁇ 5
- the content is preferably 40% by weight or more in order to drive the voltage sufficiently.
- the compound (5) is a bicyclic compound, and therefore has the effects of lowering the viscosity, adjusting the optical anisotropy, or increasing the dielectric anisotropy.
- the compounds (6) and (7) are tricyclic compounds and the compound (8) is a tetracyclic compound, they have the effect of increasing the upper limit temperature, increasing the optical anisotropy, or increasing the dielectric anisotropy. be.
- Compounds (9) to (13) have the effect of increasing the dielectric anisotropy.
- the content of the component (c) is preferably 40% by weight or more, more preferably 50% based on the weight of the liquid crystal composition. It ranges from% to 95% by weight.
- the content of the component (c) is preferably 30% by weight or less.
- Component (d) is a compound having a halogen or fluorine-containing group at the right end.
- Preferred examples of the component (d) include compounds (21-1) to (21-16), compounds (22-1) to (22-116), and compounds (23-1) to (23-59). Can be done.
- R 16 is alkenyl having 2 to 10 carbon alkyl or C 1 to 10 carbon atoms, in the R 16, at least one -CH 2 - may be replaced by -O-, at least One hydrogen may be replaced by fluorine.
- X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 .
- Component (d) has a positive dielectric anisotropy and very good stability against heat and light, and is therefore used when preparing a composition for modes such as IPS, FFS, and OCB.
- the content of the component (d) is preferably in the range of 1% by weight to 99% by weight, preferably in the range of 10% by weight to 97% by weight, more preferably from 40% by weight, based on the weight of the liquid crystal composition. It is in the range of 95% by weight.
- the content of the component (d) is preferably 30% by weight or less.
- Component (e) is compound (24) whose right terminal group is -C ⁇ N or -C ⁇ C-C ⁇ N.
- Preferred examples of the component (e) include compounds (24-1) to (24-64).
- R 17 is alkenyl having 2 to 10 carbon alkyl or C 1 to 10 carbon atoms, in the R 17, at least one -CH 2 - may be replaced by -O-, At least one hydrogen may be replaced with fluorine.
- X 12 is -C ⁇ N or -C ⁇ C-C ⁇ N.
- the component (e) has a positive dielectric anisotropy and a large value, and is therefore used when preparing a composition for a mode such as TN. By adding this component (e), the dielectric anisotropy of the composition can be increased.
- the component (e) has the effect of widening the temperature range of the liquid crystal phase, adjusting the viscosity, or adjusting the optical anisotropy.
- the component (e) is also useful for adjusting the voltage-transmittance curve of the device.
- the content of the component (e) is preferably in the range of 1% by weight to 99% by weight, preferably 10% by weight, based on the weight of the liquid crystal composition. % To 97% by weight, more preferably 40% to 95% by weight.
- the content of the component (e) is preferably 30% by weight or less.
- Directionality ie, large optical anisotropy or small optical anisotropy
- positive or negative large dielectric anisotropy large specific resistance
- appropriate elastic constants ie, large elastic constants or small elastic constants
- a liquid crystal composition satisfying at least one of the physical characteristics can be prepared.
- Devices containing such compositions have a wide temperature range in which the device can be used, short response times, high voltage retention, low threshold voltage, high contrast ratio, low flicker rate, and long lifetime.
- the flicker rate (%) can be expressed by (
- An element having a flicker rate in the range of 0% to 1% is less likely to cause flicker on the display screen even if the element is used for a long time.
- This flicker is related to image burn-in and is presumed to be caused by the potential difference between the positive and negative frames when driven by alternating current.
- the composition containing the compound (1) is also useful for reducing the occurrence of flicker.
- the liquid crystal composition is prepared by a known method. For example, the constituent compounds are mixed and dissolved by heating. Additives may be added to this composition depending on the application. Examples of additives are polymerizable compounds, polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, ultraviolet absorbers, light stabilizers, heat stabilizers, dyes, defoamers and the like. Such additives are well known to those of skill in the art and are described in the literature.
- the composition contains a polymer.
- the polymerizable compound is added for the purpose of forming a polymer in the composition.
- a polymer is produced in the composition by irradiating ultraviolet rays with a voltage applied between the electrodes to polymerize the polymerizable compound.
- Preferred examples of the polymerizable compound are acrylate, methacrylate, vinyl compound, vinyloxy compound, propenyl ether, epoxy compound (oxylane, oxetane), and vinyl ketone. More preferred examples are compounds having at least one acryloyloxy and compounds having at least one methacryloyloxy. More preferred examples also include compounds having both acryloyloxy and methacryloyloxy.
- R 25 to R 31 are independently hydrogen or methyl;
- R 32 , R 33 , and R 34 are independently hydrogen or alkyl having 1 to 5 carbon atoms, R 32 , At least one of R 33 , and R 34 is an alkyl having 1 to 5 carbon atoms;
- v, w, and x are 0 or 1 independently;
- u and y are independently 1 to 10 It is an integer.
- L 21 to L 26 are independently hydrogen or fluorine;
- L 27 and L 28 are independently hydrogen, fluorine, or methyl.
- the polymerizable compound can be rapidly polymerized by adding a polymerization initiator. By optimizing the reaction conditions, the amount of residual polymerizable compound can be reduced.
- photoradical polymerization initiators are TPO, 1173, and 4265 from BASF's DaroCure series and 184,369,500,651,784,819,907,1300,1700,1800,1850 from the Irgacure series. , And 2959.
- photoradical polymerization initiators include 4-methoxyphenyl-2,4-bis (trichloromethyl) triazine, 2- (4-butoxystylyl) -5-trichloromethyl-1,3,4-oxadiazole, 9-Phenylaclysine, 9,10-benzphenazine, benzophenone / Michler's ketone mixture, hexaarylbiimidazole / mercaptobenzimidazole mixture, 1- (4-isopropylphenyl) -2-hydroxy-2-methylpropan-1-one, benzyl Dimethylketal, 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinopropane-1-one, 2,4-diethylxanthone / p-dimethylaminomethyl benzoate mixture, benzophenone / methyltriethanolamine mixture Is.
- polymerization After adding a photoradical polymerization initiator to the liquid crystal composition, polymerization can be carried out by irradiating ultraviolet rays with an electric field applied. However, unreacted polymerization initiators or degradation products of the polymerization initiators may cause display defects such as image burn-in on the device. In order to prevent this, photopolymerization may be carried out without adding a polymerization initiator.
- the preferred wavelength of the emitted light is in the range of 150 nm to 500 nm. More preferred wavelengths are in the range of 250 nm to 450 nm, and most preferred wavelengths are in the range of 300 nm to 400 nm.
- a polymerization inhibitor When storing the polymerizable compound, a polymerization inhibitor may be added to prevent polymerization.
- the polymerizable compound is usually added to the composition without removing the polymerization inhibitor.
- polymerization inhibitors are hydroquinone, hydroquinone derivatives such as methylhydroquinone, 4-t-butylcatechol, 4-methoxyphenol, phenothiazine and the like.
- the optically active compound has the effect of preventing reverse twisting by inducing a helical structure in the liquid crystal molecule to give a necessary twist angle.
- the spiral pitch can be adjusted by adding an optically active compound.
- Two or more optically active compounds may be added for the purpose of adjusting the temperature dependence of the spiral pitch.
- Preferred examples of the optically active compound include the following compounds (Op-1) to (Op-18).
- ring J is 1,4-cyclohexylene or 1,4-phenylene
- R 28 is an alkyl having 1 to 10 carbon atoms. * Marks represent asymmetric carbon.
- Antioxidants are effective in maintaining a large voltage retention rate.
- Preferred examples of the antioxidant include the following compounds (AO-1) and (AO-2); Irganox415, Irganox565, Irganox1010, Irganox1035, Irganox3114, and Irganox1098 (trade name: BASF).
- the ultraviolet absorber is effective for preventing a decrease in the upper limit temperature.
- UV absorber is benzophenone derivatives, benzoate derivatives, triazole derivatives and the like, and specific examples thereof include the following compounds (AO-3) and (AO-4); Tinuvin 328, and Tinuvin 99-2 (trade name; BASF); and 1,4-diazabicyclo [2.2.2] octane (DABCO) can be mentioned.
- a light stabilizer such as amine with steric hindrance is preferable in order to maintain a large voltage holding ratio.
- Preferred examples of light stabilizers are the following compounds (AO-5), (AO-6), (AO-7), (AO-8), and (AO-9); Product name; BASF); LA-52, LA-57, LA-77Y, and LA-77G (trade name: ADEKA) can be mentioned.
- a heat stabilizer is also effective for maintaining a large voltage holding ratio, and Irgafos 168 (trade name; BASF) can be mentioned as a preferable example.
- Dichroic dyes such as azo dyes, anthraquinone dyes, etc. are added to the composition to accommodate devices in GH (guest host) mode. Defoamers are effective in preventing foaming.
- Preferred examples of the defoaming agent are dimethyl silicone oil, methyl phenyl silicone oil and the like.
- R 40 is an alkyl having 1 to 20 carbon atoms, an alkoxy having 1 to 20 carbon atoms, -COOR 41 , or-(CH 2 ) 2- COOR 41 , where R 41 is carbon. Alkoxy of numbers 1 to 20.
- R 42 is an alkyl having 1 to 20 carbon atoms.
- R 43 is hydrogen, methyl or O ⁇ (oxygen radical);
- ring G 1 is 1,4-cyclohexylene or 1,4-phenylene;
- ring G 2 is 1,4-cyclohexylene, 1,4-phenylene, or 1,4-phenylene in which at least one hydrogen has been replaced with fluorine; compound (AO-5),.
- z is 1, 2, or 3.
- the liquid crystal composition has an operation mode such as PC, TN, STN, OCB, PSA, and can be used for a liquid crystal display element driven by an active matrix method.
- This composition has an operation mode such as PC, TN, STN, OCB, VA, and IPS, and can also be used for a liquid crystal display element driven by a passive matrix method.
- These elements can be applied to any type of reflective type, transmissive type, and semitransparent type.
- This composition is also suitable for NCAP (nematic curvilinear aligned phase) devices, where the composition is microencapsulated.
- This composition can also be used in a polymer-dispersed liquid crystal display element (PDLCD) and a polymer network liquid crystal display element (PNLCD).
- PDLCD polymer-dispersed liquid crystal display element
- PLCD polymer network liquid crystal display element
- a large amount of the polymerizable compound is added.
- a liquid crystal display element in PSA mode is produced.
- the preferred proportion is in the range of 0.1% by weight to 2% by weight.
- a more preferable ratio is in the range of 0.2% by weight to 1.0% by weight.
- the PSA mode element can be driven by a drive system such as an active matrix system or a passive matrix system. Such an element can be applied to any type of reflective type, transmissive type, and semitransparent type.
- NMR analysis DRX-500 manufactured by Bruker Biospin Co., Ltd. was used for the measurement. 1 In the 1 H-NMR measurement, the sample was dissolved in a deuterated solvent such as CDCl 3 and measured at room temperature, 500 MHz, and the number of integrations was 16 times. Tetramethylsilane was used as an internal standard. 19 In the F-NMR measurement, CFCl 3 was used as an internal standard, and the number of integrations was 24. In the description of the nuclear magnetic resonance spectrum, s means singlet, d means doublet, t means triplet, q means quartet, quin means quintet, sext means sextet, m means multiplet, and br means broad.
- a GC-2010 type gas chromatograph manufactured by Shimadzu Corporation was used for the measurement.
- a capillary column DB-1 (length 60 m, inner diameter 0.25 mm, film thickness 0.25 ⁇ m) manufactured by Agilent Technologies Inc. was used.
- Helium (1 mL / min) was used as the carrier gas.
- the temperature of the sample vaporization chamber was set to 300 ° C., and the temperature of the detector (FID) was set to 300 ° C.
- the sample was dissolved in acetone to prepare a 1% by weight solution, and 1 ⁇ L of the obtained solution was injected into the sample vaporization chamber.
- a GC Solution system manufactured by Shimadzu Corporation was used as the recorder.
- Gas chromatograph mass spectrometry A QP-2010 Ultra type gas chromatograph mass spectrometer manufactured by Shimadzu Corporation was used for the measurement.
- a capillary column DB-1 (length 60 m, inner diameter 0.25 mm, film thickness 0.25 ⁇ m) manufactured by Agilent Technologies Inc. was used.
- Helium (1 mL / min) was used as the carrier gas.
- the temperature of the sample vaporization chamber was set to 300 ° C.
- the temperature of the ion source was set to 200 ° C.
- the ionization voltage was set to 70 eV
- the emission current was set to 150 uA.
- the sample was dissolved in acetone to prepare a 1% by weight solution, and 1 ⁇ L of the obtained solution was injected into the sample vaporization chamber.
- a GCMS solution system manufactured by Shimadzu Corporation was used as the recorder.
- HPLC analysis Prominence (LC-20AD; SPD-20A) manufactured by Shimadzu Corporation was used for the measurement.
- YMC-Pack ODS-A length 150 mm, inner diameter 4.6 mm, particle diameter 5 ⁇ m
- the eluate used was an appropriate mixture of acetonitrile and water.
- the detector a UV detector, an RI detector, a CORONA detector and the like were appropriately used. When a UV detector was used, the detection wavelength was 254 nm.
- the sample was prepared to dissolve in acetonitrile to form a 0.1% by weight solution, and 1 ⁇ L of this solution was introduced into the sample chamber.
- C-R7Aplus manufactured by Shimadzu Corporation was used.
- Ultraviolet-visible spectroscopic analysis For the measurement, PharmaSpec UV-1700 manufactured by Shimadzu Corporation was used. The detection wavelength was 190 nm to 700 nm. The sample was prepared by dissolving it in acetonitrile to form a solution of 0.01 mmol / L, and placed in a quartz cell (optical path length 1 cm) for measurement.
- Measurement sample When measuring the phase structure and transition temperature (transparency point, melting point, polymerization start temperature, etc.), the compound itself was used as a sample. When measuring physical properties such as the upper limit temperature, viscosity, optical anisotropy, and dielectric anisotropy of the nematic phase, a mixture of the compound and the mother liquid crystal was used as a sample.
- the ratio of the compound to the mother liquid crystal is 10% by weight: 90% by weight, 5% by weight: 95% by weight, 1% by weight: 99% by weight.
- the physical properties of the sample were measured at the rate at which the crystals (or smectic phase) did not precipitate at 25 ° C.
- the ratio of the compound to the mother liquid crystal display is 15% by weight: 85% by weight.
- the dielectric anisotropy of the compound was zero or positive
- the following mother liquid crystal display (A) was used.
- the ratio of each component was expressed in% by weight.
- the dielectric anisotropy of the compound was zero or negative
- the following mother liquid crystal display (B) was used.
- the ratio of each component was expressed in% by weight.
- Mother liquid crystal (C) A mother liquid crystal (C) containing the following fluorine-based compounds as components was also used. The ratio of the components of the mother liquid crystal display (C) was expressed in% by weight.
- the ratio of the compound and the mother liquid crystal display (C) was 20% by weight: 80% by weight.
- the ratio of the compound to the mother liquid crystal (C) is 15% by weight: 85% by weight, 10% by weight: 90% by weight, 5% by weight.
- the changes were made in the order of: 95% by weight, 1% by weight: 99% by weight, and the physical characteristics of the sample were measured at a rate at which crystals (or smectic phase) did not precipitate at 25 ° C.
- the ratio of the compound to the mother liquid crystal display (C) is 20% by weight: 80% by weight.
- Measurement method The physical properties were measured by the following method. Many of these are described in the JEITA standard (JEITA ED-2521B), which is deliberated and enacted by the Japan Electronics and Information Technology Industries Association (JEITA). A modified method was also used. A thin film transistor (TFT) was not attached to the TN element used for the measurement.
- Phase structure A sample was placed on a hot plate (FP-52 type hot stage manufactured by METTLER CORPORATION) of a melting point measuring device equipped with a polarizing microscope. The phase state and its change were observed with a polarizing microscope while heating this sample at a rate of 3 ° C./min to identify the type of phase.
- FP-52 type hot stage manufactured by METTLER CORPORATION
- Transition temperature (° C.): A scanning calorimeter manufactured by PerkinElmer, a Diamond DSC system, or a high-sensitivity differential scanning calorimeter manufactured by SII Nanotechnology, X-DSC7000 was used for the measurement. The temperature of the sample was raised and lowered at a rate of 3 ° C./min, and the start point of the endothermic peak or the exothermic peak accompanying the phase change of the sample was determined by extrapolation to determine the transition temperature. The melting point of the compound and the polymerization initiation temperature were also measured using this device.
- the temperature at which a compound transitions from a solid to a liquid crystal phase such as a smectic phase or a nematic phase may be abbreviated as "lower limit temperature of the liquid crystal phase”.
- the temperature at which a compound transitions from the liquid crystal phase to a liquid may be abbreviated as "transparency point”.
- the crystal was represented as C.
- the smectic phase was represented as S and the nematic phase was represented as N.
- the liquid (isotropic) was represented as I.
- the transition temperature is expressed as, for example, "C 50.0 N 100.0 I". This indicates that the transition temperature from the crystal to the nematic phase is 50.0 ° C. and the transition temperature from the nematic phase to the liquid is 100.0 ° C.
- Upper limit temperature of nematic phase ( TNI or NI; ° C.): A sample was placed on a hot plate of a melting point measuring device equipped with a polarizing microscope and heated at a rate of 1 ° C./min. The temperature at which a part of the sample changed from the nematic phase to the isotropic liquid was measured. When the sample was a mixture of compound (1) and the mother liquid crystal display, it was indicated by the TNI symbol. When the sample was a mixture of compound (1) and a compound selected from compounds (2) to (15), it was indicated by the symbol NI.
- the upper limit temperature of the nematic phase may be abbreviated as "upper limit temperature".
- T C Minimum Temperature of a Nematic Phase
- Viscosity (bulk viscosity; ⁇ ; measured at 20 ° C.; mPa ⁇ s): An E-type rotational viscometer manufactured by Tokyo Keiki Co., Ltd. was used for the measurement.
- VHR-1 Voltage retention rate (VHR-1; measured at 25 ° C.;%):
- the TN element used for the measurement had a polyimide alignment film, and the distance (cell gap) between the two glass substrates was 5 ⁇ m. .. This device was sealed with an adhesive that cures with ultraviolet light after the sample was placed. A pulse voltage (60 microseconds at 5 V) was applied to this device to charge it. The decaying voltage was measured with a high-speed voltmeter for 16.7 milliseconds, and the area A between the voltage curve and the horizontal axis in a unit period was determined. Area B was the area when there was no attenuation. The voltage holding ratio is expressed as a percentage of the area A with respect to the area B.
- VHR-2 Voltage retention rate (10) Voltage retention rate (VHR-2; measured at 80 ° C.;%): The voltage retention rate was measured by the above method except that the measurement was performed at 80 ° C. instead of 25 ° C. The results obtained are indicated by the symbol VHR-2.
- Flicker rate (measured at 25 ° C.;%): A multimedia display tester 3298F manufactured by Yokogawa Electric Corporation was used for the measurement.
- the light source was an LED.
- the sample was placed in an FFS element in a normally black mode in which the distance (cell gap) between the two glass substrates was 3.5 ⁇ m and the rubbing direction was antiparallel. This element was sealed with an UV curable adhesive.
- a voltage was applied to this device, and the voltage at which the amount of light transmitted through the device was maximized was measured. While applying this voltage to the element, the sensor unit was brought close to the element and the displayed flicker rate was read.
- the method of measuring physical properties may differ between a sample with a positive dielectric anisotropy and a sample with a negative dielectric anisotropy.
- the measuring method when the dielectric anisotropy is positive is described in measurement (12a) to measurement (16a).
- the dielectric anisotropy was negative, it was described in measurement (12b) to measurement (16b).
- Viscosity Rotational viscosity; ⁇ 1; measured at 25 ° C; mPa ⁇ s; sample with positive dielectric anisotropy: Measurement was performed by M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, The method described in 37 (1995) was followed. The sample was placed in a TN device having a twist angle of 0 degrees and a distance (cell gap) between the two glass substrates of 5 ⁇ m. A stepwise application of 16 V to 19.5 V was applied to this device in 0.5 V increments. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (rectangular pulse; 0.2 seconds) and no application (2 seconds).
- Viscosity Rotational viscosity; ⁇ 1; measured at 25 ° C; mPa ⁇ s; sample with negative dielectric anisotropy: Measurement was performed by M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, The method described in 37 (1995) was followed. The sample was placed in a VA element having a distance (cell gap) between two glass substrates of 20 ⁇ m. A stepwise application of 39 V to 50 V was applied to this device in 1 V increments. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (rectangular pulse; 0.2 seconds) and no application (2 seconds). The peak current and peak time of the transient current generated by this application were measured.
- a sample was placed in a VA element in which the distance (cell gap) between the two glass substrates was 4 ⁇ m, and this element was sealed with an adhesive that cures with ultraviolet rays.
- a sine wave (0.5 V, 1 kHz) was applied to this element, and after 2 seconds, the dielectric constant ( ⁇ ) of the liquid crystal molecule in the long axis direction was measured.
- the sample was placed in a TN element in which the distance (cell gap) between the two glass substrates was 9 ⁇ m and the twist angle was 80 degrees.
- a sine wave (0.5 V, 1 kHz) was applied to this element, and after 2 seconds, the permittivity ( ⁇ ) of the liquid crystal molecule in the minor axis direction was measured.
- Threshold voltage (Vth; measured at 25 ° C.; V; sample with positive dielectric anisotropy): An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement.
- the light source was a halogen lamp.
- the sample was placed in a normally white mode TN element in which the distance (cell gap) between the two glass substrates was 0.45 / ⁇ n ( ⁇ m) and the twist angle was 80 degrees.
- the voltage (32 Hz, square wave) applied to this device was gradually increased by 0.02 V from 0 V to 10 V.
- the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured.
- a voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum.
- the threshold voltage is expressed as the voltage when the transmittance reaches 90%.
- Threshold voltage (Vth; measured at 25 ° C.; V; sample with negative dielectric anisotropy): An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement.
- the light source was a halogen lamp.
- a sample is placed in a VA element in normally black mode where the distance (cell gap) between the two glass substrates is 4 ⁇ m and the rubbing direction is anti-parallel, and an adhesive that cures this element with ultraviolet rays is applied. Sealed using.
- the voltage (60 Hz, square wave) applied to this device was gradually increased by 0.02 V from 0 V to 20 V.
- the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured.
- a voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum.
- the threshold voltage is expressed as the voltage when the transmittance reaches 10%.
- the rise time ( ⁇ r: rise time; millisecond) is the time required for the transmittance to change from 90% to 10%.
- the fall time ( ⁇ f: fall time; millisecond) is the time required for the transmittance to change from 10% to 90%.
- the response time was expressed as the sum of the rise time and the fall time obtained in this way.
- a square wave (60 Hz, 10 V, 0.5 seconds) was applied to this device.
- the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. It was considered that the transmittance was 100% when the amount of light was maximum, and the transmittance was 0% when the amount of light was minimum.
- the response time was expressed as the time required for the transmittance to change from 90% to 10% (fall time; fall time; millisecond).
- Second step Synthesis of compound (t-9)
- Commercially available compound (t-7) (12.5 g, 65.5 mmol), 1-bromobutane (9.86 g, 72.0 mmol), potassium carbonate (11.8 g, 85.1 mmol) was dissolved in N, N-dimethylformamide (125 mL) and stirred at 80 ° C. for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with a 2N-NaOH aqueous solution and water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by short silica gel chromatography (heptane) to give compound (t-9) (14.2 g, 57.5 mmol) as a light brown liquid.
- Phase transition temperature C 142.5 I.
- the physical property value could not be measured because 3% was not dissolved.
- Second step Synthesis of compound (t-16) Compound (t-15) (18.0 g, 72.8 mmol), benzylamine (9.37 g, 87.4 mmol), t-butoxysodium (10.5 g, 109 mmol) ) Is dissolved in toluene (252 mL), degassed under reduced pressure, and palladium (0) bis (dibenzylideneacetone) (0.838 g), 2- (di-t-butylphosphino) biphenyl (0.870 g, 2. 91 mmol) was added, and the mixture was heated and stirred at 60 ° C.
- the dielectric anisotropy of compound (a-5) and comparative compound (Ref-1) was compared as follows.
- the comparative compound (Ref-1) is compound (1-2-5) described in paragraph [0143] of WO 2015/129412.
- the synthesis was carried out according to the method of paragraphs [0143] to [0154] of International Publication No. 2015/129412.
- the dielectric anisotropy ( ⁇ ) of the compound (a-5) obtained by the synthesis of the compound (3) and the comparative compound (Ref-1) was compared. It was found that the dielectric anisotropy of compound (a-5) was much larger in the negative. Therefore, it can be concluded that compound (1) is superior to similar compounds.
- the present invention will be described in more detail by way of examples.
- the present invention is not limited by the examples, as the examples are typical.
- the present invention includes, in addition to the composition of Examples, a mixture of the composition of Example 1 and the composition of Example 2.
- the present invention also includes a mixture prepared by mixing at least two of the compositions of Examples.
- the compounds in the use cases are represented by symbols based on the definitions in Table 2 below.
- Table 2 the configuration for 1,4-cyclohexylene is trans.
- the number in parentheses after the symbol represents the chemical formula to which the compound belongs.
- the symbol (-) means a liquid crystal compound different from the compounds (1) to (15).
- the proportion (percentage) of the liquid crystal compound is a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additives.
- liquid crystal compound of the present invention has good physical characteristics. Liquid crystal compositions containing this compound can be widely used in liquid crystal display elements such as personal computers and televisions.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Nonlinear Science (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
Abstract
This compound is represented by formula (1). R1 and R2 are each C1-C15 alkyl or the like; Ra is hydrogen or the like; a ring A1 and a ring A2 are each 1,4-cyclohexylene, 1,4-phenylene, or the like; a ring N1 and a ring N2 are each 1,2-cyclopropylene, 1,3-cyclopentylene, or the like; Z1, Z2, Z3, and Z4 are each a single bond or the like; L1, L2, L3, L4, L5, and L6 are each fluorine or the like; and l and o are each 0 or 1 and m and n are each 0, 1, or 2.
Description
本発明は、カルバゾール環を有する液晶性化合物、液晶組成物、および液晶表示素子に関する。さらに詳しくは、カルバゾール環を有し、誘電率異方性が負の液晶性化合物、これを含有する液晶組成物、およびこの組成物を含む液晶表示素子に関する。
The present invention relates to a liquid crystal compound having a carbazole ring, a liquid crystal composition, and a liquid crystal display element. More specifically, the present invention relates to a liquid crystal compound having a carbazole ring and having a negative dielectric anisotropy, a liquid crystal composition containing the same, and a liquid crystal display element containing the composition.
液晶表示素子において、液晶分子の動作モードに基づいた分類は、PC(phase change)、TN(twisted nematic)、STN(super twisted nematic)、ECB(electrically controlled birefringence)、OCB(optically compensated bend)、IPS(in-plane switching)、VA(vertical alignment)、FFS(fringe field switching)、FPA(field-induced photo-reactive alignment)などのモードである。素子の駆動方式に基づいた分類は、PM(passive matrix)とAM(active matrix)である。PMは、スタティック(static)、マルチプレックス(multiplex)などに分類され、AMは、TFT(thin film transistor)、MIM(metal insulator metal)などに分類される。
In the liquid crystal display element, the classification based on the operation mode of the liquid crystal molecule is PC (phase change), TN (twisted nematic), STN (super twisted nematic), ECB (electrically controlled birefringence), OCB (optically compensated bend), IPS. (In-plane switching), VA (vertical alignment), FFS (fringe field switching), FPA (field-induced photo-reactive alignment) and other modes. The classifications based on the drive method of the element are PM (passive matrix) and AM (active matrix). PM is classified into static, multiplex, etc., and AM is classified into TFT (thin film transistor), MIM (metal insulator metal), and the like.
この素子には液晶組成物が封入される。この組成物の物性は、素子の特性に関連する。組成物における物性の例は、熱や光に対する安定性、ネマチック相の温度範囲、粘度、光学異方性、誘電率異方性、比抵抗、弾性定数などである。組成物は多くの液晶性化合物を混合して調製される。化合物に必要な物性は、水、空気、熱、光などの環境に対する高い安定性、液晶相の広い温度範囲、小さな粘度、適切な光学異方性、大きな誘電率異方性、適切な弾性定数、他の液晶性化合物との良好な相溶性などである。ネマチック相の高い上限温度を有する化合物は好ましい。ネマチック相、スメクチック相などの液晶相において低い下限温度を有する化合物は好ましい。小さな粘度を有する化合物は素子の短い応答時間に寄与する。光学異方性の適切な値は素子の動作モードの種類に依存する。低い電圧で素子を駆動するには正または負に大きな誘電率異方性を有する化合物が好ましい。組成物を調製するには他の液晶性化合物との良好な相溶性を有する化合物が好ましい。素子を氷点下の温度で使うこともあるので、低い温度で良好な相溶性を有する化合物が好ましい。
A liquid crystal composition is enclosed in this element. The physical characteristics of this composition are related to the properties of the device. Examples of physical properties in the composition are stability to heat and light, temperature range of nematic phase, viscosity, optical anisotropy, dielectric anisotropy, specific resistance, elastic constant and the like. The composition is prepared by mixing many liquid crystal compounds. The physical characteristics required for the compound are high stability to the environment such as water, air, heat and light, wide temperature range of liquid crystal phase, small viscosity, appropriate optical anisotropy, large dielectric anisotropy, appropriate elastic constant. , Good compatibility with other liquid crystal compounds, etc. Compounds with a high upper temperature limit of the nematic phase are preferred. Compounds having a low lower limit temperature in the liquid crystal phase such as the nematic phase and the smectic phase are preferable. Compounds with low viscosities contribute to the short response time of the device. The appropriate value of optical anisotropy depends on the type of operating mode of the device. In order to drive the device at a low voltage, a compound having a large positive or negative dielectric anisotropy is preferable. In order to prepare the composition, a compound having good compatibility with other liquid crystal compounds is preferable. Since the device may be used at a temperature below freezing, a compound having good compatibility at a low temperature is preferable.
これまでに、数多くの液晶性化合物が合成されてきた。新しい液晶性化合物の開発は今でも続けられている。新規な化合物には、従来の化合物にはない良好な物性が期待されるからである。新規な化合物が組成物における少なくとも2つの物性に適切なバランスを付与することもあるからである。下記の二価基を有する化合物についての報告例は少ない。なお、下記の二価基において、Xは、水素、または置換基である。
So far, many liquid crystal compounds have been synthesized. Development of new liquid crystal compounds is still ongoing. This is because new compounds are expected to have good physical properties that conventional compounds do not have. This is because the novel compound may impart an appropriate balance to at least two physical characteristics in the composition. There are few reports on compounds having the following divalent groups. In the following divalent groups, X is hydrogen or a substituent.
例えば、特許文献1には、番号が53、54、および56である化合物が41頁の表4に開示され、番号が125、および127である化合物が45頁の表8に開示されている。
For example, Patent Document 1 discloses compounds having numbers 53, 54, and 56 in Table 4 on page 41, and compounds having numbers 125 and 127 in Table 8 on page 45.
特許文献2には、10頁に実施例3のII-a化合物が開示され、14頁に実施例7のIII-a化合物が開示されている。
Patent Document 2 discloses the II-a compound of Example 3 on page 10, and the III-a compound of Example 7 on page 14.
第一の課題は、熱や光に対する高い安定性、高い透明点(またはネマチック相の高い上限温度)、液晶相の低い下限温度、小さな粘度、適切な光学異方性、負に大きな誘電率異方性、適切な弾性定数、他の液晶性化合物との良好な相溶性などの物性の少なくとも1つを充足する液晶性化合物を提供することである。類似の化合物と比較して、負に大きな誘電率異方性を有する化合物を提供することである。第二の課題は、この化合物を含有し、熱や光に対する高い安定性、ネマチック相の高い上限温度、ネマチック相の低い下限温度、小さな粘度、適切な光学異方性、負に大きな誘電率異方性、大きな比抵抗、適切な弾性定数などの物性の少なくとも1つを充足する液晶組成物を提供することである。この課題は、少なくとも2つの物性に関して適切なバランスを有する液晶組成物を提供することである。第三の課題は、この組成物を含み、素子を使用できる広い温度範囲、短い応答時間、大きな電圧保持率、低いしきい値電圧、大きなコントラスト比、小さなフリッカ率、および長い寿命を有する液晶表示素子を提供することである。
The first challenge is high stability to heat and light, high transparency (or high upper limit temperature of nematic phase), lower lower limit temperature of liquid crystal phase, small viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal compound that satisfies at least one of physical characteristics such as anisotropy, an appropriate elastic constant, and good compatibility with other liquid crystal compounds. It is to provide a compound having a negatively large dielectric anisotropy as compared with a similar compound. The second challenge is that it contains this compound and has high stability to heat and light, high upper limit temperature of nematic phase, lower lower limit temperature of nematic phase, small viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal composition that satisfies at least one of physical characteristics such as anisotropy, a large specific resistance, and an appropriate elastic constant. The challenge is to provide a liquid crystal composition having an appropriate balance with respect to at least two physical characteristics. A third challenge is a liquid crystal display that contains this composition and has a wide temperature range in which the device can be used, a short response time, a large voltage retention rate, a low threshold voltage, a large contrast ratio, a small flicker rate, and a long life. It is to provide an element.
本発明は、式(1)で表される化合物、この化合物を含む液晶組成物、およびこの液晶組成物を含む液晶表示素子に関する。
The present invention relates to a compound represented by the formula (1), a liquid crystal composition containing this compound, and a liquid crystal display element containing this liquid crystal composition.
式(1)において、
R1は、水素、または炭素数1から15のアルキルであり、このR1において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
R2は、水素、フッ素、塩素、-C≡N、-C≡C-C≡N、または炭素数1から15のアルキルであり、このR2において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L1、L2、L3、L4、L5、およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L5およびL6が共に水素であるとき、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L1、L2、L3、およびL4が共に水素であるとき、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
lおよびoは独立して、0、または1であり、mおよびnは独立して、0、1、または2であり、l、m、n、およびoの和は、0から4の整数であり;
lが0であるとき、R1が水素となることはなく、oが0であるとき、R2が水素となることはない。 In equation (1)
R 1 is alkyl hydrogen, or from 1 to 15 carbon atoms, in the R 1, at least one of -CH 2 -, -O -, - may be replaced by S-, or -CO-, At least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, and at least one hydrogen may be replaced by fluorine or chlorine;
R 2 is hydrogen, fluorine, chlorine, -C≡N, alkyl of -C≡C-C≡N or 1 to 15 carbon atoms, in the R 2, at least one of -CH 2 -, - It may be replaced by O-, -S-, or -CO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 One hydrogen may be replaced with fluorine or chlorine;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
When both L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
When L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
l and o are independently 0, or 1, m and n are independently 0, 1, or 2, and the sum of l, m, n, and o is an integer from 0 to 4. can be;
When l is 0, R 1 does not become hydrogen, and when o is 0, R 2 does not become hydrogen.
R1は、水素、または炭素数1から15のアルキルであり、このR1において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
R2は、水素、フッ素、塩素、-C≡N、-C≡C-C≡N、または炭素数1から15のアルキルであり、このR2において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L1、L2、L3、L4、L5、およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L5およびL6が共に水素であるとき、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L1、L2、L3、およびL4が共に水素であるとき、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
lおよびoは独立して、0、または1であり、mおよびnは独立して、0、1、または2であり、l、m、n、およびoの和は、0から4の整数であり;
lが0であるとき、R1が水素となることはなく、oが0であるとき、R2が水素となることはない。 In equation (1)
R 1 is alkyl hydrogen, or from 1 to 15 carbon atoms, in the R 1, at least one of -CH 2 -, -O -, - may be replaced by S-, or -CO-, At least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, and at least one hydrogen may be replaced by fluorine or chlorine;
R 2 is hydrogen, fluorine, chlorine, -C≡N, alkyl of -C≡C-C≡N or 1 to 15 carbon atoms, in the R 2, at least one of -CH 2 -, - It may be replaced by O-, -S-, or -CO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 One hydrogen may be replaced with fluorine or chlorine;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
When both L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
When L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
l and o are independently 0, or 1, m and n are independently 0, 1, or 2, and the sum of l, m, n, and o is an integer from 0 to 4. can be;
When l is 0, R 1 does not become hydrogen, and when o is 0, R 2 does not become hydrogen.
第一の長所は、熱や光に対する高い安定性、高い透明点(またはネマチック相の高い上限温度)、液晶相の低い下限温度、小さな粘度、適切な光学異方性、負に大きな誘電率異方性、適切な弾性定数、他の液晶性化合物との良好な相溶性などの物性の少なくとも1つを充足する液晶性化合物を提供することである。類似の化合物と比較して、負に大きな誘電率異方性を有する化合物を提供することである。第二の長所は、この化合物を含有し、熱や光に対する高い安定性、ネマチック相の高い上限温度、ネマチック相の低い下限温度、小さな粘度、適切な光学異方性、負に大きな誘電率異方性、大きな比抵抗、適切な弾性定数などの物性の少なくとも1つを充足する液晶組成物を提供することである。この長所は、少なくとも2つの物性に関して適切なバランスを有する液晶組成物を提供することである。第三の長所は、この組成物を含み、素子を使用できる広い温度範囲、短い応答時間、大きな電圧保持率、低いしきい値電圧、大きなコントラスト比、小さなフリッカ率、および長い寿命を有する液晶表示素子を提供することである。
The first advantages are high stability to heat and light, high transparency (or high upper limit temperature of nematic phase), lower lower limit temperature of liquid crystal phase, low viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal compound that satisfies at least one of physical characteristics such as anisotropy, an appropriate elastic constant, and good compatibility with other liquid crystal compounds. It is to provide a compound having a negatively large dielectric anisotropy as compared with a similar compound. The second advantage is that it contains this compound and has high stability to heat and light, high upper limit temperature of nematic phase, lower lower limit temperature of nematic phase, small viscosity, proper optical anisotropy, negatively large dielectric constant difference. It is an object of the present invention to provide a liquid crystal composition that satisfies at least one of physical characteristics such as anisotropy, a large specific resistance, and an appropriate elastic constant. This advantage is to provide a liquid crystal composition having an appropriate balance with respect to at least two physical characteristics. The third advantage is that the liquid crystal display contains this composition and has a wide temperature range in which the device can be used, a short response time, a large voltage retention rate, a low threshold voltage, a large contrast ratio, a small flicker rate, and a long life. It is to provide an element.
この明細書における用語の使い方は、次のとおりである。「液晶性化合物」、「液晶組成物」、および「液晶表示素子」の用語をそれぞれ「化合物」、「組成物」、および「素子」と略すことがある。「液晶性化合物」は、ネマチック相、スメクチック相などの液晶相を有する化合物、および液晶相を有しないが、上限温度、下限温度、粘度、誘電率異方性のような組成物の物性を調節する目的で添加する化合物の総称である。この化合物は、1,4-シクロヘキシレンや1,4-フェニレンのような六員環を有し、その分子構造は棒状(rod like)である。「液晶表示素子」は液晶表示パネルおよび液晶表示モジュールの総称である。「重合性化合物」は、組成物中に重合体を生成させる目的で添加する化合物である。アルケニルを有する液晶性化合物は、その意味では重合性ではない。
The usage of terms in this specification is as follows. The terms "liquid crystal compound", "liquid crystal composition", and "liquid crystal display element" may be abbreviated as "compound", "composition", and "element", respectively. The "liquid crystal compound" is a compound having a liquid crystal phase such as a nematic phase or a smectic phase, and a compound having no liquid crystal phase but adjusting the physical properties of a composition such as an upper limit temperature, a lower limit temperature, a viscosity, and a dielectric constant anisotropy. It is a general term for compounds added for the purpose of This compound has a six-membered ring such as 1,4-cyclohexylene and 1,4-phenylene, and its molecular structure is rod-like. "Liquid crystal display element" is a general term for a liquid crystal display panel and a liquid crystal display module. The "polymerizable compound" is a compound added for the purpose of forming a polymer in the composition. Liquid crystal compounds with alkenyl are not polymerizable in that sense.
液晶組成物は、複数の液晶性化合物を混合することによって調製される。この組成物に、物性をさらに調整する目的で添加物が添加される。重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、色素、および消泡剤のような添加物が必要に応じて添加される。液晶性化合物や添加物は、このような手順で混合される。液晶性化合物の割合(含有量)は、添加物を添加した場合であっても、添加物を含まない液晶組成物の重量に基づいた重量百分率(重量%)で表される。添加物の割合(添加量)は、添加物を含まない液晶組成物の重量に基づいた重量百分率(重量%)で表される。すなわち、液晶性化合物や添加物の割合は、液晶性化合物の全重量に基づいて算出される。重量百万分率(ppm)が用いられることもある。重合開始剤および重合禁止剤の割合は、例外的に重合性化合物の重量に基づいて表される。
The liquid crystal composition is prepared by mixing a plurality of liquid crystal compounds. Additives are added to this composition for the purpose of further adjusting the physical characteristics. Additives such as polymerizable compounds, polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, UV absorbers, light stabilizers, heat stabilizers, dyes, and defoamers are added as needed. NS. The liquid crystal compounds and additives are mixed in such a procedure. The ratio (content) of the liquid crystal compound is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additive even when the additive is added. The ratio (addition amount) of the additive is expressed as a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additive. That is, the ratio of the liquid crystal compound or the additive is calculated based on the total weight of the liquid crystal compound. Parts per million by weight (ppm) may also be used. The proportions of polymerization initiators and polymerization inhibitors are exceptionally expressed based on the weight of the polymerizable compound.
「透明点」は、液晶性化合物における液晶相-等方相の転移温度である。「液晶相の下限温度」は、液晶性化合物における固体-液晶相(スメクチック相、ネマチック相など)の転移温度である。「ネマチック相の上限温度」は、液晶性化合物と母液晶との混合物または液晶組成物におけるネマチック相-等方相の転移温度であり、「上限温度」と略すことがある。「ネマチック相の下限温度」を「下限温度」と略すことがある。「誘電率異方性を上げる」の表現は、誘電率異方性が正である組成物のときは、その値が正に増加することを意味し、誘電率異方性が負である組成物のときは、その値が負に増加することを意味する。「電圧保持率が大きい」は、素子が初期段階において室温だけでなく上限温度に近い温度でも大きな電圧保持率を有し、そして長時間使用したあと室温だけでなく上限温度に近い温度でも大きな電圧保持率を有することを意味する。組成物や素子では、経時変化試験(加速劣化試験を含む)の前後で特性が検討されることがある。
The "transparency point" is the transition temperature between the liquid crystal phase and the isotropic phase in the liquid crystal compound. The "lower limit temperature of the liquid crystal phase" is the transition temperature of the solid-liquid crystal phase (smetic phase, nematic phase, etc.) in the liquid crystal compound. The "upper limit temperature of the nematic phase" is the transition temperature of the nematic phase-isotropic phase in the mixture of the liquid crystal compound and the mother liquid crystal or the liquid crystal composition, and may be abbreviated as the "upper limit temperature". The "lower limit temperature of the nematic phase" may be abbreviated as the "lower limit temperature". The expression "increase the dielectric anisotropy" means that when the composition has a positive dielectric anisotropy, its value increases positively, and the composition has a negative dielectric anisotropy. When it is a thing, it means that its value increases negatively. "Large voltage retention" means that the element has a large voltage retention not only at room temperature but also at a temperature close to the upper limit temperature at the initial stage, and after long-term use, it has a large voltage not only at room temperature but also at a temperature close to the upper limit temperature. It means having a retention rate. The characteristics of the composition or device may be examined before and after the aging test (including the accelerated deterioration test).
式(1)で表される化合物を化合物(1)と略すことがある。式(1)で表される化合物の群から選択された少なくとも1つの化合物を化合物(1)と略すことがある。「化合物(1)」は、式(1)で表される1つの化合物、2つの化合物の混合物、または3つ以上の化合物の混合物を意味する。これらのルールは、他の式で表される化合物についても適用される。式(1)から(15)において、六角形で囲んだA1、B1、C1などの記号はそれぞれ環A1、環B1、環C1などの環に対応する。六角形は、シクロヘキサンやベンゼンのような六員環を表す。六角形がナフタレンのような縮合環や、アダマンタンのような架橋環を表すことがある。
The compound represented by the formula (1) may be abbreviated as the compound (1). At least one compound selected from the group of compounds represented by the formula (1) may be abbreviated as the compound (1). "Compound (1)" means one compound represented by the formula (1), a mixture of two compounds, or a mixture of three or more compounds. These rules also apply to compounds represented by other formulas. In equations (1) to (15), symbols such as A 1 , B 1 , and C 1 enclosed in hexagons correspond to rings such as ring A 1 , ring B 1 , and ring C 1, respectively. The hexagon represents a six-membered ring such as cyclohexane or benzene. The hexagon may represent a fused ring such as naphthalene or a crosslinked ring such as adamantane.
成分化合物の化学式において、末端基R11の記号を複数の化合物に用いた。これらの化合物において、任意の2つのR11が表す2つの基は同一であってもよく、または異なってもよい。例えば、化合物(2)のR11がエチルであり、化合物(3)のR11がエチルであるケースがある。化合物(2)のR11がエチルであり、化合物(3)のR11がプロピルであるケースもある。このルールは、R12、R13、Z11などの記号にも適用される。化合物(15)において、iが2のとき、2つの環E1が存在する。この化合物において2つの環E1が表す2つの基は、同一であってもよく、または異なってもよい。iが2より大きいとき、任意の2つの環E1にも適用される。このルールは、他の記号にも適用される。
In the chemical formulas of the component compounds, with symbols of terminal groups R 11 to a plurality of compounds. In these compounds, two groups represented by any two R 11 may be may be the same or different. For example, there are cases where R 11 of compound (2) is ethyl and R 11 of compound (3) is ethyl. In some cases, R 11 of compound (2) is ethyl and R 11 of compound (3) is propyl. This rule also applies to symbols such as R 12 , R 13 , and Z 11. In the compound (15), when i is 2, two rings E 1 is present. The two two wherein the ring E 1 represents the compound may be the same or different. When i is greater than 2, also apply to any two rings E 1. This rule also applies to other symbols.
「少なくとも1つの‘A’」の表現は、‘A’の数が任意であることを意味する。「少なくとも1つの‘A’は、‘B’で置き換えられてもよい」の表現は、‘A’の数が1つのとき、‘A’の位置は任意であり、‘A’の数が2つ以上のときも、それらの位置は制限なく選択できることを意味する。このルールは、「少なくとも1つの‘A’が、‘B’で置き換えられた」の表現にも適用される。「少なくとも1つの‘A’が、‘B’、‘C’、または‘D’で置き換えられてもよい」という表現は、任意の‘A’が‘B’で置き換えられた場合、任意の‘A’が‘C’で置き換えられた場合、および任意の‘A’が‘D’で置き換えられた場合、さらに複数の‘A’が‘B’、‘C’、および/または‘D’の少なくとも2つで置き換えられた場合を含むことを意味する。例えば、「少なくとも1つの-CH2-が-O-または-CH=CH-で置き換えられてもよいアルキル」には、アルキル、アルコキシ、アルコキシアルキル、アルケニル、アルコキシアルケニル、アルケニルオキシアルキルが含まれる。なお、連続する2つの-CH2-が-O-で置き換えられて、-O-O-のようになることは好ましくない。アルキルなどにおいて、メチル部分(-CH2-H)の-CH2-が-O-で置き換えられて-O-Hになることも好ましくない。
The expression "at least one'A'" means that the number of'A's is arbitrary. The expression "at least one'A'may be replaced by'B'" is that when the number of'A's is 1, the position of the'A'is arbitrary and the number of'A's is 2. When more than one, it means that their positions can be selected without limitation. This rule also applies to the expression "at least one'A' has been replaced by a'B'". The expression "at least one'A' may be replaced by'B','C',or'D'" is any'if any'A' is replaced by a'B'. If A'is replaced by'C', and any'A' is replaced by'D', then more than one'A'is'B','C', and / or'D' It means to include the case where it is replaced by at least two. For example, " alkyl in which at least one -CH 2- may be replaced with -O- or -CH = CH-" includes alkyl, alkoxy, alkoxyalkyl, alkoxy, alkoxyalkenyl, alkenyloxyalkyl. It is not preferable that two consecutive -CH 2- are replaced with -O- to become -O-O-. Alkyl such as in, -CH 2 methyl moiety (-CH 2 -H) - by is replaced by -O- is not preferred also be the -O-H.
「R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このアルキルおよびアルケニルにおいて、少なくとも1つの-CH2-は-O-で置き換えられてもよく、これらの基において、少なくとも1つの水素はフッ素で置き換えられてもよい」の表現が使われることがある。この表現において、「これらの基において」は、文言どおりに解釈してよい。この表現では、「これらの基」は、アルキル、アルケニル、アルコキシ、アルケニルオキシなどを意味する。すなわち、「これらの基」は、「これらの基において」の用語よりも前に記載された基の総てを表す。この常識的な解釈は、「これらの一価基において」や「これらの二価基において」の用語にも適用される。例えば、「これらの一価基」は、「これらの一価基において」の用語よりも前に記載された基の総てを表す。
"R 11 and R 12 are independently alkyls with 1 to 10 carbons or alkenyl with 2 to 10 carbons, in which at least one -CH 2- is replaced with -O-. Often, in these groups, at least one hydrogen may be replaced by fluorine. " In this expression, "in these groups" may be interpreted literally. In this expression, "these groups" means alkyl, alkenyl, alkoxy, alkenyloxy and the like. That is, "these groups" refers to all of the groups described prior to the term "in these groups". This common-sense interpretation also applies to the terms "in these monovalent groups" and "in these divalent groups". For example, "these monovalent groups" refers to all of the groups described prior to the term "in these monovalent groups".
ハロゲンはフッ素、塩素、臭素、およびヨウ素を意味する。好ましいハロゲンは、フッ素および塩素である。さらに好ましいハロゲンはフッ素である。液晶性化合物のアルキルは直鎖状または分岐状であり、環状アルキルを含まない。直鎖状アルキルは、一般的に分岐状アルキルよりも好ましい。これらのことは、アルコキシ、アルケニルなどの末端基についても同様である。1,4-シクロヘキシレンに関する立体配置は、上限温度を上げるためにシスよりもトランスが好ましい。2-フルオロ-1,4-フェニレンは、下記の2つの二価基を意味する。化学式において、フッ素は左向き(L)であってもよいし、右向き(R)であってもよい。このルールは、テトラヒドロピラン-2,5-ジイルのような、環から水素を2つ除くことによって生成した非対称な二価基にも適用される。
Halogen means fluorine, chlorine, bromine, and iodine. Preferred halogens are fluorine and chlorine. A more preferred halogen is fluorine. The alkyl of the liquid crystal compound is linear or branched and does not contain cyclic alkyl. Linear alkyl is generally preferred over branched alkyl. The same applies to terminal groups such as alkoxy and alkenyl. The configuration for 1,4-cyclohexylene is preferably trans over cis in order to raise the upper temperature limit. 2-Fluoro-1,4-phenylene means the following two divalent groups. In the chemical formula, fluorine may be left-facing (L) or right-facing (R). This rule also applies to asymmetric divalent groups generated by removing two hydrogens from the ring, such as tetrahydropyran-2,5-diyl.
本発明は、下記の項などである。
The present invention includes the following items.
項1.式(1)で表される化合物。
Item 1. A compound represented by the formula (1).
式(1)において、
R1は、水素、または炭素数1から15のアルキルであり、このR1において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
R2は、水素、フッ素、塩素、-C≡N、-C≡C-C≡N、または炭素数1から15のアルキルであり、このR2において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、
フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L1、L2、L3、L4、L5、およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L5およびL6が共に水素であるとき、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L1、L2、L3、およびL4が共に水素であるとき、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
lおよびoは独立して、0、または1であり、mおよびnは独立して、0、1、または2であり、l、m、n、およびoの和は、0から4の整数であり;
lが0であるとき、R1が水素となることはなく、oが0であるとき、R2が水素となることはない。 In equation (1)
R 1 is alkyl hydrogen, or from 1 to 15 carbon atoms, in the R 1, at least one of -CH 2 -, -O -, - may be replaced by S-, or -CO-, At least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, and at least one hydrogen may be replaced by fluorine or chlorine;
R 2 is hydrogen, fluorine, chlorine, -C≡N, alkyl of -C≡C-C≡N or 1 to 15 carbon atoms, in the R 2, at least one of -CH 2 -, - It may be replaced by O-, -S-, or -CO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 One hydrogen may be replaced with fluorine or chlorine;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl,
Fran-2,5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5- Diyl, benzo [b] thiophene-2,6-diyl, 9,10-dihydrophenanthrene-2,7-diyl, 9H-xanthene-2,6-diyl, or 9H-fluorene-2,7-diyl. In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2. May be replaced by F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
When both L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
When L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
l and o are independently 0, or 1, m and n are independently 0, 1, or 2, and the sum of l, m, n, and o is an integer from 0 to 4. can be;
When l is 0, R 1 does not become hydrogen, and when o is 0, R 2 does not become hydrogen.
R1は、水素、または炭素数1から15のアルキルであり、このR1において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
R2は、水素、フッ素、塩素、-C≡N、-C≡C-C≡N、または炭素数1から15のアルキルであり、このR2において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、
フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L1、L2、L3、L4、L5、およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L5およびL6が共に水素であるとき、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L1、L2、L3、およびL4が共に水素であるとき、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
lおよびoは独立して、0、または1であり、mおよびnは独立して、0、1、または2であり、l、m、n、およびoの和は、0から4の整数であり;
lが0であるとき、R1が水素となることはなく、oが0であるとき、R2が水素となることはない。 In equation (1)
R 1 is alkyl hydrogen, or from 1 to 15 carbon atoms, in the R 1, at least one of -CH 2 -, -O -, - may be replaced by S-, or -CO-, At least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, and at least one hydrogen may be replaced by fluorine or chlorine;
R 2 is hydrogen, fluorine, chlorine, -C≡N, alkyl of -C≡C-C≡N or 1 to 15 carbon atoms, in the R 2, at least one of -CH 2 -, - It may be replaced by O-, -S-, or -CO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 One hydrogen may be replaced with fluorine or chlorine;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl,
Fran-2,5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5- Diyl, benzo [b] thiophene-2,6-diyl, 9,10-dihydrophenanthrene-2,7-diyl, 9H-xanthene-2,6-diyl, or 9H-fluorene-2,7-diyl. In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2. May be replaced by F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
When both L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
When L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
l and o are independently 0, or 1, m and n are independently 0, 1, or 2, and the sum of l, m, n, and o is an integer from 0 to 4. can be;
When l is 0, R 1 does not become hydrogen, and when o is 0, R 2 does not become hydrogen.
項2. 式(1-1)から式(1-13)で表される、項1に記載の化合物。
Item 2. Item 2. The compound according to Item 1, represented by the formulas (1-1) to (1-13).
式(1-1)から式(1-13)において、
R1は、水素、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
R2は、水素、フッ素、塩素、-CF3、-OCF3、-C≡N、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-1)、式(1-3)、式(1-5)、式(1-7)、式(1-9)、式(1-11)、および式(1-13)において、R1が水素となることはなく、式(1-1)から式(1-5)、式(1-8)、式(1-9)、式(1-12)、および式(1-13)において、R2が水素となることはない。 In equations (1-1) to (1-13),
R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms. ;
R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C≡N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
In the formula (1-1), the formula (1-3), the formula (1-5), the formula (1-7), the formula (1-9), the formula (1-11), and the formula (1-13). , R 1 does not become hydrogen, and formulas (1-1) to (1-5), formula (1-8), formula (1-9), formula (1-12), and formula (1). In -13), R 2 does not become hydrogen.
R1は、水素、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
R2は、水素、フッ素、塩素、-CF3、-OCF3、-C≡N、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-1)、式(1-3)、式(1-5)、式(1-7)、式(1-9)、式(1-11)、および式(1-13)において、R1が水素となることはなく、式(1-1)から式(1-5)、式(1-8)、式(1-9)、式(1-12)、および式(1-13)において、R2が水素となることはない。 In equations (1-1) to (1-13),
R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms. ;
R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C≡N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
In the formula (1-1), the formula (1-3), the formula (1-5), the formula (1-7), the formula (1-9), the formula (1-11), and the formula (1-13). , R 1 does not become hydrogen, and formulas (1-1) to (1-5), formula (1-8), formula (1-9), formula (1-12), and formula (1). In -13), R 2 does not become hydrogen.
項3.前記式(1-1)から式(1-13)において、
R1およびR2は独立して、水素、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、1,2-シクロプロピレン、1,3-シクロブチレン、または1,3-シクロペンチレンであり;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、またはベンゾ[b]チオフェン-2,6-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CH-、-CH=CF-、-CF=CF-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-1)、式(1-3)、式(1-5)、式(1-7)、式(1-9)、式(1-11)、および式(1-13)において、R1が水素となることはなく、式(1-1)から式(1-5)、式(1-8)、式(1-9)、式(1-12)、および式(1-13)において、R2が水素となることはない、項2に記載の化合物。 Item 3. In the formulas (1-1) to (1-13),
R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons. 9 alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, or benzo [b] thiophene-2,6-diyl In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or. It may be replaced by -OCH 2 F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-,- OCF 2 -, - (CH 2 ) 2 -, - CH = CH -, - CF = CH -, - CH = CF -, - CF = CF -, - C≡C -, - (CH 2) 4 -, -(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2- , -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2) 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH -(CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
In the formula (1-1), the formula (1-3), the formula (1-5), the formula (1-7), the formula (1-9), the formula (1-11), and the formula (1-13). , R 1 does not become hydrogen, and formulas (1-1) to (1-5), formula (1-8), formula (1-9), formula (1-12), and formula (1). Item 2. The compound according to Item 2, wherein R 2 does not become hydrogen in -13).
R1およびR2は独立して、水素、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、1,2-シクロプロピレン、1,3-シクロブチレン、または1,3-シクロペンチレンであり;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、またはベンゾ[b]チオフェン-2,6-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CH-、-CH=CF-、-CF=CF-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-1)、式(1-3)、式(1-5)、式(1-7)、式(1-9)、式(1-11)、および式(1-13)において、R1が水素となることはなく、式(1-1)から式(1-5)、式(1-8)、式(1-9)、式(1-12)、および式(1-13)において、R2が水素となることはない、項2に記載の化合物。 Item 3. In the formulas (1-1) to (1-13),
R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons. 9 alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, or benzo [b] thiophene-2,6-diyl In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or. It may be replaced by -OCH 2 F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-,- OCF 2 -, - (CH 2 ) 2 -, - CH = CH -, - CF = CH -, - CH = CF -, - CF = CF -, - C≡C -, - (CH 2) 4 -, -(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2- , -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2) 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH -(CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
In the formula (1-1), the formula (1-3), the formula (1-5), the formula (1-7), the formula (1-9), the formula (1-11), and the formula (1-13). , R 1 does not become hydrogen, and formulas (1-1) to (1-5), formula (1-8), formula (1-9), formula (1-12), and formula (1). Item 2. The compound according to Item 2, wherein R 2 does not become hydrogen in -13).
項4.式(1-14)から(1-26)で表される、項1に記載の化合物。
Item 4. Item 2. The compound according to Item 1, which is represented by the formulas (1-14) to (1-26).
式(1-14)から式(1-26)において、
R1は、水素、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
R2は、水素、フッ素、塩素、-CF3、-OCF3、-C≡N、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-14)、式(1-16)、式(1-18)、式(1-20)、式(1-22)、式(1-24)、および式(1-26)において、R1が水素となることはなく、式(1-14)から式(1-18)、式(1-21)、式(1-22)、式(1-25)、および式(1-26)において、R2が水素となることはない。 In equations (1-14) to (1-26),
R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms. ;
R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C≡N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2- May be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-. Often, at least one hydrogen may be replaced with fluorine or chlorine;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N. At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N;
In formula (1-14), formula (1-16), formula (1-18), formula (1-20), formula (1-22), formula (1-24), and formula (1-26). , R 1 does not become hydrogen, and formulas (1-14) to (1-18), formula (1-21), formula (1-22), formula (1-25), and formula (1). In -26), R 2 does not become hydrogen.
R1は、水素、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
R2は、水素、フッ素、塩素、-CF3、-OCF3、-C≡N、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-14)、式(1-16)、式(1-18)、式(1-20)、式(1-22)、式(1-24)、および式(1-26)において、R1が水素となることはなく、式(1-14)から式(1-18)、式(1-21)、式(1-22)、式(1-25)、および式(1-26)において、R2が水素となることはない。 In equations (1-14) to (1-26),
R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms. ;
R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C≡N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2- May be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-. Often, at least one hydrogen may be replaced with fluorine or chlorine;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N. At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N;
In formula (1-14), formula (1-16), formula (1-18), formula (1-20), formula (1-22), formula (1-24), and formula (1-26). , R 1 does not become hydrogen, and formulas (1-14) to (1-18), formula (1-21), formula (1-22), formula (1-25), and formula (1). In -26), R 2 does not become hydrogen.
項5.前記式(1-14)から式(1-26)において、
R1およびR2は独立して、水素、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、1,2-シクロプロピレン、1,3-シクロブチレン、または1,3-シクロペンチレンであり;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、またはベンゾ[b]チオフェン-2,6-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CH-、-CH=CF-、-CF=CF-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L5、およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、
-OCHF2、-OCH2F、または-C≡Nであり;
式(1-14)、式(1-16)、式(1-18)、式(1-20)、式(1-22)、式(1-24)、および式(1-26)において、R1が水素となることはなく、式(1-14)から式(1-18)、式(1-21)、式(1-22)、式(1-25)、および式(1-26)において、R2が水素となることはない、項4に記載の化合物。 Item 5. In the formulas (1-14) to (1-26),
R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons. 9 alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, or benzo [b] thiophene-2,6-diyl In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or. It may be replaced by -OCH 2 F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-,- OCF 2 -, - (CH 2 ) 2 -, - CH = CH -, - CF = CH -, - CH = CF -, - CF = CF -, - C≡C -, - (CH 2) 4 -, -(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2- , -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2) 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH -(CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N. At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 ,
-OCHF 2 , -OCH 2 F, or -C≡N;
In formula (1-14), formula (1-16), formula (1-18), formula (1-20), formula (1-22), formula (1-24), and formula (1-26). , R 1 does not become hydrogen, and formulas (1-14) to (1-18), formula (1-21), formula (1-22), formula (1-25), and formula (1). Item 4. The compound according to Item 4, wherein R 2 does not become hydrogen in −26).
R1およびR2は独立して、水素、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、1,2-シクロプロピレン、1,3-シクロブチレン、または1,3-シクロペンチレンであり;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、またはベンゾ[b]チオフェン-2,6-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CH-、-CH=CF-、-CF=CF-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L5、およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、
-OCHF2、-OCH2F、または-C≡Nであり;
式(1-14)、式(1-16)、式(1-18)、式(1-20)、式(1-22)、式(1-24)、および式(1-26)において、R1が水素となることはなく、式(1-14)から式(1-18)、式(1-21)、式(1-22)、式(1-25)、および式(1-26)において、R2が水素となることはない、項4に記載の化合物。 Item 5. In the formulas (1-14) to (1-26),
R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons. 9 alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, or benzo [b] thiophene-2,6-diyl In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or. It may be replaced by -OCH 2 F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-,- OCF 2 -, - (CH 2 ) 2 -, - CH = CH -, - CF = CH -, - CH = CF -, - CF = CF -, - C≡C -, - (CH 2) 4 -, -(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2- , -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2) 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH -(CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N. At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 ,
-OCHF 2 , -OCH 2 F, or -C≡N;
In formula (1-14), formula (1-16), formula (1-18), formula (1-20), formula (1-22), formula (1-24), and formula (1-26). , R 1 does not become hydrogen, and formulas (1-14) to (1-18), formula (1-21), formula (1-22), formula (1-25), and formula (1). Item 4. The compound according to Item 4, wherein R 2 does not become hydrogen in −26).
項6.式(1-1-1)、式(1-3-1)から式(1-3-6)、式(1-5-1)から式(1-5-4)、または式(1-9-1)から式(1-9-3)で表される、項1から3のいずれか1項に記載の化合物。
Item 6. Formula (1-1-1), formula (1-3-1) to formula (1-3-6), formula (1-5-1) to formula (1-5-4), or formula (1-5-1) The compound according to any one of Items 1 to 3, represented by the formulas (1-9-3) from 9-1).
式(1-1-1)、式(1-3-1)から式(1-3-6)、式(1-5-1)から式(1-5-4)、および式(1-9-1)から式(1-9-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である。 Equations (1-1-1), equations (1-3-1) to equations (1-3-6), equations (1-5-1) to equations (1-5-4), and equations (1-5-1). In equations (1-9-3) from 9-1)
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH). 2 ) 2- , -CH = CH-, -C≡C-,-(CH 2 ) 4 -,-(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2 -, -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH- CH 2 O- or -OCH 2- CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and L 1 , At least one of L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である。 Equations (1-1-1), equations (1-3-1) to equations (1-3-6), equations (1-5-1) to equations (1-5-4), and equations (1-5-1). In equations (1-9-3) from 9-1)
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH). 2 ) 2- , -CH = CH-, -C≡C-,-(CH 2 ) 4 -,-(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2 -, -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH- CH 2 O- or -OCH 2- CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and L 1 , At least one of L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
項7.前記式(1-1-1)、式(1-3-1)から式(1-3-6)、式(1-5-1)から式(1-5-4)、式(1-9-1)から式(1-9-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から10のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3または、-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3または、-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、水素であり;
X1およびX2は独立して、水素、フッ素、または塩素である、項6に記載の化合物。 Item 7. Formulas (1-1-1), formulas (1-3-1) to formulas (1-3-6), formulas (1-5-1) to formulas (1-5-4), formulas (1-5-1) In equations (1-9-3) from 9-1)
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 10 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4. Is fluorine, chlorine, -CF 3 or -OCF 3 , and at least two of L 1 , L 2 , L 3 and L 4 are hydrogen;
Item 6. The compound according to Item 6, wherein X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から10のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3または、-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3または、-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、水素であり;
X1およびX2は独立して、水素、フッ素、または塩素である、項6に記載の化合物。 Item 7. Formulas (1-1-1), formulas (1-3-1) to formulas (1-3-6), formulas (1-5-1) to formulas (1-5-4), formulas (1-5-1) In equations (1-9-3) from 9-1)
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 10 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4. Is fluorine, chlorine, -CF 3 or -OCF 3 , and at least two of L 1 , L 2 , L 3 and L 4 are hydrogen;
Item 6. The compound according to Item 6, wherein X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
項8.式(1-14-1)、式(1-16-1)から式(1-16-6)、式(1-18-1)から式(1-18-4)、または式(1-22-1)から式(1-22-3)で表される、項1、4、および5のいずれか1項に記載の化合物。
Item 8. Formulas (1-14-1), formulas (1-16-1) to formulas (1-16-6), formulas (1-18-1) to formulas (1-18-4), or formulas (1-18-1). The compound according to any one of Items 1, 4, and 5, represented by the formulas (1-22-3) from 22-1).
式(1-14-1)、式(1-16-1)から式(1-16-6)、式(1-18-1)から式(1-18-4)、および式(1-22-1)から式(1-22-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である。 Equations (1-14-1), equations (1-16-1) to equations (1-16-6), equations (1-18-1) to equations (1-18-4), and equations (1-18-1). From 22-1) to equation (1-22-3),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH). 2 ) 2- , -CH = CH-, -C≡C-,-(CH 2 ) 4 -,-(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2 -, -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH- CH 2 O- or -OCH 2- CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and at least one of L 5 and L 6 is , Fluorine, Chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である。 Equations (1-14-1), equations (1-16-1) to equations (1-16-6), equations (1-18-1) to equations (1-18-4), and equations (1-18-1). From 22-1) to equation (1-22-3),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH). 2 ) 2- , -CH = CH-, -C≡C-,-(CH 2 ) 4 -,-(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2 -, -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH- CH 2 O- or -OCH 2- CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and at least one of L 5 and L 6 is , Fluorine, Chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
項9.前記式(1-14-1)、式(1-16-1)から式(1-16-6)、式(1-18-1)から式(1-18-4)、および式(1-22-1)から式(1-22-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である、項8に記載の化合物。 Item 9. Formulas (1-14-1), formulas (1-16-1) to formulas (1-16-6), formulas (1-18-1) to formulas (1-18-4), and formulas (1). From -22-1) to equation (1-22-3),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and at least one of L 5 and L 6 is , Fluorine, Chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
Item 8. The compound according to Item 8, wherein X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である、項8に記載の化合物。 Item 9. Formulas (1-14-1), formulas (1-16-1) to formulas (1-16-6), formulas (1-18-1) to formulas (1-18-4), and formulas (1). From -22-1) to equation (1-22-3),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and at least one of L 5 and L 6 is , Fluorine, Chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
Item 8. The compound according to Item 8, wherein X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
項10.式(1-1-1)、または式(1-3-1)から(1-3-6)で表される、項1から3、6、および7のいずれか1項に記載の化合物。
Item 10. Item 6. The compound according to any one of Items 1 to 3, 6 and 7, represented by the formula (1-1-1) or the formulas (1-3-1) to (1-3-6).
式(1-1-1)、および式(1-3-1)から式(1-3-6)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
Z2は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、または-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、または-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、水素であり;
X1およびX2は独立して、水素、フッ素、または塩素である。 In the formula (1-1-1), and from the formula (1-3-1) to the formula (1-3-6),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
Z 2 is a single bond, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH- ,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH- , -CH = CH-CH 2 O-, or -OCH 2- CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4. Is fluorine, chlorine, -CF 3 , or -OCF 3 , and at least two of L 1 , L 2 , L 3 , and L 4 are hydrogen;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
Z2は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、または-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、または-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、水素であり;
X1およびX2は独立して、水素、フッ素、または塩素である。 In the formula (1-1-1), and from the formula (1-3-1) to the formula (1-3-6),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
Z 2 is a single bond, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH- ,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH- , -CH = CH-CH 2 O-, or -OCH 2- CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4. Is fluorine, chlorine, -CF 3 , or -OCF 3 , and at least two of L 1 , L 2 , L 3 , and L 4 are hydrogen;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
項11.式(1-14-1)、または式(1-16-1)から式(1-16-6)で表される、項1、4、5、8、および9のいずれか1項に記載の化合物。
Item 11. Item 2. The item 1, 4, 5, 8 and 9, which is represented by the formula (1-14-1) or the formula (1-16-1) to the formula (1-16-6). Compound.
式(1-14-1)、および式(1-16-1)から式(1-16-6)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
Z2は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、または-OCF3であり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、または-OCF3であり;
X1およびX2は独立して、水素、フッ素、または塩素である。 In equations (1-14-1), and from equations (1-16-1) to equations (1-16-6),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
Z 2 is a single bond, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH- ,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH- , -CH = CH-CH 2 O-, or -OCH 2- CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 or -OCF 3 Is;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
Z2は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、または-OCF3であり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、または-OCF3であり;
X1およびX2は独立して、水素、フッ素、または塩素である。 In equations (1-14-1), and from equations (1-16-1) to equations (1-16-6),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
Z 2 is a single bond, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH- ,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH- , -CH = CH-CH 2 O-, or -OCH 2- CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 or -OCF 3 Is;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine.
項12.式(1-1-1)、式(1-3-1-1)から式(1-3-1-7)、式(1-3-2-1)、式(1-3-2-2)、式(1-3-3-1)、式(1-3-3-2)、式(1-3-4-1)、式(1-3-4-2)、式(1-3-5-1)、式(1-3-5-2)、または式(1-3-6-1)から式(1-3-6-4)で表される、項1から3、6、7、および10のいずれか1項に記載の化合物。
Item 12. From Eqs. (1-1-1), Eqs. (1-3-1-1) to Eqs. (1-3-1-7), Eqs. (1-3-2-1), Eqs. (1-3-2- 2), Eq. (1-3-3-1), Eq. (1-3-3-2), Eq. (1-3-4-1), Eq. (1-3-4-2), Eq. (1) Items 1 to 3 represented by -3-5-1), Eq. (1-3-5-2), or Eqs. (1-3-6-1) to Eqs. (1-3-6-4). , 6, 7, and 10.
式(1-1-1)、式(1-3-1-1)から式(1-3-1-7)、式(1-3-2-1)、式(1-3-2-2)、式(1-3-3-1)、式(1-3-3-2)、式(1-3-4-1)、式(1-3-4-2)、式(1-3-5-1)、式(1-3-5-2)、および式(1-3-6-1)から式(1-3-6-4)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
L1、L2、L3、およびL4は独立して、水素、フッ素、-CF3、または、-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、フッ素、-CF3、または、-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、水素であり;
X1およびX2は独立して、水素またはフッ素である。 From Eqs. (1-1-1), Eqs. (1-3-1-1) to Eqs. (1-3-1-7), Eqs. (1-3-2-1), Eqs. (1-3-2- 2), Eq. (1-3-3-1), Eq. (1-3-3-2), Eq. (1-3-4-1), Eq. (1-3-4-2), Eq. (1) In the formulas (-3-5-1), formula (1-3-5-2), and formulas (1-3-6-1) to formulas (1-3-6-4),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, -CF 3 , or -OCF 3 , and at least two of L 1 , L 2 , L 3 , and L 4 are , Fluorine, -CF 3 , or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4 is hydrogen;
X 1 and X 2 are independently hydrogen or fluorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
L1、L2、L3、およびL4は独立して、水素、フッ素、-CF3、または、-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、フッ素、-CF3、または、-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、水素であり;
X1およびX2は独立して、水素またはフッ素である。 From Eqs. (1-1-1), Eqs. (1-3-1-1) to Eqs. (1-3-1-7), Eqs. (1-3-2-1), Eqs. (1-3-2- 2), Eq. (1-3-3-1), Eq. (1-3-3-2), Eq. (1-3-4-1), Eq. (1-3-4-2), Eq. (1) In the formulas (-3-5-1), formula (1-3-5-2), and formulas (1-3-6-1) to formulas (1-3-6-4),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, -CF 3 , or -OCF 3 , and at least two of L 1 , L 2 , L 3 , and L 4 are , Fluorine, -CF 3 , or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4 is hydrogen;
X 1 and X 2 are independently hydrogen or fluorine.
項13.式(1-14-1)、式(1-16-1-1)から式(1-16-1-7)、式(1-16-2-1)、式(1-16-2-2)、式(1-16-3-1)、式(1-16-3-2)、式(1-16-4-1)、式(1-16-4-2)、式(1-16-5-1)、式(1-16-5-2)、または式(1-16-6-1)から式(1-16-6-4)で表される、項1、4、5、8、9、および11のいずれか1項に記載の化合物。
Item 13. From Eqs. (1-14-1), Eqs. (1-16-1-1) to Eqs. (1-16-1-7), Eqs. (1-16-2-1), Eqs. (1-16-2-) 2), Eq. (1-16-3-1), Eq. (1-16-3-2), Eq. (1-16-4-1), Eq. (1-16-4-2), Eq. (1) Items 1, 4 represented by -16-5-1), Eq. (1-16-5-2), or Eqs. (1-16-6-1) to Eqs. (1-16-6-4). Item 5. The compound according to any one of 5, 8, 9, and 11.
式(1-14-1-1)、式(1-16-1-1)から式(1-16-1-7)、式(1-16-2-1)、式(1-16-2-2)、式(1-16-3-1)、式(1-16-3-2)、式(1-16-4-1)、式(1-16-4-2)、式(1-16-5-1)、式(1-16-5-2)、および式(1-16-6-1)から式(1-16-6-4)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
L5およびL6は独立して、水素、フッ素、-CF3、または、-OCF3であり、L5およびL6の少なくとも1つは、フッ素、-CF3、または、-OCF3であり;
X1およびX2は独立して、水素またはフッ素である。 Equations (1-14-1-1), equations (1-16-1-1) to equations (1-16-1-7), equations (1-16-2-1), equations (1-16-) 2-2), Equation (1-16-3-1), Equation (1-16-3-2), Equation (1-16-4-1), Equation (1-16-4-2), Equation In equations (1-16-5-1), equations (1-16-5-2), and equations (1-16-6-1) to equations (1-16-6-4).
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
L 5 and L 6 are independently hydrogen, fluorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, -CF 3 or -OCF 3 . ;
X 1 and X 2 are independently hydrogen or fluorine.
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
L5およびL6は独立して、水素、フッ素、-CF3、または、-OCF3であり、L5およびL6の少なくとも1つは、フッ素、-CF3、または、-OCF3であり;
X1およびX2は独立して、水素またはフッ素である。 Equations (1-14-1-1), equations (1-16-1-1) to equations (1-16-1-7), equations (1-16-2-1), equations (1-16-) 2-2), Equation (1-16-3-1), Equation (1-16-3-2), Equation (1-16-4-1), Equation (1-16-4-2), Equation In equations (1-16-5-1), equations (1-16-5-2), and equations (1-16-6-1) to equations (1-16-6-4).
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
L 5 and L 6 are independently hydrogen, fluorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, -CF 3 or -OCF 3 . ;
X 1 and X 2 are independently hydrogen or fluorine.
項14.式(1-1-1-1)から式(1-1-1-7)で表される、項1から3、6、7、10、および12のいずれか1項に記載の化合物。
Item 14. Item 6. The compound according to any one of Items 1 to 3, 6, 7, 10, and 12, represented by the formulas (1-1-1-1) to (1-1-1-7).
式(1-1-1-1)から(1-1-1-7)において、
R1およびR2は独立して、炭素数1から7のアルキル、炭素数1から6のアルコキシ、炭素数2から6のアルコキシアルキル、炭素数2から7のアルケニル、または炭素数2から7のアルケニルオキシである。
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルである。 In equations (1-1-1-1) to (1-1-1-7),
R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons. Alkoxyoxy.
Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms.
R1およびR2は独立して、炭素数1から7のアルキル、炭素数1から6のアルコキシ、炭素数2から6のアルコキシアルキル、炭素数2から7のアルケニル、または炭素数2から7のアルケニルオキシである。
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルである。 In equations (1-1-1-1) to (1-1-1-7),
R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons. Alkoxyoxy.
Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms.
項15.式(1-14-1-1)、または式(1-14-1-2)で表される、項1、4、5、8、9、11、および13のいずれか1項に記載の化合物。
Item 15. The item according to any one of Items 1, 4, 5, 8, 9, 11, and 13, which is represented by the formula (1-14-1-1) or the formula (1-14-1-2). Compound.
式(1-14-1-1)、または式(1-14-1-2)において、
R1およびR2は独立して、炭素数1から7のアルキル、炭素数1から6のアルコキシ、炭素数2から6のアルコキシアルキル、炭素数2から7のアルケニル、または炭素数2から7のアルケニルオキシである。
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルである。 In the formula (1-14-1-1) or the formula (1-14-1-2),
R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons. Alkoxyoxy.
Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms.
R1およびR2は独立して、炭素数1から7のアルキル、炭素数1から6のアルコキシ、炭素数2から6のアルコキシアルキル、炭素数2から7のアルケニル、または炭素数2から7のアルケニルオキシである。
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルである。 In the formula (1-14-1-1) or the formula (1-14-1-2),
R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons. Alkoxyoxy.
Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms.
項16.項1から15のいずれか1項に記載の化合物の少なくとも1つを含有する液晶組成物。
Item 16. A liquid crystal composition containing at least one of the compounds according to any one of Items 1 to 15.
項17.式(2)から式(4)で表される化合物の群から選択された少なくとも1つの化合物を含有する、項16に記載の液晶組成物。
Item 17. Item 6. The liquid crystal composition according to Item 16, which contains at least one compound selected from the group of compounds represented by the formulas (2) to (4).
式(2)から式(4)において、
R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR11およびR12において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
環B1、環B2、環B3、および環B4は独立して、1,4-シクロヘキシレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,5-ジフルオロ-1,4-フェニレン、またはピリミジン-2,5-ジイルであり;
Z11、Z12、およびZ13は独立して、単結合、-COO-、-(CH2)2-、-CH=CH-、または-C≡C-である。 In equations (2) to (4),
R 11 and R 12 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 11 and R 12, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
Ring B 1 , Ring B 2 , Ring B 3 and Ring B 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro- 1,4-phenylene, or pyrimidine-2,5-diyl;
Z 11 , Z 12 , and Z 13 are independently single-bonded, -COO-,-(CH 2 ) 2- , -CH = CH-, or -C≡C-.
R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR11およびR12において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
環B1、環B2、環B3、および環B4は独立して、1,4-シクロヘキシレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,5-ジフルオロ-1,4-フェニレン、またはピリミジン-2,5-ジイルであり;
Z11、Z12、およびZ13は独立して、単結合、-COO-、-(CH2)2-、-CH=CH-、または-C≡C-である。 In equations (2) to (4),
R 11 and R 12 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 11 and R 12, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
Ring B 1 , Ring B 2 , Ring B 3 and Ring B 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro- 1,4-phenylene, or pyrimidine-2,5-diyl;
Z 11 , Z 12 , and Z 13 are independently single-bonded, -COO-,-(CH 2 ) 2- , -CH = CH-, or -C≡C-.
項18.式(5)から式(13)で表される化合物の群から選択された少なくとも1つの化合物をさらに含有する、項16または17に記載の液晶組成物。
Item 18. Item 6. The liquid crystal composition according to Item 16 or 17, further containing at least one compound selected from the group of compounds represented by formulas (5) to (13).
式(5)から式(13)において、
R13およびR14は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR13およびR14において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
R15は、水素、フッ素、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR15において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
環C1、環C2、環C3、および環C4は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
環C5および環C6は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
Z14、Z15、Z16、およびZ17は独立して、単結合、-COO-、-CH2O-、-OCF2-、-(CH2)2-、または-OCF2-(CH2)2-であり;
L11およびL12は独立して、フッ素または塩素であり;
S11は、水素またはメチルであり;
Xは、-CHF-または-CF2-であり;
j、k、m、n、p、q、r、およびsは独立して、0または1であり、k、m、n、およびpの和は、1または2であり、q、r、およびsの和は、0、1、2、または3であり、tは、1、2、または3である。 In equations (5) to (13),
R 13 and R 14 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 13 and R 14, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
R 15 is hydrogen, fluorine, alkenyl alkyl carbon atoms or 2 to 10 from 10 1 carbon atoms, in the R 15, at least one -CH 2 - may be replaced by -O-, at least One hydrogen may be replaced by fluorine;
Ring C 1 , Ring C 2 , Ring C 3 , and Ring C 4 may independently replace 1,4-cyclohexylene, 1,4-cyclohexenylene, and at least one hydrogen with fluorine 1, 4-Phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6-diyl;
Ring C 5 and ring C 6 are each independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydropyran-2,5-diyl or decahydronaphthalene, 2,6 -Jeil;
Z 14, Z 15, Z 16 , and Z 17 are independently a single bond, -COO -, - CH 2 O -, - OCF 2 -, - (CH 2) 2 -, or -OCF 2 - (CH 2 ) 2- is;
L 11 and L 12 are independently fluorine or chlorine;
S 11 is hydrogen or methyl;
X is -CHF- or -CF 2- ;
j, k, m, n, p, q, r, and s are independently 0 or 1, and the sum of k, m, n, and p is 1 or 2, q, r, and The sum of s is 0, 1, 2, or 3, and t is 1, 2, or 3.
R13およびR14は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR13およびR14において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
R15は、水素、フッ素、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR15において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよく;
環C1、環C2、環C3、および環C4は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
環C5および環C6は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
Z14、Z15、Z16、およびZ17は独立して、単結合、-COO-、-CH2O-、-OCF2-、-(CH2)2-、または-OCF2-(CH2)2-であり;
L11およびL12は独立して、フッ素または塩素であり;
S11は、水素またはメチルであり;
Xは、-CHF-または-CF2-であり;
j、k、m、n、p、q、r、およびsは独立して、0または1であり、k、m、n、およびpの和は、1または2であり、q、r、およびsの和は、0、1、2、または3であり、tは、1、2、または3である。 In equations (5) to (13),
R 13 and R 14 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 13 and R 14, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
R 15 is hydrogen, fluorine, alkenyl alkyl carbon atoms or 2 to 10 from 10 1 carbon atoms, in the R 15, at least one -CH 2 - may be replaced by -O-, at least One hydrogen may be replaced by fluorine;
Ring C 1 , Ring C 2 , Ring C 3 , and Ring C 4 may independently replace 1,4-cyclohexylene, 1,4-cyclohexenylene, and at least one hydrogen with fluorine 1, 4-Phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6-diyl;
Ring C 5 and ring C 6 are each independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydropyran-2,5-diyl or decahydronaphthalene, 2,6 -Jeil;
Z 14, Z 15, Z 16 , and Z 17 are independently a single bond, -COO -, - CH 2 O -, - OCF 2 -, - (CH 2) 2 -, or -OCF 2 - (CH 2 ) 2- is;
L 11 and L 12 are independently fluorine or chlorine;
S 11 is hydrogen or methyl;
X is -CHF- or -CF 2- ;
j, k, m, n, p, q, r, and s are independently 0 or 1, and the sum of k, m, n, and p is 1 or 2, q, r, and The sum of s is 0, 1, 2, or 3, and t is 1, 2, or 3.
項19.式(21)から式(23)で表される化合物の群から選択された少なくとも1つの化合物をさらに含有する、項16から18のいずれか1項に記載の液晶組成物。
Item 19. Item 6. The liquid crystal composition according to any one of Items 16 to 18, further containing at least one compound selected from the group of compounds represented by the formulas (21) to (23).
式(21)から(23)において、
R16は、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR16において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
X11は、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCF2CHF2、または-OCF2CHFCF3であり;
環D1、環D2、および環D3は独立して、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
Z18、Z19、およびZ20は独立して、単結合、-COO-、-CH2O-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、または-(CH2)4-であり;
L13およびL14は独立して、水素またはフッ素である。 In equations (21) to (23),
R 16 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 16, at least one -CH 2 - may be replaced by -O-, at least one hydrogen , May be replaced with fluorine;
X 11 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 ;
Ring D 1 , Ring D 2 , and Ring D 3 are independently 1,4-cyclohexylene, 1,4-phenylene, where at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl. , 1,3-dioxane-2,5-diyl, or pyrimidine-2,5-diyl;
Z 18 , Z 19 and Z 20 are independently single-bonded, -COO-, -CH 2 O-, -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH. -, - C≡C-, or - (CH 2) 4 - a and;
L 13 and L 14 are independently hydrogen or fluorine.
R16は、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR16において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
X11は、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCF2CHF2、または-OCF2CHFCF3であり;
環D1、環D2、および環D3は独立して、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
Z18、Z19、およびZ20は独立して、単結合、-COO-、-CH2O-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、または-(CH2)4-であり;
L13およびL14は独立して、水素またはフッ素である。 In equations (21) to (23),
R 16 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 16, at least one -CH 2 - may be replaced by -O-, at least one hydrogen , May be replaced with fluorine;
X 11 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 ;
Ring D 1 , Ring D 2 , and Ring D 3 are independently 1,4-cyclohexylene, 1,4-phenylene, where at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl. , 1,3-dioxane-2,5-diyl, or pyrimidine-2,5-diyl;
Z 18 , Z 19 and Z 20 are independently single-bonded, -COO-, -CH 2 O-, -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH. -, - C≡C-, or - (CH 2) 4 - a and;
L 13 and L 14 are independently hydrogen or fluorine.
項20.式(24)で表される化合物の群から選択された少なくとも1つの化合物をさらに含有する、項16から19のいずれか1項に記載の液晶組成物。
Item 20. Item 6. The liquid crystal composition according to any one of Items 16 to 19, further containing at least one compound selected from the group of compounds represented by the formula (24).
式(24)において、
R17は、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR17において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
X12は-C≡Nまたは-C≡C-C≡Nであり;
環E1は、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
Z21は、単結合、-COO-、-CH2O-、-CF2O-、-OCF2-、-(CH2)2-、または-C≡C-であり;
L15およびL16は独立して、水素またはフッ素であり;
iは、1、2、3、または4である。 In equation (24)
R 17 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 17, at least one -CH 2 - may be replaced by -O-, at least one hydrogen May be replaced with fluorine;
X 12 is -C≡N or -C≡C-C≡N;
Ring E 1 is 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl. , Or pyrimidine-2,5-dioxane;
Z 21 is a single bond, -COO-, -CH 2 O-, -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , or -C ≡ C-;
L 15 and L 16 are independently hydrogen or fluorine;
i is 1, 2, 3, or 4.
R17は、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR17において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
X12は-C≡Nまたは-C≡C-C≡Nであり;
環E1は、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
Z21は、単結合、-COO-、-CH2O-、-CF2O-、-OCF2-、-(CH2)2-、または-C≡C-であり;
L15およびL16は独立して、水素またはフッ素であり;
iは、1、2、3、または4である。 In equation (24)
R 17 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 17, at least one -CH 2 - may be replaced by -O-, at least one hydrogen May be replaced with fluorine;
X 12 is -C≡N or -C≡C-C≡N;
Ring E 1 is 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl. , Or pyrimidine-2,5-dioxane;
Z 21 is a single bond, -COO-, -CH 2 O-, -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , or -C ≡ C-;
L 15 and L 16 are independently hydrogen or fluorine;
i is 1, 2, 3, or 4.
項21.項16から20のいずれか1項に記載の液晶組成物を含む液晶表示素子。
Item 21. A liquid crystal display device containing the liquid crystal composition according to any one of Items 16 to 20.
本発明は、次の項も含む。(a)少なくとも1つの光学活性化合物および/または重合性化合物をさらに含有する、上記の組成物。(b)少なくとも1つの酸化防止剤および/または紫外線吸収剤をさらに含有する、上記の組成物。
The present invention also includes the following items. (A) The composition described above further comprising at least one optically active compound and / or polymerizable compound. (B) The composition described above further comprising at least one antioxidant and / or UV absorber.
本発明は、次の項も含む。(c)重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、色素、および消泡剤の群から選択された1つ、2つ、または少なくとも3つの添加物をさらに含有する、上記の組成物。(d)ネマチック相の上限温度が70℃以上であり、波長589nmにおける光学異方性(25℃で測定)が0.08以上であり、そして周波数1kHzにおける誘電率異方性(25℃で測定)が-2以下である、上記の組成物。
The present invention also includes the following items. (C) One selected from the group of polymerizable compounds, polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, UV absorbers, light stabilizers, heat stabilizers, dyes, and defoamers. The composition described above further comprising two or at least three additives. (D) The upper limit temperature of the nematic phase is 70 ° C. or higher, the optical anisotropy at a wavelength of 589 nm (measured at 25 ° C.) is 0.08 or higher, and the dielectric anisotropy at a frequency of 1 kHz (measured at 25 ° C.). ) Is -2 or less, the above composition.
本発明は、次の項も含む。(e)上記の組成物を含有し、そしてPC、TN、STN、ECB、OCB、IPS、VA、FFS、FPA、またはPSAのモードを有する素子。(f)上記の組成物を含むAM素子。(g)上記の組成物を含む透過型の素子。(h)上記の組成物を、ネマチック相を有する組成物としての使用。(i)上記の組成物に光学活性な化合物を添加することによって光学活性な組成物としての使用。
The present invention also includes the following items. (E) A device containing the above composition and having a mode of PC, TN, STN, ECB, OCB, IPS, VA, FFS, FPA, or PSA. (F) AM device containing the above composition. (G) A transmissive device containing the above composition. (H) Use of the above composition as a composition having a nematic phase. (I) Use as an optically active composition by adding an optically active compound to the above composition.
化合物(1)の態様、化合物(1)の合成、液晶組成物、および液晶表示素子について順に説明する。
The aspect of compound (1), the synthesis of compound (1), the liquid crystal composition, and the liquid crystal display element will be described in order.
1.化合物(1)の態様
化合物(1)は、下記の式で表される二価基を有することを特徴とする。なお、下記の式において、Xは、水素、または置換基である。 1. 1. Aspects of Compound (1) Compound (1) is characterized by having a divalent group represented by the following formula. In the following formula, X is hydrogen or a substituent.
化合物(1)は、下記の式で表される二価基を有することを特徴とする。なお、下記の式において、Xは、水素、または置換基である。 1. 1. Aspects of Compound (1) Compound (1) is characterized by having a divalent group represented by the following formula. In the following formula, X is hydrogen or a substituent.
この化合物は、素子が通常使用される条件下において物理的および化学的に極めて安定であり、そして他の液晶性化合物との相溶性が良好である。この化合物を含有する組成物は素子が通常使用される条件下で安定である。この組成物は負に大きな誘電率異方性を有する。この化合物は、組成物の成分に必要な一般的物性、適切な光学異方性、そして適切な誘電率異方性を有する。
This compound is extremely physically and chemically stable under the conditions in which the device is normally used, and has good compatibility with other liquid crystal compounds. Compositions containing this compound are stable under the conditions in which the device is commonly used. This composition has a negatively large dielectric anisotropy. This compound has the general physical properties required for the components of the composition, the appropriate optical anisotropy, and the appropriate dielectric anisotropy.
化合物(1)における末端基R1およびR2、側方基Ra、環A1、および環A2、環N1、および環N2、結合基Z1、Z2、Z3、およびZ4、側方基L1、L2、L3、L、4、L5およびL6の好ましい例は、以下のとおりである。この例は化合物(1)の下位式にも適用される。化合物(1)において、これらの基を適切に組み合わせることによって、物性を任意に調整することが可能である。化合物の物性に大きな差異がないので、化合物(1)は、2H(重水素)、13Cなどの同位体を天然存在比の量より多く含んでもよい。なお、化合物(1)の記号の定義は、項1に記載したとおりである。
Terminal groups R 1 and R 2 , lateral groups Ra , ring A 1 , and ring A 2 , ring N 1 , and ring N 2 , binding groups Z 1 , Z 2 , Z 3 , and Z in compound (1). 4, a preferred embodiment of side groups L 1, L 2, L 3 , L, 4, L 5 and L 6 are as follows. This example also applies to the sub-formula of compound (1). In compound (1), the physical properties can be arbitrarily adjusted by appropriately combining these groups. Because large difference is not in the physical properties of the compound, the compound (1) is, 2 H (deuterium), an isotope such as 13 C may contain more than the amount of natural abundance. The definition of the symbol of compound (1) is as described in Item 1.
式(1)において、R1は、水素、または炭素数1から15のアルキルであり、このR1において、少なくとも1つの-CH2-は-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。
R2は、水素、フッ素、塩素、-C≡N、-C≡C-C≡N、または炭素数1から15のアルキルであり、このR2において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。 In formula (1), R 1 is hydrogen or alkyl of from 1 to 15 carbon atoms, in the R 1, at least one -CH 2 - is -O -, - replaced by S-, or -CO- At least one of-(CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, and at least one hydrogen may be replaced by fluorine or chlorine.
R 2 is hydrogen, fluorine, chlorine, -C≡N, alkyl of -C≡C-C≡N or 1 to 15 carbon atoms, in the R 2, at least one of -CH 2 -, - It may be replaced by O-, -S-, or -CO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 One hydrogen may be replaced with fluorine or chlorine.
R2は、水素、フッ素、塩素、-C≡N、-C≡C-C≡N、または炭素数1から15のアルキルであり、このR2において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。 In formula (1), R 1 is hydrogen or alkyl of from 1 to 15 carbon atoms, in the R 1, at least one -CH 2 - is -O -, - replaced by S-, or -CO- At least one of-(CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, and at least one hydrogen may be replaced by fluorine or chlorine.
R 2 is hydrogen, fluorine, chlorine, -C≡N, alkyl of -C≡C-C≡N or 1 to 15 carbon atoms, in the R 2, at least one of -CH 2 -, - It may be replaced by O-, -S-, or -CO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 One hydrogen may be replaced with fluorine or chlorine.
ただし、式(1)において、lが0であるとき、R1が水素となることはなく、oが0であるとき、R2が水素となることはない。
However, in the formula (1), when l is 0, R 1 does not become hydrogen, and when o is 0, R 2 does not become hydrogen.
好ましいR1またはR2は、アルキル、アルコキシ、アルコキシアルキル、アルコキシアルコキシ、アルキルチオ、アルキルチオアルコキシ、アシル、アシルアルキル、アシルオキシ、アシルオキシアルキル、アルコキシカルボニル、アルコキシカルボニルアルキル、アルケニル、アルケニルオキシ、アルケニルオキシアルキル、アルコキシアルケニル、アルキニル、およびアルキニルオキシである。このR1またはR2において、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。この例は、少なくとも2つの水素がフッ素および塩素の両方で置き換えられた基を含む。少なくとも1つの水素がフッ素だけで置き換えられた基はさらに好ましい。このR1またはR2において、分岐鎖よりも直鎖の方が好ましい。R1またはR2が分岐鎖であっても光学活性であるときは好ましい。さらに好ましいR1またはR2はアルキル、アルコキシ、アルコキシアルキル、アルケニル、モノフルオロアルキル、ポリフルオロアルキル、モノフルオロアルコキシ、およびポリフルオロアルコキシである。R2は、上記の基に加えて、フッ素、塩素、-C≡N、または-C≡C-C≡Nであってもよい。
Preferred R 1 or R 2 are alkyl, alkoxy, alkoxyalkyl, alkoxyalkoxy, alkylthio, alkylthioalkoxy, acyl, acylalkyl, acyloxy, acyloxyalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, alkenyl, alkenyloxy, alkenyloxyalkyl, alkoxy. Alkoxy, alkynyl, and alkynyloxy. In this R 1 or R 2 , at least one hydrogen may be replaced with fluorine or chlorine. This example contains a group in which at least two hydrogens have been replaced with both fluorine and chlorine. Groups in which at least one hydrogen is replaced with fluorine alone are even more preferred. In R 1 or R 2 , a straight chain is preferable to a branched chain. Even if R 1 or R 2 is a branched chain, it is preferable when it is optically active. More preferred R 1 or R 2 are alkyl, alkoxy, alkoxyalkyl, alkenyl, monofluoroalkyl, polyfluoroalkyl, monofluoroalkoxy, and polyfluoroalkoxy. R 2 may be fluorine, chlorine, -C≡N, or -C≡C-C≡N in addition to the above groups.
アルケニルにおける-CH=CH-の好ましい立体配置は、二重結合の位置に依存する。1-プロペニル、1-ブテニル、1-ペンテニル、1-ヘキセニル、3-ペンテニル、3-ヘキセニルのようなアルケニルにおいてはトランス配置が好ましい。2-ブテニル、2-ペンテニル、2-ヘキセニルのようなアルケニルにおいてはシス配置が好ましい。
The preferred configuration of -CH = CH- in alkenyl depends on the position of the double bond. Trans-configuration is preferred for alkenyl such as 1-propenyl, 1-butenyl, 1-pentenyl, 1-hexenyl, 3-pentenyl, 3-hexenyl. The cis configuration is preferred for alkenyl such as 2-butenyl, 2-pentenyl, 2-hexenyl.
具体的なR1またはR2は、メチル、エチル、プロピル、ブチル、ペンチル、ヘキシル、ヘプチル、オクチル、ノニル、メトキシ、エトキシ、プロポキシ、ブトキシ、ペンチルオキシ、ヘキシルオキシ、ヘプチルオキシ、オクチルオキシ、メトキシメチル、メトキシエチル、メトキシプロピル、エトキシメチル、エトキシエチル、エトキシプロピル、プロポキシメチル、プロポキシエチル、ブトキシメチル、ブトキシエチル、ペントキシメチル、ペントキシエチル、ビニル、1-プロペニル、2-プロペニル、1-ブテニル、2-ブテニル、3-ブテニル、1-ペンテニル、2-ペンテニル、3-ペンテニル、4-ペンテニル、1-ヘキセニル、2-ヘキセニル、3-ヘキセニル、4-ヘキセニル、5-ヘキセニル、1-へプテニル、2-へプテニル、3-へプテニル、4-へプテニル、5-へプテニル、6-へプテニル、2-プロペニルオキシ、2-ブテニルオキシ、2-ペンテニルオキシ、2-ヘキセニルオキシ、および1-プロピニルである。
Specific R 1 or R 2 are methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, methoxymethyl. , Methoxyethyl, methoxypropyl, ethoxymethyl, ethoxyethyl, ethoxypropyl, propoxymethyl, propoxyethyl, butoxymethyl, butoxyethyl, pentoxymethyl, pentoxyethyl, vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-Buthenyl, 3-Butenyl, 1-Pentenyl, 2-Pentenyl, 3-Pentenyl, 4-Pentenyl, 1-Hexenyl, 2-Hexenyl, 3-Hexenyl, 4-Hexenyl, 5-Hexenyl, 1-Heptenyl, 2 -Heptenyl, 3-heptenyl, 4-heptenyl, 5-heptenyl, 6-heptenyl, 2-propenyloxy, 2-butenyloxy, 2-pentenyloxy, 2-hexenyloxy, and 1-propynyl.
具体的なR1またはR2は、2-フルオロエチル、3-フルオロプロピル、2,2,2-トリフルオロエチル、2-フルオロビニル、2,2-ジフルオロビニル,2-フルオロ-2-ビニル、3-フルオロ-1-プロペニル、3,3,3-トリフルオロ-1-プロペニル、4-フルオロ-1-プロペニル、および4,4-ジフルオロ-3-ブテニルである。
Specific R 1 or R 2 is 2-fluoroethyl, 3-fluoropropyl, 2,2,2-trifluoroethyl, 2-fluorovinyl, 2,2-difluorovinyl, 2-fluoro-2-vinyl, 3-Fluoro-1-propenyl, 3,3,3-trifluoro-1-propenyl, 4-fluoro-1-propenyl, and 4,4-difluoro-3-butenyl.
具体的なR2は、上記の基に加えて、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-CF2CF3、-CF2CHF2、-CF2CH2F、-CF2CF2CF3、-CF2CHFCF3、-CHFCF2CF3、-OCF3、-OCHF2、-OCH2F、-OCF2CF3、-OCF2CHF2、-OCF2CH2F、-OCF2CF2CF3、-OCF2CHFCF3、および-OCHFCF2CF3であってもよい。
Specific R 2 is, in addition to the above groups, fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -CF 2 CF 3 , -CF 2 CHF 2 , -CF. 2 CH 2 F, -CF 2 CF 2 CF 3 , -CF 2 CHFCF 3 , -CHFCF 2 CF 3 , -OCF 3 , -OCHF 2 , -OCH 2 F, -OCF 2 CF 3 , -OCF 2 CHF 2 , It may be -OCF 2 CH 2 F, -OCF 2 CF 2 CF 3 , -OCF 2 CHFCF 3 , and -OCHFCF 2 CF 3.
さらに好ましいR1またはR2は、エチル、プロピル、ブチル、ペンチル、ヘキシル、ヘプチル、メトキシ、エトキシ、プロポキシ、ブトキシ、ペンチルオキシ、ヘキシルオキシ、メトキシメチル、エトキシメチル、エトキシエチル、プロポキシメチル、プロポキシエチル、ブトキシメチル、ペントキシメチル、ビニル、1-プロペニル、2-プロペニル、1-ブテニル、2-ブテニル、3-ブテニル、1-ペンテニル、2-ペンテニル、3-ペンテニル、4-ペンテニル、1-ヘキセニル、2-ヘキセニル、3-ヘキセニル、4-ヘキセニル、5-ヘキセニル、2-プロペニルオキシ、2-ブテニルオキシ、および2-ペンテニルオキシである。加えて、さらに好ましいR2は、-OCF3、-OCHF2、-OCH2F、-OCF2CF3、-OCF2CHF2、-OCF2CH2F、-OCF2CF2CF3、-OCF2CHFCF3、-OCHFCF2CF3、フッ素、塩素、および-C≡Nである。最も好ましいR1またはR2は、エチル、プロピル、ブチル、ペンチル、へキシル、メトキシ、エトキシ、プロポキシ、ブトキシ、ペンチルオキシ、メトキシメチル、エトキシメチル、プロポキシメチル、ブトキシメチル、ビニル、1-プロペニル、3-ブテニル、および3-ペンテニルである。加えて、最も好ましいR2は、-OCF3、-OCHF2、-CF3、-CHF2、-CH2F、-OCF2CHF2、-OCF2CHFCF3、フッ素、および-C≡Nである。
More preferred R 1 or R 2 are ethyl, propyl, butyl, pentyl, hexyl, heptyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, methoxymethyl, ethoxymethyl, ethoxyethyl, propoxymethyl, propoxyethyl, Butoxymethyl, pentoxymethyl, vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2 -Hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 2-propenyloxy, 2-butenyloxy, and 2-pentenyloxy. In addition, more preferably R 2 is, -OCF 3, -OCHF 2, -OCH 2 F, -OCF 2 CF 3, -OCF 2 CHF 2, -OCF 2 CH 2 F, -OCF 2 CF 2 CF 3, - OCF 2 CHFCF 3 , -OCHFCF 2 CF 3 , fluorine, chlorine, and -C≡N. The most preferred R 1 or R 2 are ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, methoxymethyl, ethoxymethyl, propoxymethyl, butoxymethyl, vinyl, 1-propenyl, 3 -Butenyl, and 3-pentenyl. In addition, the most preferred R 2 is, -OCF 3, -OCHF 2, -CF 3, -CHF 2, -CH 2 F, -OCF 2 CHF 2, -OCF 2 CHFCF 3, fluorine, and -C≡N be.
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルである。
Ra is hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms.
好ましいRaは、メチル、エチル、プロピル、ブチル、ペンチル、ヘキシル、イソプロピル,sec-ブチル、ペンタン-2-イル、ヘキサン-2-イル、ペンタン-3-イル、ヘキサン-3-イル、tert-ブチル、tert-ペンチル、3-メチルペンタン-3-イル、および3-エチルペンタン-3-イルである。さらに好ましいRaは、メチル、エチル、プロピル、ブチル、イソプロピル、sec-ブチル、およびtert-ブチルである。特に好ましいRaは、メチル、エチル、プロピル、およびイソプロピルである。最も好ましいRaは、メチル、およびエチルである。
Preferred Ras are methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, sec-butyl, pentane-2-yl, hexane-2-yl, pentane-3-yl, hexane-3-yl, tert-butyl. , Tert-pentyl, 3-methylpentane-3-yl, and 3-ethylpentane-3-yl. More preferred Ra are methyl, ethyl, propyl, butyl, isopropyl, sec-butyl, and tert-butyl. Particularly preferred Ra are methyl, ethyl, propyl, and isopropyl. The most preferred Ra are methyl and ethyl.
式(1)において、環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよい。
In the formula (1), the ring A 1 and the ring A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the ring A 1 and the ring A 2 , at least one -CH 2- is -O. It may be replaced with −, and at least one − (CH 2 ) 2 − may be replaced with −CH = CH−.
好ましい環A1または環A2の例は、下記式(25-1)から式(25-27)で表される二価基である。さらに好ましい例は、式(25-1)から式(25-17)で表される二価基である。特に好ましい例は、式(25-1)から式(25-3)、および式(25-13)から式(25-17)で表される二価基である。最も好ましい例は、式(25-1)から式(25-3)で表される二価基である。
An example of a preferred ring A 1 or ring A 2 is a divalent group represented by the following formulas (25-1) to (25-27). A more preferable example is a divalent group represented by the formulas (25-1) to (25-17). Particularly preferred examples are divalent groups represented by formulas (25-1) to (25-3) and formulas (25-13) to formulas (25-17). The most preferable example is a divalent group represented by the formulas (25-1) to (25-3).
式(1)において、環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよい。
In formula (1), ring N 1 and ring N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4. -Tetrahydronaphthalene-2,6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran -2,5-diyl, dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4- Diyl, furan-2,5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2, With 5-diyl, benzo [b] thiophene-2,6-diyl, 9,10-dihydrophenanthrene-2,7-diyl, 9H-xanthene-2,6-diyl, or 9H-fluorene-2,7-diyl Yes, in rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH. It may be replaced by 2F.
「環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよい」の好ましい例は、下記式(26-1)から式(26-71)で表される二価基である。さらに好ましい例は、式(26-1)から式(26-4)、式(26-6)、式(26-10)から式(26-15)、および式(26-54)から(26-59)で表される二価基である。
"In Ring N 1 and Ring N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2. A preferred example of "may be replaced by F" is a divalent group represented by the following formulas (26-1) to (26-71). More preferred examples are equations (26-1) to (26-4), equations (26-6), equations (26-10) to (26-15), and equations (26-54) to (26). It is a divalent group represented by -59).
さらに好ましい環N1または環N2は、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,3-ジオキサン-2,5-ジイル、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,3-ジフルオロ-1,4-フェニレン、2,5-ジフルオロ-1,4-フェニレン、2,6-ジフルオロ-1,4-フェニレン、2,3,5-トリフルオロ-1,4-フェニレン、ピリジン-2,5-ジイル、3-フルオロピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、ピリダジン-2,5-ジイル、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、およびナフタレン-2,6-ジイルである。1,4-シクロヘキシレンおよび1,3-ジオキサン-2,5-ジイルの立体配置はシスよりもトランスが好ましい。
More preferred ring N 1 or ring N 2 is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,3-dioxane-2,5-diyl, 1,4-phenylene, 2-fluoro-1, 4-Phenylene, 2,3-difluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, 2,3,5-trifluoro-1 , 4-Phenylene, pyridine-2,5-diyl, 3-fluoropyridine-2,5-diyl, pyrimidine-2,5-diyl, pyridazine-2,5-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, and naphthalene-2,6-diyl. The configuration of 1,4-cyclohexylene and 1,3-dioxane-2,5-diyl is preferably trans over cis.
特に好ましい環N1または環N2は、1,4-シクロヘキシレン、1,3-ジオキサン-2,5-ジイル、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,3-ジフルオロ-1,4-フェニレン、2,5-ジフルオロ-1,4-フェニレン、2,6-ジフルオロ-1,4-フェニレン、ピリジン-2,5-ジイル、およびピリミジン-2,5-ジイルである。最も好ましい環N1または環N2は、1,4-シクロヘキシレンおよび1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,3-ジフルオロ-1,4-フェニレンである。
Particularly preferred ring N 1 or ring N 2 is 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-. Difluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, pyridine-2,5-diyl, and pyrimidine-2,5-diyl. .. The most preferred ring N 1 or ring N 2 is 1,4-cyclohexylene and 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene.
式(1)において、Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、-CO-、または-SiH2-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよい。
In formula (1), Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, in Z 1 , Z 2 , Z 3 , and Z 4 . , At least one -CH 2- may be replaced with -O-, -S-, -CO-, or -SiH 2- , and at least one- (CH 2 ) 2 -is -CH = CH. -Or -C≡C- may be replaced, and at least one hydrogen may be replaced with fluorine or chlorine.
Z1、Z2、Z3、またはZ4の具体的な例は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CH-、-CH=CF-、-CF=CF-、-C≡C-、-CH2CO-、-COCH2-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、および-OCH2-CH=CH-である。-CH=CH-、-CF=CF-、-CH=CH-CH2O-、-OCH2-CH=CH-のような結合基の二重結合に関する立体配置はシスよりもトランスが好ましい。
Specific examples of Z 1 , Z 2 , Z 3 , or Z 4 are single bond, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH-, -CF = CH-, -CH = CF-, -CF = CF-, -C≡C-, -CH 2 CO-, -COCH 2- ,-(CH 2 ) 4 -,-(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2- , -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH) 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, and -OCH 2-CH = CH-. .. Trans is preferred over cis for the configuration of the double bond of the linking group such as -CH = CH-, -CF = CF-, -CH = CH-CH 2 O-, -OCH 2-CH = CH-.
好ましいZ1、Z2、Z3、またはZ4は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、および-OCH2-CH=CH-である。さらに好ましいZ1、Z2またはZ3は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-CH=CH-、-(CH2)2-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、および-(CH2)2-CH=CH-である。最も好ましいZ1、Z2、Z3、またはZ4は、単結合、-CH2O-または-OCH2-である。
Preferred Z 1 , Z 2 , Z 3 or Z 4 are single bonds, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-( CH 2 ) 2- , -CH = CH-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2- , -(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, and -OCH 2-CH = CH-. More preferred Z 1 , Z 2 or Z 3 are single bonds, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2- , -CH = CH- ,-(CH 2 ) 2 -,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2-, and-( CH 2 ) 2- CH = CH-. The most preferred Z 1 , Z 2 , Z 3 or Z 4 are single bonds, -CH 2 O- or -OCH 2- .
式(1)において、L1、L2、L3、L4、L5、およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nである。
In formula (1), L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently contain hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, and -OCF. 3, -OCHF 2, a -OCH 2 F or -C≡N,.
式(1)において、L5およびL6が共に水素であるとき、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L1、L2、L3、およびL4の少なくとも1つは、水素であってもよい。さらに好ましいL1、L2、L3、およびL4は、フッ素または-CF3である。特に好ましいL1、L2、L3、およびL4は、フッ素である。
In formula (1), when both L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH. 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 1 , L 2 , L 3 , and L 4 may be hydrogen. More preferred L 1 , L 2 , L 3 and L 4 are fluorine or -CF 3 . Particularly preferred L 1 , L 2 , L 3 and L 4 are fluorine.
式(1)において、L1、L2、L3、およびL4が共に水素であるとき、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L5およびL6の少なくとも1つは、水素であってもよい。さらに好ましいL5およびL6は、フッ素または-CF3である。特に好ましいL5およびL6は、フッ素である。
In formula (1), when L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH. 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 5 and L 6 may be hydrogen. More preferred L 5 and L 6 are fluorine or -CF 3 . Particularly preferred L 5 and L 6 are fluorine.
式(1)において、l、およびoは独立して、0、または1であり、m、およびnは独立して、0、1、または2であり、l、m、n、およびoの和は0から4の整数である。化合物(1)は、一環から五環を有する。これらの環には通常の六員環に加えて縮合環や架橋された六員環も含まれる。化合物(1)が一、二環を有するときは、他の液晶性化合物との相溶性が良好であり、粘度が小さい。化合物(1)が三環または四環を有するときは、上限温度が高い。化合物(1)が四環を有するときは、液晶相の温度範囲が広い。
In formula (1), l and o are independently 0, or 1, and m, and n are independently 0, 1, or 2, and the sum of l, m, n, and o. Is an integer from 0 to 4. Compound (1) has five rings from one part. These rings include fused rings and crosslinked 6-membered rings in addition to the usual 6-membered rings. When the compound (1) has one or two rings, the compatibility with other liquid crystal compounds is good and the viscosity is low. When compound (1) has three or four rings, the upper limit temperature is high. When compound (1) has four rings, the temperature range of the liquid crystal phase is wide.
化合物(1)の末端基、環および結合基を適切に選択することによって、光学異方性、誘電率異方性などの物性を任意に調整することが可能である。末端基R1およびR2、環A1、およびA2、結合基Z1、Z2、Z3、およびZ4の種類が、化合物(1)の物性に及ぼす効果を以下に説明する。
By appropriately selecting the terminal group, ring and bonding group of compound (1), it is possible to arbitrarily adjust physical properties such as optical anisotropy and dielectric anisotropy. The effects of the types of terminal groups R 1 and R 2 , rings A 1 and A 2 , binding groups Z 1 , Z 2 , Z 3 and Z 4 on the physical properties of compound (1) will be described below.
化合物(1)において、R1またはR2が直鎖であるときは液晶相の温度範囲が広くそして粘度が小さい。R1またはR2が分岐鎖であるとき、他の液晶性化合物との相溶性が良好である。R1またはR2が光学活性基である化合物は、キラルドーパントとして有用である。この化合物を組成物に添加することによって、素子に発生するリバース・ツイスト・ドメイン(Reverse twisted domain)を防止することができる。R1またはR2が光学活性基でない化合物は、組成物の成分として有用である。R1またはR2がアルケニルであるとき、好ましい立体配置は二重結合の位置に依存する。好ましい立体配置を有するアルケニル化合物は、高い上限温度または液晶相の広い温度範囲を有する。Mol. Cryst. Liq. Cryst., 1985, 131, 109およびMol. Cryst. Liq. Cryst., 1985, 131, 327に詳細な説明がある。
In compound (1), when R 1 or R 2 is linear, the temperature range of the liquid crystal phase is wide and the viscosity is low. When R 1 or R 2 is a branched chain, the compatibility with other liquid crystal compounds is good. Compounds in which R 1 or R 2 are optically active groups are useful as chiral dopants. By adding this compound to the composition, it is possible to prevent the reverse twisted domain generated in the device. Compounds in which R 1 or R 2 is not an optically active group are useful as components of the composition. When R 1 or R 2 is alkenyl, the preferred configuration depends on the position of the double bond. Alkenyl compounds with a preferred configuration have a high upper temperature limit or a wide temperature range of the liquid crystal phase. Mol. Cryst. Liq. Cryst., 1985, 131, 109 and Mol. Cryst. Liq. Cryst., 1985, 131, 327 have detailed explanations.
環A1、または環A2が、少なくとも1つの水素がフッ素または塩素で置き換えられてもよい1,4-フェニレン、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、またはピリダジン-3,6-ジイルであるとき、光学異方性が大きい。環が、1,4-シクロヘキシレン、1,4-シクロヘキセニレンまたは1,3-ジオキサン-2,5-ジイルであるとき、光学異方性が小さい。
Ring A 1 or ring A 2 may have at least one hydrogen substituted with fluorine or chlorine 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, or pyridazine-3. When it is 6,6-diyl, the optical anisotropy is large. When the ring is 1,4-cyclohexylene, 1,4-cyclohexenylene or 1,3-dioxane-2,5-diyl, the optical anisotropy is small.
少なくとも2つの環が1,4-シクロヘキシレンであるとき、上限温度が高く、光学異方性が小さく、そして粘度が小さい。少なくとも1つの環が1,4-フェニレンのとき、光学異方性が比較的大きく、そして配向秩序パラメーター(orientational order parameter)が大きい。少なくとも2つの環が1,4-フェニレンであるとき、光学異方性が大きく、液晶相の温度範囲が広く、そして上限温度が高い。
When at least two rings are 1,4-cyclohexylene, the upper limit temperature is high, the optical anisotropy is small, and the viscosity is small. When at least one ring is 1,4-phenylene, the optical anisotropy is relatively large and the orientation parameter is large. When at least two rings are 1,4-phenylene, the optical anisotropy is large, the temperature range of the liquid crystal phase is wide, and the upper limit temperature is high.
結合基Z1、Z2、Z3、またはZ4が単結合、-CH2O-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CF-、または-(CH2)4-であるとき、粘度が小さい。結合基が単結合、-OCF2-、-CF2O-、-(CH2)2-、または-CH=CH-であるときは粘度がより小さい。結合基が-CH=CH-であるとき、液晶相の温度範囲が広く、そして弾性定数比K33/K11(K33:ベンド弾性定数、K11:スプレイ弾性定数)が大きい。結合基が-C≡C-のとき、光学異方性が大きい。
Bonding group Z 1, Z 2, Z 3 or Z 4 is a single bond,, -CH 2 O -, - CF 2 O -, - OCF 2 -, - (CH 2) 2 -, - CH = CH -, - CF = CF-, or - (CH 2) 4 - is when the viscosity is small. The viscosity is smaller when the binding group is a single bond, -OCF 2- , -CF 2 O-,-(CH 2 ) 2- , or -CH = CH-. When the bonding group is −CH = CH−, the temperature range of the liquid crystal phase is wide, and the elastic constant ratio K 33 / K 11 (K 33 : bend elastic constant, K 11 : spray elastic constant) is large. When the bonding group is −C≡C−, the optical anisotropy is large.
化合物(1)が一環または二環を有するときは粘度が小さい。化合物(1)が四環または五環を有するときは上限温度が高い。以上のように、末端基、環、および結合基の種類、環の数を適当に選択することにより必要な物性を有する化合物を得ることができる。したがって、化合物(1)はPC、TN、STN、ECB、OCB、IPS、VAなどモードを有する素子に用いられる組成物の成分として有用である。
When compound (1) has one or two rings, the viscosity is low. When compound (1) has four or five rings, the upper limit temperature is high. As described above, a compound having the required physical properties can be obtained by appropriately selecting the type of terminal group, ring, and bonding group, and the number of rings. Therefore, compound (1) is useful as a component of compositions used in devices having modes such as PC, TN, STN, ECB, OCB, IPS, and VA.
式(1)において、L5およびL6が共に水素であるとき、L1、L2、L3、またはL4がフッ素、塩素、-CF3、または-CHF2であるとき、この化合物は好ましい。L5およびL6が共に水素であるとき、L1、L2、L3、またはL4がフッ素または塩素であるとき、この化合物はさらに好ましい。L5およびL6が共に水素であるとき、L1、L2、L3、またはL4がフッ素であるとき、この化合物は最も好ましい。
In formula (1), this compound is when both L 5 and L 6 are hydrogen, and when L 1 , L 2 , L 3 or L 4 is fluorine, chlorine, -CF 3 , or -CHF 2. preferable. This compound is even more preferred when both L 5 and L 6 are hydrogen and when L 1 , L 2 , L 3 or L 4 is fluorine or chlorine. This compound is most preferred when both L 5 and L 6 are hydrogen and when L 1 , L 2 , L 3 or L 4 is fluorine.
式(1)において、L1、L2、L3、およびL4が共に水素であるとき、L5またはL6がフッ素、塩素、-CF3、または-CHF2であるとき、この化合物は好ましい。L1、L2、L3、およびL4が共に水素であるとき、L5またはL6がフッ素または塩素であるとき、この化合物はさらに好ましい。L1、L2、L3、およびL4が共に水素であるとき、L5またはL6がフッ素であるとき、この化合物は最も好ましい。
In formula (1), when L 1 , L 2 , L 3 , and L 4 are all hydrogen, and L 5 or L 6 is fluorine, chlorine, -CF 3 , or -CHF 2 , this compound is preferable. This compound is even more preferred when L 1 , L 2 , L 3 , and L 4 are all hydrogen, and when L 5 or L 6 is fluorine or chlorine. This compound is most preferred when L 1 , L 2 , L 3 , and L 4 are all hydrogen, and when L 5 or L 6 is fluorine.
化合物(1)の好ましい例は、項2および4に記載した化合物(1-1)から(1-26)である。さらに好ましい例は、項6および8などにおいて下位式で示した化合物である。化合物(1)は、VA、IPS、PSAなどのモードを有する素子に適している。
Preferred examples of the compound (1) are the compounds (1-1) to (1-26) described in Items 2 and 4. A more preferable example is the compound represented by the lower formula in Items 6 and 8. Compound (1) is suitable for devices having modes such as VA, IPS, and PSA.
2.化合物(1)の合成
化合物(1)の合成法を説明する。化合物(1)は、有機合成化学の方法を適切に組み合わせることによって合成できる。必要とする末端基、環および結合基を出発物に導入する方法は、「オーガニック・シンセシス」(Organic Syntheses, John Wiley & Sons, Inc.)、「オーガニック・リアクションズ」(Organic Reactions, John Wiley & Sons, Inc.)、「コンプリヘンシブ・オーガニック・シンセシス」(Comprehensive Organic Synthesis, Pergamon Press)、「新実験化学講座」(丸善)などの成書に記載されている。 2. Synthesis of Compound (1) A method for synthesizing compound (1) will be described. Compound (1) can be synthesized by appropriately combining the methods of synthetic organic chemistry. The methods for introducing the required end groups, rings and binding groups into the starting material are "Organic Syntheses" (John Wiley & Sons, Inc.), "Organic Reactions" (John Wiley & Sons). , Inc.), "Comprehensive Organic Synthesis" (Pergamon Press), "New Experimental Chemistry Course" (Maruzen), etc.
化合物(1)の合成法を説明する。化合物(1)は、有機合成化学の方法を適切に組み合わせることによって合成できる。必要とする末端基、環および結合基を出発物に導入する方法は、「オーガニック・シンセシス」(Organic Syntheses, John Wiley & Sons, Inc.)、「オーガニック・リアクションズ」(Organic Reactions, John Wiley & Sons, Inc.)、「コンプリヘンシブ・オーガニック・シンセシス」(Comprehensive Organic Synthesis, Pergamon Press)、「新実験化学講座」(丸善)などの成書に記載されている。 2. Synthesis of Compound (1) A method for synthesizing compound (1) will be described. Compound (1) can be synthesized by appropriately combining the methods of synthetic organic chemistry. The methods for introducing the required end groups, rings and binding groups into the starting material are "Organic Syntheses" (John Wiley & Sons, Inc.), "Organic Reactions" (John Wiley & Sons). , Inc.), "Comprehensive Organic Synthesis" (Pergamon Press), "New Experimental Chemistry Course" (Maruzen), etc.
2-1.結合基Zの生成
結合基Z1からZ4を生成する方法に関して、最初にスキームを示す。次に、方法(1)から(11)でスキームに記載した反応を説明する。このスキームにおいて、MSG1(またはMSG2)は少なくとも1つの環を有する一価の有機基である。スキームで用いた複数のMSG1(またはMSG2)が表わす一価の有機基は、同一であってもよいし、または異なってもよい。化合物(1A)から(1J)は化合物(1)に相当する。 2-1. From generation bonding group Z 1 of the bonding group Z on how to generate Z 4, illustrating a first scheme. Next, the reactions described in the scheme according to the methods (1) to (11) will be described. In this scheme, MSG 1 (or MSG 2 ) is a monovalent organic group having at least one ring. The monovalent organic groups represented by the plurality of MSG 1 (or MSG 2 ) used in the scheme may be the same or different. Compounds (1A) to (1J) correspond to compound (1).
結合基Z1からZ4を生成する方法に関して、最初にスキームを示す。次に、方法(1)から(11)でスキームに記載した反応を説明する。このスキームにおいて、MSG1(またはMSG2)は少なくとも1つの環を有する一価の有機基である。スキームで用いた複数のMSG1(またはMSG2)が表わす一価の有機基は、同一であってもよいし、または異なってもよい。化合物(1A)から(1J)は化合物(1)に相当する。 2-1. From generation bonding group Z 1 of the bonding group Z on how to generate Z 4, illustrating a first scheme. Next, the reactions described in the scheme according to the methods (1) to (11) will be described. In this scheme, MSG 1 (or MSG 2 ) is a monovalent organic group having at least one ring. The monovalent organic groups represented by the plurality of MSG 1 (or MSG 2 ) used in the scheme may be the same or different. Compounds (1A) to (1J) correspond to compound (1).
(1)単結合の生成
公知の方法で合成されるアリールホウ酸(31)とハロゲン化物(32)とを、炭酸塩およびテトラキス(トリフェニルホスフィン)パラジウムのような触媒の存在下で反応させて化合物(1A)を合成する。この化合物(1A)は、公知の方法で合成されるハロゲン化物(33)にn-ブチルリチウムを、次いで塩化亜鉛を反応させ、ジクロロビス(トリフェニルホスフィン)パラジウムのような触媒の存在下でハロゲン化物(32)を反応させることによっても合成される。 (1) Generation of single bond A compound by reacting arylboric acid (31) and a halide (32) synthesized by a known method in the presence of a catalyst such as carbonate and tetrakis (triphenylphosphine) palladium. (1A) is synthesized. This compound (1A) is prepared by reacting a halide (33) synthesized by a known method with n-butyllithium and then zinc chloride, and in the presence of a catalyst such as dichlorobis (triphenylphosphine) palladium. It is also synthesized by reacting (32).
公知の方法で合成されるアリールホウ酸(31)とハロゲン化物(32)とを、炭酸塩およびテトラキス(トリフェニルホスフィン)パラジウムのような触媒の存在下で反応させて化合物(1A)を合成する。この化合物(1A)は、公知の方法で合成されるハロゲン化物(33)にn-ブチルリチウムを、次いで塩化亜鉛を反応させ、ジクロロビス(トリフェニルホスフィン)パラジウムのような触媒の存在下でハロゲン化物(32)を反応させることによっても合成される。 (1) Generation of single bond A compound by reacting arylboric acid (31) and a halide (32) synthesized by a known method in the presence of a catalyst such as carbonate and tetrakis (triphenylphosphine) palladium. (1A) is synthesized. This compound (1A) is prepared by reacting a halide (33) synthesized by a known method with n-butyllithium and then zinc chloride, and in the presence of a catalyst such as dichlorobis (triphenylphosphine) palladium. It is also synthesized by reacting (32).
(2)-COO-の生成
ハロゲン化物(33)にn-ブチルリチウムを、続いて二酸化炭素を反応させてカルボン酸(34)を得る。公知の方法で合成される化合物(35)とカルボン酸(34)とをDDC(1,3-ジシクロヘキシルカルボジイミド)とDMAP(4-ジメチルアミノピリジン)の存在下で脱水させて化合物(1B)を合成する。 (2) Production of -COO- The halide (33) is reacted with n-butyllithium and then carbon dioxide to obtain a carboxylic acid (34). Compound (1B) is synthesized by dehydrating compound (35) and carboxylic acid (34) synthesized by a known method in the presence of DDC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine). do.
ハロゲン化物(33)にn-ブチルリチウムを、続いて二酸化炭素を反応させてカルボン酸(34)を得る。公知の方法で合成される化合物(35)とカルボン酸(34)とをDDC(1,3-ジシクロヘキシルカルボジイミド)とDMAP(4-ジメチルアミノピリジン)の存在下で脱水させて化合物(1B)を合成する。 (2) Production of -COO- The halide (33) is reacted with n-butyllithium and then carbon dioxide to obtain a carboxylic acid (34). Compound (1B) is synthesized by dehydrating compound (35) and carboxylic acid (34) synthesized by a known method in the presence of DDC (1,3-dicyclohexylcarbodiimide) and DMAP (4-dimethylaminopyridine). do.
(3)-CF2O-の生成
化合物(1B)をローソン試薬のような硫黄化剤で処理してチオノエステル(36)を得る。チオノエステル(36)をフッ化水素ピリジン錯体とNBS(N-ブロモスクシンイミド)でフッ素化し、化合物(1C)を合成する。M. Kuroboshi et al., Chem. Lett., 1992,827.を参照。化合物(1C)はチオノエステル(36)をDAST((ジエチルアミノ)サルファートリフルオリド)でフッ素化しても合成される。W. H. Bunnelle et al., J. Org. Chem. 1990, 55, 768.を参照。Peer. Kirsch et al., Angew. Chem. Int. Ed. 2001, 40, 1480. に記載の方法によってこの結合基を生成させることも可能である。 (3) -Production of -CF 2 O- Compound (1B) is treated with a sulfurizing agent such as Lawesson's reagent to obtain thionoester (36). The thionoester (36) is fluorinated with a hydrogen fluoride pyridine complex and NBS (N-bromosuccinimide) to synthesize compound (1C). See M. Kuroboshi et al., Chem. Lett., 1992, 827. Compound (1C) is also synthesized by fluorinating thionoester (36) with DAST ((diethylamino) sulfur trifluoride). See W. H. Bunnelle et al., J. Org. Chem. 1990, 55, 768. It is also possible to generate this linking group by the method described in Peer. Kirsch et al., Angew. Chem. Int. Ed. 2001, 40, 1480.
化合物(1B)をローソン試薬のような硫黄化剤で処理してチオノエステル(36)を得る。チオノエステル(36)をフッ化水素ピリジン錯体とNBS(N-ブロモスクシンイミド)でフッ素化し、化合物(1C)を合成する。M. Kuroboshi et al., Chem. Lett., 1992,827.を参照。化合物(1C)はチオノエステル(36)をDAST((ジエチルアミノ)サルファートリフルオリド)でフッ素化しても合成される。W. H. Bunnelle et al., J. Org. Chem. 1990, 55, 768.を参照。Peer. Kirsch et al., Angew. Chem. Int. Ed. 2001, 40, 1480. に記載の方法によってこの結合基を生成させることも可能である。 (3) -Production of -CF 2 O- Compound (1B) is treated with a sulfurizing agent such as Lawesson's reagent to obtain thionoester (36). The thionoester (36) is fluorinated with a hydrogen fluoride pyridine complex and NBS (N-bromosuccinimide) to synthesize compound (1C). See M. Kuroboshi et al., Chem. Lett., 1992, 827. Compound (1C) is also synthesized by fluorinating thionoester (36) with DAST ((diethylamino) sulfur trifluoride). See W. H. Bunnelle et al., J. Org. Chem. 1990, 55, 768. It is also possible to generate this linking group by the method described in Peer. Kirsch et al., Angew. Chem. Int. Ed. 2001, 40, 1480.
(4)-CH=CH-の生成
ハロゲン化物(32)をn-ブチルリチウムで処理した後、DMF(N,N-ジメチルホルムアミド)と反応させてアルデヒド(38)を得る。公知の方法で合成されるホスホニウム塩(37)をカリウムt-ブトキシドのような塩基で処理してリンイリドを発生させる。このリンイリドをアルデヒド(38)に反応させて化合物(1D)を合成する。反応条件によってはシス体が生成するので、必要に応じて公知の方法によりシス体をトランス体に異性化する。 (4) Production of -CH = CH- The halide (32) is treated with n-butyllithium and then reacted with DMF (N, N-dimethylformamide) to obtain an aldehyde (38). The phosphonium salt (37) synthesized by a known method is treated with a base such as potassium t-butoxide to generate phosphorus irid. This phosphorus irid is reacted with aldehyde (38) to synthesize compound (1D). Since a cis form is produced depending on the reaction conditions, the cis form is isomerized to a trans form by a known method if necessary.
ハロゲン化物(32)をn-ブチルリチウムで処理した後、DMF(N,N-ジメチルホルムアミド)と反応させてアルデヒド(38)を得る。公知の方法で合成されるホスホニウム塩(37)をカリウムt-ブトキシドのような塩基で処理してリンイリドを発生させる。このリンイリドをアルデヒド(38)に反応させて化合物(1D)を合成する。反応条件によってはシス体が生成するので、必要に応じて公知の方法によりシス体をトランス体に異性化する。 (4) Production of -CH = CH- The halide (32) is treated with n-butyllithium and then reacted with DMF (N, N-dimethylformamide) to obtain an aldehyde (38). The phosphonium salt (37) synthesized by a known method is treated with a base such as potassium t-butoxide to generate phosphorus irid. This phosphorus irid is reacted with aldehyde (38) to synthesize compound (1D). Since a cis form is produced depending on the reaction conditions, the cis form is isomerized to a trans form by a known method if necessary.
(5)-(CH2)2-の生成
化合物(1D)をパラジウム炭素のような触媒の存在下で水素化することにより、化合物(1E)を合成する。 (5)-(CH 2 ) 2- Production Compound (1E) is synthesized by hydrogenating compound (1D) in the presence of a catalyst such as palladium carbon.
化合物(1D)をパラジウム炭素のような触媒の存在下で水素化することにより、化合物(1E)を合成する。 (5)-(CH 2 ) 2- Production Compound (1E) is synthesized by hydrogenating compound (1D) in the presence of a catalyst such as palladium carbon.
(6)-(CH2)4-の生成
ホスホニウム塩(37)の代わりにホスホニウム塩(39)を用い、方法(4)の方法に従って-(CH2)2-CH=CH-を有する化合物を得る。これを接触水素化して化合物(1F)を合成する。 (6)-(CH 2 ) 4- Formation A phosphonium salt (39) is used instead of the phosphonium salt (37), and a compound having- (CH 2 ) 2- CH = CH-is prepared according to the method of method (4). obtain. This is catalytically hydrogenated to synthesize compound (1F).
ホスホニウム塩(37)の代わりにホスホニウム塩(39)を用い、方法(4)の方法に従って-(CH2)2-CH=CH-を有する化合物を得る。これを接触水素化して化合物(1F)を合成する。 (6)-(CH 2 ) 4- Formation A phosphonium salt (39) is used instead of the phosphonium salt (37), and a compound having- (CH 2 ) 2- CH = CH-is prepared according to the method of method (4). obtain. This is catalytically hydrogenated to synthesize compound (1F).
(7)-CH2CH=CHCH2-の生成
ホスホニウム塩(37)の代わりにホスホニウム塩(40)を、アルデヒド(38)の代わりにアルデヒド(41)を用い、方法(4)の方法に従って化合物(1G)を合成する。反応条件によってはトランス体が生成するので、必要に応じて公知の方法によりトランス体をシス体に異性化する。 (7) -CH 2 CH = CHCH 2- Formation A compound according to the method (4), using a phosphonium salt (40) instead of the phosphonium salt (37) and an aldehyde (41) instead of the aldehyde (38). (1G) is synthesized. Since a trans form is produced depending on the reaction conditions, the trans form is isomerized to a cis form by a known method if necessary.
ホスホニウム塩(37)の代わりにホスホニウム塩(40)を、アルデヒド(38)の代わりにアルデヒド(41)を用い、方法(4)の方法に従って化合物(1G)を合成する。反応条件によってはトランス体が生成するので、必要に応じて公知の方法によりトランス体をシス体に異性化する。 (7) -CH 2 CH = CHCH 2- Formation A compound according to the method (4), using a phosphonium salt (40) instead of the phosphonium salt (37) and an aldehyde (41) instead of the aldehyde (38). (1G) is synthesized. Since a trans form is produced depending on the reaction conditions, the trans form is isomerized to a cis form by a known method if necessary.
(8)-C≡C-の生成
ジクロロパラジウムとハロゲン化銅との触媒存在下で、ハロゲン化物(33)に2-メチル-3-ブチン-2-オールを反応させたのち、塩基性条件下で脱保護して化合物(32)を得る。ジクロロパラジウムとハロゲン化銅との触媒存在下、化合物(42)をハロゲン化物(32)と反応させて、化合物(1H)を合成する。 (8) Production of -C≡C- After reacting the halide (33) with 2-methyl-3-butin-2-ol in the presence of a catalyst of dichloropalladium and copper halide, under basic conditions. Deprotection with to give compound (32). Compound (42) is reacted with a halide (32) in the presence of a catalyst of dichloropalladium and copper halide to synthesize compound (1H).
ジクロロパラジウムとハロゲン化銅との触媒存在下で、ハロゲン化物(33)に2-メチル-3-ブチン-2-オールを反応させたのち、塩基性条件下で脱保護して化合物(32)を得る。ジクロロパラジウムとハロゲン化銅との触媒存在下、化合物(42)をハロゲン化物(32)と反応させて、化合物(1H)を合成する。 (8) Production of -C≡C- After reacting the halide (33) with 2-methyl-3-butin-2-ol in the presence of a catalyst of dichloropalladium and copper halide, under basic conditions. Deprotection with to give compound (32). Compound (42) is reacted with a halide (32) in the presence of a catalyst of dichloropalladium and copper halide to synthesize compound (1H).
(9)-CF=CF-の生成
ハロゲン化物(33)をn-ブチルリチウムで処理したあと、テトラフルオロエチレンを反応させて化合物(43)を得る。ハロゲン化物(32)をn-ブチルリチウムで処理したあと化合物(43)と反応させて化合物(1I)を合成する。 (9) Production of -CF = CF-The halide (33) is treated with n-butyllithium and then reacted with tetrafluoroethylene to obtain compound (43). The halide (32) is treated with n-butyllithium and then reacted with the compound (43) to synthesize the compound (1I).
ハロゲン化物(33)をn-ブチルリチウムで処理したあと、テトラフルオロエチレンを反応させて化合物(43)を得る。ハロゲン化物(32)をn-ブチルリチウムで処理したあと化合物(43)と反応させて化合物(1I)を合成する。 (9) Production of -CF = CF-The halide (33) is treated with n-butyllithium and then reacted with tetrafluoroethylene to obtain compound (43). The halide (32) is treated with n-butyllithium and then reacted with the compound (43) to synthesize the compound (1I).
(10)-OCH2-の生成
アルデヒド(38)を水素化ホウ素ナトリウムなどの還元剤で還元して化合物(44)を得る。化合物(44)を臭化水素酸などで臭素化して臭化物(45)を得る。炭酸カリウムなどの塩基存在下で、臭化物(45)を化合物(46)と反応させて化合物(1J)を合成する。 (10) -Production of -OCH 2- The aldehyde (38) is reduced with a reducing agent such as sodium borohydride to obtain the compound (44). Compound (44) is bromide with hydrobromic acid or the like to obtain bromide (45). In the presence of a base such as potassium carbonate, the bromide (45) is reacted with the compound (46) to synthesize the compound (1J).
アルデヒド(38)を水素化ホウ素ナトリウムなどの還元剤で還元して化合物(44)を得る。化合物(44)を臭化水素酸などで臭素化して臭化物(45)を得る。炭酸カリウムなどの塩基存在下で、臭化物(45)を化合物(46)と反応させて化合物(1J)を合成する。 (10) -Production of -OCH 2- The aldehyde (38) is reduced with a reducing agent such as sodium borohydride to obtain the compound (44). Compound (44) is bromide with hydrobromic acid or the like to obtain bromide (45). In the presence of a base such as potassium carbonate, the bromide (45) is reacted with the compound (46) to synthesize the compound (1J).
(11)-(CF2)2-の生成
J. Am. Chem. Soc., 2001, 123, 5414. に記載された方法に従い、ジケトン(-COCO-)をフッ化水素触媒の存在下、四フッ化硫黄でフッ素化して-(CF2)2-を有する化合物を得る。 (11)-(CF 2 ) 2- Generation of diketone (-COCO-) in the presence of hydrogen fluoride catalyst according to the method described in J. Am. Chem. Soc., 2001, 123, 5414. Fluorination with sulfur fluoride gives a compound having- (CF 2 ) 2-.
J. Am. Chem. Soc., 2001, 123, 5414. に記載された方法に従い、ジケトン(-COCO-)をフッ化水素触媒の存在下、四フッ化硫黄でフッ素化して-(CF2)2-を有する化合物を得る。 (11)-(CF 2 ) 2- Generation of diketone (-COCO-) in the presence of hydrogen fluoride catalyst according to the method described in J. Am. Chem. Soc., 2001, 123, 5414. Fluorination with sulfur fluoride gives a compound having- (CF 2 ) 2-.
2-2.環A1からA3および環N1の生成
次に、環A1からA3および環N1に関する生成法を説明する。1,4-シクロヘキシレン、1,3-ジオキサン-2,5-ジイル、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,3-ジフルオロ-1,4-フェニレン、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイルなどの環に関しては出発物が市販されているか、または生成法がよく知られている。そこで、下に示した化合物(64)、(67)、および(71)について説明する。 2-2. Generated from ring A 1 of A 3 and ring N 1 Next, a production method related to A 3 and ring N 1 illustrating the rings A 1. 1,4-Cyclohexylene, 1,3-dioxane-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene, pyridine-2 For rings such as, 5-dioxane and pyrimidine-2,5-dioxane, starting materials are commercially available or the production method is well known. Therefore, the compounds (64), (67), and (71) shown below will be described.
次に、環A1からA3および環N1に関する生成法を説明する。1,4-シクロヘキシレン、1,3-ジオキサン-2,5-ジイル、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,3-ジフルオロ-1,4-フェニレン、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイルなどの環に関しては出発物が市販されているか、または生成法がよく知られている。そこで、下に示した化合物(64)、(67)、および(71)について説明する。 2-2. Generated from ring A 1 of A 3 and ring N 1 Next, a production method related to A 3 and ring N 1 illustrating the rings A 1. 1,4-Cyclohexylene, 1,3-dioxane-2,5-diyl, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene, pyridine-2 For rings such as, 5-dioxane and pyrimidine-2,5-dioxane, starting materials are commercially available or the production method is well known. Therefore, the compounds (64), (67), and (71) shown below will be described.
デカヒドロナフタレン-2,6-ジオン(64)はデカヒドロナフタレン-2,6-ジイルを有する化合物の出発物である。この化合物(64)は、特開2000-239564号公報に記載された方法に従って、ジオール(63)を酸化ルテニウム存在下で接触水素還元し、さらに酸化クロムで酸化することによって得られる。この化合物は通常の方法によって化合物(1)に変換する。
Decahydronaphthalen-2,6-dione (64) is a starting material for compounds having decahydronaphthalen-2,6-diyl. This compound (64) is obtained by catalytically reducing diol (63) with ruthenium oxide in the presence of ruthenium oxide and further oxidizing with chromium oxide according to the method described in JP-A-2000-239564. This compound is converted to compound (1) by a usual method.
2,3-(ビストリフルオロメチル)フェニレンの構造単位は、Org. Lett., 2000, 2 (21), 3345 に記載された方法で合成する。フラン(65)と1,1,1,4,4,4-ヘキサフルオロ-2-ブチンとを高温でディールス・アルダー型の反応をさせることによってアニリン(66)を合成する。この化合物に、Org. Synth. Coll., Vol. 2, 1943, 355 に記載された方法にしたがい、ザンドマイヤー型反応を行ってヨウ化物(67)を得る。この化合物は通常の方法によって化合物(1)に変換する。
The structural unit of 2,3- (bistrifluoromethyl) phenylene is synthesized by the method described in Org. Lett., 2000, 2 (21), 3345. Aniline (66) is synthesized by reacting furan (65) with 1,1,1,4,4,4-hexafluoro-2-butin at a high temperature in a Diels-Alder type reaction. This compound is subjected to a Sandmeyer-type reaction according to the method described in Org. Synth. Coll., Vol. 2, 1943, 355 to obtain an iodide (67). This compound is converted to compound (1) by a usual method.
2-ジフルオロメチル-3-フルオロフェニレンの構造単位は、次のような方法で合成する。化合物(68)の水酸基を適切な保護基で保護して化合物(69)を得る。Pは保護基を意味する。化合物(69)にs-ブチルリチウムを作用させ、続いてN,N-ジメチルホルムアミド(DMF)を反応させてアルデヒド(70)を得る。この化合物をジエチルアミノサルファートリフルオリド(DAST)でフッ素化し、続いて脱保護してフェノール(71)を得る。この化合物は通常の方法によって化合物(1)に変換する。
The structural unit of 2-difluoromethyl-3-fluorophenylene is synthesized by the following method. The hydroxyl group of compound (68) is protected with an appropriate protecting group to obtain compound (69). P means protecting group. Compound (69) is reacted with s-butyllithium followed by N, N-dimethylformamide (DMF) to give aldehyde (70). This compound is fluorinated with diethylaminosulfur trifluoride (DAST) and subsequently deprotected to give phenol (71). This compound is converted to compound (1) by a usual method.
2-3.3,6-ジヒドロ-2H-ピラン環の生成
この環を生成する方法を、式(pr-1)で表される二価基を有する化合物(1a)および(1b)を用いて説明する。式(pr-2)で表される二価基を有する化合物も、この方法によって合成できる。化合物(1a)の合成スキームは次のとおりである。 Formation of 2-3.3,6-dihydro-2H-pyran ring A method for forming this ring is carried out using compounds (1a) and (1b) having a divalent group represented by the formula (pr-1). explain. A compound having a divalent group represented by the formula (pr-2) can also be synthesized by this method. The synthetic scheme of compound (1a) is as follows.
この環を生成する方法を、式(pr-1)で表される二価基を有する化合物(1a)および(1b)を用いて説明する。式(pr-2)で表される二価基を有する化合物も、この方法によって合成できる。化合物(1a)の合成スキームは次のとおりである。 Formation of 2-3.3,6-dihydro-2H-pyran ring A method for forming this ring is carried out using compounds (1a) and (1b) having a divalent group represented by the formula (pr-1). explain. A compound having a divalent group represented by the formula (pr-2) can also be synthesized by this method. The synthetic scheme of compound (1a) is as follows.
化合物(s-1)は、特開2011-136924号公報に記載の方法に従って合成する。化合物(s-1)を、水素化ホウ素ナトリウムなどの還元剤で還元して化合物(s-2)を得る。この化合物をトリフェニルホスフィンと四ハロゲン化炭素によりハロゲン化し、ジアザビシクロウンデセン(DBU)などの脱ハロゲン化剤で処理することにより、目的の化合物(1a)を得る。
Compound (s-1) is synthesized according to the method described in JP-A-2011-136924. Compound (s-1) is reduced with a reducing agent such as sodium borohydride to obtain compound (s-2). This compound is halogenated with triphenylphosphine and carbon tetrahalogenate, and treated with a dehalogenating agent such as diazabicycloundecene (DBU) to obtain the target compound (1a).
化合物(1b)の合成スキームは、上記のとおりである。化合物(s-3)に三フッ化ホウ素ジエチルエーテル錯体などのルイス酸存在下、アルデヒド(17)を反応させた後、水素添加することにより化合物(s-4)を得る。この化合物を水素化アルミニウムリチウムなどの還元剤で還元して化合物(s-5)を得る。この化合物をトリフェニルホスフィンと四ハロゲン化炭素によりハロゲン化し、ジアザビシクロウンデセン(DBU)などの脱ハロゲン化剤で処理することにより、化合物(1b)を得る。
The synthesis scheme of compound (1b) is as described above. Compound (s-4) is obtained by reacting compound (s-3) with aldehyde (17) in the presence of a Lewis acid such as boron trifluoride diethyl ether complex, and then hydrogenating the compound (s-3). This compound is reduced with a reducing agent such as lithium aluminum hydride to obtain compound (s-5). Compound (1b) is obtained by halogenating this compound with triphenylphosphine and carbon tetrahalogenate and treating it with a dehalogenating agent such as diazabicycloundecene (DBU).
2-4.カルバゾール環の生成
化合物(1c)~(1f)の合成スキームは次のとおりである。 2-4. Carbazole ring formation The synthetic schemes of the compounds (1c) to (1f) are as follows.
化合物(1c)~(1f)の合成スキームは次のとおりである。 2-4. Carbazole ring formation The synthetic schemes of the compounds (1c) to (1f) are as follows.
化合物(s-6)、化合物(s-7)、Pd(amphos)Cl2、とt-ブトキシナトリウムを反応させ化合物(s-8)を得る。Pは保護基を意味する。この化合物の脱保護を行い、化合物(s-9)を得る。この化合物と酢酸パラジウムを酢酸中で反応させ(1c)を得る。この化合物のアルキル化を行い、化合物(1d)を得る。これらの化合物において、L1、L2、L3およびL4の定義は、項1に記載した記号の定義と同一である。RA1またはRA2の定義は、MSG1と項1に記載したR1またはR2の定義と同一である。
Compound (s-6), compound (s-7), Pd (amphos) Cl2, and t-butoxysodium are reacted to obtain compound (s-8). P means protecting group. Deprotection of this compound is performed to obtain compound (s-9). This compound is reacted with palladium acetate in acetic acid to obtain (1c). Alkylation of this compound is carried out to obtain compound (1d). In these compounds, the definitions of L 1 , L 2 , L 3 and L 4 are the same as the definitions of the symbols described in Item 1. The definition of RA 1 or RA 2 is the same as the definition of R 1 or R 2 described in MSG 1 and Item 1.
化合物(s-10)、化合物(s-11)、Pd(amphos)Cl2、とt-ブトキシナトリウムを反応させ化合物(s-12)を得る。Pは保護基を意味する。この化合物の脱保護を行い、化合物(s-13)を得る。この化合物と酢酸パラジウムを酢酸中で反応させ(1e)を得る。この化合物のアルキル化を行い、化合物(1f)を得る。これらの化合物において、L5およびL6の定義は、項1に記載した記号の定義と同一である。RA1またはRA2の定義は、MSG1と項1に記載したR1またはR2の定義と同一である。
Compound (s-10), compound (s-11), Pd (amphos) Cl2, and t-butoxysodium are reacted to obtain compound (s-12). P means protecting group. Deprotection of this compound is performed to obtain compound (s-13). This compound is reacted with palladium acetate in acetic acid to obtain (1e). Alkylation of this compound is carried out to obtain compound (1f). In these compounds, the definitions of L 5 and L 6 are the same as the definitions of the symbols described in Item 1. The definition of RA 1 or RA 2 is the same as the definition of R 1 or R 2 described in MSG 1 and Item 1.
3.液晶組成物
3-1.成分化合物
本発明の液晶組成物について説明をする。この組成物は、少なくとも1つの化合物(1)を成分(a)として含有する。この組成物は、2つまたは3つ以上の化合物(1)を含有してもよい。組成物の成分が化合物(1)のみであってもよい。組成物は、化合物(1)の少なくとも1つを1重量%から99重量%の範囲で含有することが、良好な物性を発現させるために好ましい。誘電率異方性が負である組成物において、化合物(1)の好ましい含有量は5重量%から60重量%の範囲である。誘電率異方性が正である組成物において、化合物(1)の好ましい含有量は30重量%以下である。 3. 3. Liquid crystal composition 3-1. Ingredients Compounds The liquid crystal composition of the present invention will be described. This composition contains at least one compound (1) as a component (a). The composition may contain two or more compounds (1). The component of the composition may be only compound (1). The composition preferably contains at least one of the compound (1) in the range of 1% by weight to 99% by weight in order to exhibit good physical properties. In the composition having a negative dielectric anisotropy, the preferable content of the compound (1) is in the range of 5% by weight to 60% by weight. In the composition having a positive dielectric anisotropy, the preferable content of the compound (1) is 30% by weight or less.
3-1.成分化合物
本発明の液晶組成物について説明をする。この組成物は、少なくとも1つの化合物(1)を成分(a)として含有する。この組成物は、2つまたは3つ以上の化合物(1)を含有してもよい。組成物の成分が化合物(1)のみであってもよい。組成物は、化合物(1)の少なくとも1つを1重量%から99重量%の範囲で含有することが、良好な物性を発現させるために好ましい。誘電率異方性が負である組成物において、化合物(1)の好ましい含有量は5重量%から60重量%の範囲である。誘電率異方性が正である組成物において、化合物(1)の好ましい含有量は30重量%以下である。 3. 3. Liquid crystal composition 3-1. Ingredients Compounds The liquid crystal composition of the present invention will be described. This composition contains at least one compound (1) as a component (a). The composition may contain two or more compounds (1). The component of the composition may be only compound (1). The composition preferably contains at least one of the compound (1) in the range of 1% by weight to 99% by weight in order to exhibit good physical properties. In the composition having a negative dielectric anisotropy, the preferable content of the compound (1) is in the range of 5% by weight to 60% by weight. In the composition having a positive dielectric anisotropy, the preferable content of the compound (1) is 30% by weight or less.
この組成物は、化合物(1)を成分(a)として含有する。この組成物は、表1に示す成分(b)から(e)から選択された液晶性化合物をさらに含有することが好ましい。この組成物を調製するときには、誘電率異方性の正負と大きさとを考慮して成分(b)から(e)を選択することが好ましい。この組成物は、化合物(1)から(13)および(21)から(24)とは異なる液晶性化合物を含有してもよい。この組成物は、そのような液晶性化合物を含有しなくてもよい。
This composition contains compound (1) as component (a). The composition preferably further contains a liquid crystal compound selected from the components (b) to (e) shown in Table 1. When preparing this composition, it is preferable to select the components (b) to (e) in consideration of the positive and negative of the dielectric anisotropy and the magnitude. This composition may contain liquid crystalline compounds different from compounds (1) to (13) and (21) to (24). This composition does not have to contain such a liquid crystal compound.
成分(b)は、2つの末端基がアルキルなどである化合物である。成分(b)の好ましい例として、化合物(2-1)から(2-11)、化合物(3-1)から(3-19)、および化合物(4-1)から(4-7)を挙げることができる。これらの化合物において、R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR11およびR12において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよい。
Component (b) is a compound having two terminal groups such as alkyl. Preferred examples of the component (b) include compounds (2-1) to (2-11), compounds (3-1) to (3-19), and compounds (4-1) to (4-7). be able to. In these compounds, R 11 and R 12 are independently alkyls with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, and in these R 11 and R 12 , at least one -CH 2- It may be replaced with —O—, and at least one hydrogen may be replaced with fluorine.
成分(b)は、小さな誘電率異方性を有する。成分(b)は中性に近い。化合物(2)は、粘度を下げるまたは光学異方性を調整する効果がある。化合物(3)および(4)は、上限温度を上げることによってネマチック相の温度範囲を広げる、または光学異方性を調整する効果がある。
Component (b) has a small dielectric anisotropy. Component (b) is close to neutral. Compound (2) has the effect of lowering the viscosity or adjusting the optical anisotropy. Compounds (3) and (4) have the effect of widening the temperature range of the nematic phase or adjusting the optical anisotropy by raising the upper limit temperature.
成分(b)の含有量を増加させるにつれて組成物の粘度は小さくなるが誘電率異方性が小さくなる。そこで、素子のしきい値電圧の要求値を満たす限り、含有量は多いほうが好ましい。IPS、VAなどのモード用の組成物を調製する場合には、成分(b)の含有量は、液晶組成物の重量に基づいて、好ましくは30重量%以上、さらに好ましくは40重量%以上である。
As the content of the component (b) is increased, the viscosity of the composition decreases, but the dielectric anisotropy decreases. Therefore, as long as the required value of the threshold voltage of the element is satisfied, it is preferable that the content is large. When preparing a composition for a mode such as IPS or VA, the content of the component (b) is preferably 30% by weight or more, more preferably 40% by weight or more, based on the weight of the liquid crystal composition. be.
成分(c)は、化合物(5)から(13)である。これらの化合物は、2,3-ジフルオロ-1,4-フェニレンのように、ラテラル位が2つのハロゲンで置換されたフェニレンを有する。成分(c)の好ましい例として、化合物(5-1)から(5-9)、化合物(6-1)から(6-19)、化合物(7-1)および(7-2)、化合物(8-1)から(8-3)、化合物(9-1)から(9-3)、化合物(10-1)から(10-11)、化合物(11-1)から(11-3)、化合物(12-1)から(12-3)、および化合物(13-1)を挙げることができる。これらの化合物において、R13およびR14は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR13およびR14において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく、R15は、水素、フッ素、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR15において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、このR15において、少なくとも1つの水素は、フッ素で置き換えられてもよい。
The component (c) is a compound (5) to (13). These compounds have phenylene in which the lateral position is replaced by two halogens, such as 2,3-difluoro-1,4-phenylene. Preferred examples of the component (c) include compounds (5-1) to (5-9), compounds (6-1) to (6-19), compounds (7-1) and (7-2), compounds ( 8-1) to (8-3), compounds (9-1) to (9-3), compounds (10-1) to (10-11), compounds (11-1) to (11-3), Compounds (12-1) to (12-3), and compound (13-1) can be mentioned. In these compounds, R 13 and R 14 are independently alkyls with 1 to 10 carbon atoms or alkenyl with 2 to 10 carbon atoms, and in these R 13 and R 14 , at least one -CH 2- may be replaced by -O-, at least one hydrogen may be replaced by fluorine, R 15 is hydrogen, fluorine, alkenyl alkyl or 2 to 10 carbon atoms from 10 1 carbon atoms, In this R 15 , at least one -CH 2- may be replaced by -O-, and in this R 15 , at least one hydrogen may be replaced by fluorine.
成分(c)は、誘電率異方性が負に大きい。成分(c)は、IPS、VA、PSAなどのモード用の組成物を調製する場合に用いられる。成分(c)の含有量を増加させるにつれて組成物の誘電率異方性が負に大きくなるが、粘度が大きくなる。そこで、素子のしきい値電圧の要求値を満たす限り、含有量は少ないほうが好ましい。誘電率異方性が-5程度であることを考慮すると、充分な電圧駆動をさせるには、含有量が40重量%以上であることが好ましい。
Component (c) has a large negative dielectric anisotropy. Ingredient (c) is used when preparing compositions for modes such as IPS, VA, PSA. As the content of the component (c) is increased, the dielectric anisotropy of the composition becomes negatively large, but the viscosity becomes large. Therefore, as long as the required value of the threshold voltage of the element is satisfied, the content is preferably small. Considering that the dielectric anisotropy is about −5, the content is preferably 40% by weight or more in order to drive the voltage sufficiently.
成分(c)のうち、化合物(5)は二環化合物であるので、粘度を下げる、光学異方性を調整する、または誘電率異方性を上げる効果がある。化合物(6)および(7)は三環化合物であり、化合物(8)は四環化合物であるので、上限温度を上げる、光学異方性を上げる、または誘電率異方性を上げるという効果がある。化合物(9)から(13)は、誘電率異方性を上げるという効果がある。
Of the component (c), the compound (5) is a bicyclic compound, and therefore has the effects of lowering the viscosity, adjusting the optical anisotropy, or increasing the dielectric anisotropy. Since the compounds (6) and (7) are tricyclic compounds and the compound (8) is a tetracyclic compound, they have the effect of increasing the upper limit temperature, increasing the optical anisotropy, or increasing the dielectric anisotropy. be. Compounds (9) to (13) have the effect of increasing the dielectric anisotropy.
IPS、VA、PSAなどのモード用の組成物を調製する場合には、成分(c)の含有量は、液晶組成物の重量に基づいて、好ましくは40重量%以上であり、さらに好ましくは50重量%から95重量%の範囲である。成分(c)を誘電率異方性が正である組成物に添加する場合は、成分(c)の含有量は30重量%以下が好ましい。成分(c)を添加することにより、組成物の弾性定数を調整し、素子の電圧-透過率曲線を調整することが可能となる。
When preparing a composition for a mode such as IPS, VA, PSA, the content of the component (c) is preferably 40% by weight or more, more preferably 50% based on the weight of the liquid crystal composition. It ranges from% to 95% by weight. When the component (c) is added to a composition having a positive dielectric anisotropy, the content of the component (c) is preferably 30% by weight or less. By adding the component (c), it is possible to adjust the elastic constant of the composition and adjust the voltage-transmittance curve of the device.
成分(d)は、右末端にハロゲンまたはフッ素含有基を有する化合物である。成分(d)の好ましい例として、化合物(21-1)から(21-16)、化合物(22-1)から(22-116)、化合物(23-1)から(23-59)を挙げることができる。これらの化合物において、R16は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR16において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素はフッ素で置き換えられてもよい。X11は、フッ素、塩素、-OCF3、-OCHF2、-CF3、-CHF2、-CH2F、-OCF2CHF2、または-OCF2CHFCF3である。
Component (d) is a compound having a halogen or fluorine-containing group at the right end. Preferred examples of the component (d) include compounds (21-1) to (21-16), compounds (22-1) to (22-116), and compounds (23-1) to (23-59). Can be done. In these compounds, R 16 is alkenyl having 2 to 10 carbon alkyl or C 1 to 10 carbon atoms, in the R 16, at least one -CH 2 - may be replaced by -O-, at least One hydrogen may be replaced by fluorine. X 11 is fluorine, chlorine, -OCF 3 , -OCHF 2 , -CF 3 , -CHF 2 , -CH 2 F, -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 .
成分(d)は、誘電率異方性が正であり、熱や光に対する安定性が非常に良好であるので、IPS、FFS、OCBなどのモード用の組成物を調製する場合に用いられる。成分(d)の含有量は、液晶組成物の重量に基づいて1重量%から99重量%の範囲が適しており、好ましくは10重量%から97重量%の範囲、さらに好ましくは40重量%から95重量%の範囲である。成分(d)を誘電率異方性が負である組成物に添加する場合、成分(d)の含有量は30重量%以下が好ましい。成分(d)を添加することにより、組成物の弾性定数を調整し、素子の電圧-透過率曲線を調整することが可能となる。
Component (d) has a positive dielectric anisotropy and very good stability against heat and light, and is therefore used when preparing a composition for modes such as IPS, FFS, and OCB. The content of the component (d) is preferably in the range of 1% by weight to 99% by weight, preferably in the range of 10% by weight to 97% by weight, more preferably from 40% by weight, based on the weight of the liquid crystal composition. It is in the range of 95% by weight. When the component (d) is added to a composition having a negative dielectric anisotropy, the content of the component (d) is preferably 30% by weight or less. By adding the component (d), it is possible to adjust the elastic constant of the composition and adjust the voltage-transmittance curve of the device.
成分(e)は、右末端基が-C≡Nまたは-C≡C-C≡Nである化合物(24)である。成分(e)の好ましい例として、化合物(24-1)から(24-64)を挙げることができる。これらの化合物において、R17は炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR17において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよい。X12は-C≡Nまたは-C≡C-C≡Nである。
Component (e) is compound (24) whose right terminal group is -C≡N or -C≡C-C≡N. Preferred examples of the component (e) include compounds (24-1) to (24-64). In these compounds, R 17 is alkenyl having 2 to 10 carbon alkyl or C 1 to 10 carbon atoms, in the R 17, at least one -CH 2 - may be replaced by -O-, At least one hydrogen may be replaced with fluorine. X 12 is -C ≡ N or -C ≡ C-C ≡ N.
成分(e)は、誘電率異方性が正であり、その値が大きいので、TNなどのモード用の組成物を調製する場合に用いられる。この成分(e)を添加することにより、組成物の誘電率異方性を上げることができる。成分(e)は、液晶相の温度範囲を広げる、粘度を調整する、または光学異方性を調整する、という効果がある。成分(e)は、素子の電圧-透過率曲線の調整にも有用である。
The component (e) has a positive dielectric anisotropy and a large value, and is therefore used when preparing a composition for a mode such as TN. By adding this component (e), the dielectric anisotropy of the composition can be increased. The component (e) has the effect of widening the temperature range of the liquid crystal phase, adjusting the viscosity, or adjusting the optical anisotropy. The component (e) is also useful for adjusting the voltage-transmittance curve of the device.
TNなどのモード用の組成物を調製する場合には、成分(e)の含有量は、液晶組成物の重量に基づいて1重量%から99重量%の範囲が適しており、好ましくは10重量%から97重量%の範囲、さらに好ましくは40重量%から95重量%の範囲である。成分(e)を誘電率異方性が負である組成物に添加する場合、成分(e)の含有量は30重量%以下が好ましい。成分(e)を添加することにより、組成物の弾性定数を調整し、素子の電圧-透過率曲線を調整することが可能となる。
When preparing a composition for a mode such as TN, the content of the component (e) is preferably in the range of 1% by weight to 99% by weight, preferably 10% by weight, based on the weight of the liquid crystal composition. % To 97% by weight, more preferably 40% to 95% by weight. When the component (e) is added to a composition having a negative dielectric anisotropy, the content of the component (e) is preferably 30% by weight or less. By adding the component (e), it is possible to adjust the elastic constant of the composition and adjust the voltage-transmittance curve of the device.
上記の成分(b)から(e)から適切に選択された化合物と化合物(1)とを組み合わせることによって熱や光に対する高い安定性、高い上限温度、低い下限温度、小さな粘度、適切な光学異方性(すなわち、大きな光学異方性または小さな光学異方性)、正または負に大きな誘電率異方性、大きな比抵抗、適切な弾性定数(すなわち、大きな弾性定数または小さな弾性定数)などの物性の少なくとも1つを充足する液晶組成物を調製することができる。このような組成物を含む素子は、素子を使用できる広い温度範囲、短い応答時間、大きな電圧保持率、低いしきい値電圧、大きなコントラスト比、小さなフリッカ率、および長い寿命を有する。
High stability to heat and light, high upper limit temperature, lower lower limit temperature, small viscosity, suitable optical anisotropy by combining the compound appropriately selected from the above components (b) to (e) and the compound (1). Directionality (ie, large optical anisotropy or small optical anisotropy), positive or negative large dielectric anisotropy, large specific resistance, appropriate elastic constants (ie, large elastic constants or small elastic constants), etc. A liquid crystal composition satisfying at least one of the physical characteristics can be prepared. Devices containing such compositions have a wide temperature range in which the device can be used, short response times, high voltage retention, low threshold voltage, high contrast ratio, low flicker rate, and long lifetime.
素子を長時間使用すると、表示画面にフリッカ(flicker)が発生することがある。フリッカ率(%)は、(|正の電圧を印加したときの輝度-負の電圧を印加したときの輝度|/平均輝度)×100、によって表すことができる。フリッカ率が0%から1%の範囲である素子は、素子を長時間使用しても、表示画面にフリッカ(flicker)が発生しにくい。このフリッカは、画像の焼き付きに関連し、交流で駆動させる際に正フレームと負フレームの間の電位差によって発生すると推定される。化合物(1)を含有する組成物は、フリッカの発生を低減させるのにも有用である。
If the element is used for a long time, flicker may occur on the display screen. The flicker rate (%) can be expressed by (| brightness when a positive voltage is applied-brightness when a negative voltage is applied | / average brightness) x 100. An element having a flicker rate in the range of 0% to 1% is less likely to cause flicker on the display screen even if the element is used for a long time. This flicker is related to image burn-in and is presumed to be caused by the potential difference between the positive and negative frames when driven by alternating current. The composition containing the compound (1) is also useful for reducing the occurrence of flicker.
3-2.添加物
液晶組成物は公知の方法によって調製される。例えば、成分化合物を混合し、そして加熱によって互いに溶解させる。用途に応じて、この組成物に添加物を添加してよい。添加物の例は、重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、色素、消泡剤などである。このような添加物は当業者によく知られており、文献に記載されている。 3-2. Additives The liquid crystal composition is prepared by a known method. For example, the constituent compounds are mixed and dissolved by heating. Additives may be added to this composition depending on the application. Examples of additives are polymerizable compounds, polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, ultraviolet absorbers, light stabilizers, heat stabilizers, dyes, defoamers and the like. Such additives are well known to those of skill in the art and are described in the literature.
液晶組成物は公知の方法によって調製される。例えば、成分化合物を混合し、そして加熱によって互いに溶解させる。用途に応じて、この組成物に添加物を添加してよい。添加物の例は、重合性化合物、重合開始剤、重合禁止剤、光学活性化合物、酸化防止剤、紫外線吸収剤、光安定剤、熱安定剤、色素、消泡剤などである。このような添加物は当業者によく知られており、文献に記載されている。 3-2. Additives The liquid crystal composition is prepared by a known method. For example, the constituent compounds are mixed and dissolved by heating. Additives may be added to this composition depending on the application. Examples of additives are polymerizable compounds, polymerization initiators, polymerization inhibitors, optically active compounds, antioxidants, ultraviolet absorbers, light stabilizers, heat stabilizers, dyes, defoamers and the like. Such additives are well known to those of skill in the art and are described in the literature.
PSA(polymer sustained alignment;高分子支持配向)モードを有する液晶表示素子では、組成物が重合体を含有する。重合性化合物は、組成物中に重合体を生成させる目的で添加される。電極間に電圧を印加した状態で紫外線を照射して、重合性化合物を重合させることによって、組成物の中に重合体を生成させる。この方法によって、適切なプレチルトが達成されるので、応答時間が短縮され、画像の焼き付きが改善された素子が作製される。
In a liquid crystal display element having a PSA (polymer sustained alignment) mode, the composition contains a polymer. The polymerizable compound is added for the purpose of forming a polymer in the composition. A polymer is produced in the composition by irradiating ultraviolet rays with a voltage applied between the electrodes to polymerize the polymerizable compound. By this method, an appropriate pre-tilt is achieved, so that the response time is shortened and the device with improved image burn-in is produced.
重合性化合物の好ましい例は、アクリレート、メタクリレート、ビニル化合物、ビニルオキシ化合物、プロペニルエーテル、エポキシ化合物(オキシラン、オキセタン)、およびビニルケトンである。さらに好ましい例は、少なくとも1つのアクリロイルオキシを有する化合物および少なくとも1つのメタクリロイルオキシを有する化合物である。さらに好ましい例には、アクリロイルオキシとメタクリロイルオキシの両方を有する化合物も含まれる。
Preferred examples of the polymerizable compound are acrylate, methacrylate, vinyl compound, vinyloxy compound, propenyl ether, epoxy compound (oxylane, oxetane), and vinyl ketone. More preferred examples are compounds having at least one acryloyloxy and compounds having at least one methacryloyloxy. More preferred examples also include compounds having both acryloyloxy and methacryloyloxy.
さらに好ましい例は、化合物(M-1)から(M-18)である。これらの化合物において、R25からR31は独立して、水素またはメチルであり;R32、R33、およびR34は独立して、水素または炭素数1から5のアルキルであり、R32、R33、およびR34の少なくとも1つは炭素数1から5のアルキルであり;v、w、およびxは独立して、0または1であり;uおよびyは独立して、1から10の整数である。L21からL26は独立して、水素またはフッ素であり;L27およびL28は独立して、水素、フッ素、またはメチルである。
More preferred examples are compounds (M-1) to (M-18). In these compounds, R 25 to R 31 are independently hydrogen or methyl; R 32 , R 33 , and R 34 are independently hydrogen or alkyl having 1 to 5 carbon atoms, R 32 , At least one of R 33 , and R 34 is an alkyl having 1 to 5 carbon atoms; v, w, and x are 0 or 1 independently; u and y are independently 1 to 10 It is an integer. L 21 to L 26 are independently hydrogen or fluorine; L 27 and L 28 are independently hydrogen, fluorine, or methyl.
重合性化合物は、重合開始剤を添加することによって、速やかに重合させることができる。反応条件を最適化することによって、残存する重合性化合物の量を減少させることができる。光ラジカル重合開始剤の例は、BASF社のダロキュアシリーズからTPO、1173、および4265であり、イルガキュアシリーズから184、369、500、651、784、819、907、1300、1700、1800、1850、および2959である。
The polymerizable compound can be rapidly polymerized by adding a polymerization initiator. By optimizing the reaction conditions, the amount of residual polymerizable compound can be reduced. Examples of photoradical polymerization initiators are TPO, 1173, and 4265 from BASF's DaroCure series and 184,369,500,651,784,819,907,1300,1700,1800,1850 from the Irgacure series. , And 2959.
光ラジカル重合開始剤の追加例は、4-メトキシフェニル-2,4-ビス(トリクロロメチル)トリアジン、2-(4-ブトキシスチリル)-5-トリクロロメチル-1,3,4-オキサジアゾール、9-フェニルアクリジン、9,10-ベンズフェナジン、ベンゾフェノン/ミヒラーズケトン混合物、ヘキサアリールビイミダゾール/メルカプトベンズイミダゾール混合物、1-(4-イソプロピルフェニル)-2-ヒドロキシ-2-メチルプロパン-1-オン、ベンジルジメチルケタール、2-メチル-1-[4-(メチルチオ)フェニル]-2-モルホリノプロパン-1-オン、2,4-ジエチルキサントン/p-ジメチルアミノ安息香酸メチル混合物、ベンゾフェノン/メチルトリエタノールアミン混合物である。
Additional examples of photoradical polymerization initiators include 4-methoxyphenyl-2,4-bis (trichloromethyl) triazine, 2- (4-butoxystylyl) -5-trichloromethyl-1,3,4-oxadiazole, 9-Phenylaclysine, 9,10-benzphenazine, benzophenone / Michler's ketone mixture, hexaarylbiimidazole / mercaptobenzimidazole mixture, 1- (4-isopropylphenyl) -2-hydroxy-2-methylpropan-1-one, benzyl Dimethylketal, 2-methyl-1- [4- (methylthio) phenyl] -2-morpholinopropane-1-one, 2,4-diethylxanthone / p-dimethylaminomethyl benzoate mixture, benzophenone / methyltriethanolamine mixture Is.
液晶組成物に光ラジカル重合開始剤を添加したあと、電場を印加した状態で紫外線を照射することによって重合を行うことができる。しかし、未反応の重合開始剤または重合開始剤の分解生成物は、素子に画像の焼き付きなどの表示不良を引き起こすかもしれない。これを防ぐために重合開始剤を添加しないまま光重合を行ってもよい。照射する光の好ましい波長は150nmから500nmの範囲である。さらに好ましい波長は250nmから450nmの範囲であり、最も好ましい波長は300nmから400nmの範囲である。
After adding a photoradical polymerization initiator to the liquid crystal composition, polymerization can be carried out by irradiating ultraviolet rays with an electric field applied. However, unreacted polymerization initiators or degradation products of the polymerization initiators may cause display defects such as image burn-in on the device. In order to prevent this, photopolymerization may be carried out without adding a polymerization initiator. The preferred wavelength of the emitted light is in the range of 150 nm to 500 nm. More preferred wavelengths are in the range of 250 nm to 450 nm, and most preferred wavelengths are in the range of 300 nm to 400 nm.
重合性化合物を保管するとき、重合を防止するために重合禁止剤を添加してもよい。重合性化合物は、通常は重合禁止剤を除去しないまま組成物に添加される。重合禁止剤の例は、ヒドロキノン、メチルヒドロキノンのようなヒドロキノン誘導体、4-t-ブチルカテコール、4-メトキシフェノール、フェノチアジンなどである。
When storing the polymerizable compound, a polymerization inhibitor may be added to prevent polymerization. The polymerizable compound is usually added to the composition without removing the polymerization inhibitor. Examples of polymerization inhibitors are hydroquinone, hydroquinone derivatives such as methylhydroquinone, 4-t-butylcatechol, 4-methoxyphenol, phenothiazine and the like.
光学活性化合物は、液晶分子にらせん構造を誘起して必要なねじれ角を与えることによって逆ねじれを防ぐ、という効果を有する。光学活性化合物を添加することによって、らせんピッチを調整することができる。らせんピッチの温度依存性を調整する目的で2つ以上の光学活性化合物を添加してもよい。光学活性化合物の好ましい例として、下記の化合物(Op-1)から(Op-18)を挙げることができる。化合物(Op-18)において、環Jは1,4-シクロヘキシレンまたは1,4-フェニレンであり、R28は炭素数1から10のアルキルである。*印は不斉炭素を表す。
The optically active compound has the effect of preventing reverse twisting by inducing a helical structure in the liquid crystal molecule to give a necessary twist angle. The spiral pitch can be adjusted by adding an optically active compound. Two or more optically active compounds may be added for the purpose of adjusting the temperature dependence of the spiral pitch. Preferred examples of the optically active compound include the following compounds (Op-1) to (Op-18). In compound (Op-18), ring J is 1,4-cyclohexylene or 1,4-phenylene, and R 28 is an alkyl having 1 to 10 carbon atoms. * Marks represent asymmetric carbon.
酸化防止剤は、大きな電圧保持率を維持するために有効である。酸化防止剤の好ましい例として、下記の化合物(AO-1)および(AO-2);Irganox415、Irganox565、Irganox1010、Irganox1035、Irganox3114、およびIrganox1098(商品名;BASF社)を挙げることができる。紫外線吸収剤は、上限温度の低下を防ぐために有効である。紫外線吸収剤の好ましい例は、ベンゾフェノン誘導体、ベンゾエート誘導体、トリアゾール誘導体などであり、具体例として下記の化合物(AO-3)および(AO-4);Tinuvin329、TinuvinP、Tinuvin326、Tinuvin234、Tinuvin213、Tinuvin400、Tinuvin328、およびTinuvin99-2(商品名;BASF社);および1,4-ジアザビシクロ[2.2.2]オクタン(DABCO)を挙げることができる。
Antioxidants are effective in maintaining a large voltage retention rate. Preferred examples of the antioxidant include the following compounds (AO-1) and (AO-2); Irganox415, Irganox565, Irganox1010, Irganox1035, Irganox3114, and Irganox1098 (trade name: BASF). The ultraviolet absorber is effective for preventing a decrease in the upper limit temperature. Preferred examples of the UV absorber are benzophenone derivatives, benzoate derivatives, triazole derivatives and the like, and specific examples thereof include the following compounds (AO-3) and (AO-4); Tinuvin 328, and Tinuvin 99-2 (trade name; BASF); and 1,4-diazabicyclo [2.2.2] octane (DABCO) can be mentioned.
立体障害のあるアミンのような光安定剤は、大きな電圧保持率を維持するために好ましい。光安定剤の好ましい例として、下記の化合物(AO-5)、(AO-6)、(AO-7)、(AO-8)、および(AO-9);Tinuvin144、Tinuvin765、Tinuvin770DF、Tinuvin780(商品名;BASF社);LA-52、LA-57、LA-77Y、およびLA-77G(商品名;ADEKA社)を挙げることができる。熱安定剤も大きな電圧保持率を維持するために有効であり、好ましい例としてIrgafos168(商品名;BASF社)を挙げることができる。GH(guest host)モードの素子に適合させるために、アゾ系色素、アントラキノン系色素などのような二色性色素(dichroic dye)が組成物に添加される。消泡剤は、泡立ちを防ぐために有効である。消泡剤の好ましい例は、ジメチルシリコーンオイル、メチルフェニルシリコーンオイルなどである。
A light stabilizer such as amine with steric hindrance is preferable in order to maintain a large voltage holding ratio. Preferred examples of light stabilizers are the following compounds (AO-5), (AO-6), (AO-7), (AO-8), and (AO-9); Product name; BASF); LA-52, LA-57, LA-77Y, and LA-77G (trade name: ADEKA) can be mentioned. A heat stabilizer is also effective for maintaining a large voltage holding ratio, and Irgafos 168 (trade name; BASF) can be mentioned as a preferable example. Dichroic dyes such as azo dyes, anthraquinone dyes, etc. are added to the composition to accommodate devices in GH (guest host) mode. Defoamers are effective in preventing foaming. Preferred examples of the defoaming agent are dimethyl silicone oil, methyl phenyl silicone oil and the like.
化合物(AO-1)において、R40は炭素数1から20のアルキル、炭素数1から20のアルコキシ、-COOR41、または-(CH2)2-COOR41であり、ここでR41は炭素数1から20のアルキルである。化合物(AO-2)および(AO-5)において、R42は炭素数1から20のアルキルである。化合物(AO-5)において、R43は水素、メチルまたはO・(酸素ラジカル)であり;環G1は1,4-シクロヘキシレンまたは1,4-フェニレンであり;化合物(AO-7)および(AO-8)において、環G2は1,4-シクロヘキシレン、1,4-フェニレン、または少なくとも1つの水素がフッ素で置き換えられた1,4-フェニレンであり;化合物(AO-5)、(AO-7)、および(AO-8)において、zは、1、2、または3である。
In compound (AO-1), R 40 is an alkyl having 1 to 20 carbon atoms, an alkoxy having 1 to 20 carbon atoms, -COOR 41 , or-(CH 2 ) 2- COOR 41 , where R 41 is carbon. Alkoxy of numbers 1 to 20. In compounds (AO-2) and (AO-5), R 42 is an alkyl having 1 to 20 carbon atoms. In the compound (AO-5), R 43 is hydrogen, methyl or O · (oxygen radical); ring G 1 is 1,4-cyclohexylene or 1,4-phenylene; Compound (AO-7) and In (AO-8), ring G 2 is 1,4-cyclohexylene, 1,4-phenylene, or 1,4-phenylene in which at least one hydrogen has been replaced with fluorine; compound (AO-5),. In (AO-7) and (AO-8), z is 1, 2, or 3.
4.液晶表示素子
液晶組成物は、PC、TN、STN、OCB、PSAなどの動作モードを有し、アクティブマトリックス方式で駆動する液晶表示素子に使用できる。この組成物は、PC、TN、STN、OCB、VA、IPSなどの動作モードを有し、パッシブマトリクス方式で駆動する液晶表示素子にも使用することができる。これらの素子は、反射型、透過型、半透過型のいずれのタイプにも適用ができる。 4. Liquid crystal display element The liquid crystal composition has an operation mode such as PC, TN, STN, OCB, PSA, and can be used for a liquid crystal display element driven by an active matrix method. This composition has an operation mode such as PC, TN, STN, OCB, VA, and IPS, and can also be used for a liquid crystal display element driven by a passive matrix method. These elements can be applied to any type of reflective type, transmissive type, and semitransparent type.
液晶組成物は、PC、TN、STN、OCB、PSAなどの動作モードを有し、アクティブマトリックス方式で駆動する液晶表示素子に使用できる。この組成物は、PC、TN、STN、OCB、VA、IPSなどの動作モードを有し、パッシブマトリクス方式で駆動する液晶表示素子にも使用することができる。これらの素子は、反射型、透過型、半透過型のいずれのタイプにも適用ができる。 4. Liquid crystal display element The liquid crystal composition has an operation mode such as PC, TN, STN, OCB, PSA, and can be used for a liquid crystal display element driven by an active matrix method. This composition has an operation mode such as PC, TN, STN, OCB, VA, and IPS, and can also be used for a liquid crystal display element driven by a passive matrix method. These elements can be applied to any type of reflective type, transmissive type, and semitransparent type.
この組成物は、NCAP(nematic curvilinear aligned phase)素子にも適しており、ここでは組成物がマイクロカプセル化されている。この組成物は、ポリマー分散型液晶表示素子(PDLCD)や、ポリマーネットワーク液晶表示素子(PNLCD)にも使用できる。これらの組成物においては、重合性化合物が多量に添加される。一方、重合性化合物の割合が液晶組成物の重量に基づいて10重量%以下であるとき、PSAモードの液晶表示素子が作製される。好ましい割合は0.1重量%から2重量%の範囲である。さらに好ましい割合は、0.2重量%から1.0重量%の範囲である。PSAモードの素子は、アクティブマトリックス方式、パッシブマトリクス方式のような駆動方式で駆動させることができる。このような素子は、反射型、透過型、半透過型のいずれのタイプにも適用ができる。
This composition is also suitable for NCAP (nematic curvilinear aligned phase) devices, where the composition is microencapsulated. This composition can also be used in a polymer-dispersed liquid crystal display element (PDLCD) and a polymer network liquid crystal display element (PNLCD). In these compositions, a large amount of the polymerizable compound is added. On the other hand, when the proportion of the polymerizable compound is 10% by weight or less based on the weight of the liquid crystal composition, a liquid crystal display element in PSA mode is produced. The preferred proportion is in the range of 0.1% by weight to 2% by weight. A more preferable ratio is in the range of 0.2% by weight to 1.0% by weight. The PSA mode element can be driven by a drive system such as an active matrix system or a passive matrix system. Such an element can be applied to any type of reflective type, transmissive type, and semitransparent type.
1.化合物(1)の実施例
実施例により本発明をさらに詳しく説明する。実施例は典型的な例であるので、本発明は実施例によって制限されない。化合物(1)は、下記の手順により合成した。合成した化合物は、NMR分析などの方法により同定した。化合物や組成物の物性、および素子の特性は、下記の方法により測定した。 1. 1. Examples of Compound (1) The present invention will be described in more detail by way of examples. The present invention is not limited by the examples, as the examples are typical. Compound (1) was synthesized by the following procedure. The synthesized compound was identified by a method such as NMR analysis. The physical characteristics of the compound or composition and the characteristics of the device were measured by the following methods.
実施例により本発明をさらに詳しく説明する。実施例は典型的な例であるので、本発明は実施例によって制限されない。化合物(1)は、下記の手順により合成した。合成した化合物は、NMR分析などの方法により同定した。化合物や組成物の物性、および素子の特性は、下記の方法により測定した。 1. 1. Examples of Compound (1) The present invention will be described in more detail by way of examples. The present invention is not limited by the examples, as the examples are typical. Compound (1) was synthesized by the following procedure. The synthesized compound was identified by a method such as NMR analysis. The physical characteristics of the compound or composition and the characteristics of the device were measured by the following methods.
NMR分析:測定には、ブルカーバイオスピン社製のDRX-500を用いた。1H-NMRの測定では、試料をCDCl3などの重水素化溶媒に溶解させ、室温、500MHz、積算回数16回の条件で測定した。テトラメチルシランを内部標準として用いた。19F-NMRの測定では、CFCl3を内部標準として用い、積算回数24回で行った。核磁気共鳴スペクトルの説明において、sはシングレット、dはダブレット、tはトリプレット、qはカルテット、quinはクインテット、sextはセクステット、mはマルチプレット、brはブロードであることを意味する。
NMR analysis: DRX-500 manufactured by Bruker Biospin Co., Ltd. was used for the measurement. 1 In the 1 H-NMR measurement, the sample was dissolved in a deuterated solvent such as CDCl 3 and measured at room temperature, 500 MHz, and the number of integrations was 16 times. Tetramethylsilane was used as an internal standard. 19 In the F-NMR measurement, CFCl 3 was used as an internal standard, and the number of integrations was 24. In the description of the nuclear magnetic resonance spectrum, s means singlet, d means doublet, t means triplet, q means quartet, quin means quintet, sext means sextet, m means multiplet, and br means broad.
ガスクロマト分析:測定には、島津製作所製のGC-2010型ガスクロマトグラフを用いた。カラムは、Agilent Technologies Inc.製のキャピラリカラムDB-1(長さ60m、内径0.25mm、膜厚0.25μm)を用いた。キャリアーガスとしてはヘリウム(1mL/分)を用いた。試料気化室の温度を300℃、検出器(FID)の温度を300℃に設定した。試料はアセトンに溶解して、1重量%の溶液となるように調製し、得られた溶液1μLを試料気化室に注入した。記録計には島津製作所製のGCSolutionシステムなどを用いた。
Gas chromatograph analysis: A GC-2010 type gas chromatograph manufactured by Shimadzu Corporation was used for the measurement. As the column, a capillary column DB-1 (length 60 m, inner diameter 0.25 mm, film thickness 0.25 μm) manufactured by Agilent Technologies Inc. was used. Helium (1 mL / min) was used as the carrier gas. The temperature of the sample vaporization chamber was set to 300 ° C., and the temperature of the detector (FID) was set to 300 ° C. The sample was dissolved in acetone to prepare a 1% by weight solution, and 1 μL of the obtained solution was injected into the sample vaporization chamber. A GC Solution system manufactured by Shimadzu Corporation was used as the recorder.
ガスクロマトグラフ質量分析:測定には、島津製作所製のQP-2010Ultra型ガスクロマトグラフ質量分析計を用いた。カラムは、Agilent Technologies Inc.製のキャピラリカラムDB-1(長さ60m、内径0.25mm、膜厚0.25μm)を用いた。キャリアーガスとしてはヘリウム(1mL/分)を用いた。試料気化室の温度を300℃、イオン源の温度を200℃、イオン化電圧を70eV、エミッション電流を150uAに設定した。試料はアセトンに溶解して、1重量%の溶液となるように調製し、得られた溶液1μLを試料気化室に注入した。記録計には島津製作所製のGCMSsolutionシステムを用いた。
Gas chromatograph mass spectrometry: A QP-2010 Ultra type gas chromatograph mass spectrometer manufactured by Shimadzu Corporation was used for the measurement. As the column, a capillary column DB-1 (length 60 m, inner diameter 0.25 mm, film thickness 0.25 μm) manufactured by Agilent Technologies Inc. was used. Helium (1 mL / min) was used as the carrier gas. The temperature of the sample vaporization chamber was set to 300 ° C., the temperature of the ion source was set to 200 ° C., the ionization voltage was set to 70 eV, and the emission current was set to 150 uA. The sample was dissolved in acetone to prepare a 1% by weight solution, and 1 μL of the obtained solution was injected into the sample vaporization chamber. A GCMS solution system manufactured by Shimadzu Corporation was used as the recorder.
HPLC分析:測定には、島津製作所製のProminence(LC-20AD;SPD-20A)を用いた。カラムはワイエムシー製のYMC-Pack ODS-A(長さ150mm、内径4.6mm、粒子径5μm)を用いた。溶出液はアセトニトリルと水を適宜混合して用いた。検出器としてはUV検出器、RI検出器、CORONA検出器などを適宜用いた。UV検出器を用いた場合、検出波長は254nmとした。試料はアセトニトリルに溶解して、0.1重量%の溶液となるように調製し、この溶液1μLを試料室に導入した。記録計としては島津製作所製のC-R7Aplusを用いた。
HPLC analysis: Prominence (LC-20AD; SPD-20A) manufactured by Shimadzu Corporation was used for the measurement. As the column, YMC-Pack ODS-A (length 150 mm, inner diameter 4.6 mm, particle diameter 5 μm) manufactured by YMC was used. The eluate used was an appropriate mixture of acetonitrile and water. As the detector, a UV detector, an RI detector, a CORONA detector and the like were appropriately used. When a UV detector was used, the detection wavelength was 254 nm. The sample was prepared to dissolve in acetonitrile to form a 0.1% by weight solution, and 1 μL of this solution was introduced into the sample chamber. As a recorder, C-R7Aplus manufactured by Shimadzu Corporation was used.
紫外可視分光分析:測定には、島津製作所製のPharmaSpec UV-1700用いた。検出波長は190nmから700nmとした。試料はアセトニトリルに溶解して、0.01mmol/Lの溶液となるように調製し、石英セル(光路長1cm)に入れて測定した。
Ultraviolet-visible spectroscopic analysis: For the measurement, PharmaSpec UV-1700 manufactured by Shimadzu Corporation was used. The detection wavelength was 190 nm to 700 nm. The sample was prepared by dissolving it in acetonitrile to form a solution of 0.01 mmol / L, and placed in a quartz cell (optical path length 1 cm) for measurement.
測定試料:相構造および転移温度(透明点、融点、重合開始温度など)を測定するときには、化合物そのものを試料として用いた。ネマチック相の上限温度、粘度、光学異方性、誘電率異方性などの物性を測定するときには、化合物と母液晶との混合物を試料として用いた。
Measurement sample: When measuring the phase structure and transition temperature (transparency point, melting point, polymerization start temperature, etc.), the compound itself was used as a sample. When measuring physical properties such as the upper limit temperature, viscosity, optical anisotropy, and dielectric anisotropy of the nematic phase, a mixture of the compound and the mother liquid crystal was used as a sample.
化合物を母液晶と混合した試料を用いた場合は、次のように測定した。化合物15重量%と母液晶85重量%とを混合して試料を調製した。この試料の測定値から、次の等式にしたがって外挿値を算出し、この値を記載した。〈外挿値〉=(100×〈試料の測定値〉-〈母液晶の重量%〉×〈母液晶の測定値〉)/〈化合物の重量%〉
When a sample in which the compound was mixed with the mother liquid crystal was used, the measurement was performed as follows. A sample was prepared by mixing 15% by weight of the compound and 85% by weight of the mother liquid crystal display. Extrapolated values were calculated from the measured values of this sample according to the following equation, and these values are described. <Extrapolation value> = (100 x <measured value of sample>-<weight% of mother liquid crystal> x <measured value of mother liquid crystal>) / <weight% of compound>
この割合で結晶(または、スメクチック相)が25℃で析出する場合には、化合物と母液晶との割合を10重量%:90重量%、5重量%:95重量%、1重量%:99重量%の順に変更をしていき、結晶(または、スメクチック相)が25℃で析出しなくなった割合で試料の物性を測定した。なお、特に断りのない限り、化合物と母液晶との割合は、15重量%:85重量%である。
When crystals (or smectic phase) are precipitated at this ratio at 25 ° C., the ratio of the compound to the mother liquid crystal is 10% by weight: 90% by weight, 5% by weight: 95% by weight, 1% by weight: 99% by weight. The physical properties of the sample were measured at the rate at which the crystals (or smectic phase) did not precipitate at 25 ° C. Unless otherwise specified, the ratio of the compound to the mother liquid crystal display is 15% by weight: 85% by weight.
化合物の誘電率異方性がゼロまたは正であるときは、下記の母液晶(A)を用いた。各成分の割合を、重量%で表した。
When the dielectric anisotropy of the compound was zero or positive, the following mother liquid crystal display (A) was used. The ratio of each component was expressed in% by weight.
化合物の誘電率異方性がゼロまたは負であるときは、下記の母液晶(B)を用いた。各成分の割合を重量%で表した。
When the dielectric anisotropy of the compound was zero or negative, the following mother liquid crystal display (B) was used. The ratio of each component was expressed in% by weight.
母液晶(C):下記のフッ素系化合物を成分とする母液晶(C)も用いた。母液晶(C)の成分の割合を重量%で表した。
Mother liquid crystal (C): A mother liquid crystal (C) containing the following fluorine-based compounds as components was also used. The ratio of the components of the mother liquid crystal display (C) was expressed in% by weight.
化合物と母液晶(C)の割合は、20重量%:80重量%にした。この割合で結晶(または、スメクチック相)が25℃で析出する場合には、化合物と母液晶(C)との割合を15重量%:85重量%、10重量%:90重量%、5重量%:95重量%、1重量%:99重量%の順に変更をしていき、結晶(または、スメクチック相)が25℃で析出しなくなった割合で試料の物性を測定した。なお、特に断りのない限り、化合物と母液晶(C)との割合は、20重量%:80重量%である。
The ratio of the compound and the mother liquid crystal display (C) was 20% by weight: 80% by weight. When crystals (or smectic phase) are precipitated at this ratio at 25 ° C., the ratio of the compound to the mother liquid crystal (C) is 15% by weight: 85% by weight, 10% by weight: 90% by weight, 5% by weight. The changes were made in the order of: 95% by weight, 1% by weight: 99% by weight, and the physical characteristics of the sample were measured at a rate at which crystals (or smectic phase) did not precipitate at 25 ° C. Unless otherwise specified, the ratio of the compound to the mother liquid crystal display (C) is 20% by weight: 80% by weight.
測定方法:物性の測定は下記の方法で行った。これらの多くは、社団法人電子情報技術産業協会(JEITA;Japan Electronics and Information Technology Industries Association)で審議制定されるJEITA規格(JEITA・ED-2521B)に記載されている。これを修飾した方法も用いた。測定に用いたTN素子には、薄膜トランジスター(TFT)を取り付けなかった。
Measurement method: The physical properties were measured by the following method. Many of these are described in the JEITA standard (JEITA ED-2521B), which is deliberated and enacted by the Japan Electronics and Information Technology Industries Association (JEITA). A modified method was also used. A thin film transistor (TFT) was not attached to the TN element used for the measurement.
(1)相構造:偏光顕微鏡を備えた融点測定装置のホットプレート(メトラー社FP-52型ホットステージ)に試料を置いた。この試料を、3℃/分の速度で加熱しながら相状態とその変化を偏光顕微鏡で観察し、相の種類を特定した。
(1) Phase structure: A sample was placed on a hot plate (FP-52 type hot stage manufactured by METTLER CORPORATION) of a melting point measuring device equipped with a polarizing microscope. The phase state and its change were observed with a polarizing microscope while heating this sample at a rate of 3 ° C./min to identify the type of phase.
(2)転移温度(℃):測定には、パーキンエルマー社製の走査熱量計、Diamond DSCシステムまたはエスアイアイ・ナノテクノロジー社製の高感度示差走査熱量計、X-DSC7000を用いた。試料は、3℃/分の速度で昇降温し、試料の相変化に伴う吸熱ピークまたは発熱ピークの開始点を外挿により求め、転移温度を決定した。化合物の融点、重合開始温度もこの装置を使って測定した。化合物が固体からスメクチック相、ネマチック相などの液晶相に転移する温度を「液晶相の下限温度」と略すことがある。化合物が液晶相から液体に転移する温度を「透明点」と略すことがある。
(2) Transition temperature (° C.): A scanning calorimeter manufactured by PerkinElmer, a Diamond DSC system, or a high-sensitivity differential scanning calorimeter manufactured by SII Nanotechnology, X-DSC7000 was used for the measurement. The temperature of the sample was raised and lowered at a rate of 3 ° C./min, and the start point of the endothermic peak or the exothermic peak accompanying the phase change of the sample was determined by extrapolation to determine the transition temperature. The melting point of the compound and the polymerization initiation temperature were also measured using this device. The temperature at which a compound transitions from a solid to a liquid crystal phase such as a smectic phase or a nematic phase may be abbreviated as "lower limit temperature of the liquid crystal phase". The temperature at which a compound transitions from the liquid crystal phase to a liquid may be abbreviated as "transparency point".
結晶はCと表した。結晶を二種類に区別できる場合は、それぞれをC1またはC2と表した。スメクチック相はS、ネマチック相はNと表した。スメクチックA相、スメクチックB相、スメクチックC相、およびスメクチックF相のような相の区別がつく場合は、それぞれSA、SB、SC、およびSFと表した。液体(アイソトロピック)はIと表した。転移温度は、例えば、「C 50.0 N 100.0 I」のように表記した。これは、結晶からネマチック相への転移温度が50.0℃であり、ネマチック相から液体への転移温度が100.0℃であることを示す。
The crystal was represented as C. When the crystals can be distinguished into two types, each is represented as C 1 or C 2. The smectic phase was represented as S and the nematic phase was represented as N. Smectic A phase, a smectic B phase, a smectic C phase, and if can be distinguished phases such as smectic F phase, represented respectively S A, S B, S C, and the S F. The liquid (isotropic) was represented as I. The transition temperature is expressed as, for example, "C 50.0 N 100.0 I". This indicates that the transition temperature from the crystal to the nematic phase is 50.0 ° C. and the transition temperature from the nematic phase to the liquid is 100.0 ° C.
(3)化合物の相溶性:化合物の割合が、20重量%、15重量%、10重量%、5重量%、3重量%、または1重量%となるように母液晶と化合物とを混合した試料を調製した。試料をガラス瓶に入れ、-10℃または-20℃の冷凍庫で一定期間保管した。試料のネマチック相が維持されたか、または結晶(またはスメクチック相)が析出したかを観察した。ネマチック相が維持される条件を相溶性の尺度として用いた。必要に応じて化合物の割合や冷凍庫の温度を変更することもある。
(3) Compatibility of compounds: A sample in which a mother liquid crystal and a compound are mixed so that the ratio of the compound is 20% by weight, 15% by weight, 10% by weight, 5% by weight, 3% by weight, or 1% by weight. Was prepared. The sample was placed in a glass bottle and stored in a freezer at −10 ° C. or −20 ° C. for a certain period of time. It was observed whether the nematic phase of the sample was maintained or whether crystals (or smectic phase) were precipitated. The conditions under which the nematic phase was maintained were used as a measure of compatibility. The proportion of compounds and the temperature of the freezer may be changed as needed.
(4)ネマチック相の上限温度(TNIまたはNI;℃):偏光顕微鏡を備えた融点測定装置のホットプレートに試料を置き、1℃/分の速度で加熱した。試料の一部がネマチック相から等方性液体に変化したときの温度を測定した。試料が化合物(1)と母液晶との混合物であるときは、TNIの記号で示した。試料が化合物(1)と、化合物(2)から(15)から選択された化合物との混合物であるときは、NIの記号で示した。ネマチック相の上限温度を「上限温度」と略すことがある。
(4) Upper limit temperature of nematic phase ( TNI or NI; ° C.): A sample was placed on a hot plate of a melting point measuring device equipped with a polarizing microscope and heated at a rate of 1 ° C./min. The temperature at which a part of the sample changed from the nematic phase to the isotropic liquid was measured. When the sample was a mixture of compound (1) and the mother liquid crystal display, it was indicated by the TNI symbol. When the sample was a mixture of compound (1) and a compound selected from compounds (2) to (15), it was indicated by the symbol NI. The upper limit temperature of the nematic phase may be abbreviated as "upper limit temperature".
(5)ネマチック相の下限温度(TC;℃):ネマチック相を有する試料をガラス瓶に入れ、0℃、-10℃、-20℃、-30℃、および-40℃のフリーザー中に10日間保管したあと、液晶相を観察した。例えば、試料が-20℃ではネマチック相のままであり、-30℃では結晶またはスメクチック相に変化したとき、TCを<-20℃と記載した。ネマチック相の下限温度を「下限温度」と略すことがある。
(5) Minimum Temperature of a Nematic Phase (T C; ° C.): A sample having a nematic phase was put in a glass bottle, 0 ℃, -10 ℃, -20 ℃, -30 ℃, and -40 ℃ for 10 days in a freezer After storage, the liquid crystal phase was observed. For example, TC was described as <-20 ° C. when the sample remained in the nematic phase at −20 ° C. and changed to a crystalline or smectic phase at −30 ° C. The lower limit temperature of the nematic phase may be abbreviated as "lower limit temperature".
(6)粘度(バルク粘度;η;20℃で測定;mPa・s):測定には、東京計器株式会社製のE型回転粘度計を用いた。
(6) Viscosity (bulk viscosity; η; measured at 20 ° C.; mPa · s): An E-type rotational viscometer manufactured by Tokyo Keiki Co., Ltd. was used for the measurement.
(7)光学異方性(屈折率異方性;25℃で測定;Δn):測定は、波長589nmの光を用い、接眼鏡に偏光板を取り付けたアッベ屈折計により行なった。主プリズムの表面を一方向にラビングしたあと、試料を主プリズムに滴下した。屈折率(n∥)は偏光の方向がラビングの方向と平行であるときに測定した。屈折率(n⊥)は偏光の方向がラビングの方向と垂直であるときに測定した。光学異方性(Δn)の値は、Δn=n∥-n⊥、の等式から計算した。
(7) Optical anisotropy (refractive index anisotropy; measured at 25 ° C.; Δn): The measurement was performed using light having a wavelength of 589 nm and using an Abbe refractometer with a polarizing plate attached to the eyepiece. After rubbing the surface of the main prism in one direction, the sample was dropped onto the main prism. The refractive index (n∥) was measured when the direction of polarization was parallel to the direction of rubbing. The refractive index (n⊥) was measured when the direction of polarization was perpendicular to the direction of rubbing. The value of optical anisotropy (Δn) was calculated from the equation of Δn = n∥−n⊥.
(8)比抵抗(ρ;25℃で測定;Ωcm):電極を備えた容器に試料1.0mLを注入した。この容器に直流電圧(10V)を印加し、10秒後の直流電流を測定した。比抵抗は次の等式から算出した。(比抵抗)={(電圧)×(容器の電気容量)}/{(直流電流)×(真空の誘電率)}。
(8) Specific resistance (ρ; measured at 25 ° C; Ωcm): 1.0 mL of the sample was injected into a container equipped with an electrode. A DC voltage (10 V) was applied to this container, and the DC current after 10 seconds was measured. The specific resistance was calculated from the following equation. (Specific resistance) = {(voltage) x (capacitance of container)} / {(DC current) x (vacuum permittivity)}.
(9)電圧保持率(VHR-1;25℃で測定;%):測定に用いたTN素子はポリイミド配向膜を有し、そして2枚のガラス基板の間隔(セルギャップ)は5μmであった。この素子は試料を入れたあと紫外線で硬化する接着剤で密閉した。この素子にパルス電圧(5Vで60マイクロ秒)を印加して充電した。減衰する電圧を高速電圧計で16.7ミリ秒のあいだ測定し、単位周期における電圧曲線と横軸との間の面積Aを求めた。面積Bは減衰しなかったときの面積であった。電圧保持率は面積Bに対する面積Aの百分率で表した。
(9) Voltage retention rate (VHR-1; measured at 25 ° C.;%): The TN element used for the measurement had a polyimide alignment film, and the distance (cell gap) between the two glass substrates was 5 μm. .. This device was sealed with an adhesive that cures with ultraviolet light after the sample was placed. A pulse voltage (60 microseconds at 5 V) was applied to this device to charge it. The decaying voltage was measured with a high-speed voltmeter for 16.7 milliseconds, and the area A between the voltage curve and the horizontal axis in a unit period was determined. Area B was the area when there was no attenuation. The voltage holding ratio is expressed as a percentage of the area A with respect to the area B.
(10)電圧保持率(VHR-2;80℃で測定;%):25℃の代わりに、80℃で測定した以外は、上記の方法で電圧保持率を測定した。得られた結果をVHR-2の記号で示した。
(10) Voltage retention rate (VHR-2; measured at 80 ° C.;%): The voltage retention rate was measured by the above method except that the measurement was performed at 80 ° C. instead of 25 ° C. The results obtained are indicated by the symbol VHR-2.
(11)フリッカ率(25℃で測定;%):測定には横河電機(株)製のマルチメディアディスプレイテスタ3298Fを用いた。光源はLEDであった。2枚のガラス基板の間隔(セルギャップ)が3.5μmであり、ラビング方向がアンチパラレルであるノーマリーブラックモード(normally black mode)のFFS素子に試料を入れた。この素子を紫外線で硬化する接着剤を用いて密閉した。この素子に電圧を印加し、素子を透過した光量が最大になる電圧を測定した。この電圧を素子に印加しながらセンサ部を素子に近づけ、表示されたフリッカ率を読み取った。
(11) Flicker rate (measured at 25 ° C.;%): A multimedia display tester 3298F manufactured by Yokogawa Electric Corporation was used for the measurement. The light source was an LED. The sample was placed in an FFS element in a normally black mode in which the distance (cell gap) between the two glass substrates was 3.5 μm and the rubbing direction was antiparallel. This element was sealed with an UV curable adhesive. A voltage was applied to this device, and the voltage at which the amount of light transmitted through the device was maximized was measured. While applying this voltage to the element, the sensor unit was brought close to the element and the displayed flicker rate was read.
誘電率異方性が正の試料と負の試料とでは、物性の測定法が異なることがある。誘電率異方性が正であるときの測定法は、測定(12a)から測定(16a)に記載した。誘電率異方性が負の場合は、測定(12b)から測定(16b)に記載した。
The method of measuring physical properties may differ between a sample with a positive dielectric anisotropy and a sample with a negative dielectric anisotropy. The measuring method when the dielectric anisotropy is positive is described in measurement (12a) to measurement (16a). When the dielectric anisotropy was negative, it was described in measurement (12b) to measurement (16b).
(12a)粘度(回転粘度;γ1;25℃で測定;mPa・s;誘電率異方性が正の試料):測定は、M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37(1995) に記載された方法に従った。ツイスト角が0度であり、そして2枚のガラス基板の間隔(セルギャップ)が5μmであるTN素子に試料を入れた。この素子に16Vから19.5Vまで0.5V毎に段階的に印加した。0.2秒の無印加のあと、ただ1つの矩形波(矩形パルス;0.2秒)と無印加(2秒)の条件で印加を繰り返した。この印加によって発生した過渡電流(transient current)のピーク電流(peak current)とピーク時間(peak time)を測定した。これらの測定値とM.Imaiらの論文、40頁の等式(8)とから回転粘度の値を得た。この計算で必要な誘電率異方性の値は、この回転粘度を測定した素子を用い、下に記載した方法で求めた。
(12a) Viscosity (rotational viscosity; γ1; measured at 25 ° C; mPa · s; sample with positive dielectric anisotropy): Measurement was performed by M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, The method described in 37 (1995) was followed. The sample was placed in a TN device having a twist angle of 0 degrees and a distance (cell gap) between the two glass substrates of 5 μm. A stepwise application of 16 V to 19.5 V was applied to this device in 0.5 V increments. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (rectangular pulse; 0.2 seconds) and no application (2 seconds). The peak current and peak time of the transient current generated by this application were measured. These measurements and M.I. Rotational viscosity values were obtained from the paper by Imai et al., Equation (8) on page 40. The value of the dielectric anisotropy required for this calculation was obtained by the method described below using the device for which the rotational viscosity was measured.
(12b)粘度(回転粘度;γ1;25℃で測定;mPa・s;誘電率異方性が負の試料):測定は、M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37(1995) に記載された方法に従った。2枚のガラス基板の間隔(セルギャップ)が20μmのVA素子に試料を入れた。この素子に39Vから50Vまで1V毎に段階的に印加した。0.2秒の無印加のあと、ただ1つの矩形波(矩形パルス;0.2秒)と無印加(2秒)の条件で印加を繰り返した。この印加によって発生した過渡電流(transient current)のピーク電流(peak current)とピーク時間(peak time)を測定した。これらの測定値とM.Imaiらの論文、40頁の等式(8)とから回転粘度の値を得た。この計算に必要な誘電率異方性は、下記の誘電率異方性の項で測定した。
(12b) Viscosity (rotational viscosity; γ1; measured at 25 ° C; mPa · s; sample with negative dielectric anisotropy): Measurement was performed by M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, The method described in 37 (1995) was followed. The sample was placed in a VA element having a distance (cell gap) between two glass substrates of 20 μm. A stepwise application of 39 V to 50 V was applied to this device in 1 V increments. After no application for 0.2 seconds, application was repeated under the conditions of only one square wave (rectangular pulse; 0.2 seconds) and no application (2 seconds). The peak current and peak time of the transient current generated by this application were measured. These measurements and M.I. Rotational viscosity values were obtained from the paper by Imai et al., Equation (8) on page 40. The permittivity anisotropy required for this calculation was measured in the section of permittivity anisotropy below.
(13a)誘電率異方性(Δε;25℃で測定;誘電率異方性が正の試料):2枚のガラス基板の間隔(セルギャップ)が9μmであり、そしてツイスト角が80度であるTN素子に試料を入れた。この素子にサイン波(10V、1kHz)を印加し、2秒後に液晶分子の長軸方向における誘電率(ε∥)を測定した。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の短軸方向における誘電率(ε⊥)を測定した。誘電率異方性の値は、Δε=ε∥-ε⊥、の等式から計算した。
(13a) Dielectric anisotropy (Δε; measured at 25 ° C; sample with positive permittivity anisotropy): The distance between the two glass substrates (cell gap) is 9 μm, and the twist angle is 80 degrees. A sample was placed in a TN element. A sine wave (10 V, 1 kHz) was applied to this device, and after 2 seconds, the dielectric constant (ε∥) of the liquid crystal molecule in the long axis direction was measured. A sine wave (0.5 V, 1 kHz) was applied to this element, and after 2 seconds, the permittivity (ε⊥) of the liquid crystal molecule in the minor axis direction was measured. The value of permittivity anisotropy was calculated from the equation of Δε = ε∥-ε⊥.
(13b)誘電率異方性(Δε;25℃で測定;誘電率異方性が負の試料):誘電率異方性の値は、Δε=ε∥-ε⊥、の等式から計算した。誘電率(ε∥およびε⊥)は次のように測定した。
1)誘電率(ε∥)の測定:よく洗浄したガラス基板にオクタデシルトリエトキシシラン(0.16mL)のエタノール(20mL)溶液を塗布した。ガラス基板をスピンナーで回転させたあと、150℃で1時間加熱した。2枚のガラス基板の間隔(セルギャップ)が4μmであるVA素子に試料を入れ、この素子を紫外線で硬化する接着剤で密閉した。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の長軸方向における誘電率(ε∥)を測定した。
2)誘電率(ε⊥)の測定:よく洗浄したガラス基板にポリイミド溶液を塗布した。このガラス基板を焼成した後、得られた配向膜にラビング処理をした。2枚のガラス基板の間隔(セルギャップ)が9μmであり、ツイスト角が80度であるTN素子に試料を入れた。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の短軸方向における誘電率(ε⊥)を測定した。 (13b) Permittivity anisotropy (Δε; measured at 25 ° C; sample with negative permittivity anisotropy): The value of permittivity anisotropy was calculated from the equation Δε = ε∥−ε⊥. .. The permittivity (ε∥ and ε⊥) was measured as follows.
1) Measurement of permittivity (ε∥): A solution of octadecyltriethoxysilane (0.16 mL) in ethanol (20 mL) was applied to a well-washed glass substrate. After rotating the glass substrate with a spinner, it was heated at 150 ° C. for 1 hour. A sample was placed in a VA element in which the distance (cell gap) between the two glass substrates was 4 μm, and this element was sealed with an adhesive that cures with ultraviolet rays. A sine wave (0.5 V, 1 kHz) was applied to this element, and after 2 seconds, the dielectric constant (ε∥) of the liquid crystal molecule in the long axis direction was measured.
2) Measurement of permittivity (ε⊥): A polyimide solution was applied to a well-cleaned glass substrate. After firing this glass substrate, the obtained alignment film was subjected to a rubbing treatment. The sample was placed in a TN element in which the distance (cell gap) between the two glass substrates was 9 μm and the twist angle was 80 degrees. A sine wave (0.5 V, 1 kHz) was applied to this element, and after 2 seconds, the permittivity (ε⊥) of the liquid crystal molecule in the minor axis direction was measured.
1)誘電率(ε∥)の測定:よく洗浄したガラス基板にオクタデシルトリエトキシシラン(0.16mL)のエタノール(20mL)溶液を塗布した。ガラス基板をスピンナーで回転させたあと、150℃で1時間加熱した。2枚のガラス基板の間隔(セルギャップ)が4μmであるVA素子に試料を入れ、この素子を紫外線で硬化する接着剤で密閉した。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の長軸方向における誘電率(ε∥)を測定した。
2)誘電率(ε⊥)の測定:よく洗浄したガラス基板にポリイミド溶液を塗布した。このガラス基板を焼成した後、得られた配向膜にラビング処理をした。2枚のガラス基板の間隔(セルギャップ)が9μmであり、ツイスト角が80度であるTN素子に試料を入れた。この素子にサイン波(0.5V、1kHz)を印加し、2秒後に液晶分子の短軸方向における誘電率(ε⊥)を測定した。 (13b) Permittivity anisotropy (Δε; measured at 25 ° C; sample with negative permittivity anisotropy): The value of permittivity anisotropy was calculated from the equation Δε = ε∥−ε⊥. .. The permittivity (ε∥ and ε⊥) was measured as follows.
1) Measurement of permittivity (ε∥): A solution of octadecyltriethoxysilane (0.16 mL) in ethanol (20 mL) was applied to a well-washed glass substrate. After rotating the glass substrate with a spinner, it was heated at 150 ° C. for 1 hour. A sample was placed in a VA element in which the distance (cell gap) between the two glass substrates was 4 μm, and this element was sealed with an adhesive that cures with ultraviolet rays. A sine wave (0.5 V, 1 kHz) was applied to this element, and after 2 seconds, the dielectric constant (ε∥) of the liquid crystal molecule in the long axis direction was measured.
2) Measurement of permittivity (ε⊥): A polyimide solution was applied to a well-cleaned glass substrate. After firing this glass substrate, the obtained alignment film was subjected to a rubbing treatment. The sample was placed in a TN element in which the distance (cell gap) between the two glass substrates was 9 μm and the twist angle was 80 degrees. A sine wave (0.5 V, 1 kHz) was applied to this element, and after 2 seconds, the permittivity (ε⊥) of the liquid crystal molecule in the minor axis direction was measured.
(14a)弾性定数(K;25℃で測定;pN;誘電率異方性が正の試料):測定には横河・ヒューレットパッカード株式会社製のHP4284A型LCRメータを用いた。2枚のガラス基板の間隔(セルギャップ)が20μmである水平配向素子に試料を入れた。この素子に0Vから20V電荷を印加し、静電容量(C)および印加電圧(V)を測定した。これらの測定値を「液晶デバイスハンドブック」(日刊工業新聞社)、75頁にある等式(2.98)、等式(2.101)を用いてフィッティングし、等式(2.99)からK11およびK33の値を得た。次に171頁にある等式(3.18)に、先ほど求めたK11およびK33の値を用いてK22を算出した。弾性定数Kは、このようにして求めたK11、K22、およびK33の平均値で表した。
(14a) Elastic constant (K; measured at 25 ° C.; pN; sample with positive dielectric anisotropy): An HP4284A type LCR meter manufactured by Yokogawa Hewlett-Packard Co., Ltd. was used for the measurement. The sample was placed in a horizontally oriented element in which the distance (cell gap) between the two glass substrates was 20 μm. An electric charge of 0 V to 20 V was applied to this device, and the capacitance (C) and the applied voltage (V) were measured. These measured values are fitted using the equation (2.98) and equation (2.11) on page 75 of the "LCD Device Handbook" (Nikkan Kogyo Shimbun), and from the equation (2.99). Values for K 11 and K 33 were obtained. Next, K 22 was calculated using the values of K 11 and K 33 obtained earlier in the equation (3.18) on page 171. The elastic constant K is represented by the average value of K 11 , K 22 , and K 33 thus obtained.
(14b)弾性定数(K11およびK33;25℃で測定;pN;誘電率異方性が負の試料):測定には株式会社東陽テクニカ製のEC-1型弾性定数測定器を用いた。2枚のガラス基板の間隔(セルギャップ)が20μmである垂直配向素子に試料を入れた。この素子に20Vから0V電荷を印加し、静電容量(C)および印加電圧(V)を測定した。これらの値を、「液晶デバイスハンドブック」(日刊工業新聞社)、75頁にある等式(2.98)、等式(2.101)を用いてフィッティングし、等式(2.100)から弾性定数の値を得た。
(14b) Elastic constants (K 11 and K 33 ; measured at 25 ° C; pN; sample with negative dielectric anisotropy): An EC-1 type elastic constant measuring device manufactured by Toyo Technica Co., Ltd. was used for the measurement. .. The sample was placed in a vertically oriented element in which the distance (cell gap) between the two glass substrates was 20 μm. An electric charge of 20 V to 0 V was applied to this device, and the capacitance (C) and the applied voltage (V) were measured. These values are fitted using the equation (2.98) and equation (2.11) on page 75 of the "LCD Device Handbook" (Nikkan Kogyo Shimbun), and from the equation (2.10). The value of the elastic constant was obtained.
(15a)しきい値電圧(Vth;25℃で測定;V;誘電率異方性が正の試料):測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。2枚のガラス基板の間隔(セルギャップ)が0.45/Δn(μm)であり、ツイスト角が80度であるノーマリーホワイトモード(normally white mode)のTN素子に試料を入れた。この素子に印加する電圧(32Hz、矩形波)は0Vから10Vまで0.02Vずつ段階的に増加させた。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%である電圧-透過率曲線を作成した。しきい値電圧は透過率が90%になったときの電圧で表した。
(15a) Threshold voltage (Vth; measured at 25 ° C.; V; sample with positive dielectric anisotropy): An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. The sample was placed in a normally white mode TN element in which the distance (cell gap) between the two glass substrates was 0.45 / Δn (μm) and the twist angle was 80 degrees. The voltage (32 Hz, square wave) applied to this device was gradually increased by 0.02 V from 0 V to 10 V. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. A voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum. The threshold voltage is expressed as the voltage when the transmittance reaches 90%.
(15b)しきい値電圧(Vth;25℃で測定;V;誘電率異方性が負の試料):測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。2枚のガラス基板の間隔(セルギャップ)が4μmであり、ラビング方向がアンチパラレルであるノーマリーブラックモード(normally black mode)のVA素子に試料を入れ、この素子を紫外線で硬化する接着剤を用いて密閉した。この素子に印加する電圧(60Hz、矩形波)は0Vから20Vまで0.02Vずつ段階的に増加させた。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%である電圧-透過率曲線を作成した。しきい値電圧は透過率が10%になったときの電圧で表した。
(15b) Threshold voltage (Vth; measured at 25 ° C.; V; sample with negative dielectric anisotropy): An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. A sample is placed in a VA element in normally black mode where the distance (cell gap) between the two glass substrates is 4 μm and the rubbing direction is anti-parallel, and an adhesive that cures this element with ultraviolet rays is applied. Sealed using. The voltage (60 Hz, square wave) applied to this device was gradually increased by 0.02 V from 0 V to 20 V. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. A voltage-transmittance curve was created in which the transmittance was 100% when the amount of light was maximum and the transmittance was 0% when the amount of light was minimum. The threshold voltage is expressed as the voltage when the transmittance reaches 10%.
(16a)応答時間(τ;25℃で測定;ms;誘電率異方性が正の試料):測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。ローパス・フィルター(Low-pass filter)は5kHzに設定した。2枚のガラス基板の間隔(セルギャップ)が5.0μmであり、ツイスト角が80度であるノーマリーホワイトモード(normally white mode)のTN素子に試料を入れた。この素子に矩形波(60Hz、5V、0.5秒)を印加した。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%であるとみなした。立ち上がり時間(τr:rise time;ミリ秒)は、透過率が90%から10%に変化するのに要した時間である。立ち下がり時間(τf:fall time;ミリ秒)は透過率10%から90%に変化するのに要した時間である。応答時間は、このようにして求めた立ち上がり時間と立ち下がり時間との和で表した。
(16a) Response time (τ; measured at 25 ° C.; ms; sample with positive dielectric anisotropy): An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. The low-pass filter was set to 5 kHz. The sample was placed in a normally white mode TN element in which the distance (cell gap) between the two glass substrates was 5.0 μm and the twist angle was 80 degrees. A square wave (60 Hz, 5 V, 0.5 seconds) was applied to this device. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. It was considered that the transmittance was 100% when the amount of light was maximum, and the transmittance was 0% when the amount of light was minimum. The rise time (τr: rise time; millisecond) is the time required for the transmittance to change from 90% to 10%. The fall time (τf: fall time; millisecond) is the time required for the transmittance to change from 10% to 90%. The response time was expressed as the sum of the rise time and the fall time obtained in this way.
(16b)応答時間(τ;25℃で測定;ms;誘電率異方性が負の試料):測定には大塚電子株式会社製のLCD5100型輝度計を用いた。光源はハロゲンランプであった。ローパス・フィルター(Low-pass filter)は5kHzに設定した。2枚のガラス基板の間隔(セルギャップ)が3.2μmであり、ラビング方向がアンチパラレルであるノーマリーブラックモード(normally black mode)のPVA素子に試料を入れた。この素子を紫外線で硬化する接着剤を用いて密閉した。この素子にしきい値電圧を若干超える程度の電圧を1分間印加し、次に5.6Vの電圧を印加しながら23.5mW/cm2の紫外線を8分間照射した。この素子に矩形波(60Hz、10V、0.5秒)を印加した。この際に、素子に垂直方向から光を照射し、素子を透過した光量を測定した。この光量が最大になったときが透過率100%であり、この光量が最小であったときが透過率0%であるとみなした。応答時間は透過率90%から10%に変化するのに要した時間(立ち下がり時間;fall time;ミリ秒)で表した。
(16b) Response time (τ; measured at 25 ° C.; ms; sample with negative dielectric anisotropy): An LCD5100 type luminance meter manufactured by Otsuka Electronics Co., Ltd. was used for the measurement. The light source was a halogen lamp. The low-pass filter was set to 5 kHz. The sample was placed in a normally black mode PVA element in which the distance between the two glass substrates (cell gap) was 3.2 μm and the rubbing direction was antiparallel. This element was sealed with an UV curable adhesive. A voltage slightly exceeding the threshold voltage was applied to this device for 1 minute, and then 23.5 mW / cm 2 ultraviolet rays were irradiated for 8 minutes while applying a voltage of 5.6 V. A square wave (60 Hz, 10 V, 0.5 seconds) was applied to this device. At this time, the element was irradiated with light from the vertical direction, and the amount of light transmitted through the element was measured. It was considered that the transmittance was 100% when the amount of light was maximum, and the transmittance was 0% when the amount of light was minimum. The response time was expressed as the time required for the transmittance to change from 90% to 10% (fall time; fall time; millisecond).
[合成例1]
化合物(a-71)の合成 [Synthesis Example 1]
Synthesis of compound (a-71)
化合物(a-71)の合成 [Synthesis Example 1]
Synthesis of compound (a-71)
第1工程:化合物(t-2)の合成
市販の化合物(t-1)(10.0g,68.2mmol)、ヨードエタン(12.8g,81.9mmol)、炭酸カリウム(18.9g,136mmol)をN,N-ジメチルホルムアミド(100mL)に溶解させ、70~80℃で2時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=4:1)で精製することにより、化合物(t-2)(9.83g、56.3mmol)を無色液体として得た。 First step: Synthesis of compound (t-2) Commercially available compound (t-1) (10.0 g, 68.2 mmol), iodoethane (12.8 g, 81.9 mmol), potassium carbonate (18.9 g, 136 mmol) Was dissolved in N, N-dimethylformamide (100 mL) and stirred at 70-80 ° C. for 2 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 4: 1) to give compound (t-2) (9.83 g, 56.3 mmol) as a colorless liquid.
市販の化合物(t-1)(10.0g,68.2mmol)、ヨードエタン(12.8g,81.9mmol)、炭酸カリウム(18.9g,136mmol)をN,N-ジメチルホルムアミド(100mL)に溶解させ、70~80℃で2時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=4:1)で精製することにより、化合物(t-2)(9.83g、56.3mmol)を無色液体として得た。 First step: Synthesis of compound (t-2) Commercially available compound (t-1) (10.0 g, 68.2 mmol), iodoethane (12.8 g, 81.9 mmol), potassium carbonate (18.9 g, 136 mmol) Was dissolved in N, N-dimethylformamide (100 mL) and stirred at 70-80 ° C. for 2 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 4: 1) to give compound (t-2) (9.83 g, 56.3 mmol) as a colorless liquid.
第2工程:化合物(t-4)の合成
化合物(t-3)(10.0g,63.7mmol)、1-ヨードブタン(14.1g,76.4mmol)、炭酸カリウム(17.6g,127mmol)をDMF(100mL)に溶解させ、70~80℃で2時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(t-4)(13.2g、61.9mmol)を黄色液体として得た。 Second step: Synthesis of compound (t-4) Compound (t-3) (10.0 g, 63.7 mmol), 1-iodobutane (14.1 g, 76.4 mmol), potassium carbonate (17.6 g, 127 mmol) Was dissolved in DMF (100 mL) and stirred at 70-80 ° C. for 2 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (t-4) (13.2 g, 61.9 mmol) as a yellow liquid.
化合物(t-3)(10.0g,63.7mmol)、1-ヨードブタン(14.1g,76.4mmol)、炭酸カリウム(17.6g,127mmol)をDMF(100mL)に溶解させ、70~80℃で2時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(t-4)(13.2g、61.9mmol)を黄色液体として得た。 Second step: Synthesis of compound (t-4) Compound (t-3) (10.0 g, 63.7 mmol), 1-iodobutane (14.1 g, 76.4 mmol), potassium carbonate (17.6 g, 127 mmol) Was dissolved in DMF (100 mL) and stirred at 70-80 ° C. for 2 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (t-4) (13.2 g, 61.9 mmol) as a yellow liquid.
第3工程:化合物(t-5)の合成
化合物(t-4)(13.2g、61.9mmol)を2-プロパノール(140mL)に溶解させ、5%パラジウム-炭素(0.660g)を添加し、水素添加した。触媒を濾別後、減圧濃縮し残渣をシリカゲルクロマトグラフィー(トルエン)で精製することにより、化合物(t-5)(4.50g、24.6mmol)を褐色固体として得た。 Third step: Synthesis of compound (t-5) Compound (t-4) (13.2 g, 61.9 mmol) is dissolved in 2-propanol (140 mL) and 5% palladium-carbon (0.660 g) is added. And hydrogenated. The catalyst was filtered off, concentrated under reduced pressure, and the residue was purified by silica gel chromatography (toluene) to give compound (t-5) (4.50 g, 24.6 mmol) as a brown solid.
化合物(t-4)(13.2g、61.9mmol)を2-プロパノール(140mL)に溶解させ、5%パラジウム-炭素(0.660g)を添加し、水素添加した。触媒を濾別後、減圧濃縮し残渣をシリカゲルクロマトグラフィー(トルエン)で精製することにより、化合物(t-5)(4.50g、24.6mmol)を褐色固体として得た。 Third step: Synthesis of compound (t-5) Compound (t-4) (13.2 g, 61.9 mmol) is dissolved in 2-propanol (140 mL) and 5% palladium-carbon (0.660 g) is added. And hydrogenated. The catalyst was filtered off, concentrated under reduced pressure, and the residue was purified by silica gel chromatography (toluene) to give compound (t-5) (4.50 g, 24.6 mmol) as a brown solid.
第4工程:化合物(t-6)の合成
化合物(t-2)(4.29g、24.6mmol)、化合物(t-5)(4.50g、24.6mmol)、t-ブトキシナトリウム(3.54g、36.8mmol)および、Pd(amphos)Cl2(0.174g)をキシレン(50mL)に溶解させ、110℃で3時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=4:1)で精製することにより、化合物(t-6)(4.67g、14.5mmol)を桃色液体として得た。 Fourth step: Synthesis of compound (t-6) Compound (t-2) (4.29 g, 24.6 mmol), compound (t-5) (4.50 g, 24.6 mmol), t-butoxysodium (3) .54 g, 36.8 mmol) and Pd (amphos) Cl2 (0.174 g) were dissolved in xylene (50 mL) and stirred at 110 ° C. for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 4: 1) to give compound (t-6) (4.67 g, 14.5 mmol) as a pink liquid.
化合物(t-2)(4.29g、24.6mmol)、化合物(t-5)(4.50g、24.6mmol)、t-ブトキシナトリウム(3.54g、36.8mmol)および、Pd(amphos)Cl2(0.174g)をキシレン(50mL)に溶解させ、110℃で3時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=4:1)で精製することにより、化合物(t-6)(4.67g、14.5mmol)を桃色液体として得た。 Fourth step: Synthesis of compound (t-6) Compound (t-2) (4.29 g, 24.6 mmol), compound (t-5) (4.50 g, 24.6 mmol), t-butoxysodium (3) .54 g, 36.8 mmol) and Pd (amphos) Cl2 (0.174 g) were dissolved in xylene (50 mL) and stirred at 110 ° C. for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 4: 1) to give compound (t-6) (4.67 g, 14.5 mmol) as a pink liquid.
第5工程:化合物(a-71)の合成
化合物(t-6)(4.67g、14.5mmol)を酢酸(80mL)に溶解させ、酢酸パラジウム(3.91g、17.4mmol)を加え、50分加熱還流した。反応終了後、室温まで冷まし、フロリジル/セライトでろ過し、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(a-71)(1.61g、5.04mmol)を無色固体として得た。 Fifth step: Synthesis of compound (a-71) Compound (t-6) (4.67 g, 14.5 mmol) was dissolved in acetic acid (80 mL), palladium acetate (3.91 g, 17.4 mmol) was added, and the mixture was added. The mixture was heated under reflux for 50 minutes. After completion of the reaction, the mixture was cooled to room temperature, filtered through Floridil / Celite, poured into water, and extracted 3 times with toluene. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (a-71) (1.61 g, 5.04 mmol) as a colorless solid.
化合物(t-6)(4.67g、14.5mmol)を酢酸(80mL)に溶解させ、酢酸パラジウム(3.91g、17.4mmol)を加え、50分加熱還流した。反応終了後、室温まで冷まし、フロリジル/セライトでろ過し、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(a-71)(1.61g、5.04mmol)を無色固体として得た。 Fifth step: Synthesis of compound (a-71) Compound (t-6) (4.67 g, 14.5 mmol) was dissolved in acetic acid (80 mL), palladium acetate (3.91 g, 17.4 mmol) was added, and the mixture was added. The mixture was heated under reflux for 50 minutes. After completion of the reaction, the mixture was cooled to room temperature, filtered through Floridil / Celite, poured into water, and extracted 3 times with toluene. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (a-71) (1.61 g, 5.04 mmol) as a colorless solid.
1H-NMR(CDCl3;δppm):8.13(brs,J=8.13Hz,1H)、7.58(d,J=8.6Hz,2H)、6.89(ddd,J=7.9,7.8,1.1Hz,2H)、4.21(q,J=7.0Hz,2H)、4.14(t,J=6.6Hz,2H)、1.84(quin,J=6.7Hz,2H)、1.54(sext,J=7.5Hz,2H)、1.48(t,J=7.1Hz,3H)、1.00(t,J=7.4Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 8.13 (brs, J = 8.13Hz, 1H), 7.58 (d, J = 8.6Hz, 2H), 6.89 (ddd, J = 7) 9.9,7.8,1.1Hz, 2H), 4.21 (q, J = 7.0Hz, 2H), 4.14 (t, J = 6.6Hz, 2H), 1.84 (quin, quin, J = 6.7Hz, 2H), 1.54 (sex, J = 7.5Hz, 2H), 1.48 (t, J = 7.1Hz, 3H), 1.00 (t, J = 7.4Hz) , 3H).
相転移温度:C 92.4 I.上限温度(NI)=-45.7℃;誘電率異方性(Δε)=-1.48;光学異方性(Δn)=0.147;粘度(η)=127.4mPa・s.
Phase transition temperature: C 92.4 I. Upper limit temperature (NI) = −45.7 ° C.; Dielectric constant anisotropy (Δε) = −1.48; Optical anisotropy (Δn) = 0.147; Viscosity (η) = 127.4 mPa · s.
[合成例2]
化合物(a-74)の合成 [Synthesis Example 2]
Synthesis of compound (a-74)
化合物(a-74)の合成 [Synthesis Example 2]
Synthesis of compound (a-74)
化合物(a-71)(0.710g、2.22mmol)をN,N-ジメチルホルムアミド(10mL)に溶解させ、氷冷し、水素化ナトリウム(0.196g、4.49mmol)を少しずつ加え、30分撹拌した。ヨウ化メチル(0.821g、2.59mmol)を滴下し、氷冷しながら1時間撹拌した。反応終了後、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(a-74)(0.52g、1.56mmol)を無色固体として得た。
Compound (a-71) (0.710 g, 2.22 mmol) was dissolved in N, N-dimethylformamide (10 mL), ice-cooled, and sodium hydride (0.196 g, 4.49 mmol) was added little by little. The mixture was stirred for 30 minutes. Methyl iodide (0.821 g, 2.59 mmol) was added dropwise, and the mixture was stirred for 1 hour while cooling with ice. After completion of the reaction, the mixture was poured into water and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (a-74) (0.52 g, 1.56 mmol) as a colorless solid.
1H-NMR(CDCl3;δppm):7.56(d,J=8.5Hz,2H)、6.86(dd,J=7.8,7.8,1.4Hz,1H)、4.21(s,3H)、4.20(q,J=7.0Hz,2H)、4.12(t,J=6.6Hz,2H)、1.84(quin,J=6.6Hz,2H)、1.55(sext,J=7.4Hz,2H)、1.48(t,J=7.0Hz,3H)、1.00(t,J=7.4Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.56 (d, J = 8.5Hz, 2H), 6.86 (dd, J = 7.8, 7.8, 1.4Hz, 1H), 4 .21 (s, 3H), 4.20 (q, J = 7.0Hz, 2H), 4.12 (t, J = 6.6Hz, 2H), 1.84 (quin, J = 6.6Hz, 2H), 1.55 (sext, J = 7.4Hz, 2H), 1.48 (t, J = 7.0Hz, 3H), 1.00 (t, J = 7.4Hz, 3H).
相転移温度:C 71.0 I.上限温度(NI)=37.0℃;誘電率異方性(Δε)=-3.14;光学異方性(Δn)=0.194;粘度(η)=54.1mPa・s.
Phase transition temperature: C 71.0 I. Upper limit temperature (NI) = 37.0 ° C.; Dielectric constant anisotropy (Δε) =-3.14; Optical anisotropy (Δn) = 0.194; Viscosity (η) = 54.1 mPa · s.
[合成例3]
化合物(a-5)の合成 [Synthesis Example 3]
Synthesis of compound (a-5)
化合物(a-5)の合成 [Synthesis Example 3]
Synthesis of compound (a-5)
第1工程:化合物(t-8)の合成
市販の化合物(t-7)(12.5g,64.1mmol)、炭酸カリウム(11.6g,83.4mmol)をN,N-ジメチルホルムアミド(125mL)溶解させ、60℃まで昇温した。ヨードエタン(11.2g,70.6mmol)のN,N-ジメチルホルムアミド(20mL)溶液を滴下し、60℃で6時間半撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を1N-NaOH水溶液、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をショートシリカゲルクロマトグラフィー(へプタン)で精製することにより、化合物(t-8)(12.5g、56.9mmol)を無色液体として得た。 First step: Synthesis of compound (t-8) Commercially available compound (t-7) (12.5 g, 64.1 mmol) and potassium carbonate (11.6 g, 83.4 mmol) were added to N, N-dimethylformamide (125 mL). ) Was dissolved and the temperature was raised to 60 ° C. A solution of iodoethane (11.2 g, 70.6 mmol) in N, N-dimethylformamide (20 mL) was added dropwise, and the mixture was stirred at 60 ° C. for 6 and a half hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with 1N- NaOH aqueous solution and water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by short silica gel chromatography (heptane) to give compound (t-8) (12.5 g, 56.9 mmol) as a colorless liquid.
市販の化合物(t-7)(12.5g,64.1mmol)、炭酸カリウム(11.6g,83.4mmol)をN,N-ジメチルホルムアミド(125mL)溶解させ、60℃まで昇温した。ヨードエタン(11.2g,70.6mmol)のN,N-ジメチルホルムアミド(20mL)溶液を滴下し、60℃で6時間半撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を1N-NaOH水溶液、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をショートシリカゲルクロマトグラフィー(へプタン)で精製することにより、化合物(t-8)(12.5g、56.9mmol)を無色液体として得た。 First step: Synthesis of compound (t-8) Commercially available compound (t-7) (12.5 g, 64.1 mmol) and potassium carbonate (11.6 g, 83.4 mmol) were added to N, N-dimethylformamide (125 mL). ) Was dissolved and the temperature was raised to 60 ° C. A solution of iodoethane (11.2 g, 70.6 mmol) in N, N-dimethylformamide (20 mL) was added dropwise, and the mixture was stirred at 60 ° C. for 6 and a half hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with 1N- NaOH aqueous solution and water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by short silica gel chromatography (heptane) to give compound (t-8) (12.5 g, 56.9 mmol) as a colorless liquid.
第2工程:化合物(t-9)の合成
市販の化合物(t-7)(12.5g,65.5mmol)、1-ブロモブタン(9.86g,72.0mmol)、炭酸カリウム(11.8g,85.1mmol)をN,N-ジメチルホルムアミド(125mL)に溶解させ、80℃で3時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を2N-NaOH水溶液、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をショートシリカゲルクロマトグラフィー(へプタン)で精製することにより、化合物(t-9)(14.2g、57.5mmol)を淡茶色液体として得た。 Second step: Synthesis of compound (t-9) Commercially available compound (t-7) (12.5 g, 65.5 mmol), 1-bromobutane (9.86 g, 72.0 mmol), potassium carbonate (11.8 g, 85.1 mmol) was dissolved in N, N-dimethylformamide (125 mL) and stirred at 80 ° C. for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with a 2N-NaOH aqueous solution and water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by short silica gel chromatography (heptane) to give compound (t-9) (14.2 g, 57.5 mmol) as a light brown liquid.
市販の化合物(t-7)(12.5g,65.5mmol)、1-ブロモブタン(9.86g,72.0mmol)、炭酸カリウム(11.8g,85.1mmol)をN,N-ジメチルホルムアミド(125mL)に溶解させ、80℃で3時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を2N-NaOH水溶液、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をショートシリカゲルクロマトグラフィー(へプタン)で精製することにより、化合物(t-9)(14.2g、57.5mmol)を淡茶色液体として得た。 Second step: Synthesis of compound (t-9) Commercially available compound (t-7) (12.5 g, 65.5 mmol), 1-bromobutane (9.86 g, 72.0 mmol), potassium carbonate (11.8 g, 85.1 mmol) was dissolved in N, N-dimethylformamide (125 mL) and stirred at 80 ° C. for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with a 2N-NaOH aqueous solution and water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by short silica gel chromatography (heptane) to give compound (t-9) (14.2 g, 57.5 mmol) as a light brown liquid.
第3工程:化合物(t-10)の合成
化合物(t-9)(14.0g,56.7mmol)、ベンジルアミン(7.29g,68.0mmol)、t-ブトキシナトリウム(8.17g,85.0mmol)をトルエン(196mL)に溶解させ、減圧脱気し、パラジウム(0)ビス(ジベンジリデンアセトン)(0.652g)、2-(ジ-t-ブチルホスフィノ)ビフェニル(0.676g,2.27mmol)を加え、60℃で加熱撹拌した。発熱がおさまったところで、還流温度まで少しずつ昇温し、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=9:1)で精製することにより、化合物(t-10)(15.0g、54.9mmol)を褐色液体として得た。 Third step: Synthesis of compound (t-10) Compound (t-9) (14.0 g, 56.7 mmol), benzylamine (7.29 g, 68.0 mmol), t-butoxysodium (8.17 g, 85). .0 mmol) was dissolved in toluene (196 mL), degassed under reduced pressure, palladium (0) bis (dibenzylideneacetone) (0.652 g), 2- (di-t-butylphosphino) biphenyl (0.676 g, 2.27 mmol) was added, and the mixture was heated and stirred at 60 ° C. When the heat generation had subsided, the temperature was gradually raised to the reflux temperature, and the mixture was heated under reflux for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: ethyl acetate = 9: 1) to give compound (t-10) (15.0 g, 54.9 mmol) as a brown liquid.
化合物(t-9)(14.0g,56.7mmol)、ベンジルアミン(7.29g,68.0mmol)、t-ブトキシナトリウム(8.17g,85.0mmol)をトルエン(196mL)に溶解させ、減圧脱気し、パラジウム(0)ビス(ジベンジリデンアセトン)(0.652g)、2-(ジ-t-ブチルホスフィノ)ビフェニル(0.676g,2.27mmol)を加え、60℃で加熱撹拌した。発熱がおさまったところで、還流温度まで少しずつ昇温し、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=9:1)で精製することにより、化合物(t-10)(15.0g、54.9mmol)を褐色液体として得た。 Third step: Synthesis of compound (t-10) Compound (t-9) (14.0 g, 56.7 mmol), benzylamine (7.29 g, 68.0 mmol), t-butoxysodium (8.17 g, 85). .0 mmol) was dissolved in toluene (196 mL), degassed under reduced pressure, palladium (0) bis (dibenzylideneacetone) (0.652 g), 2- (di-t-butylphosphino) biphenyl (0.676 g, 2.27 mmol) was added, and the mixture was heated and stirred at 60 ° C. When the heat generation had subsided, the temperature was gradually raised to the reflux temperature, and the mixture was heated under reflux for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: ethyl acetate = 9: 1) to give compound (t-10) (15.0 g, 54.9 mmol) as a brown liquid.
第4工程:化合物(t-11)の合成
化合物(t-10)(11.0g、40.2mmol)、化合物(t-8)(8.82g、40.2mmol)、t-ブトキシナトリウム(5.80g、60.4mmol)および、Pd(amphos)Cl2(0.0285g)をトルエン(330mL)に溶解させ、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(t-11)(11.6g、28.2mmol)を無色液体として得た。 Fourth step: Synthesis of compound (t-11) Compound (t-10) (11.0 g, 40.2 mmol), compound (t-8) (8.82 g, 40.2 mmol), t-butoxysodium (5). .80 g, 60.4 mmol) and Pd (amphos) Cl2 (0.0285 g) were dissolved in toluene (330 mL) and refluxed by heating for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (t-11) (11.6 g, 28.2 mmol) as a colorless liquid.
化合物(t-10)(11.0g、40.2mmol)、化合物(t-8)(8.82g、40.2mmol)、t-ブトキシナトリウム(5.80g、60.4mmol)および、Pd(amphos)Cl2(0.0285g)をトルエン(330mL)に溶解させ、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(t-11)(11.6g、28.2mmol)を無色液体として得た。 Fourth step: Synthesis of compound (t-11) Compound (t-10) (11.0 g, 40.2 mmol), compound (t-8) (8.82 g, 40.2 mmol), t-butoxysodium (5). .80 g, 60.4 mmol) and Pd (amphos) Cl2 (0.0285 g) were dissolved in toluene (330 mL) and refluxed by heating for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (t-11) (11.6 g, 28.2 mmol) as a colorless liquid.
第5工程:化合物(t-12)の合成
化合物(t-11)(11.6g、28.2mmol)をトルエン(30mL)および、2-プロパノール(60mL)に溶解させ、水酸化パラジウム(0.580g)を添加し、水素添加した。触媒を濾別後、減圧濃縮し残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=4:1)で精製することにより、化合物(t-12)(7.70g、24.0mmol)を褐色液体として得た。 Fifth step: Synthesis of compound (t-12) Compound (t-11) (11.6 g, 28.2 mmol) was dissolved in toluene (30 mL) and 2-propanol (60 mL), and palladium hydroxide (0. 580 g) was added and hydrogenated. The catalyst was filtered off, concentrated under reduced pressure, and the residue was purified by silica gel chromatography (heptane: ethyl acetate = 4: 1) to turn compound (t-12) (7.70 g, 24.0 mmol) into a brown liquid. Obtained.
化合物(t-11)(11.6g、28.2mmol)をトルエン(30mL)および、2-プロパノール(60mL)に溶解させ、水酸化パラジウム(0.580g)を添加し、水素添加した。触媒を濾別後、減圧濃縮し残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=4:1)で精製することにより、化合物(t-12)(7.70g、24.0mmol)を褐色液体として得た。 Fifth step: Synthesis of compound (t-12) Compound (t-11) (11.6 g, 28.2 mmol) was dissolved in toluene (30 mL) and 2-propanol (60 mL), and palladium hydroxide (0. 580 g) was added and hydrogenated. The catalyst was filtered off, concentrated under reduced pressure, and the residue was purified by silica gel chromatography (heptane: ethyl acetate = 4: 1) to turn compound (t-12) (7.70 g, 24.0 mmol) into a brown liquid. Obtained.
第6工程:化合物(a-5)の合成
化合物(t-12)(6.70g、20.9mmol)を酢酸(110mL)に溶解させ、酢酸パラジウム(5.61g、25.0mmol)を加え、50分加熱還流した。反応終了後、室温まで冷まし、フロリジル/セライトでろ過し、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(a-5)(1.34g、4.20mmol)を無色固体として得た。 Sixth step: Synthesis of compound (a-5) Compound (t-12) (6.70 g, 20.9 mmol) is dissolved in acetic acid (110 mL), palladium acetate (5.61 g, 25.0 mmol) is added, and the mixture is added. The mixture was heated under reflux for 50 minutes. After completion of the reaction, the mixture was cooled to room temperature, filtered through Floridil / Celite, poured into water, and extracted 3 times with toluene. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (a-5) (1.34 g, 4.20 mmol) as a colorless solid.
化合物(t-12)(6.70g、20.9mmol)を酢酸(110mL)に溶解させ、酢酸パラジウム(5.61g、25.0mmol)を加え、50分加熱還流した。反応終了後、室温まで冷まし、フロリジル/セライトでろ過し、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水、飽和塩化ナトリウム水溶液にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(a-5)(1.34g、4.20mmol)を無色固体として得た。 Sixth step: Synthesis of compound (a-5) Compound (t-12) (6.70 g, 20.9 mmol) is dissolved in acetic acid (110 mL), palladium acetate (5.61 g, 25.0 mmol) is added, and the mixture is added. The mixture was heated under reflux for 50 minutes. After completion of the reaction, the mixture was cooled to room temperature, filtered through Floridil / Celite, poured into water, and extracted 3 times with toluene. The combined organic layers were washed with water and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (a-5) (1.34 g, 4.20 mmol) as a colorless solid.
1H-NMR(CDCl3;δppm):7.80(brs,1H)、7.56(dd,J=11.0,2.1Hz,2H)、6.94(d,J=6.9Hz,1H)、4.15(q,J=7.0Hz,2H)、4.08(t,J=6.6Hz,2H)、1.86(quin,J=6.6,2H)、1.54(sext,J=7.5Hz,2H)、1.50(t,J=7.0Hz,3H)、1.00(t,J=7.4Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.80 (brs, 1H), 7.56 (dd, J = 11.0, 2.1Hz, 2H), 6.94 (d, J = 6.9Hz) , 1H), 4.15 (q, J = 7.0Hz, 2H), 4.08 (t, J = 6.6Hz, 2H), 1.86 (quin, J = 6.6, 2H), 1 .54 (sext, J = 7.5Hz, 2H), 1.50 (t, J = 7.0Hz, 3H), 1.00 (t, J = 7.4Hz, 3H).
相転移温度:C 217.3 I.上限温度(NI)=71.0℃;誘電率異方性(Δε)=-22.5;光学異方性(Δn)=0.220;粘度(η)=202.9mPa・s.
Phase transition temperature: C 217.3 I. Upper limit temperature (NI) = 71.0 ° C.; Dielectric constant anisotropy (Δε) = -22.5; Optical anisotropy (Δn) = 0.220; Viscosity (η) = 202.9 mPa · s.
[合成例4]
化合物(a-11)の合成 [Synthesis Example 4]
Synthesis of compound (a-11)
化合物(a-11)の合成 [Synthesis Example 4]
Synthesis of compound (a-11)
化合物(a-5)(0.26g、0.81mmol)をN,N-ジメチルホルムアミド(5.0mL)に溶解させ、氷冷し、水素化ナトリウム(0.0718g、1.64mmol)を少しずつ加え、30分撹拌した。ヨウ化メチル(0.301g、2.11mmol)を滴下し、氷冷しながら3時間撹拌した。反応終了後、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=1:1)で精製することにより、化合物(a-11)(0.20g、0.600mmol)を無色固体として得た。
Compound (a-5) (0.26 g, 0.81 mmol) was dissolved in N, N-dimethylformamide (5.0 mL), ice-cooled, and sodium hydride (0.0718 g, 1.64 mmol) was added little by little. In addition, it was stirred for 30 minutes. Methyl iodide (0.301 g, 2.11 mmol) was added dropwise, and the mixture was stirred with ice for 3 hours. After completion of the reaction, the mixture was poured into water and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 1: 1) to give compound (a-11) (0.20 g, 0.600 mmol) as a colorless solid.
1H-NMR(CDCl3;δppm):7.58(dd,J=11.0,2.3Hz,2H)、6.86(d,J=6.8Hz,1H)、4.21(q,J=7.0Hz,2H)、4.13(t,J=6.6Hz,2H)、3.75(s,3H)、1.88(quin,J=6.6Hz,2H)、1.56(sext,J=7.5Hz,2H)、1.52(t,J=7.0Hz,3H)、1.01(t,J=7.4Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.58 (dd, J = 11.0, 2.3Hz, 2H), 6.86 (d, J = 6.8Hz, 1H), 4.21 (q) , J = 7.0Hz, 2H), 4.13 (t, J = 6.6Hz, 2H), 3.75 (s, 3H), 1.88 (quin, J = 6.6Hz, 2H), 1 .56 (sext, J = 7.5Hz, 2H), 1.52 (t, J = 7.0Hz, 3H), 1.01 (t, J = 7.4Hz, 3H).
相転移温度:C 142.5 I.;3%も溶解しなかったため、物性値測定できず。
Phase transition temperature: C 142.5 I. The physical property value could not be measured because 3% was not dissolved.
[合成例5]
化合物(a-36)の合成 [Synthesis Example 5]
Synthesis of compound (a-36)
化合物(a-36)の合成 [Synthesis Example 5]
Synthesis of compound (a-36)
第1工程:化合物(t-14)の合成
市販の化合物(t-13)(25.0g,120mmol)、ヨードエタン(20.5g,132mmol)、炭酸カリウム(21.5g,156mmol)をN,N-ジメチルホルムアミド(250mL)溶解させ、80℃で4時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を2N-NaOH水溶液、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をショートシリカゲルクロマトグラフィー(トルエン)で精製することにより、化合物(t-14)(25.8g、109mmol)を褐色液体として得た。 First step: Synthesis of compound (t-14) N, N of commercially available compound (t-13) (25.0 g, 120 mmol), iodoethane (20.5 g, 132 mmol), potassium carbonate (21.5 g, 156 mmol) -Dimethylformamide (250 mL) was dissolved and stirred at 80 ° C. for 4 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with a 2N-NaOH aqueous solution and water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by short silica gel chromatography (toluene) to give compound (t-14) (25.8 g, 109 mmol) as a brown liquid.
市販の化合物(t-13)(25.0g,120mmol)、ヨードエタン(20.5g,132mmol)、炭酸カリウム(21.5g,156mmol)をN,N-ジメチルホルムアミド(250mL)溶解させ、80℃で4時間撹拌した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を2N-NaOH水溶液、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をショートシリカゲルクロマトグラフィー(トルエン)で精製することにより、化合物(t-14)(25.8g、109mmol)を褐色液体として得た。 First step: Synthesis of compound (t-14) N, N of commercially available compound (t-13) (25.0 g, 120 mmol), iodoethane (20.5 g, 132 mmol), potassium carbonate (21.5 g, 156 mmol) -Dimethylformamide (250 mL) was dissolved and stirred at 80 ° C. for 4 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with a 2N-NaOH aqueous solution and water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by short silica gel chromatography (toluene) to give compound (t-14) (25.8 g, 109 mmol) as a brown liquid.
第2工程:化合物(t-16)の合成
化合物(t-15)(18.0g,72.8mmol)、ベンジルアミン(9.37g,87.4mmol)、t-ブトキシナトリウム(10.5g,109mmol)をトルエン(252mL)に溶解させ、減圧脱気し、パラジウム(0)ビス(ジベンジリデンアセトン)(0.838g)、2-(ジ-t-ブチルホスフィノ)ビフェニル(0.870g,2.91mmol)を加え、60℃で加熱撹拌した。発熱がおさまったところで、還流温度まで少しずつ昇温し、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=9:1)で精製することにより、化合物(t-16)(15.6g、57.1mmol)を褐色液体として得た。 Second step: Synthesis of compound (t-16) Compound (t-15) (18.0 g, 72.8 mmol), benzylamine (9.37 g, 87.4 mmol), t-butoxysodium (10.5 g, 109 mmol) ) Is dissolved in toluene (252 mL), degassed under reduced pressure, and palladium (0) bis (dibenzylideneacetone) (0.838 g), 2- (di-t-butylphosphino) biphenyl (0.870 g, 2. 91 mmol) was added, and the mixture was heated and stirred at 60 ° C. When the heat generation had subsided, the temperature was gradually raised to the reflux temperature, and the mixture was heated under reflux for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: ethyl acetate = 9: 1) to give compound (t-16) (15.6 g, 57.1 mmol) as a brown liquid.
化合物(t-15)(18.0g,72.8mmol)、ベンジルアミン(9.37g,87.4mmol)、t-ブトキシナトリウム(10.5g,109mmol)をトルエン(252mL)に溶解させ、減圧脱気し、パラジウム(0)ビス(ジベンジリデンアセトン)(0.838g)、2-(ジ-t-ブチルホスフィノ)ビフェニル(0.870g,2.91mmol)を加え、60℃で加熱撹拌した。発熱がおさまったところで、還流温度まで少しずつ昇温し、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=9:1)で精製することにより、化合物(t-16)(15.6g、57.1mmol)を褐色液体として得た。 Second step: Synthesis of compound (t-16) Compound (t-15) (18.0 g, 72.8 mmol), benzylamine (9.37 g, 87.4 mmol), t-butoxysodium (10.5 g, 109 mmol) ) Is dissolved in toluene (252 mL), degassed under reduced pressure, and palladium (0) bis (dibenzylideneacetone) (0.838 g), 2- (di-t-butylphosphino) biphenyl (0.870 g, 2. 91 mmol) was added, and the mixture was heated and stirred at 60 ° C. When the heat generation had subsided, the temperature was gradually raised to the reflux temperature, and the mixture was heated under reflux for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: ethyl acetate = 9: 1) to give compound (t-16) (15.6 g, 57.1 mmol) as a brown liquid.
第3工程:化合物(t-17)の合成
化合物(t-14)(13.0g、54.9mmol)、化合物(t-16)(15.0g、54.9mmol)、t-ブトキシナトリウム(7.91g、82.3mmol)をトルエン(450mL)に溶解させ、減圧脱気し、Pd(amphos)Cl2(0.0389g)を加え、60℃で加熱撹拌した。発熱がおさまったところで、還流温度まで少しずつ昇温し、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=2:1)で精製することにより、化合物(t-17)(15.0g、34.9mmol)を褐色液体として得た。 Third step: Synthesis of compound (t-17) Compound (t-14) (13.0 g, 54.9 mmol), compound (t-16) (15.0 g, 54.9 mmol), t-butoxysodium (7) .91 g, 82.3 mmol) was dissolved in toluene (450 mL), degassed under reduced pressure, Pd (amphos) Cl2 (0.0389 g) was added, and the mixture was heated and stirred at 60 ° C. When the heat generation had subsided, the temperature was gradually raised to the reflux temperature, and the mixture was heated under reflux for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 2: 1) to give compound (t-17) (15.0 g, 34.9 mmol) as a brown liquid.
化合物(t-14)(13.0g、54.9mmol)、化合物(t-16)(15.0g、54.9mmol)、t-ブトキシナトリウム(7.91g、82.3mmol)をトルエン(450mL)に溶解させ、減圧脱気し、Pd(amphos)Cl2(0.0389g)を加え、60℃で加熱撹拌した。発熱がおさまったところで、還流温度まで少しずつ昇温し、3時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:トルエン=2:1)で精製することにより、化合物(t-17)(15.0g、34.9mmol)を褐色液体として得た。 Third step: Synthesis of compound (t-17) Compound (t-14) (13.0 g, 54.9 mmol), compound (t-16) (15.0 g, 54.9 mmol), t-butoxysodium (7) .91 g, 82.3 mmol) was dissolved in toluene (450 mL), degassed under reduced pressure, Pd (amphos) Cl2 (0.0389 g) was added, and the mixture was heated and stirred at 60 ° C. When the heat generation had subsided, the temperature was gradually raised to the reflux temperature, and the mixture was heated under reflux for 3 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: toluene = 2: 1) to give compound (t-17) (15.0 g, 34.9 mmol) as a brown liquid.
第4工程:化合物(t-18)の合成
化合物(t-17)(15.0g、34.9mmol)をトルエン(37.5mL)および、2-プロパノール(75mL)に溶解させ、水酸化パラジウム(0.75g)を添加し、水素添加した。触媒を濾別後、減圧濃縮し残渣をシリカゲルクロマトグラフィー(トルエン)で精製することにより、化合物(t-18)(13.1g、38.6mmol)を淡茶色液体として得た。 Fourth step: Synthesis of compound (t-18) Compound (t-17) (15.0 g, 34.9 mmol) is dissolved in toluene (37.5 mL) and 2-propanol (75 mL), and palladium hydroxide (palladium hydroxide (15.0 g)) is dissolved in 2-propanol (75 mL). 0.75 g) was added and hydrogenated. The catalyst was filtered off, concentrated under reduced pressure, and the residue was purified by silica gel chromatography (toluene) to give compound (t-18) (13.1 g, 38.6 mmol) as a light brown liquid.
化合物(t-17)(15.0g、34.9mmol)をトルエン(37.5mL)および、2-プロパノール(75mL)に溶解させ、水酸化パラジウム(0.75g)を添加し、水素添加した。触媒を濾別後、減圧濃縮し残渣をシリカゲルクロマトグラフィー(トルエン)で精製することにより、化合物(t-18)(13.1g、38.6mmol)を淡茶色液体として得た。 Fourth step: Synthesis of compound (t-18) Compound (t-17) (15.0 g, 34.9 mmol) is dissolved in toluene (37.5 mL) and 2-propanol (75 mL), and palladium hydroxide (palladium hydroxide (15.0 g)) is dissolved in 2-propanol (75 mL). 0.75 g) was added and hydrogenated. The catalyst was filtered off, concentrated under reduced pressure, and the residue was purified by silica gel chromatography (toluene) to give compound (t-18) (13.1 g, 38.6 mmol) as a light brown liquid.
第5工程:化合物(a-36)の合成
化合物(t-18)(12.0g、35.4mmol)、炭酸カリウム(0.489g、3.54mmol)をピバル酸(120mL)に溶解させ、酢酸パラジウム(0.794g)を加え、空気下で16時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を炭酸ナトリウムで中和し、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=3:1)で精製することにより、化合物(a-36)(1.50g、4.45mmol)を無色固体として得た。 Fifth step: Synthesis of compound (a-36) Compound (t-18) (12.0 g, 35.4 mmol) and potassium carbonate (0.489 g, 3.54 mmol) are dissolved in pivalic acid (120 mL) to acetic acid. Palladium (0.794 g) was added, and the mixture was heated under reflux in air for 16 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were neutralized with sodium carbonate, washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: ethyl acetate = 3: 1) to give compound (a-36) (1.50 g, 4.45 mmol) as a colorless solid.
化合物(t-18)(12.0g、35.4mmol)、炭酸カリウム(0.489g、3.54mmol)をピバル酸(120mL)に溶解させ、酢酸パラジウム(0.794g)を加え、空気下で16時間加熱還流した。反応終了後、室温まで冷まし、水に注ぎ、トルエンで3回抽出した。合わせた有機層を炭酸ナトリウムで中和し、水にて洗浄した後、無水硫酸マグネシウムで乾燥し、減圧濃縮した。残渣をシリカゲルクロマトグラフィー(へプタン:酢酸エチル=3:1)で精製することにより、化合物(a-36)(1.50g、4.45mmol)を無色固体として得た。 Fifth step: Synthesis of compound (a-36) Compound (t-18) (12.0 g, 35.4 mmol) and potassium carbonate (0.489 g, 3.54 mmol) are dissolved in pivalic acid (120 mL) to acetic acid. Palladium (0.794 g) was added, and the mixture was heated under reflux in air for 16 hours. After completion of the reaction, the mixture was cooled to room temperature, poured into water, and extracted with toluene three times. The combined organic layers were neutralized with sodium carbonate, washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (heptane: ethyl acetate = 3: 1) to give compound (a-36) (1.50 g, 4.45 mmol) as a colorless solid.
1H-NMR(CDCl3;δppm):7.83(brs,1H)、7.74(d,J=10.5Hz,1H)、6.94(d,J=6.5Hz,1H)、6.72(d,J=5.5Hz,1H)、4.16(q,J=7.0Hz,2H)、4.08(t,J=6.5Hz,2H)、1.86(quin,J=7.1,2H)、1.55(sext,J=7.5Hz,2H)、1.50(t,J=7.0Hz,3H)、1.00(t,J=7.5Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.83 (brs, 1H), 7.74 (d, J = 10.5Hz, 1H), 6.94 (d, J = 6.5Hz, 1H), 6.72 (d, J = 5.5Hz, 1H), 4.16 (q, J = 7.0Hz, 2H), 4.08 (t, J = 6.5Hz, 2H), 1.86 (quin) , J = 7.1, 2H), 1.55 (sex, J = 7.5Hz, 2H), 1.50 (t, J = 7.0Hz, 3H), 1.00 (t, J = 7. 5Hz, 3H).
相転移温度:C 187.5 I.上限温度(NI)=84.3℃;誘電率異方性(Δε)=-21.5;光学異方性(Δn)=0.187;粘度(η)=149.4mPa・s.
Phase transition temperature: C 187.5 I. Upper limit temperature (NI) = 84.3 ° C.; Dielectric constant anisotropy (Δε) = -21.5; Optical anisotropy (Δn) = 0.187; Viscosity (η) = 149.4 mPa · s.
[比較実験]
化合物(a-5)と比較化合物(Ref-1)の誘電率異方性を次のように比較した。比較化合物(Ref-1)は、国際公開第2015/129412号の段落[0143]に記載された、化合物(1-2-5)である。合成は、国際公開第2015/129412号の段落[0143]~[0154]の方法に従い行った。
化合物(3)の合成で得られた化合物(a-5)と比較化合物(Ref-1)の誘電率異方性(Δε)を比較した。化合物(a-5)の方が、誘電率異方性が負にとても大きいことが分かった。したがって、化合物(1)は、類似の化合物と比較して優れていると結論できる。 [Comparative experiment]
The dielectric anisotropy of compound (a-5) and comparative compound (Ref-1) was compared as follows. The comparative compound (Ref-1) is compound (1-2-5) described in paragraph [0143] of WO 2015/129412. The synthesis was carried out according to the method of paragraphs [0143] to [0154] of International Publication No. 2015/129412.
The dielectric anisotropy (Δε) of the compound (a-5) obtained by the synthesis of the compound (3) and the comparative compound (Ref-1) was compared. It was found that the dielectric anisotropy of compound (a-5) was much larger in the negative. Therefore, it can be concluded that compound (1) is superior to similar compounds.
化合物(a-5)と比較化合物(Ref-1)の誘電率異方性を次のように比較した。比較化合物(Ref-1)は、国際公開第2015/129412号の段落[0143]に記載された、化合物(1-2-5)である。合成は、国際公開第2015/129412号の段落[0143]~[0154]の方法に従い行った。
化合物(3)の合成で得られた化合物(a-5)と比較化合物(Ref-1)の誘電率異方性(Δε)を比較した。化合物(a-5)の方が、誘電率異方性が負にとても大きいことが分かった。したがって、化合物(1)は、類似の化合物と比較して優れていると結論できる。 [Comparative experiment]
The dielectric anisotropy of compound (a-5) and comparative compound (Ref-1) was compared as follows. The comparative compound (Ref-1) is compound (1-2-5) described in paragraph [0143] of WO 2015/129412. The synthesis was carried out according to the method of paragraphs [0143] to [0154] of International Publication No. 2015/129412.
The dielectric anisotropy (Δε) of the compound (a-5) obtained by the synthesis of the compound (3) and the comparative compound (Ref-1) was compared. It was found that the dielectric anisotropy of compound (a-5) was much larger in the negative. Therefore, it can be concluded that compound (1) is superior to similar compounds.
合成例に記載された方法や、「2.化合物(1)の合成」の項を参考にしながら、以下に示す化合物を合成することが可能である。
It is possible to synthesize the compounds shown below by referring to the method described in the synthesis example and the section "2. Synthesis of compound (1)".
合成例に記載された方法や、「2.化合物(1)の合成」の項を参考にしながら、以下に示す化合物を合成した。
The following compounds were synthesized with reference to the method described in the synthesis example and the section "2. Synthesis of compound (1)".
1H-NMR(CDCl3;δppm):7.79(brs,1H)、7.62(d,J=10.9Hz,1H)、7.50(d,J=10.3Hz,1H)、7.15(d,J=6.3Hz,1H)、6.94(d,J=6.9Hz,1H)、4.17(q,J=6.9Hz,2H)、2.76(t,J=7.5Hz,2H)、1.67(quin,J=7.5Hz,2H)、1.51(t,J=6.9Hz,3H)、1.40-1.32(m,4H)、0.90(t,J=7.5Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.79 (brs, 1H), 7.62 (d, J = 10.9Hz, 1H), 7.50 (d, J = 10.3Hz, 1H), 7.15 (d, J = 6.3Hz, 1H), 6.94 (d, J = 6.9Hz, 1H), 4.17 (q, J = 6.9Hz, 2H), 2.76 (t) , J = 7.5Hz, 2H), 1.67 (quin, J = 7.5Hz, 2H), 1.51 (t, J = 6.9Hz, 3H), 1.40-1.32 (m, 4H), 0.90 (t, J = 7.5Hz, 3H).
化合物(a-4)の物性は、次のとおりであった。
転移温度:C 173.7 I.
上限温度(TNI)=47.3℃;光学的異方性(Δn)=0.187;誘電率異方性(Δε)=-15.18;粘度(η)=258.2mPa・s. The physical characteristics of compound (a-4) were as follows.
Transition temperature: C 173.7 I.
Maximum temperature (T NI) = 47.3 ℃; optical anisotropy (Δn) = 0.187; dielectric anisotropy (Δε) = - 15.18; Viscosity (η) = 258.2mPa · s.
転移温度:C 173.7 I.
上限温度(TNI)=47.3℃;光学的異方性(Δn)=0.187;誘電率異方性(Δε)=-15.18;粘度(η)=258.2mPa・s. The physical characteristics of compound (a-4) were as follows.
Transition temperature: C 173.7 I.
Maximum temperature (T NI) = 47.3 ℃; optical anisotropy (Δn) = 0.187; dielectric anisotropy (Δε) = - 15.18; Viscosity (η) = 258.2mPa · s.
1H-NMR(CDCl3;δppm):7.64(d,J=11.5Hz,1H)、7.53(d,J=9.7Hz,1H)、7.10(d,J=6.3Hz,1H)、6.87(d,J=6.9Hz,1H)、4.22(q,J=6.9Hz,2H)、3.77(s,3H)、2.80(t,J=7.5Hz,2H)、1.70(quin,J=7.5Hz,2H)、1.53(t,J=6.9Hz,3H)、1.41-1.35(m,4H)、0.91(t,J=7.5Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.64 (d, J = 11.5Hz, 1H), 7.53 (d, J = 9.7Hz, 1H), 7.10 (d, J = 6) .3Hz, 1H), 6.87 (d, J = 6.9Hz, 1H), 4.22 (q, J = 6.9Hz, 2H), 3.77 (s, 3H), 2.80 (t) , J = 7.5Hz, 2H), 1.70 (quin, J = 7.5Hz, 2H), 1.53 (t, J = 6.9Hz, 3H), 1.41-1.35 (m, 4H), 0.91 (t, J = 7.5Hz, 3H).
化合物(a-9)の物性は、次のとおりであった。
転移温度:C 73.4 I.
上限温度(TNI)=-44.7℃;光学的異方性(Δn)=0.127;誘電率異方性(Δε)=-7.72;粘度(η)=145.7mPa・s. The physical characteristics of compound (a-9) were as follows.
Transition temperature: C 73.4 I.
Maximum temperature (T NI) = - 44.7 ℃ ; optical anisotropy (Δn) = 0.127; dielectric anisotropy (Δε) = - 7.72; viscosity (η) = 145.7mPa · s ..
転移温度:C 73.4 I.
上限温度(TNI)=-44.7℃;光学的異方性(Δn)=0.127;誘電率異方性(Δε)=-7.72;粘度(η)=145.7mPa・s. The physical characteristics of compound (a-9) were as follows.
Transition temperature: C 73.4 I.
Maximum temperature (T NI) = - 44.7 ℃ ; optical anisotropy (Δn) = 0.127; dielectric anisotropy (Δε) = - 7.72; viscosity (η) = 145.7mPa · s ..
1H-NMR(CDCl3;δppm):7.79(brs,1H)、7.57(d,J=4.0Hz,1H)、7.55(d,J=3.5Hz,1H)、6.95(d,J=6.3Hz,1H)、6.94(d,J=6.3Hz,1H)、4.17(q,J=6.9Hz,2H)、3.88(d,J=6.3Hz,2H)、1.98-1.94(m,2H)、1.87-1.80(m,3H)、1.51(t,J=6.9Hz,3H)、1.37-1,16(m,5H)、1.09(dq,J=2.9,12.6Hz,2H)、0.96(dq,J=2.9,12.6Hz,2H)、0.89(t,J=7.5Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.79 (brs, 1H), 7.57 (d, J = 4.0Hz, 1H), 7.55 (d, J = 3.5Hz, 1H), 6.95 (d, J = 6.3Hz, 1H), 6.94 (d, J = 6.3Hz, 1H), 4.17 (q, J = 6.9Hz, 2H), 3.88 (d) , J = 6.3Hz, 2H), 1.98-1.94 (m, 2H), 1.87-1.80 (m, 3H), 1.51 (t, J = 6.9Hz, 3H) , 1.37-1,16 (m, 5H), 1.09 (dq, J = 2.9, 12.6Hz, 2H), 0.96 (dq, J = 2.9, 12.6Hz, 2H) ), 0.89 (t, J = 7.5Hz, 3H).
化合物(b-7)の物性は、次のとおりであった。
転移温度:C 233.1 I.
上限温度(TNI)=114.3℃;光学的異方性(Δn)=0.187;誘電率異方性(Δε)=-10.5;粘度(η)=99.4mPa・s. The physical characteristics of compound (b-7) were as follows.
Transition temperature: C 233.1 I.
Maximum temperature (T NI) = 114.3 ℃; optical anisotropy (Δn) = 0.187; dielectric anisotropy (Δε) = - 10.5; Viscosity (η) = 99.4mPa · s.
転移温度:C 233.1 I.
上限温度(TNI)=114.3℃;光学的異方性(Δn)=0.187;誘電率異方性(Δε)=-10.5;粘度(η)=99.4mPa・s. The physical characteristics of compound (b-7) were as follows.
Transition temperature: C 233.1 I.
Maximum temperature (T NI) = 114.3 ℃; optical anisotropy (Δn) = 0.187; dielectric anisotropy (Δε) = - 10.5; Viscosity (η) = 99.4mPa · s.
1H-NMR(CDCl3;δppm):7.59(d,J=3.5Hz,1H)、7.57(d,J=4.0Hz,1H)、6.87(d,J=6.9Hz,1H)、6.85(d,J=6.9Hz,1H)、4.21(q,J=6.9Hz,2H)、3.91(d,J=6.3Hz,2H)、3.75(s,3H)、2.00-1.96(m,2H)、1.91-1.81(m,3H)、1.52(t,J=6.9Hz,3H)、1.37-1,17(m,5H)、1.11(dq,J=3.5,12.6Hz,2H)、0.97(dq,J=3.5,12.6Hz,2H)、0.89(t,J=7.5Hz,3H).
1 1 H-NMR (CDCl 3 ; δppm): 7.59 (d, J = 3.5Hz, 1H), 7.57 (d, J = 4.0Hz, 1H), 6.87 (d, J = 6) .9Hz, 1H), 6.85 (d, J = 6.9Hz, 1H), 4.21 (q, J = 6.9Hz, 2H), 3.91 (d, J = 6.3Hz, 2H) 3.75 (s, 3H), 2.00-1.96 (m, 2H), 1.91-1.81 (m, 3H), 1.52 (t, J = 6.9Hz, 3H) , 1.37-1,17 (m, 5H), 1.11 (dq, J = 3.5, 12.6Hz, 2H), 0.97 (dq, J = 3.5, 12.6Hz, 2H) ), 0.89 (t, J = 7.5Hz, 3H).
化合物(b-19)の物性は、次のとおりであった。
転移温度:C 170.9 I.
上限温度(TNI)=84.3℃;光学的異方性(Δn)=0.187;誘電率異方性(Δε)=-11.5;粘度(η)=145.4mPa・s. The physical characteristics of compound (b-19) were as follows.
Transition temperature: C 170.9 I.
Maximum temperature (T NI) = 84.3 ℃; optical anisotropy (Δn) = 0.187; dielectric anisotropy (Δε) = - 11.5; Viscosity (η) = 145.4mPa · s.
転移温度:C 170.9 I.
上限温度(TNI)=84.3℃;光学的異方性(Δn)=0.187;誘電率異方性(Δε)=-11.5;粘度(η)=145.4mPa・s. The physical characteristics of compound (b-19) were as follows.
Transition temperature: C 170.9 I.
Maximum temperature (T NI) = 84.3 ℃; optical anisotropy (Δn) = 0.187; dielectric anisotropy (Δε) = - 11.5; Viscosity (η) = 145.4mPa · s.
2.組成物の実施例
実施例により本発明をさらに詳しく説明する。実施例は典型的な例であるので、本発明は実施例によって制限されない。例えば、本発明は、使用例の組成物に加えて、使用例1の組成物と使用例2の組成物との混合物を含む。本発明は、使用例の組成物の少なくとも2つを混合することによって調製した混合物をも含む。使用例における化合物は、下記の表2の定義に基づいて記号により表した。表2において、1,4-シクロヘキシレンに関する立体配置はトランスである。使用例において記号の後にあるかっこ内の番号は、化合物が属する化学式を表す。(-)の記号は、化合物(1)から(15)とは異なる液晶性化合物を意味する。液晶性化合物の割合(百分率)は、添加物を含まない液晶組成物の重量に基づいた重量百分率(重量%)である。最後に、組成物の物性値をまとめた。物性は、先に記載した方法にしたがって測定し、測定値を(外挿することなく)そのまま記載した。 2. Examples of Composition The present invention will be described in more detail by way of examples. The present invention is not limited by the examples, as the examples are typical. For example, the present invention includes, in addition to the composition of Examples, a mixture of the composition of Example 1 and the composition of Example 2. The present invention also includes a mixture prepared by mixing at least two of the compositions of Examples. The compounds in the use cases are represented by symbols based on the definitions in Table 2 below. In Table 2, the configuration for 1,4-cyclohexylene is trans. In use cases, the number in parentheses after the symbol represents the chemical formula to which the compound belongs. The symbol (-) means a liquid crystal compound different from the compounds (1) to (15). The proportion (percentage) of the liquid crystal compound is a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additives. Finally, the physical characteristics of the composition are summarized. The physical properties were measured according to the method described above, and the measured values were described as they were (without extrapolation).
実施例により本発明をさらに詳しく説明する。実施例は典型的な例であるので、本発明は実施例によって制限されない。例えば、本発明は、使用例の組成物に加えて、使用例1の組成物と使用例2の組成物との混合物を含む。本発明は、使用例の組成物の少なくとも2つを混合することによって調製した混合物をも含む。使用例における化合物は、下記の表2の定義に基づいて記号により表した。表2において、1,4-シクロヘキシレンに関する立体配置はトランスである。使用例において記号の後にあるかっこ内の番号は、化合物が属する化学式を表す。(-)の記号は、化合物(1)から(15)とは異なる液晶性化合物を意味する。液晶性化合物の割合(百分率)は、添加物を含まない液晶組成物の重量に基づいた重量百分率(重量%)である。最後に、組成物の物性値をまとめた。物性は、先に記載した方法にしたがって測定し、測定値を(外挿することなく)そのまま記載した。 2. Examples of Composition The present invention will be described in more detail by way of examples. The present invention is not limited by the examples, as the examples are typical. For example, the present invention includes, in addition to the composition of Examples, a mixture of the composition of Example 1 and the composition of Example 2. The present invention also includes a mixture prepared by mixing at least two of the compositions of Examples. The compounds in the use cases are represented by symbols based on the definitions in Table 2 below. In Table 2, the configuration for 1,4-cyclohexylene is trans. In use cases, the number in parentheses after the symbol represents the chemical formula to which the compound belongs. The symbol (-) means a liquid crystal compound different from the compounds (1) to (15). The proportion (percentage) of the liquid crystal compound is a weight percentage (% by weight) based on the weight of the liquid crystal composition containing no additives. Finally, the physical characteristics of the composition are summarized. The physical properties were measured according to the method described above, and the measured values were described as they were (without extrapolation).
[使用例1]
2O-Ca(3F,6F)-O4 (a-5) 3%
1-BB-3 (2-8) 7%
1-BB-5 (2-8) 8%
2-BTB-1 (2-10) 3%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
3-HHB-3 (3-1) 14%
3-HHB-F (22-1) 4%
2-HHB(F)-F (22-2) 7%
3-HHB(F)-F (22-2) 7%
5-HHB(F)-F (22-2) 7%
3-HHB(F,F)-F (22-3) 2%
3-HHEB-F (22-10) 4%
5-HHEB-F (22-10) 4%
2-HB-C (24-1) 5%
3-HB-C (24-1) 12%
NI=95.7℃;η=22.1mPa・s;Δn=0.112;Δε=3.8. [Usage example 1]
2O-Ca (3F, 6F) -O4 (a-5) 3%
1-BB-3 (2-8) 7%
1-BB-5 (2-8) 8%
2-BTB-1 (2-10) 3%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
3-HHB-3 (3-1) 14%
3-HHB-F (22-1) 4%
2-HHB (F) -F (22-2) 7%
3-HHB (F) -F (22-2) 7%
5-HHB (F) -F (22-2) 7%
3-HHB (F, F) -F (22-3) 2%
3-HHEB-F (22-10) 4%
5-HHEB-F (22-10) 4%
2-HB-C (24-1) 5%
3-HB-C (24-1) 12%
NI = 95.7 ° C; η = 22.1 mPa · s; Δn = 0.112; Δε = 3.8.
2O-Ca(3F,6F)-O4 (a-5) 3%
1-BB-3 (2-8) 7%
1-BB-5 (2-8) 8%
2-BTB-1 (2-10) 3%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
3-HHB-3 (3-1) 14%
3-HHB-F (22-1) 4%
2-HHB(F)-F (22-2) 7%
3-HHB(F)-F (22-2) 7%
5-HHB(F)-F (22-2) 7%
3-HHB(F,F)-F (22-3) 2%
3-HHEB-F (22-10) 4%
5-HHEB-F (22-10) 4%
2-HB-C (24-1) 5%
3-HB-C (24-1) 12%
NI=95.7℃;η=22.1mPa・s;Δn=0.112;Δε=3.8. [Usage example 1]
2O-Ca (3F, 6F) -O4 (a-5) 3%
1-BB-3 (2-8) 7%
1-BB-5 (2-8) 8%
2-BTB-1 (2-10) 3%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
3-HHB-3 (3-1) 14%
3-HHB-F (22-1) 4%
2-HHB (F) -F (22-2) 7%
3-HHB (F) -F (22-2) 7%
5-HHB (F) -F (22-2) 7%
3-HHB (F, F) -F (22-3) 2%
3-HHEB-F (22-10) 4%
5-HHEB-F (22-10) 4%
2-HB-C (24-1) 5%
3-HB-C (24-1) 12%
NI = 95.7 ° C; η = 22.1 mPa · s; Δn = 0.112; Δε = 3.8.
[使用例2]
4O-Ca(1F,8F)-O2 (a-71) 8%
3-HH-4 (2-1) 12%
7-HB-1 (2-5) 3%
5-HB-O2 (2-5) 2%
5-HBB(F)B-2 (4-5) 7%
5-HBB(F)B-3 (4-5) 6%
3-HB-CL (21-2) 5%
3-HHB(F,F)-F (22-3) 3%
3-HBB(F,F)-F (22-24) 30%
5-HBB(F,F)-F (22-24) 24%
NI=73.6℃;η=32.5mPa・s;Δn=0.125;Δε=5.2. [Usage example 2]
4O-Ca (1F, 8F) -O2 (a-71) 8%
3-HH-4 (2-1) 12%
7-HB-1 (2-5) 3%
5-HB-O2 (2-5) 2%
5-HBB (F) B-2 (4-5) 7%
5-HBB (F) B-3 (4-5) 6%
3-HB-CL (21-2) 5%
3-HHB (F, F) -F (22-3) 3%
3-HBB (F, F) -F (22-24) 30%
5-HBB (F, F) -F (22-24) 24%
NI = 73.6 ° C.; η = 32.5 mPa · s; Δn = 0.125; Δε = 5.2.
4O-Ca(1F,8F)-O2 (a-71) 8%
3-HH-4 (2-1) 12%
7-HB-1 (2-5) 3%
5-HB-O2 (2-5) 2%
5-HBB(F)B-2 (4-5) 7%
5-HBB(F)B-3 (4-5) 6%
3-HB-CL (21-2) 5%
3-HHB(F,F)-F (22-3) 3%
3-HBB(F,F)-F (22-24) 30%
5-HBB(F,F)-F (22-24) 24%
NI=73.6℃;η=32.5mPa・s;Δn=0.125;Δε=5.2. [Usage example 2]
4O-Ca (1F, 8F) -O2 (a-71) 8%
3-HH-4 (2-1) 12%
7-HB-1 (2-5) 3%
5-HB-O2 (2-5) 2%
5-HBB (F) B-2 (4-5) 7%
5-HBB (F) B-3 (4-5) 6%
3-HB-CL (21-2) 5%
3-HHB (F, F) -F (22-3) 3%
3-HBB (F, F) -F (22-24) 30%
5-HBB (F, F) -F (22-24) 24%
NI = 73.6 ° C.; η = 32.5 mPa · s; Δn = 0.125; Δε = 5.2.
[使用例3]
2O-Ca(3F,6F,9Me)-O4 (a-11) 3%
1V2-HH-1 (2-1) 3%
1V2-HH-3 (2-1) 4%
7-HB(F,F)-F (21-4) 3%
2-HHB(F)-F (22-2) 10%
3-HHB(F)-F (22-2) 10%
5-HHB(F)-F (22-2) 7%
2-HBB-F (22-22) 4%
3-HBB-F (22-22) 4%
5-HBB-F (22-22) 3%
2-HBB(F)-F (22-23) 9%
3-HBB(F)-F (22-23) 9%
5-HBB(F)-F (22-23) 16%
3-HBB(F,F)-F (22-24) 5%
5-HBB(F,F)-F (22-24) 10% [Usage example 3]
2O-Ca (3F, 6F, 9Me) -O4 (a-11) 3%
1V2-HH-1 (2-1) 3%
1V2-HH-3 (2-1) 4%
7-HB (F, F) -F (21-4) 3%
2-HHB (F) -F (22-2) 10%
3-HHB (F) -F (22-2) 10%
5-HHB (F) -F (22-2) 7%
2-HBB-F (22-22) 4%
3-HBB-F (22-22) 4%
5-HBB-F (22-22) 3%
2-HBB (F) -F (22-23) 9%
3-HBB (F) -F (22-23) 9%
5-HBB (F) -F (22-23) 16%
3-HBB (F, F) -F (22-24) 5%
5-HBB (F, F) -F (22-24) 10%
2O-Ca(3F,6F,9Me)-O4 (a-11) 3%
1V2-HH-1 (2-1) 3%
1V2-HH-3 (2-1) 4%
7-HB(F,F)-F (21-4) 3%
2-HHB(F)-F (22-2) 10%
3-HHB(F)-F (22-2) 10%
5-HHB(F)-F (22-2) 7%
2-HBB-F (22-22) 4%
3-HBB-F (22-22) 4%
5-HBB-F (22-22) 3%
2-HBB(F)-F (22-23) 9%
3-HBB(F)-F (22-23) 9%
5-HBB(F)-F (22-23) 16%
3-HBB(F,F)-F (22-24) 5%
5-HBB(F,F)-F (22-24) 10% [Usage example 3]
2O-Ca (3F, 6F, 9Me) -O4 (a-11) 3%
1V2-HH-1 (2-1) 3%
1V2-HH-3 (2-1) 4%
7-HB (F, F) -F (21-4) 3%
2-HHB (F) -F (22-2) 10%
3-HHB (F) -F (22-2) 10%
5-HHB (F) -F (22-2) 7%
2-HBB-F (22-22) 4%
3-HBB-F (22-22) 4%
5-HBB-F (22-22) 3%
2-HBB (F) -F (22-23) 9%
3-HBB (F) -F (22-23) 9%
5-HBB (F) -F (22-23) 16%
3-HBB (F, F) -F (22-24) 5%
5-HBB (F, F) -F (22-24) 10%
[使用例4]
4O-Ca(1F,8F,9Me)-O2 (a-74) 10%
2-HH-3 (2-1) 4%
3-HH-4 (2-1) 12%
1O1-HBBH-5 (4-1) 3%
5-HB-CL (21-2) 16%
3-HHB-F (22-1) 4%
3-HHB-CL (22-1) 3%
4-HHB-CL (22-1) 4%
3-HHB(F)-F (22-2) 5%
4-HHB(F)-F (22-2) 4%
5-HHB(F)-F (22-2) 9%
7-HHB(F)-F (22-2) 8%
5-HBB(F)-F (22-23) 4%
3-HHBB(F,F)-F (23-6) 2%
4-HHBB(F,F)-F (23-6) 3%
5-HHBB(F,F)-F (23-6) 3%
3-HH2BB(F,F)-F (23-15) 3%
4-HH2BB(F,F)-F (23-15) 3%
NI=106.7℃;η=21.6mPa・s;Δn=0.101;Δε=2.7. [Usage example 4]
4O-Ca (1F, 8F, 9Me) -O2 (a-74) 10%
2-HH-3 (2-1) 4%
3-HH-4 (2-1) 12%
1O1-HBBH-5 (4-1) 3%
5-HB-CL (21-2) 16%
3-HHB-F (22-1) 4%
3-HHB-CL (22-1) 3%
4-HHB-CL (22-1) 4%
3-HHB (F) -F (22-2) 5%
4-HHB (F) -F (22-2) 4%
5-HHB (F) -F (22-2) 9%
7-HHB (F) -F (22-2) 8%
5-HBB (F) -F (22-23) 4%
3-HHBB (F, F) -F (23-6) 2%
4-HHBB (F, F) -F (23-6) 3%
5-HHBB (F, F) -F (23-6) 3%
3-HH2BB (F, F) -F (23-15) 3%
4-HH2BB (F, F) -F (23-15) 3%
NI = 106.7 ° C; η = 21.6 mPa · s; Δn = 0.101; Δε = 2.7.
4O-Ca(1F,8F,9Me)-O2 (a-74) 10%
2-HH-3 (2-1) 4%
3-HH-4 (2-1) 12%
1O1-HBBH-5 (4-1) 3%
5-HB-CL (21-2) 16%
3-HHB-F (22-1) 4%
3-HHB-CL (22-1) 3%
4-HHB-CL (22-1) 4%
3-HHB(F)-F (22-2) 5%
4-HHB(F)-F (22-2) 4%
5-HHB(F)-F (22-2) 9%
7-HHB(F)-F (22-2) 8%
5-HBB(F)-F (22-23) 4%
3-HHBB(F,F)-F (23-6) 2%
4-HHBB(F,F)-F (23-6) 3%
5-HHBB(F,F)-F (23-6) 3%
3-HH2BB(F,F)-F (23-15) 3%
4-HH2BB(F,F)-F (23-15) 3%
NI=106.7℃;η=21.6mPa・s;Δn=0.101;Δε=2.7. [Usage example 4]
4O-Ca (1F, 8F, 9Me) -O2 (a-74) 10%
2-HH-3 (2-1) 4%
3-HH-4 (2-1) 12%
1O1-HBBH-5 (4-1) 3%
5-HB-CL (21-2) 16%
3-HHB-F (22-1) 4%
3-HHB-CL (22-1) 3%
4-HHB-CL (22-1) 4%
3-HHB (F) -F (22-2) 5%
4-HHB (F) -F (22-2) 4%
5-HHB (F) -F (22-2) 9%
7-HHB (F) -F (22-2) 8%
5-HBB (F) -F (22-23) 4%
3-HHBB (F, F) -F (23-6) 2%
4-HHBB (F, F) -F (23-6) 3%
5-HHBB (F, F) -F (23-6) 3%
3-HH2BB (F, F) -F (23-15) 3%
4-HH2BB (F, F) -F (23-15) 3%
NI = 106.7 ° C; η = 21.6 mPa · s; Δn = 0.101; Δε = 2.7.
[使用例5]
2O-Ca(3F,4F,6F)-O4 (a-36) 2%
V-HBB-2 (3-4) 10%
1O1-HBBH-4 (4-1) 4%
1O1-HBBH-5 (4-1) 2%
3-HHB(F,F)-F (22-3) 9%
3-H2HB(F,F)-F (22-15) 8%
4-H2HB(F,F)-F (22-15) 8%
5-H2HB(F,F)-F (22-15) 8%
3-HBB(F,F)-F (22-24) 11%
5-HBB(F,F)-F (22-24) 20%
3-H2BB(F,F)-F (22-27) 10%
5-HHBB(F,F)-F (23-6) 3%
3-HH2BB(F,F)-F (23-15) 3%
5-HHEBB-F (23-17) 2%
NI=103.0℃;η=34.3mPa・s;Δn=0.123;Δε=7.8. [Usage example 5]
2O-Ca (3F, 4F, 6F) -O4 (a-36) 2%
V-HBB-2 (3-4) 10%
1O1-HBBH-4 (4-1) 4%
1O1-HBBH-5 (4-1) 2%
3-HHB (F, F) -F (22-3) 9%
3-H2HB (F, F) -F (22-15) 8%
4-H2HB (F, F) -F (22-15) 8%
5-H2HB (F, F) -F (22-15) 8%
3-HBB (F, F) -F (22-24) 11%
5-HBB (F, F) -F (22-24) 20%
3-H2BB (F, F) -F (22-27) 10%
5-HHBB (F, F) -F (23-6) 3%
3-HH2BB (F, F) -F (23-15) 3%
5-HHEBB-F (23-17) 2%
NI = 103.0 ° C.; η = 34.3 mPa · s; Δn = 0.123; Δε = 7.8.
2O-Ca(3F,4F,6F)-O4 (a-36) 2%
V-HBB-2 (3-4) 10%
1O1-HBBH-4 (4-1) 4%
1O1-HBBH-5 (4-1) 2%
3-HHB(F,F)-F (22-3) 9%
3-H2HB(F,F)-F (22-15) 8%
4-H2HB(F,F)-F (22-15) 8%
5-H2HB(F,F)-F (22-15) 8%
3-HBB(F,F)-F (22-24) 11%
5-HBB(F,F)-F (22-24) 20%
3-H2BB(F,F)-F (22-27) 10%
5-HHBB(F,F)-F (23-6) 3%
3-HH2BB(F,F)-F (23-15) 3%
5-HHEBB-F (23-17) 2%
NI=103.0℃;η=34.3mPa・s;Δn=0.123;Δε=7.8. [Usage example 5]
2O-Ca (3F, 4F, 6F) -O4 (a-36) 2%
V-HBB-2 (3-4) 10%
1O1-HBBH-4 (4-1) 4%
1O1-HBBH-5 (4-1) 2%
3-HHB (F, F) -F (22-3) 9%
3-H2HB (F, F) -F (22-15) 8%
4-H2HB (F, F) -F (22-15) 8%
5-H2HB (F, F) -F (22-15) 8%
3-HBB (F, F) -F (22-24) 11%
5-HBB (F, F) -F (22-24) 20%
3-H2BB (F, F) -F (22-27) 10%
5-HHBB (F, F) -F (23-6) 3%
3-HH2BB (F, F) -F (23-15) 3%
5-HHEBB-F (23-17) 2%
NI = 103.0 ° C.; η = 34.3 mPa · s; Δn = 0.123; Δε = 7.8.
[使用例6]
2O-Ca(3F,4F,6F)-4 (a-232) 3%
5-HBBH-3 (4-1) 3%
3-HB(F)BH-3 (4-2) 3%
5-HB-F (21-2) 9%
6-HB-F (21-2) 9%
7-HB-F (21-2) 7%
2-HHB-OCF3 (22-1) 7%
3-HHB-OCF3 (22-1) 7%
4-HHB-OCF3 (22-1) 7%
5-HHB-OCF3 (22-1) 5%
3-HHB(F,F)-OCF2H (22-3) 4%
3-HHB(F,F)-OCF3 (22-3) 5%
3-HH2B-OCF3 (22-4) 4%
5-HH2B-OCF3 (22-4) 4%
3-HH2B(F)-F (22-5) 3%
3-HBB(F)-F (22-23) 10%
5-HBB(F)-F (22-23) 10% [Usage example 6]
2O-Ca (3F, 4F, 6F) -4 (a-232) 3%
5-HBBH-3 (4-1) 3%
3-HB (F) BH-3 (4-2) 3%
5-HB-F (21-2) 9%
6-HB-F (21-2) 9%
7-HB-F (21-2) 7%
2-HHB-OCF3 (22-1) 7%
3-HHB-OCF3 (22-1) 7%
4-HHB-OCF3 (22-1) 7%
5-HHB-OCF3 (22-1) 5%
3-HHB (F, F) -OCF2H (22-3) 4%
3-HHB (F, F) -OCF3 (22-3) 5%
3-HH2B-OCF3 (22-4) 4%
5-HH2B-OCF3 (22-4) 4%
3-HH2B (F) -F (22-5) 3%
3-HBB (F) -F (22-23) 10%
5-HBB (F) -F (22-23) 10%
2O-Ca(3F,4F,6F)-4 (a-232) 3%
5-HBBH-3 (4-1) 3%
3-HB(F)BH-3 (4-2) 3%
5-HB-F (21-2) 9%
6-HB-F (21-2) 9%
7-HB-F (21-2) 7%
2-HHB-OCF3 (22-1) 7%
3-HHB-OCF3 (22-1) 7%
4-HHB-OCF3 (22-1) 7%
5-HHB-OCF3 (22-1) 5%
3-HHB(F,F)-OCF2H (22-3) 4%
3-HHB(F,F)-OCF3 (22-3) 5%
3-HH2B-OCF3 (22-4) 4%
5-HH2B-OCF3 (22-4) 4%
3-HH2B(F)-F (22-5) 3%
3-HBB(F)-F (22-23) 10%
5-HBB(F)-F (22-23) 10% [Usage example 6]
2O-Ca (3F, 4F, 6F) -4 (a-232) 3%
5-HBBH-3 (4-1) 3%
3-HB (F) BH-3 (4-2) 3%
5-HB-F (21-2) 9%
6-HB-F (21-2) 9%
7-HB-F (21-2) 7%
2-HHB-OCF3 (22-1) 7%
3-HHB-OCF3 (22-1) 7%
4-HHB-OCF3 (22-1) 7%
5-HHB-OCF3 (22-1) 5%
3-HHB (F, F) -OCF2H (22-3) 4%
3-HHB (F, F) -OCF3 (22-3) 5%
3-HH2B-OCF3 (22-4) 4%
5-HH2B-OCF3 (22-4) 4%
3-HH2B (F) -F (22-5) 3%
3-HBB (F) -F (22-23) 10%
5-HBB (F) -F (22-23) 10%
[使用例7]
2O-Ca(3F,6F)-5 (a-4) 3%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 4%
5-B(F)BB-2 (3-8) 4%
5-HB-CL (21-2) 11%
3-HHB(F,F)-F (22-3) 8%
3-HHEB(F,F)-F (22-12) 7%
4-HHEB(F,F)-F (22-12) 3%
5-HHEB(F,F)-F (22-12) 3%
3-HBB(F,F)-F (22-24) 20%
5-HBB(F,F)-F (22-24) 15%
2-HBEB(F,F)-F (22-39) 3%
3-HBEB(F,F)-F (22-39) 5%
5-HBEB(F,F)-F (22-39) 3%
3-HHBB(F,F)-F (23-6) 6% [Usage example 7]
2O-Ca (3F, 6F) -5 (a-4) 3%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 4%
5-B (F) BB-2 (3-8) 4%
5-HB-CL (21-2) 11%
3-HHB (F, F) -F (22-3) 8%
3-HHEB (F, F) -F (22-12) 7%
4-HHEB (F, F) -F (22-12) 3%
5-HHEB (F, F) -F (22-12) 3%
3-HBB (F, F) -F (22-24) 20%
5-HBB (F, F) -F (22-24) 15%
2-HBEB (F, F) -F (22-39) 3%
3-HBEB (F, F) -F (22-39) 5%
5-HBEB (F, F) -F (22-39) 3%
3-HHBB (F, F) -F (23-6) 6%
2O-Ca(3F,6F)-5 (a-4) 3%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 4%
5-B(F)BB-2 (3-8) 4%
5-HB-CL (21-2) 11%
3-HHB(F,F)-F (22-3) 8%
3-HHEB(F,F)-F (22-12) 7%
4-HHEB(F,F)-F (22-12) 3%
5-HHEB(F,F)-F (22-12) 3%
3-HBB(F,F)-F (22-24) 20%
5-HBB(F,F)-F (22-24) 15%
2-HBEB(F,F)-F (22-39) 3%
3-HBEB(F,F)-F (22-39) 5%
5-HBEB(F,F)-F (22-39) 3%
3-HHBB(F,F)-F (23-6) 6% [Usage example 7]
2O-Ca (3F, 6F) -5 (a-4) 3%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 4%
5-B (F) BB-2 (3-8) 4%
5-HB-CL (21-2) 11%
3-HHB (F, F) -F (22-3) 8%
3-HHEB (F, F) -F (22-12) 7%
4-HHEB (F, F) -F (22-12) 3%
5-HHEB (F, F) -F (22-12) 3%
3-HBB (F, F) -F (22-24) 20%
5-HBB (F, F) -F (22-24) 15%
2-HBEB (F, F) -F (22-39) 3%
3-HBEB (F, F) -F (22-39) 5%
5-HBEB (F, F) -F (22-39) 3%
3-HHBB (F, F) -F (23-6) 6%
[使用例8]
2O-Ca(3F,4F)-4 (a-233) 3%
V2-HHB-1 (3-1) 5%
3-HB-CL (21-2) 6%
5-HB-CL (21-2) 4%
3-HHB-OCF3 (22-1) 5%
5-HHB(F)-F (22-2) 5%
V-HHB(F)-F (22-2) 5%
3-H2HB-OCF3 (22-13) 5%
5-H2HB(F,F)-F (22-15) 5%
5-H4HB-OCF3 (22-19) 12%
5-H4HB(F,F)-F (22-21) 7%
3-H4HB(F,F)-CF3 (22-21) 8%
5-H4HB(F,F)-CF3 (22-21) 10%
2-H2BB(F)-F (22-26) 5%
3-H2BB(F)-F (22-26) 10%
3-HBEB(F,F)-F (22-39) 5% [Usage example 8]
2O-Ca (3F, 4F) -4 (a-233) 3%
V2-HHB-1 (3-1) 5%
3-HB-CL (21-2) 6%
5-HB-CL (21-2) 4%
3-HHB-OCF3 (22-1) 5%
5-HHB (F) -F (22-2) 5%
V-HHB (F) -F (22-2) 5%
3-H2HB-OCF3 (22-13) 5%
5-H2HB (F, F) -F (22-15) 5%
5-H4HB-OCF3 (22-19) 12%
5-H4HB (F, F) -F (22-21) 7%
3-H4HB (F, F) -CF3 (22-21) 8%
5-H4HB (F, F) -CF3 (22-21) 10%
2-H2BB (F) -F (22-26) 5%
3-H2BB (F) -F (22-26) 10%
3-HBEB (F, F) -F (22-39) 5%
2O-Ca(3F,4F)-4 (a-233) 3%
V2-HHB-1 (3-1) 5%
3-HB-CL (21-2) 6%
5-HB-CL (21-2) 4%
3-HHB-OCF3 (22-1) 5%
5-HHB(F)-F (22-2) 5%
V-HHB(F)-F (22-2) 5%
3-H2HB-OCF3 (22-13) 5%
5-H2HB(F,F)-F (22-15) 5%
5-H4HB-OCF3 (22-19) 12%
5-H4HB(F,F)-F (22-21) 7%
3-H4HB(F,F)-CF3 (22-21) 8%
5-H4HB(F,F)-CF3 (22-21) 10%
2-H2BB(F)-F (22-26) 5%
3-H2BB(F)-F (22-26) 10%
3-HBEB(F,F)-F (22-39) 5% [Usage example 8]
2O-Ca (3F, 4F) -4 (a-233) 3%
V2-HHB-1 (3-1) 5%
3-HB-CL (21-2) 6%
5-HB-CL (21-2) 4%
3-HHB-OCF3 (22-1) 5%
5-HHB (F) -F (22-2) 5%
V-HHB (F) -F (22-2) 5%
3-H2HB-OCF3 (22-13) 5%
5-H2HB (F, F) -F (22-15) 5%
5-H4HB-OCF3 (22-19) 12%
5-H4HB (F, F) -F (22-21) 7%
3-H4HB (F, F) -CF3 (22-21) 8%
5-H4HB (F, F) -CF3 (22-21) 10%
2-H2BB (F) -F (22-26) 5%
3-H2BB (F) -F (22-26) 10%
3-HBEB (F, F) -F (22-39) 5%
[使用例9]
2O-Ca(6F)-5 (a-234) 3%
3-HH-4 (2-1) 10%
3-HH-5 (2-1) 5%
3-HB-O2 (2-5) 15%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
5-HB-CL (21-2) 14%
7-HB(F,F)-F (21-4) 3%
2-HHB(F)-F (22-2) 7%
3-HHB(F)-F (22-2) 7%
5-HHB(F)-F (22-2) 7%
3-HHB(F,F)-F (22-3) 6%
3-H2HB(F,F)-F (22-15) 5%
4-H2HB(F,F)-F (22-15) 5% [Usage example 9]
2O-Ca (6F) -5 (a-234) 3%
3-HH-4 (2-1) 10%
3-HH-5 (2-1) 5%
3-HB-O2 (2-5) 15%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
5-HB-CL (21-2) 14%
7-HB (F, F) -F (21-4) 3%
2-HHB (F) -F (22-2) 7%
3-HHB (F) -F (22-2) 7%
5-HHB (F) -F (22-2) 7%
3-HHB (F, F) -F (22-3) 6%
3-H2HB (F, F) -F (22-15) 5%
4-H2HB (F, F) -F (22-15) 5%
2O-Ca(6F)-5 (a-234) 3%
3-HH-4 (2-1) 10%
3-HH-5 (2-1) 5%
3-HB-O2 (2-5) 15%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
5-HB-CL (21-2) 14%
7-HB(F,F)-F (21-4) 3%
2-HHB(F)-F (22-2) 7%
3-HHB(F)-F (22-2) 7%
5-HHB(F)-F (22-2) 7%
3-HHB(F,F)-F (22-3) 6%
3-H2HB(F,F)-F (22-15) 5%
4-H2HB(F,F)-F (22-15) 5% [Usage example 9]
2O-Ca (6F) -5 (a-234) 3%
3-HH-4 (2-1) 10%
3-HH-5 (2-1) 5%
3-HB-O2 (2-5) 15%
3-HHB-1 (3-1) 8%
3-HHB-O1 (3-1) 5%
5-HB-CL (21-2) 14%
7-HB (F, F) -F (21-4) 3%
2-HHB (F) -F (22-2) 7%
3-HHB (F) -F (22-2) 7%
5-HHB (F) -F (22-2) 7%
3-HHB (F, F) -F (22-3) 6%
3-H2HB (F, F) -F (22-15) 5%
4-H2HB (F, F) -F (22-15) 5%
[使用例10]
5-HCa(3F,6F)-3 (b-1) 3%
3-HH-4 (2-1) 9%
3-HH-5 (2-1) 10%
3-HHB-3 (3-1) 10%
5-HB-CL (21-2) 3%
7-HB(F)-F (21-3) 7%
2-HHB(F,F)-F (22-3) 4%
3-HHB(F,F)-F (22-3) 5%
3-HHEB-F (22-10) 8%
5-HHEB-F (22-10) 8%
3-HHEB(F,F)-F (22-12) 10%
4-HHEB(F,F)-F (22-12) 5%
3-GHB(F,F)-F (22-109) 5%
4-GHB(F,F)-F (22-109) 6%
5-GHB(F,F)-F (22-109) 7%
NI=82.6℃;η=21.7mPa・s;Δn=0.068;Δε=5.9. [Usage example 10]
5-HCa (3F, 6F) -3 (b-1) 3%
3-HH-4 (2-1) 9%
3-HH-5 (2-1) 10%
3-HHB-3 (3-1) 10%
5-HB-CL (21-2) 3%
7-HB (F) -F (21-3) 7%
2-HHB (F, F) -F (22-3) 4%
3-HHB (F, F) -F (22-3) 5%
3-HHEB-F (22-10) 8%
5-HHEB-F (22-10) 8%
3-HHEB (F, F) -F (22-12) 10%
4-HHEB (F, F) -F (22-12) 5%
3-GHB (F, F) -F (22-109) 5%
4-GHB (F, F) -F (22-109) 6%
5-GHB (F, F) -F (22-109) 7%
NI = 82.6 ° C.; η = 21.7 mPa · s; Δn = 0.068; Δε = 5.9.
5-HCa(3F,6F)-3 (b-1) 3%
3-HH-4 (2-1) 9%
3-HH-5 (2-1) 10%
3-HHB-3 (3-1) 10%
5-HB-CL (21-2) 3%
7-HB(F)-F (21-3) 7%
2-HHB(F,F)-F (22-3) 4%
3-HHB(F,F)-F (22-3) 5%
3-HHEB-F (22-10) 8%
5-HHEB-F (22-10) 8%
3-HHEB(F,F)-F (22-12) 10%
4-HHEB(F,F)-F (22-12) 5%
3-GHB(F,F)-F (22-109) 5%
4-GHB(F,F)-F (22-109) 6%
5-GHB(F,F)-F (22-109) 7%
NI=82.6℃;η=21.7mPa・s;Δn=0.068;Δε=5.9. [Usage example 10]
5-HCa (3F, 6F) -3 (b-1) 3%
3-HH-4 (2-1) 9%
3-HH-5 (2-1) 10%
3-HHB-3 (3-1) 10%
5-HB-CL (21-2) 3%
7-HB (F) -F (21-3) 7%
2-HHB (F, F) -F (22-3) 4%
3-HHB (F, F) -F (22-3) 5%
3-HHEB-F (22-10) 8%
5-HHEB-F (22-10) 8%
3-HHEB (F, F) -F (22-12) 10%
4-HHEB (F, F) -F (22-12) 5%
3-GHB (F, F) -F (22-109) 5%
4-GHB (F, F) -F (22-109) 6%
5-GHB (F, F) -F (22-109) 7%
NI = 82.6 ° C.; η = 21.7 mPa · s; Δn = 0.068; Δε = 5.9.
[使用例11]
3-H1OCa(3F,6F)-3 (b-227) 3%
3-HH-VFF (2-1) 5%
5-HH-VFF (2-1) 25%
2-BTB-1 (2-10) 7%
3-HHB-1 (3-1) 4%
VFF-HHB-1 (3-1) 8%
VFF2-HHB-1 (3-1) 11%
3-H2BTB-2 (3-17) 5%
3-H2BTB-3 (3-17) 4%
3-H2BTB-4 (3-17) 4%
3-HB-C (24-1) 18%
1V2-BEB(F,F)-C (24-15) 6% [Usage example 11]
3-H1OCa (3F, 6F) -3 (b-227) 3%
3-HH-VFF (2-1) 5%
5-HH-VFF (2-1) 25%
2-BTB-1 (2-10) 7%
3-HHB-1 (3-1) 4%
VFF-HHB-1 (3-1) 8%
VFF2-HHB-1 (3-1) 11%
3-H2BTB-2 (3-17) 5%
3-H2BTB-3 (3-17) 4%
3-H2BTB-4 (3-17) 4%
3-HB-C (24-1) 18%
1V2-BEB (F, F) -C (24-15) 6%
3-H1OCa(3F,6F)-3 (b-227) 3%
3-HH-VFF (2-1) 5%
5-HH-VFF (2-1) 25%
2-BTB-1 (2-10) 7%
3-HHB-1 (3-1) 4%
VFF-HHB-1 (3-1) 8%
VFF2-HHB-1 (3-1) 11%
3-H2BTB-2 (3-17) 5%
3-H2BTB-3 (3-17) 4%
3-H2BTB-4 (3-17) 4%
3-HB-C (24-1) 18%
1V2-BEB(F,F)-C (24-15) 6% [Usage example 11]
3-H1OCa (3F, 6F) -3 (b-227) 3%
3-HH-VFF (2-1) 5%
5-HH-VFF (2-1) 25%
2-BTB-1 (2-10) 7%
3-HHB-1 (3-1) 4%
VFF-HHB-1 (3-1) 8%
VFF2-HHB-1 (3-1) 11%
3-H2BTB-2 (3-17) 5%
3-H2BTB-3 (3-17) 4%
3-H2BTB-4 (3-17) 4%
3-HB-C (24-1) 18%
1V2-BEB (F, F) -C (24-15) 6%
[使用例12]
2O-Ca(3F,6F)-O4 (a-5) 4%
3-HH-V (2-1) 35%
3-HH-V1 (2-1) 5%
5-HH-V (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
2-BB(F)B-3 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F,F)XB(F,F)-F (22-97) 6%
3-BB(2F,3F)XB(F,F)-F (22-114) 3%
3-HHBB(F,F)-F (23-6) 3%
3-HBBXB(F,F)-F (23-32) 3%
5-HB(F)B(F,F)XB(F,F)-F (23-41) 5%
3-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 5%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
NI=81.0℃;η=18.0mPa・s;Δn=0.102;Δε=3.5. [Usage example 12]
2O-Ca (3F, 6F) -O4 (a-5) 4%
3-HH-V (2-1) 35%
3-HH-V1 (2-1) 5%
5-HH-V (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
2-BB (F) B-3 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F, F) XB (F, F) -F (22-97) 6%
3-BB (2F, 3F) XB (F, F) -F (22-114) 3%
3-HHBB (F, F) -F (23-6) 3%
3-HBBXB (F, F) -F (23-32) 3%
5-HB (F) B (F, F) XB (F, F) -F (23-41) 5%
3-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 5%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
NI = 81.0 ° C.; η = 18.0 mPa · s; Δn = 0.102; Δε = 3.5.
2O-Ca(3F,6F)-O4 (a-5) 4%
3-HH-V (2-1) 35%
3-HH-V1 (2-1) 5%
5-HH-V (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
2-BB(F)B-3 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F,F)XB(F,F)-F (22-97) 6%
3-BB(2F,3F)XB(F,F)-F (22-114) 3%
3-HHBB(F,F)-F (23-6) 3%
3-HBBXB(F,F)-F (23-32) 3%
5-HB(F)B(F,F)XB(F,F)-F (23-41) 5%
3-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 5%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
NI=81.0℃;η=18.0mPa・s;Δn=0.102;Δε=3.5. [Usage example 12]
2O-Ca (3F, 6F) -O4 (a-5) 4%
3-HH-V (2-1) 35%
3-HH-V1 (2-1) 5%
5-HH-V (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
2-BB (F) B-3 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F, F) XB (F, F) -F (22-97) 6%
3-BB (2F, 3F) XB (F, F) -F (22-114) 3%
3-HHBB (F, F) -F (23-6) 3%
3-HBBXB (F, F) -F (23-32) 3%
5-HB (F) B (F, F) XB (F, F) -F (23-41) 5%
3-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 5%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
NI = 81.0 ° C.; η = 18.0 mPa · s; Δn = 0.102; Δε = 3.5.
[使用例13]
4O-Ca(1F,8F)-O2 (a-71) 10%
3-HH-V (2-1) 31%
3-HH-V1 (2-1) 7%
V-HH-V1 (2-1) 6%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
1-BB(F)B-2V (3-6) 4%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F,F)XB(F,F)-F (22-97) 3%
3-HHXB(F,F)-CF3 (22-100) 3%
3-GB(F,F)XB(F,F)-F (22-113) 2%
3-GB(F)B(F,F)-F (22-116) 2%
3-HHBB(F,F)-F (23-6) 3%
3-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 5%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
3-GB(F)B(F,F)XB(F,F)-F (23-57) 3%
NI=72.3℃;η=19.9mPa・s;Δn=0.106;Δε=3.7. [Usage example 13]
4O-Ca (1F, 8F) -O2 (a-71) 10%
3-HH-V (2-1) 31%
3-HH-V1 (2-1) 7%
V-HH-V1 (2-1) 6%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
1-BB (F) B-2V (3-6) 4%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F, F) XB (F, F) -F (22-97) 3%
3-HHXB (F, F) -CF3 (22-100) 3%
3-GB (F, F) XB (F, F) -F (22-113) 2%
3-GB (F) B (F, F) -F (22-116) 2%
3-HHBB (F, F) -F (23-6) 3%
3-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 5%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
3-GB (F) B (F, F) XB (F, F) -F (23-57) 3%
NI = 72.3 ° C.; η = 19.9 mPa · s; Δn = 0.106; Δε = 3.7.
4O-Ca(1F,8F)-O2 (a-71) 10%
3-HH-V (2-1) 31%
3-HH-V1 (2-1) 7%
V-HH-V1 (2-1) 6%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
1-BB(F)B-2V (3-6) 4%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F,F)XB(F,F)-F (22-97) 3%
3-HHXB(F,F)-CF3 (22-100) 3%
3-GB(F,F)XB(F,F)-F (22-113) 2%
3-GB(F)B(F,F)-F (22-116) 2%
3-HHBB(F,F)-F (23-6) 3%
3-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 5%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
3-GB(F)B(F,F)XB(F,F)-F (23-57) 3%
NI=72.3℃;η=19.9mPa・s;Δn=0.106;Δε=3.7. [Usage example 13]
4O-Ca (1F, 8F) -O2 (a-71) 10%
3-HH-V (2-1) 31%
3-HH-V1 (2-1) 7%
V-HH-V1 (2-1) 6%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
1-BB (F) B-2V (3-6) 4%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F, F) XB (F, F) -F (22-97) 3%
3-HHXB (F, F) -CF3 (22-100) 3%
3-GB (F, F) XB (F, F) -F (22-113) 2%
3-GB (F) B (F, F) -F (22-116) 2%
3-HHBB (F, F) -F (23-6) 3%
3-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 5%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
3-GB (F) B (F, F) XB (F, F) -F (23-57) 3%
NI = 72.3 ° C.; η = 19.9 mPa · s; Δn = 0.106; Δε = 3.7.
[使用例14]
2O-Ca(3F,6F,9Me)-O4 (a-11) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
3-HBB-2 (3-4) 5%
V2-BB(F)B-1 (3-6) 5%
3-HHEH-3 (3-13) 3%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F,F)XB(F,F)-F (22-97) 4%
3-GB(F,F)XB(F,F)-F (22-113) 3%
3-HHBB(F,F)-F (23-6) 3%
3-HBB(F,F)XB(F,F)-F (23-38) 3%
3-BB(F)B(F,F)XB(F)-F (23-46) 3%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
3-GB(F)B(F,F)XB(F,F)-F (23-57) 5%
4-GB(F)B(F,F)XB(F,F)-F (23-57) 3%
5-GB(F)B(F,F)XB(F,F)-F (23-57) 2% [Usage example 14]
2O-Ca (3F, 6F, 9Me) -O4 (a-11) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
3-HBB-2 (3-4) 5%
V2-BB (F) B-1 (3-6) 5%
3-HHEH-3 (3-13) 3%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F, F) XB (F, F) -F (22-97) 4%
3-GB (F, F) XB (F, F) -F (22-113) 3%
3-HHBB (F, F) -F (23-6) 3%
3-HBB (F, F) XB (F, F) -F (23-38) 3%
3-BB (F) B (F, F) XB (F) -F (23-46) 3%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
3-GB (F) B (F, F) XB (F, F) -F (23-57) 5%
4-GB (F) B (F, F) XB (F, F) -F (23-57) 3%
5-GB (F) B (F, F) XB (F, F) -F (23-57) 2%
2O-Ca(3F,6F,9Me)-O4 (a-11) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
3-HBB-2 (3-4) 5%
V2-BB(F)B-1 (3-6) 5%
3-HHEH-3 (3-13) 3%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F,F)XB(F,F)-F (22-97) 4%
3-GB(F,F)XB(F,F)-F (22-113) 3%
3-HHBB(F,F)-F (23-6) 3%
3-HBB(F,F)XB(F,F)-F (23-38) 3%
3-BB(F)B(F,F)XB(F)-F (23-46) 3%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
3-GB(F)B(F,F)XB(F,F)-F (23-57) 5%
4-GB(F)B(F,F)XB(F,F)-F (23-57) 3%
5-GB(F)B(F,F)XB(F,F)-F (23-57) 2% [Usage example 14]
2O-Ca (3F, 6F, 9Me) -O4 (a-11) 5%
3-HH-V (2-1) 30%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
3-HBB-2 (3-4) 5%
V2-BB (F) B-1 (3-6) 5%
3-HHEH-3 (3-13) 3%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F, F) XB (F, F) -F (22-97) 4%
3-GB (F, F) XB (F, F) -F (22-113) 3%
3-HHBB (F, F) -F (23-6) 3%
3-HBB (F, F) XB (F, F) -F (23-38) 3%
3-BB (F) B (F, F) XB (F) -F (23-46) 3%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
3-GB (F) B (F, F) XB (F, F) -F (23-57) 5%
4-GB (F) B (F, F) XB (F, F) -F (23-57) 3%
5-GB (F) B (F, F) XB (F, F) -F (23-57) 2%
[使用例15]
4O-Ca(1F,8F,9Me)-O2 (a-74) 9%
3-HH-V (2-1) 25%
3-HH-V1 (2-1) 4%
3-HHB-1 (3-1) 5%
V-HHB-1 (3-1) 4%
V2-BB(F)B-1 (3-6) 4%
3-HHEH-5 (3-13) 3%
3-HHEBH-3 (4-6) 4%
1V2-BB―F (21-1) 4%
3-BB(F)B(F,F)-F (22-69) 3%
3-BB(F,F)XB(F,F)-F (22-97) 5%
3-HHBB(F,F)-F (23-6) 3%
5-HB(F)B(F,F)XB(F,F)-F (23-41) 4%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 5%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
2-dhBB(F,F)XB(F,F)-F (23-50) 2%
3-dhBB(F,F)XB(F,F)-F (23-50) 3%
3-GBB(F)B(F,F)-F (23-55) 3%
4-GBB(F)B(F,F)-F (23-55) 3%
3-BB(F,F)XB(F)B(F,F)-F (23-56) 4%
NI=83.2℃;η=25.5mPa・s;Δn=0.115;Δε=5.5. [Usage example 15]
4O-Ca (1F, 8F, 9Me) -O2 (a-74) 9%
3-HH-V (2-1) 25%
3-HH-V1 (2-1) 4%
3-HHB-1 (3-1) 5%
V-HHB-1 (3-1) 4%
V2-BB (F) B-1 (3-6) 4%
3-HHEH-5 (3-13) 3%
3-HHEBH-3 (4-6) 4%
1V2-BB-F (21-1) 4%
3-BB (F) B (F, F) -F (22-69) 3%
3-BB (F, F) XB (F, F) -F (22-97) 5%
3-HHBB (F, F) -F (23-6) 3%
5-HB (F) B (F, F) XB (F, F) -F (23-41) 4%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 5%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
2-dhBB (F, F) XB (F, F) -F (23-50) 2%
3-dhBB (F, F) XB (F, F) -F (23-50) 3%
3-GBB (F) B (F, F) -F (23-55) 3%
4-GBB (F) B (F, F) -F (23-55) 3%
3-BB (F, F) XB (F) B (F, F) -F (23-56) 4%
NI = 83.2 ° C; η = 25.5 mPa · s; Δn = 0.115; Δε = 5.5.
4O-Ca(1F,8F,9Me)-O2 (a-74) 9%
3-HH-V (2-1) 25%
3-HH-V1 (2-1) 4%
3-HHB-1 (3-1) 5%
V-HHB-1 (3-1) 4%
V2-BB(F)B-1 (3-6) 4%
3-HHEH-5 (3-13) 3%
3-HHEBH-3 (4-6) 4%
1V2-BB―F (21-1) 4%
3-BB(F)B(F,F)-F (22-69) 3%
3-BB(F,F)XB(F,F)-F (22-97) 5%
3-HHBB(F,F)-F (23-6) 3%
5-HB(F)B(F,F)XB(F,F)-F (23-41) 4%
4-BB(F)B(F,F)XB(F,F)-F (23-47) 5%
5-BB(F)B(F,F)XB(F,F)-F (23-47) 3%
2-dhBB(F,F)XB(F,F)-F (23-50) 2%
3-dhBB(F,F)XB(F,F)-F (23-50) 3%
3-GBB(F)B(F,F)-F (23-55) 3%
4-GBB(F)B(F,F)-F (23-55) 3%
3-BB(F,F)XB(F)B(F,F)-F (23-56) 4%
NI=83.2℃;η=25.5mPa・s;Δn=0.115;Δε=5.5. [Usage example 15]
4O-Ca (1F, 8F, 9Me) -O2 (a-74) 9%
3-HH-V (2-1) 25%
3-HH-V1 (2-1) 4%
3-HHB-1 (3-1) 5%
V-HHB-1 (3-1) 4%
V2-BB (F) B-1 (3-6) 4%
3-HHEH-5 (3-13) 3%
3-HHEBH-3 (4-6) 4%
1V2-BB-F (21-1) 4%
3-BB (F) B (F, F) -F (22-69) 3%
3-BB (F, F) XB (F, F) -F (22-97) 5%
3-HHBB (F, F) -F (23-6) 3%
5-HB (F) B (F, F) XB (F, F) -F (23-41) 4%
4-BB (F) B (F, F) XB (F, F) -F (23-47) 5%
5-BB (F) B (F, F) XB (F, F) -F (23-47) 3%
2-dhBB (F, F) XB (F, F) -F (23-50) 2%
3-dhBB (F, F) XB (F, F) -F (23-50) 3%
3-GBB (F) B (F, F) -F (23-55) 3%
4-GBB (F) B (F, F) -F (23-55) 3%
3-BB (F, F) XB (F) B (F, F) -F (23-56) 4%
NI = 83.2 ° C; η = 25.5 mPa · s; Δn = 0.115; Δε = 5.5.
[使用例16]
2O-Ca(3F,4F,6F)-O4 (a-36) 2%
3-HH-V (2-1) 33%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
V2-BB(F)B-1 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F)B(F,F)-CF3 (22-69) 3%
3-BB(F,F)XB(F,F)-F (22-97) 5%
3-HHXB(F,F)-F (22-100) 5%
3-GB(F,F)XB(F,F)-F (22-113) 3%
3-GB(F)B(F)-F (22-115) 3%
3-HHBB(F,F)-F (23-6) 3%
5-HB(F)B(F,F)XB(F,F)-F (23-41) 3%
3-GB(F)B(F,F)XB(F,F)-F (23-57) 3%
3-GBB(F,F)XB(F,F)-F (23-58) 3%
4-GBB(F,F)XB(F,F)-F (23-58) 3%
5-GBB(F,F)XB(F,F)-F (23-58) 3%
3-GB(F)B(F)B(F)-F (23-59) 3%
NI=81.9℃;η=19.0mPa・s;Δn=0.096;Δε=5.4. [Usage example 16]
2O-Ca (3F, 4F, 6F) -O4 (a-36) 2%
3-HH-V (2-1) 33%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
V2-BB (F) B-1 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F) B (F, F) -CF3 (22-69) 3%
3-BB (F, F) XB (F, F) -F (22-97) 5%
3-HHXB (F, F) -F (22-100) 5%
3-GB (F, F) XB (F, F) -F (22-113) 3%
3-GB (F) B (F) -F (22-115) 3%
3-HHBB (F, F) -F (23-6) 3%
5-HB (F) B (F, F) XB (F, F) -F (23-41) 3%
3-GB (F) B (F, F) XB (F, F) -F (23-57) 3%
3-GBB (F, F) XB (F, F) -F (23-58) 3%
4-GBB (F, F) XB (F, F) -F (23-58) 3%
5-GBB (F, F) XB (F, F) -F (23-58) 3%
3-GB (F) B (F) B (F) -F (23-59) 3%
NI = 81.9 ° C; η = 19.0 mPa · s; Δn = 0.096; Δε = 5.4.
2O-Ca(3F,4F,6F)-O4 (a-36) 2%
3-HH-V (2-1) 33%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
V2-BB(F)B-1 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB―F (21-1) 3%
3-BB(F)B(F,F)-CF3 (22-69) 3%
3-BB(F,F)XB(F,F)-F (22-97) 5%
3-HHXB(F,F)-F (22-100) 5%
3-GB(F,F)XB(F,F)-F (22-113) 3%
3-GB(F)B(F)-F (22-115) 3%
3-HHBB(F,F)-F (23-6) 3%
5-HB(F)B(F,F)XB(F,F)-F (23-41) 3%
3-GB(F)B(F,F)XB(F,F)-F (23-57) 3%
3-GBB(F,F)XB(F,F)-F (23-58) 3%
4-GBB(F,F)XB(F,F)-F (23-58) 3%
5-GBB(F,F)XB(F,F)-F (23-58) 3%
3-GB(F)B(F)B(F)-F (23-59) 3%
NI=81.9℃;η=19.0mPa・s;Δn=0.096;Δε=5.4. [Usage example 16]
2O-Ca (3F, 4F, 6F) -O4 (a-36) 2%
3-HH-V (2-1) 33%
3-HH-V1 (2-1) 5%
3-HHB-1 (3-1) 4%
V-HHB-1 (3-1) 5%
V2-BB (F) B-1 (3-6) 5%
3-HHEH-5 (3-13) 3%
1V2-BB-F (21-1) 3%
3-BB (F) B (F, F) -CF3 (22-69) 3%
3-BB (F, F) XB (F, F) -F (22-97) 5%
3-HHXB (F, F) -F (22-100) 5%
3-GB (F, F) XB (F, F) -F (22-113) 3%
3-GB (F) B (F) -F (22-115) 3%
3-HHBB (F, F) -F (23-6) 3%
5-HB (F) B (F, F) XB (F, F) -F (23-41) 3%
3-GB (F) B (F, F) XB (F, F) -F (23-57) 3%
3-GBB (F, F) XB (F, F) -F (23-58) 3%
4-GBB (F, F) XB (F, F) -F (23-58) 3%
5-GBB (F, F) XB (F, F) -F (23-58) 3%
3-GB (F) B (F) B (F) -F (23-59) 3%
NI = 81.9 ° C; η = 19.0 mPa · s; Δn = 0.096; Δε = 5.4.
[使用例17]
2O-Ca(3F,4F,6F)-4 (a-232) 4%
3-HH-4 (2-1) 5%
3-HB-O1 (2-5) 15%
3-HHB-1 (3-1) 6%
3-HB(2F,3F)-O2 (5-1) 12%
5-HB(2F,3F)-O2 (5-1) 12%
2-HHB(2F,3F)-1 (6-1) 8%
3-HHB(2F,3F)-1 (6-1) 12%
3-HHB(2F,3F)-O2 (6-1) 13%
5-HHB(2F,3F)-O2 (6-1) 13% [Usage example 17]
2O-Ca (3F, 4F, 6F) -4 (a-232) 4%
3-HH-4 (2-1) 5%
3-HB-O1 (2-5) 15%
3-HHB-1 (3-1) 6%
3-HB (2F, 3F) -O2 (5-1) 12%
5-HB (2F, 3F) -O2 (5-1) 12%
2-HHB (2F, 3F) -1 (6-1) 8%
3-HHB (2F, 3F) -1 (6-1) 12%
3-HHB (2F, 3F) -O2 (6-1) 13%
5-HHB (2F, 3F) -O2 (6-1) 13%
2O-Ca(3F,4F,6F)-4 (a-232) 4%
3-HH-4 (2-1) 5%
3-HB-O1 (2-5) 15%
3-HHB-1 (3-1) 6%
3-HB(2F,3F)-O2 (5-1) 12%
5-HB(2F,3F)-O2 (5-1) 12%
2-HHB(2F,3F)-1 (6-1) 8%
3-HHB(2F,3F)-1 (6-1) 12%
3-HHB(2F,3F)-O2 (6-1) 13%
5-HHB(2F,3F)-O2 (6-1) 13% [Usage example 17]
2O-Ca (3F, 4F, 6F) -4 (a-232) 4%
3-HH-4 (2-1) 5%
3-HB-O1 (2-5) 15%
3-HHB-1 (3-1) 6%
3-HB (2F, 3F) -O2 (5-1) 12%
5-HB (2F, 3F) -O2 (5-1) 12%
2-HHB (2F, 3F) -1 (6-1) 8%
3-HHB (2F, 3F) -1 (6-1) 12%
3-HHB (2F, 3F) -O2 (6-1) 13%
5-HHB (2F, 3F) -O2 (6-1) 13%
[使用例18]
2O-Ca(3F,6F)-5 (a-4) 2%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-H2B(2F,3F)-O2 (5-4) 15%
5-H2B(2F,3F)-O2 (5-4) 13%
2-HBB(2F,3F)-O2 (6-7) 3%
3-HBB(2F,3F)-O2 (6-7) 9%
5-HBB(2F,3F)-O2 (6-7) 9%
3-HHB(2F,3Cl)-O2 (6-12) 5% [Usage example 18]
2O-Ca (3F, 6F) -5 (a-4) 2%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-H2B (2F, 3F) -O2 (5-4) 15%
5-H2B (2F, 3F) -O2 (5-4) 13%
2-HBB (2F, 3F) -O2 (6-7) 3%
3-HBB (2F, 3F) -O2 (6-7) 9%
5-HBB (2F, 3F) -O2 (6-7) 9%
3-HHB (2F, 3Cl) -O2 (6-12) 5%
2O-Ca(3F,6F)-5 (a-4) 2%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-H2B(2F,3F)-O2 (5-4) 15%
5-H2B(2F,3F)-O2 (5-4) 13%
2-HBB(2F,3F)-O2 (6-7) 3%
3-HBB(2F,3F)-O2 (6-7) 9%
5-HBB(2F,3F)-O2 (6-7) 9%
3-HHB(2F,3Cl)-O2 (6-12) 5% [Usage example 18]
2O-Ca (3F, 6F) -5 (a-4) 2%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-H2B (2F, 3F) -O2 (5-4) 15%
5-H2B (2F, 3F) -O2 (5-4) 13%
2-HBB (2F, 3F) -O2 (6-7) 3%
3-HBB (2F, 3F) -O2 (6-7) 9%
5-HBB (2F, 3F) -O2 (6-7) 9%
3-HHB (2F, 3Cl) -O2 (6-12) 5%
[使用例19]
2O-Ca(3F,4F)-4 (a-233) 4%
2-HH-3 (2-1) 16%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 9%
3-HHB-1 (3-1) 5%
3-HHB-O1 (3-1) 3%
5-B(F)BB-2 (3-8) 2%
3-BB(2F,3F)-O2 (5-3) 9%
5-BB(2F,3F)-O2 (5-3) 6%
2-HH1OB(2F,3F)-O2 (6-5) 13%
3-HH1OB(2F,3F)-O2 (6-5) 17% [Usage example 19]
2O-Ca (3F, 4F) -4 (a-233) 4%
2-HH-3 (2-1) 16%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 9%
3-HHB-1 (3-1) 5%
3-HHB-O1 (3-1) 3%
5-B (F) BB-2 (3-8) 2%
3-BB (2F, 3F) -O2 (5-3) 9%
5-BB (2F, 3F) -O2 (5-3) 6%
2-HH1OB (2F, 3F) -O2 (6-5) 13%
3-HH1OB (2F, 3F) -O2 (6-5) 17%
2O-Ca(3F,4F)-4 (a-233) 4%
2-HH-3 (2-1) 16%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 9%
3-HHB-1 (3-1) 5%
3-HHB-O1 (3-1) 3%
5-B(F)BB-2 (3-8) 2%
3-BB(2F,3F)-O2 (5-3) 9%
5-BB(2F,3F)-O2 (5-3) 6%
2-HH1OB(2F,3F)-O2 (6-5) 13%
3-HH1OB(2F,3F)-O2 (6-5) 17% [Usage example 19]
2O-Ca (3F, 4F) -4 (a-233) 4%
2-HH-3 (2-1) 16%
2-HH-5 (2-1) 5%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 9%
3-HHB-1 (3-1) 5%
3-HHB-O1 (3-1) 3%
5-B (F) BB-2 (3-8) 2%
3-BB (2F, 3F) -O2 (5-3) 9%
5-BB (2F, 3F) -O2 (5-3) 6%
2-HH1OB (2F, 3F) -O2 (6-5) 13%
3-HH1OB (2F, 3F) -O2 (6-5) 17%
[使用例20]
2O-Ca(6F)-5 (a-234) 3%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 10%
5-HB-O2 (2-5) 8%
5-HBB(F)B-2 (4-5) 7%
5-HBB(F)B-3 (4-5) 10%
3-HB(2F,3F)-O2 (5-1) 17%
5-HB(2F,3F)-O2 (5-1) 16%
3-HHB(2F,3Cl)-O2 (6-12) 3%
4-HHB(2F,3Cl)-O2 (6-12) 3%
5-HHB(2F,3Cl)-O2 (6-12) 2%
3-HH1OCro(7F,8F)-5 (10-6) 5% [Usage example 20]
2O-Ca (6F) -5 (a-234) 3%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 10%
5-HB-O2 (2-5) 8%
5-HBB (F) B-2 (4-5) 7%
5-HBB (F) B-3 (4-5) 10%
3-HB (2F, 3F) -O2 (5-1) 17%
5-HB (2F, 3F) -O2 (5-1) 16%
3-HHB (2F, 3Cl) -O2 (6-12) 3%
4-HHB (2F, 3Cl) -O2 (6-12) 3%
5-HHB (2F, 3Cl) -O2 (6-12) 2%
3-HH1OCro (7F, 8F) -5 (10-6) 5%
2O-Ca(6F)-5 (a-234) 3%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 10%
5-HB-O2 (2-5) 8%
5-HBB(F)B-2 (4-5) 7%
5-HBB(F)B-3 (4-5) 10%
3-HB(2F,3F)-O2 (5-1) 17%
5-HB(2F,3F)-O2 (5-1) 16%
3-HHB(2F,3Cl)-O2 (6-12) 3%
4-HHB(2F,3Cl)-O2 (6-12) 3%
5-HHB(2F,3Cl)-O2 (6-12) 2%
3-HH1OCro(7F,8F)-5 (10-6) 5% [Usage example 20]
2O-Ca (6F) -5 (a-234) 3%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 10%
5-HB-O2 (2-5) 8%
5-HBB (F) B-2 (4-5) 7%
5-HBB (F) B-3 (4-5) 10%
3-HB (2F, 3F) -O2 (5-1) 17%
5-HB (2F, 3F) -O2 (5-1) 16%
3-HHB (2F, 3Cl) -O2 (6-12) 3%
4-HHB (2F, 3Cl) -O2 (6-12) 3%
5-HHB (2F, 3Cl) -O2 (6-12) 2%
3-HH1OCro (7F, 8F) -5 (10-6) 5%
[使用例21]
5-HCa(3F,6F)-3 (b-1) 3%
3-HH-V (2-1) 29%
1-BB-3 (2-8) 10%
3-HHB-1 (3-1) 8%
5-B(F)BB-2 (3-8) 6%
3-BB(2F,3F)-O2 (5-3) 13%
2-HH1OB(2F,3F)-O2 (6-5) 17%
3-HH1OB(2F,3F)-O2 (6-5) 14% [Usage example 21]
5-HCa (3F, 6F) -3 (b-1) 3%
3-HH-V (2-1) 29%
1-BB-3 (2-8) 10%
3-HHB-1 (3-1) 8%
5-B (F) BB-2 (3-8) 6%
3-BB (2F, 3F) -O2 (5-3) 13%
2-HH1OB (2F, 3F) -O2 (6-5) 17%
3-HH1OB (2F, 3F) -O2 (6-5) 14%
5-HCa(3F,6F)-3 (b-1) 3%
3-HH-V (2-1) 29%
1-BB-3 (2-8) 10%
3-HHB-1 (3-1) 8%
5-B(F)BB-2 (3-8) 6%
3-BB(2F,3F)-O2 (5-3) 13%
2-HH1OB(2F,3F)-O2 (6-5) 17%
3-HH1OB(2F,3F)-O2 (6-5) 14% [Usage example 21]
5-HCa (3F, 6F) -3 (b-1) 3%
3-HH-V (2-1) 29%
1-BB-3 (2-8) 10%
3-HHB-1 (3-1) 8%
5-B (F) BB-2 (3-8) 6%
3-BB (2F, 3F) -O2 (5-3) 13%
2-HH1OB (2F, 3F) -O2 (6-5) 17%
3-HH1OB (2F, 3F) -O2 (6-5) 14%
[使用例22]
3-H1OCa(3F,6F)-3 (b-227) 2%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 9%
1V2-HH-1 (2-1) 7%
1V2-HH-3 (2-1) 6%
4-HH-V (2-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
3-BB(2F,3F)-O2 (5-3) 8%
5-BB(2F,3F)-O2 (5-3) 4%
3-H1OB(2F,3F)-O2 (5-5) 7%
3-HDhB(2F,3F)-O2 (6-3) 7%
2-HH1OB(2F,3F)-O2 (6-5) 8%
3-HH1OB(2F,3F)-O2 (6-5) 17%
2-BB(2F,3F)B-3 (7-1) 11% [Usage example 22]
3-H1OCa (3F, 6F) -3 (b-227) 2%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 9%
1V2-HH-1 (2-1) 7%
1V2-HH-3 (2-1) 6%
4-HH-V (2-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
3-BB (2F, 3F) -O2 (5-3) 8%
5-BB (2F, 3F) -O2 (5-3) 4%
3-H1OB (2F, 3F) -O2 (5-5) 7%
3-HDhB (2F, 3F) -O2 (6-3) 7%
2-HH1OB (2F, 3F) -O2 (6-5) 8%
3-HH1OB (2F, 3F) -O2 (6-5) 17%
2-BB (2F, 3F) B-3 (7-1) 11%
3-H1OCa(3F,6F)-3 (b-227) 2%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 9%
1V2-HH-1 (2-1) 7%
1V2-HH-3 (2-1) 6%
4-HH-V (2-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
3-BB(2F,3F)-O2 (5-3) 8%
5-BB(2F,3F)-O2 (5-3) 4%
3-H1OB(2F,3F)-O2 (5-5) 7%
3-HDhB(2F,3F)-O2 (6-3) 7%
2-HH1OB(2F,3F)-O2 (6-5) 8%
3-HH1OB(2F,3F)-O2 (6-5) 17%
2-BB(2F,3F)B-3 (7-1) 11% [Usage example 22]
3-H1OCa (3F, 6F) -3 (b-227) 2%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 9%
1V2-HH-1 (2-1) 7%
1V2-HH-3 (2-1) 6%
4-HH-V (2-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
3-BB (2F, 3F) -O2 (5-3) 8%
5-BB (2F, 3F) -O2 (5-3) 4%
3-H1OB (2F, 3F) -O2 (5-5) 7%
3-HDhB (2F, 3F) -O2 (6-3) 7%
2-HH1OB (2F, 3F) -O2 (6-5) 8%
3-HH1OB (2F, 3F) -O2 (6-5) 17%
2-BB (2F, 3F) B-3 (7-1) 11%
[使用例23]
2O-Ca(3F,6F)-O4 (a-5) 3%
3-HH-4 (2-1) 5%
3-HH-VFF (2-1) 4%
3-HB-O1 (2-5) 15%
1-BB-5 (2-8) 4%
3-HHB-1 (3-1) 6%
5-HB(2F,3F)-O2 (5-1) 9%
V-HB(2F,3F)-O2 (5-1) 4%
2-HHB(2F,3F)-1 (6-1) 12%
3-HHB(2F,3F)-1 (6-1) 12%
3-HHB(2F,3F)-O2 (6-1) 13%
5-HHB(2F,3F)-O2 (6-1) 13%
NI=88.1℃;η=37.4mPa・s;Δn=0.096;Δε=-3.5. [Usage example 23]
2O-Ca (3F, 6F) -O4 (a-5) 3%
3-HH-4 (2-1) 5%
3-HH-VFF (2-1) 4%
3-HB-O1 (2-5) 15%
1-BB-5 (2-8) 4%
3-HHB-1 (3-1) 6%
5-HB (2F, 3F) -O2 (5-1) 9%
V-HB (2F, 3F) -O2 (5-1) 4%
2-HHB (2F, 3F) -1 (6-1) 12%
3-HHB (2F, 3F) -1 (6-1) 12%
3-HHB (2F, 3F) -O2 (6-1) 13%
5-HHB (2F, 3F) -O2 (6-1) 13%
NI = 88.1 ° C.; η = 37.4 mPa · s; Δn = 0.096; Δε = −3.5.
2O-Ca(3F,6F)-O4 (a-5) 3%
3-HH-4 (2-1) 5%
3-HH-VFF (2-1) 4%
3-HB-O1 (2-5) 15%
1-BB-5 (2-8) 4%
3-HHB-1 (3-1) 6%
5-HB(2F,3F)-O2 (5-1) 9%
V-HB(2F,3F)-O2 (5-1) 4%
2-HHB(2F,3F)-1 (6-1) 12%
3-HHB(2F,3F)-1 (6-1) 12%
3-HHB(2F,3F)-O2 (6-1) 13%
5-HHB(2F,3F)-O2 (6-1) 13%
NI=88.1℃;η=37.4mPa・s;Δn=0.096;Δε=-3.5. [Usage example 23]
2O-Ca (3F, 6F) -O4 (a-5) 3%
3-HH-4 (2-1) 5%
3-HH-VFF (2-1) 4%
3-HB-O1 (2-5) 15%
1-BB-5 (2-8) 4%
3-HHB-1 (3-1) 6%
5-HB (2F, 3F) -O2 (5-1) 9%
V-HB (2F, 3F) -O2 (5-1) 4%
2-HHB (2F, 3F) -1 (6-1) 12%
3-HHB (2F, 3F) -1 (6-1) 12%
3-HHB (2F, 3F) -O2 (6-1) 13%
5-HHB (2F, 3F) -O2 (6-1) 13%
NI = 88.1 ° C.; η = 37.4 mPa · s; Δn = 0.096; Δε = −3.5.
[使用例24]
4O-Ca(1F,8F)-O2 (a-71) 5%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 8%
5-HB-O2 (2-5) 7%
5-HBB(F)B-2 (4-5) 9%
5-HBB(F)B-3 (4-5) 10%
3-HB(2F,3F)-O2 (5-1) 13%
5-HB(2F,3F)-O2 (5-1) 11%
2-H1OB(2F,3F)-O2 (5-5) 2%
3-H1OB(2F,3F)-O2 (5-5) 2%
2O-B(2F,3F)B(F)-O2 (5-9) 2%
4O-B(2F,3F)B(F)-O2 (5-9) 2%
V-HHB(2F,3F)-O2 (6-1) 5%
V2-HHB(2F,3F)-O2 (6-1) 4%
5-HHB(2F,3Cl)-O2 (6-12) 2%
3-HH1OCro(7F,8F)-5 (10-6) 2%
NI=74.1℃;η=24.6mPa・s;Δn=0.108;Δε=-2.4. [Usage example 24]
4O-Ca (1F, 8F) -O2 (a-71) 5%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 8%
5-HB-O2 (2-5) 7%
5-HBB (F) B-2 (4-5) 9%
5-HBB (F) B-3 (4-5) 10%
3-HB (2F, 3F) -O2 (5-1) 13%
5-HB (2F, 3F) -O2 (5-1) 11%
2-H1OB (2F, 3F) -O2 (5-5) 2%
3-H1OB (2F, 3F) -O2 (5-5) 2%
2OB (2F, 3F) B (F) -O2 (5-9) 2%
4OB (2F, 3F) B (F) -O2 (5-9) 2%
V-HHB (2F, 3F) -O2 (6-1) 5%
V2-HHB (2F, 3F) -O2 (6-1) 4%
5-HHB (2F, 3Cl) -O2 (6-12) 2%
3-HH1OCro (7F, 8F) -5 (10-6) 2%
NI = 74.1 ° C.; η = 24.6 mPa · s; Δn = 0.108; Δε = -2.4.
4O-Ca(1F,8F)-O2 (a-71) 5%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 8%
5-HB-O2 (2-5) 7%
5-HBB(F)B-2 (4-5) 9%
5-HBB(F)B-3 (4-5) 10%
3-HB(2F,3F)-O2 (5-1) 13%
5-HB(2F,3F)-O2 (5-1) 11%
2-H1OB(2F,3F)-O2 (5-5) 2%
3-H1OB(2F,3F)-O2 (5-5) 2%
2O-B(2F,3F)B(F)-O2 (5-9) 2%
4O-B(2F,3F)B(F)-O2 (5-9) 2%
V-HHB(2F,3F)-O2 (6-1) 5%
V2-HHB(2F,3F)-O2 (6-1) 4%
5-HHB(2F,3Cl)-O2 (6-12) 2%
3-HH1OCro(7F,8F)-5 (10-6) 2%
NI=74.1℃;η=24.6mPa・s;Δn=0.108;Δε=-2.4. [Usage example 24]
4O-Ca (1F, 8F) -O2 (a-71) 5%
2-HH-3 (2-1) 16%
7-HB-1 (2-5) 8%
5-HB-O2 (2-5) 7%
5-HBB (F) B-2 (4-5) 9%
5-HBB (F) B-3 (4-5) 10%
3-HB (2F, 3F) -O2 (5-1) 13%
5-HB (2F, 3F) -O2 (5-1) 11%
2-H1OB (2F, 3F) -O2 (5-5) 2%
3-H1OB (2F, 3F) -O2 (5-5) 2%
2OB (2F, 3F) B (F) -O2 (5-9) 2%
4OB (2F, 3F) B (F) -O2 (5-9) 2%
V-HHB (2F, 3F) -O2 (6-1) 5%
V2-HHB (2F, 3F) -O2 (6-1) 4%
5-HHB (2F, 3Cl) -O2 (6-12) 2%
3-HH1OCro (7F, 8F) -5 (10-6) 2%
NI = 74.1 ° C.; η = 24.6 mPa · s; Δn = 0.108; Δε = -2.4.
[使用例25]
2O-Ca(3F,6F,9Me)-O4 (a-11) 3%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-DhB(2F,3F)-O2 (5-2) 3%
2-BB(2F,3F)-O2 (5-3) 9%
5-H2B(2F,3F)-O2 (5-4) 9%
3-HH2B(2F,3F)-O2 (6-4) 3%
3-HBB(2F,3F)-O2 (6-7) 9%
5-HBB(2F,3F)-O2 (6-7) 9%
V-HBB(2F,3F)-O2 (6-7) 3%
3-HHB(2F,3Cl)-O2 (6-12) 5%
2O-B(2F,3F)B(F)H-3 (6-19) 3% [Usage example 25]
2O-Ca (3F, 6F, 9Me) -O4 (a-11) 3%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-DhB (2F, 3F) -O2 (5-2) 3%
2-BB (2F, 3F) -O2 (5-3) 9%
5-H2B (2F, 3F) -O2 (5-4) 9%
3-HH2B (2F, 3F) -O2 (6-4) 3%
3-HBB (2F, 3F) -O2 (6-7) 9%
5-HBB (2F, 3F) -O2 (6-7) 9%
V-HBB (2F, 3F) -O2 (6-7) 3%
3-HHB (2F, 3Cl) -O2 (6-12) 5%
2OB (2F, 3F) B (F) H-3 (6-19) 3%
2O-Ca(3F,6F,9Me)-O4 (a-11) 3%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-DhB(2F,3F)-O2 (5-2) 3%
2-BB(2F,3F)-O2 (5-3) 9%
5-H2B(2F,3F)-O2 (5-4) 9%
3-HH2B(2F,3F)-O2 (6-4) 3%
3-HBB(2F,3F)-O2 (6-7) 9%
5-HBB(2F,3F)-O2 (6-7) 9%
V-HBB(2F,3F)-O2 (6-7) 3%
3-HHB(2F,3Cl)-O2 (6-12) 5%
2O-B(2F,3F)B(F)H-3 (6-19) 3% [Usage example 25]
2O-Ca (3F, 6F, 9Me) -O4 (a-11) 3%
2-HH-5 (2-1) 3%
3-HH-4 (2-1) 15%
3-HH-5 (2-1) 4%
3-HB-O2 (2-5) 12%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 4%
3-HHB-O1 (3-1) 3%
3-DhB (2F, 3F) -O2 (5-2) 3%
2-BB (2F, 3F) -O2 (5-3) 9%
5-H2B (2F, 3F) -O2 (5-4) 9%
3-HH2B (2F, 3F) -O2 (6-4) 3%
3-HBB (2F, 3F) -O2 (6-7) 9%
5-HBB (2F, 3F) -O2 (6-7) 9%
V-HBB (2F, 3F) -O2 (6-7) 3%
3-HHB (2F, 3Cl) -O2 (6-12) 5%
2OB (2F, 3F) B (F) H-3 (6-19) 3%
[使用例26]
4O-Ca(1F,8F,9Me)-O2 (a-74) 12%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 10%
1V2-HH-1 (2-1) 8%
1V2-HH-3 (2-1) 7%
V-HHB-1 (3-1) 3%
V2-HHB-1 (3-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
5-BB(2F,3F)-O2 (5-3) 4%
V2-BB(2F,3F)-O2 (5-3) 4%
3-H1OB(2F,3F)-O2 (5-5) 7%
3-HDhB(2F,3F)-O2 (6-3) 7%
3-HH1OB(2F,3F)-O2 (6-5) 13%
3-dhBB(2F,3F)-O2 (6-9) 3%
3-HchB(2F,3F)-O2 (6-18) 3%
2-BB(2F,3F)B-3 (7-1) 5%
NI=84.1℃;η=20.7mPa・s;Δn=0.114;Δε=-3.7. [Usage example 26]
4O-Ca (1F, 8F, 9Me) -O2 (a-74) 12%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 10%
1V2-HH-1 (2-1) 8%
1V2-HH-3 (2-1) 7%
V-HHB-1 (3-1) 3%
V2-HHB-1 (3-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
5-BB (2F, 3F) -O2 (5-3) 4%
V2-BB (2F, 3F) -O2 (5-3) 4%
3-H1OB (2F, 3F) -O2 (5-5) 7%
3-HDhB (2F, 3F) -O2 (6-3) 7%
3-HH1OB (2F, 3F) -O2 (6-5) 13%
3-dhBB (2F, 3F) -O2 (6-9) 3%
3-HchB (2F, 3F) -O2 (6-18) 3%
2-BB (2F, 3F) B-3 (7-1) 5%
NI = 84.1 ° C.; η = 20.7 mPa · s; Δn = 0.114; Δε = -3.7.
4O-Ca(1F,8F,9Me)-O2 (a-74) 12%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 10%
1V2-HH-1 (2-1) 8%
1V2-HH-3 (2-1) 7%
V-HHB-1 (3-1) 3%
V2-HHB-1 (3-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
5-BB(2F,3F)-O2 (5-3) 4%
V2-BB(2F,3F)-O2 (5-3) 4%
3-H1OB(2F,3F)-O2 (5-5) 7%
3-HDhB(2F,3F)-O2 (6-3) 7%
3-HH1OB(2F,3F)-O2 (6-5) 13%
3-dhBB(2F,3F)-O2 (6-9) 3%
3-HchB(2F,3F)-O2 (6-18) 3%
2-BB(2F,3F)B-3 (7-1) 5%
NI=84.1℃;η=20.7mPa・s;Δn=0.114;Δε=-3.7. [Usage example 26]
4O-Ca (1F, 8F, 9Me) -O2 (a-74) 12%
2-HH-3 (2-1) 6%
3-HH-V1 (2-1) 10%
1V2-HH-1 (2-1) 8%
1V2-HH-3 (2-1) 7%
V-HHB-1 (3-1) 3%
V2-HHB-1 (3-1) 3%
3-HHB-1 (3-1) 3%
3-HHB-3 (3-1) 2%
5-BB (2F, 3F) -O2 (5-3) 4%
V2-BB (2F, 3F) -O2 (5-3) 4%
3-H1OB (2F, 3F) -O2 (5-5) 7%
3-HDhB (2F, 3F) -O2 (6-3) 7%
3-HH1OB (2F, 3F) -O2 (6-5) 13%
3-dhBB (2F, 3F) -O2 (6-9) 3%
3-HchB (2F, 3F) -O2 (6-18) 3%
2-BB (2F, 3F) B-3 (7-1) 5%
NI = 84.1 ° C.; η = 20.7 mPa · s; Δn = 0.114; Δε = -3.7.
[使用例27]
2O-Ca(3F,4F,6F)-O4 (a-36) 2%
2-HH-3 (2-1) 21%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 5%
3-HHB-1 (3-1) 3%
3-HHB-O1 (3-1) 3%
V-HBB-2 (3-4) 3%
5-B(F)BB-2 (3-8) 3%
3-BB(2F,3F)-O2 (5-3) 9%
5-BB(2F,3F)-O2 (5-3) 6%
2-HH1OB(2F,3F)-O2 (6-5) 13%
3-HH1OB(2F,3F)-O2 (6-5) 13%
3-HB(2F,3F)B-2 (7-2) 4%
V-HH2BB(2F,3F)-O2 (8-3) 4%
NI=76.8℃;η=17.2mPa・s;Δn=0.100;Δε=-3.2. [Usage example 27]
2O-Ca (3F, 4F, 6F) -O4 (a-36) 2%
2-HH-3 (2-1) 21%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 5%
3-HHB-1 (3-1) 3%
3-HHB-O1 (3-1) 3%
V-HBB-2 (3-4) 3%
5-B (F) BB-2 (3-8) 3%
3-BB (2F, 3F) -O2 (5-3) 9%
5-BB (2F, 3F) -O2 (5-3) 6%
2-HH1OB (2F, 3F) -O2 (6-5) 13%
3-HH1OB (2F, 3F) -O2 (6-5) 13%
3-HB (2F, 3F) B-2 (7-2) 4%
V-HH2BB (2F, 3F) -O2 (8-3) 4%
NI = 76.8 ° C.; η = 17.2 mPa · s; Δn = 0.100; Δε = -3.2.
2O-Ca(3F,4F,6F)-O4 (a-36) 2%
2-HH-3 (2-1) 21%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 5%
3-HHB-1 (3-1) 3%
3-HHB-O1 (3-1) 3%
V-HBB-2 (3-4) 3%
5-B(F)BB-2 (3-8) 3%
3-BB(2F,3F)-O2 (5-3) 9%
5-BB(2F,3F)-O2 (5-3) 6%
2-HH1OB(2F,3F)-O2 (6-5) 13%
3-HH1OB(2F,3F)-O2 (6-5) 13%
3-HB(2F,3F)B-2 (7-2) 4%
V-HH2BB(2F,3F)-O2 (8-3) 4%
NI=76.8℃;η=17.2mPa・s;Δn=0.100;Δε=-3.2. [Usage example 27]
2O-Ca (3F, 4F, 6F) -O4 (a-36) 2%
2-HH-3 (2-1) 21%
3-HH-4 (2-1) 9%
3-HB-O2 (2-5) 2%
1-BB-3 (2-8) 5%
3-HHB-1 (3-1) 3%
3-HHB-O1 (3-1) 3%
V-HBB-2 (3-4) 3%
5-B (F) BB-2 (3-8) 3%
3-BB (2F, 3F) -O2 (5-3) 9%
5-BB (2F, 3F) -O2 (5-3) 6%
2-HH1OB (2F, 3F) -O2 (6-5) 13%
3-HH1OB (2F, 3F) -O2 (6-5) 13%
3-HB (2F, 3F) B-2 (7-2) 4%
V-HH2BB (2F, 3F) -O2 (8-3) 4%
NI = 76.8 ° C.; η = 17.2 mPa · s; Δn = 0.100; Δε = -3.2.
[使用例28]
2O-Ca(3F,4F,6F)-4 (a-232) 4%
3-HH-V (2-1) 28%
1-BB-3 (2-8) 7%
3-HHB-1 (3-1) 8%
5-B(F)BB-2 (3-8) 6%
3-BB(2F,3F)-O2 (5-3) 12%
2-HH1OB(2F,3F)-O2 (6-5) 15%
3-HH1OB(2F,3F)-O2 (6-5) 14%
3-H2BBB(2F,3F)-O2 (8-1) 3%
5-HFLF4-3 (13-1) 3% [Usage example 28]
2O-Ca (3F, 4F, 6F) -4 (a-232) 4%
3-HH-V (2-1) 28%
1-BB-3 (2-8) 7%
3-HHB-1 (3-1) 8%
5-B (F) BB-2 (3-8) 6%
3-BB (2F, 3F) -O2 (5-3) 12%
2-HH1OB (2F, 3F) -O2 (6-5) 15%
3-HH1OB (2F, 3F) -O2 (6-5) 14%
3-H2BBB (2F, 3F) -O2 (8-1) 3%
5-HFLF4-3 (13-1) 3%
2O-Ca(3F,4F,6F)-4 (a-232) 4%
3-HH-V (2-1) 28%
1-BB-3 (2-8) 7%
3-HHB-1 (3-1) 8%
5-B(F)BB-2 (3-8) 6%
3-BB(2F,3F)-O2 (5-3) 12%
2-HH1OB(2F,3F)-O2 (6-5) 15%
3-HH1OB(2F,3F)-O2 (6-5) 14%
3-H2BBB(2F,3F)-O2 (8-1) 3%
5-HFLF4-3 (13-1) 3% [Usage example 28]
2O-Ca (3F, 4F, 6F) -4 (a-232) 4%
3-HH-V (2-1) 28%
1-BB-3 (2-8) 7%
3-HHB-1 (3-1) 8%
5-B (F) BB-2 (3-8) 6%
3-BB (2F, 3F) -O2 (5-3) 12%
2-HH1OB (2F, 3F) -O2 (6-5) 15%
3-HH1OB (2F, 3F) -O2 (6-5) 14%
3-H2BBB (2F, 3F) -O2 (8-1) 3%
5-HFLF4-3 (13-1) 3%
本発明の液晶性化合物は、良好な物性を有する。この化合物を含有する液晶組成物は、パソコン、テレビなどの液晶表示素子に広く利用できる。
The liquid crystal compound of the present invention has good physical characteristics. Liquid crystal compositions containing this compound can be widely used in liquid crystal display elements such as personal computers and televisions.
The liquid crystal compound of the present invention has good physical characteristics. Liquid crystal compositions containing this compound can be widely used in liquid crystal display elements such as personal computers and televisions.
Claims (21)
- 式(1)で表される化合物。
式(1)において、
R1は、水素、または炭素数1から15のアルキルであり、このR1において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
R2は、水素、フッ素、塩素、-C≡N、-C≡C-C≡N、または炭素数1から15のアルキルであり、このR2において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L1、L2、L3、L4、L5、およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L5およびL6が共に水素であるとき、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
L1、L2、L3、およびL4が共に水素であるとき、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、
-OCH2F、または-C≡Nであり;
lおよびoは独立して、0、または1であり、mおよびnは独立して、0、1、または2であり、l、m、n、およびoの和は、0から4の整数であり;
lが0であるとき、R1が水素となることはなく、oが0であるとき、R2が水素となることはない。 A compound represented by the formula (1).
In equation (1)
R 1 is alkyl hydrogen, or from 1 to 15 carbon atoms, in the R 1, at least one of -CH 2 -, -O -, - may be replaced by S-, or -CO-, At least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, and at least one hydrogen may be replaced by fluorine or chlorine;
R 2 is hydrogen, fluorine, chlorine, -C≡N, alkyl of -C≡C-C≡N or 1 to 15 carbon atoms, in the R 2, at least one of -CH 2 -, - It may be replaced by O-, -S-, or -CO-, and at least one- (CH 2 ) 2- may be replaced by -CH = CH- or -C≡C-, at least 1 One hydrogen may be replaced with fluorine or chlorine;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , L 4 , L 5 , and L 6 independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
When both L 5 and L 6 are hydrogen, at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2, be -OCH 2 F, or -C≡N,;
When L 1 , L 2 , L 3 , and L 4 are all hydrogen, at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 ,
It is -OCH 2 F, or -C≡N,;
l and o are independently 0, or 1, m and n are independently 0, 1, or 2, and the sum of l, m, n, and o is an integer from 0 to 4. can be;
When l is 0, R 1 does not become hydrogen, and when o is 0, R 2 does not become hydrogen. - 式(1-1)から式(1-13)で表される、請求項1に記載の化合物。
式(1-1)から式(1-13)において、
R1は、水素、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
R2は、水素、フッ素、塩素、-CF3、-OCF3、-C≡N、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は、-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素は、フッ素または塩素で置き換えられてもよく;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-1)、式(1-3)、式(1-5)、式(1-7)、式(1-9)、式(1-11)、および式(1-13)において、R1が水素となることはなく、式(1-1)から式(1-5)、式(1-8)、式(1-9)、式(1-12)、および式(1-13)において、R2が水素となることはない。 The compound according to claim 1, which is represented by formulas (1-1) to (1-13).
In equations (1-1) to (1-13),
R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms. ;
R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C≡N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2 -may be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -is replaced by -CH = CH- or -C≡C-. Also, at least one hydrogen may be replaced with fluorine or chlorine;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
In the formula (1-1), the formula (1-3), the formula (1-5), the formula (1-7), the formula (1-9), the formula (1-11), and the formula (1-13). , R 1 does not become hydrogen, and formulas (1-1) to (1-5), formula (1-8), formula (1-9), formula (1-12), and formula (1). In -13), R 2 does not become hydrogen. - 前記式(1-1)から式(1-13)において、
R1およびR2は独立して、水素、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、1,2-シクロプロピレン、1,3-シクロブチレン、または1,3-シクロペンチレンであり;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、またはベンゾ[b]チオフェン-2,6-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CH-、-CH=CF-、-CF=CF-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-1)、式(1-3)、式(1-5)、式(1-7)、式(1-9)、式(1-11)、および式(1-13)において、R1が水素となることはなく、式(1-1)から式(1-5)、式(1-8)、式(1-9)、式(1-12)、および式(1-13)において、R2が水素となることはない、請求項2に記載の化合物。 In the formulas (1-1) to (1-13),
R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons. 9 alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, or benzo [b] thiophene-2,6-diyl In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or. It may be replaced by -OCH 2 F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-,- OCF 2 -, - (CH 2 ) 2 -, - CH = CH -, - CF = CH -, - CH = CF -, - CF = CF -, - C≡C -, - (CH 2) 4 -, -(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2- , -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2) 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH -(CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N, and at least one of L 1 , L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , It is -OCH 2 F, or -C≡N,;
In the formula (1-1), the formula (1-3), the formula (1-5), the formula (1-7), the formula (1-9), the formula (1-11), and the formula (1-13). , R 1 does not become hydrogen, and formulas (1-1) to (1-5), formula (1-8), formula (1-9), formula (1-12), and formula (1). -13) The compound according to claim 2, wherein R 2 does not become hydrogen. - 式(1-14)から(1-26)で表される、請求項1に記載の化合物。
式(1-14)から式(1-26)において、
R1は、水素、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
R2は、水素、フッ素、塩素、-CF3、-OCF3、-C≡N、炭素数1から15のアルキル、炭素数1から14のアルコキシ、炭素数2から14のアルコキシアルキル、炭素数2から15のアルケニル、または炭素数2から14のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、炭素数3から5のシクロアルキレンであり、この環A1および環A2において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-で置き換えられてもよく;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、デカヒドロナフタレン-2,6-ジイル、1,2,3,4-テトラヒドロナフタレン-2,6-ジイル、2,6,7-トリオキサビシクロ[2.2.2]オクタン-1,4-ジイル、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、ジヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、ベンゾ[b]チオフェン-2,6-ジイル、9,10-ジヒドロフェナントレン-2,7-ジイル、9H-キサンテン-2,6-ジイル、または9H-フルオレン-2,7-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合または炭素数1から6のアルキレンであり、このZ1、Z2、Z3、およびZ4において、少なくとも1つの-CH2-は-O-、-S-、または-CO-で置き換えられてもよく、少なくとも1つの-(CH2)2-は、-CH=CH-または-C≡C-で置き換えられてもよく、少なくとも1つの水素はフッ素または塩素で置き換えられてもよく;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-14)、式(1-16)、式(1-18)、式(1-20)、式(1-22)、式(1-24)、および式(1-26)において、R1が水素となることはなく、式(1-14)から式(1-18)、式(1-21)、式(1-22)、式(1-25)、および式(1-26)において、R2が水素となることはない。 The compound according to claim 1, which is represented by the formulas (1-14) to (1-26).
In equations (1-14) to (1-26),
R 1 is hydrogen, an alkyl having 1 to 15 carbon atoms, an alkoxy having 1 to 14 carbon atoms, an alkoxy alkyl having 2 to 14 carbon atoms, an alkenyl having 2 to 15 carbon atoms, or an alkenyloxy having 2 to 14 carbon atoms. ;
R 2 is hydrogen, fluorine, chlorine, -CF 3, -OCF 3, -C≡N, alkyl of from 1 to 15 carbon atoms, alkoxy having 1 to 14 carbon atoms, from 2 to 14 carbon atoms in the alkoxyalkyl, carbon atoms 2 to 15 alkenyl, or 2 to 14 carbon alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently cycloalkylenes having 3 to 5 carbon atoms, and in the rings A 1 and A 2 , at least one -CH 2- can be replaced with -O-. Often, at least one-(CH 2 ) 2- may be replaced by -CH = CH-;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2, 6-diyl, 2,6,7-trioxabicyclo [2.2.2] octane-1,4-diyl, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl , Dihydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2, 5-diyl, thiophene-2,4-diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, benzo [b] b] thiophene-2,6-diyl, 9,10-dihydro-phenanthrene-2,7-diyl, a 9H- xanthene-2,6-diyl or 9H- fluoren-2,7-diyl, the ring N 1 And in ring N 2 , at least one hydrogen is replaced by fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or -OCH 2 F. May;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded or alkylenes with 1 to 6 carbon atoms, and in this Z 1 , Z 2 , Z 3 , and Z 4 , at least one -CH. 2- May be replaced by -O-, -S-, or -CO-, and at least one- (CH 2 ) 2 -may be replaced by -CH = CH- or -C≡C-. Often, at least one hydrogen may be replaced with fluorine or chlorine;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N. At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N;
In formula (1-14), formula (1-16), formula (1-18), formula (1-20), formula (1-22), formula (1-24), and formula (1-26). , R 1 does not become hydrogen, and formulas (1-14) to (1-18), formula (1-21), formula (1-22), formula (1-25), and formula (1). In -26), R 2 does not become hydrogen. - 前記式(1-14)から式(1-26)において、
R1およびR2は独立して、水素、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
環A1および環A2は独立して、1,2-シクロプロピレン、1,3-シクロブチレン、または1,3-シクロペンチレンであり;
環N1および環N2は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、ナフタレン-2,6-ジイル、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、ピリジン-2,5-ジイル、ピリミジン-2,5-ジイル、フラン-2,4-ジイル、フラン-2,5-ジイル、チオフェン-2,4-ジイル、チオフェン-2,5-ジイル、ベンゾフラン-2,5-ジイル、ベンゾフラン-2,6-ジイル、ベンゾ[b]チオフェン-2,5-ジイル、またはベンゾ[b]チオフェン-2,6-ジイルであり、この環N1および環N2において、少なくとも1つの水素は、フッ素、塩素、-C≡N、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、または-OCH2Fで置き換えられてもよく;
Z1、Z2、Z3、およびZ4は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-CF=CH-、-CH=CF-、-CF=CF-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり、L5、およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCH2F、または-C≡Nであり;
式(1-14)、式(1-16)、式(1-18)、式(1-20)、式(1-22)、式(1-24)、および式(1-26)において、R1が水素となることはなく、式(1-14)から式(1-18)、式(1-21)、式(1-22)、式(1-25)、および式(1-26)において、R2が水素となることはない、請求項4に記載の化合物。 In the formulas (1-14) to (1-26),
R 1 and R 2 are independently from hydrogen, alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or from 2 carbons. 9 alkenyloxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Rings A 1 and A 2 are independently 1,2-cyclopropylene, 1,3-cyclobutylene, or 1,3-cyclopentylene;
Rings N 1 and N 2 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, naphthalene-2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, furan-2,4-diyl, furan-2,5-diyl, thiophene-2,4- Diyl, thiophene-2,5-diyl, benzofuran-2,5-diyl, benzofuran-2,6-diyl, benzo [b] thiophene-2,5-diyl, or benzo [b] thiophene-2,6-diyl In the rings N 1 and N 2 , at least one hydrogen is fluorine, chlorine, -C≡N, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , or. It may be replaced by -OCH 2 F;
Z 1 , Z 2 , Z 3 , and Z 4 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-,- OCF 2 -, - (CH 2 ) 2 -, - CH = CH -, - CF = CH -, - CH = CF -, - CF = CF -, - C≡C -, - (CH 2) 4 -, -(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2- , -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2) 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH -(CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N. At least one of L 5 and L 6 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCH 2 F, or -C ≡ N;
In formula (1-14), formula (1-16), formula (1-18), formula (1-20), formula (1-22), formula (1-24), and formula (1-26). , R 1 does not become hydrogen, and formulas (1-14) to (1-18), formula (1-21), formula (1-22), formula (1-25), and formula (1). -26), the compound according to claim 4, wherein R 2 does not become hydrogen. - 式(1-1-1)、式(1-3-1)から式(1-3-6)、式(1-5-1)から式(1-5-4)、または式(1-9-1)から式(1-9-3)で表される、請求項1から3のいずれか1項に記載の化合物。
式(1-1-1)、式(1-3-1)から式(1-3-6)、式(1-5-1)から式(1-5-4)、および式(1-9-1)から式(1-9-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である。 Formula (1-1-1), formula (1-3-1) to formula (1-3-6), formula (1-5-1) to formula (1-5-4), or formula (1-5-1) The compound according to any one of claims 1 to 3, represented by the formulas (1-9-3) from 9-1).
Equations (1-1-1), equations (1-3-1) to equations (1-3-6), equations (1-5-1) to equations (1-5-4), and equations (1-5-1). In equations (1-9-3) from 9-1)
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH). 2 ) 2- , -CH = CH-, -C≡C-,-(CH 2 ) 4 -,-(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2 -, -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH- CH 2 O- or -OCH 2- CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and L 1 , At least one of L 2 , L 3 , and L 4 is fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine. - 前記式(1-1-1)、式(1-3-1)から式(1-3-6)、式(1-5-1)から式(1-5-4)、式(1-9-1)から式(1-9-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から10のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3または、-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3または、-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、水素であり;
X1およびX2は独立して、水素、フッ素、または塩素である、請求項6に記載の化合物。 Formulas (1-1-1), formulas (1-3-1) to formulas (1-3-6), formulas (1-5-1) to formulas (1-5-4), formulas (1-5-1) In equations (1-9-3) from 9-1)
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 10 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4. Is fluorine, chlorine, -CF 3 or -OCF 3 , and at least two of L 1 , L 2 , L 3 and L 4 are hydrogen;
The compound according to claim 6, wherein X 1 and X 2 are independently hydrogen, fluorine, or chlorine. - 式(1-14-1)、式(1-16-1)から式(1-16-6)、式(1-18-1)から式(1-18-4)、または式(1-22-1)から式(1-22-3)で表される、請求項1、4、および5のいずれか1項に記載の化合物。
式(1-14-1)、式(1-16-1)から式(1-16-6)、式(1-18-1)から式(1-18-4)、および式(1-22-1)から式(1-22-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-O-、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、-(CH2)4-、-(CH2)2COO-、-(CH2)2OCO-、-OCO(CH2)2-、-COO(CH2)2-、-(CH2)2CF2O-、-(CH2)2OCF2-、-OCF2(CH2)2-、-CF2O(CH2)2-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である。 Formula (1-14-1), formula (1-16-1) to formula (1-16-6), formula (1-18-1) to formula (1-18-4), or formula (1-18-1) The compound according to any one of claims 1, 4, and 5, represented by the formulas (1-22-3) from 22-1).
Equations (1-14-1), equations (1-16-1) to equations (1-16-6), equations (1-18-1) to equations (1-18-4), and equations (1-18-1). From 22-1) to equation (1-22-3),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -O-, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH). 2 ) 2- , -CH = CH-, -C≡C-,-(CH 2 ) 4 -,-(CH 2 ) 2 COO-,-(CH 2 ) 2 OCO-, -OCO (CH 2 ) 2 -, -COO (CH 2 ) 2 -,-(CH 2 ) 2 CF 2 O-,-(CH 2 ) 2 OCF 2- , -OCF 2 (CH 2 ) 2- , -CF 2 O (CH 2 ) 2 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH- CH 2 O- or -OCH 2- CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and at least one of L 5 and L 6 is , Fluorine, Chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine. - 前記式(1-14-1)、式(1-16-1)から式(1-16-6)、式(1-18-1)から式(1-18-4)、および式(1-22-1)から式(1-22-3)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から6の直鎖アルキル、または炭素数3から6の分岐鎖アルキルであり;
Z2およびZ3は独立して、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、-CHF2、-OCF3、-OCHF2、または-OCH2Fであり;
X1およびX2は独立して、水素、フッ素、または塩素である、請求項8に記載の化合物。 Formulas (1-14-1), formulas (1-16-1) to formulas (1-16-6), formulas (1-18-1) to formulas (1-18-4), and formulas (1). From -22-1) to equation (1-22-3),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 6 carbon atoms, or a branched chain alkyl having 3 to 6 carbon atoms;
Z 2 and Z 3 are independently single-bonded, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH-,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH-, -CH = CH-CH 2 O-, or -OCH 2-CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F, and at least one of L 5 and L 6 is , Fluorine, Chlorine, -CF 3 , -CHF 2 , -OCF 3 , -OCHF 2 , or -OCH 2 F;
The compound according to claim 8, wherein X 1 and X 2 are independently hydrogen, fluorine, or chlorine. - 式(1-1-1)、または式(1-3-1)から(1-3-6)で表される、請求項1から3、6、および7のいずれか1項に記載の化合物。
式(1-1-1)、および式(1-3-1)から式(1-3-6)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
Z2は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L1、L2、L3、およびL4は独立して、水素、フッ素、塩素、-CF3、または-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、フッ素、塩素、-CF3、または-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、水素であり;
X1およびX2は独立して、水素、フッ素、または塩素である。 The compound according to any one of claims 1 to 3, 6 and 7, represented by the formula (1-1-1) or the formulas (1-3-1) to (1-3-6). ..
In the formula (1-1-1), and from the formula (1-3-1) to the formula (1-3-6),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
Z 2 is a single bond, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH- ,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH- , -CH = CH-CH 2 O-, or -OCH 2- CH = CH-;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, chlorine, -CF 3 , or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4. Is fluorine, chlorine, -CF 3 , or -OCF 3 , and at least two of L 1 , L 2 , L 3 , and L 4 are hydrogen;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine. - 式(1-14-1)、または式(1-16-1)から式(1-16-6)で表される、請求項1、4、5、8、および9のいずれか1項に記載の化合物。
式(1-14-1)、および式(1-16-1)から式(1-16-6)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
Z2は、単結合、-COO-、-OCO-、-CH2O-、-OCH2-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-(CH2)4-、-(CH2)3O-、-O(CH2)3-、-CH=CH-(CH2)2-、-(CH2)2-CH=CH-、-CH=CH-CH2O-、または-OCH2-CH=CH-であり;
L5およびL6は独立して、水素、フッ素、塩素、-CF3、または-OCF3であり、L5およびL6の少なくとも1つは、フッ素、塩素、-CF3、または-OCF3であり;
X1およびX2は独立して、水素、フッ素、または塩素である。 To any one of claims 1, 4, 5, 8 and 9, which is represented by the formula (1-14-1) or the formula (1-16-1) to the formula (1-16-6). The compound described.
In equations (1-14-1), and from equations (1-16-1) to equations (1-16-6),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
Z 2 is a single bond, -COO-, -OCO-, -CH 2 O-, -OCH 2- , -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH- ,-(CH 2 ) 4 -,-(CH 2 ) 3 O-, -O (CH 2 ) 3- , -CH = CH- (CH 2 ) 2 -,-(CH 2 ) 2 -CH = CH- , -CH = CH-CH 2 O-, or -OCH 2- CH = CH-;
L 5 and L 6 are independently hydrogen, fluorine, chlorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, chlorine, -CF 3 or -OCF 3 Is;
X 1 and X 2 are independently hydrogen, fluorine, or chlorine. - 式(1-1-1)、式(1-3-1-1)から式(1-3-1-7)、式(1-3-2-1)、式(1-3-2-2)、式(1-3-3-1)、式(1-3-3-2)、式(1-3-4-1)、式(1-3-4-2)、式(1-3-5-1)、式(1-3-5-2)、または式(1-3-6-1)から式(1-3-6-4)で表される、請求項1から3、6、7、および10のいずれか1項に記載の化合物。
式(1-1-1)、式(1-3-1-1)から式(1-3-1-7)、式(1-3-2-1)、式(1-3-2-2)、式(1-3-3-1)、式(1-3-3-2)、式(1-3-4-1)、式(1-3-4-2)、式(1-3-5-1)、式(1-3-5-2)、および式(1-3-6-1)から式(1-3-6-4)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
L1、L2、L3、およびL4は独立して、水素、フッ素、-CF3、または、-OCF3であり、L1、L2、L3、およびL4の少なくとも2つは、フッ素、-CF3、または、-OCF3であり、L1、L2、L3、およびL4の少なくとも1つは、水素であり;
X1およびX2は独立して、水素またはフッ素である。 From Eqs. (1-1-1), Eqs. (1-3-1-1) to Eqs. (1-3-1-7), Eqs. (1-3-2-1), Eqs. (1-3-2- 2), Eq. (1-3-3-1), Eq. (1-3-3-2), Eq. (1-3-4-1), Eq. (1-3-4-2), Eq. (1) From claim 1 which is represented by the formula (1-3-6-1), the formula (1-3-5-2), or the formula (1-3-6-1) to the formula (1-3-6-4). The compound according to any one of 3, 6, 7, and 10.
From Eqs. (1-1-1), Eqs. (1-3-1-1) to Eqs. (1-3-1-7), Eqs. (1-3-2-1), Eqs. (1-3-2- 2), Eq. (1-3-3-1), Eq. (1-3-3-2), Eq. (1-3-4-1), Eq. (1-3-4-2), Eq. (1) In the formulas (-3-5-1), formula (1-3-5-2), and formulas (1-3-6-1) to formulas (1-3-6-4),
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
L 1 , L 2 , L 3 , and L 4 are independently hydrogen, fluorine, -CF 3 , or -OCF 3 , and at least two of L 1 , L 2 , L 3 , and L 4 are , Fluorine, -CF 3 , or -OCF 3 , and at least one of L 1 , L 2 , L 3 , and L 4 is hydrogen;
X 1 and X 2 are independently hydrogen or fluorine. - 式(1-14-1)、式(1-16-1-1)から式(1-16-1-7)、式(1-16-2-1)、式(1-16-2-2)、式(1-16-3-1)、式(1-16-3-2)、式(1-16-4-1)、式(1-16-4-2)、式(1-16-5-1)、式(1-16-5-2)、または式(1-16-6-1)から式(1-16-6-4)で表される、請求項1、4、5、8、9、および11のいずれか1項に記載の化合物。
式(1-14-1-1)、式(1-16-1-1)から式(1-16-1-7)、式(1-16-2-1)、式(1-16-2-2)、式(1-16-3-1)、式(1-16-3-2)、式(1-16-4-1)、式(1-16-4-2)、式(1-16-5-1)、式(1-16-5-2)、および式(1-16-6-1)から式(1-16-6-4)において、
R1およびR2は独立して、炭素数1から10のアルキル、炭素数1から9のアルコキシ、炭素数2から9のアルコキシアルキル、炭素数2から10のアルケニル、または炭素数2から9のアルケニルオキシであり;
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルであり;
L5およびL6は独立して、水素、フッ素、-CF3、または、-OCF3であり、L5およびL6の少なくとも1つは、フッ素、-CF3、または、-OCF3であり;
X1およびX2は独立して、水素またはフッ素である。 From Eqs. (1-14-1), Eqs. (1-16-1-1) to Eqs. (1-16-1-7), Eqs. (1-16-2-1), Eqs. (1-16-2-) 2), Eq. (1-16-3-1), Eq. (1-16-3-2), Eq. (1-16-4-1), Eq. (1-16-4-2), Eq. (1) -16-5-1), formula (1-16-5-2), or formula (1-16-6-1) to formula (1-16-6-4), claim 1, 4. The compound according to any one of 5, 8, 9, and 11.
Equations (1-14-1-1), equations (1-16-1-1) to equations (1-16-1-7), equations (1-16-2-1), equations (1-16-) 2-2), Equation (1-16-3-1), Equation (1-16-3-2), Equation (1-16-4-1), Equation (1-16-4-2), Equation In equations (1-16-5-1), equations (1-16-5-2), and equations (1-16-6-1) to equations (1-16-6-4).
R 1 and R 2 are independently alkyl with 1 to 10 carbons, alkoxy with 1 to 9 carbons, alkoxyalkyl with 2 to 9 carbons, alkenyl with 2 to 10 carbons, or alkenyl with 2 to 9 carbons. Alkoxyoxy;
Ra is a hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms;
L 5 and L 6 are independently hydrogen, fluorine, -CF 3 or -OCF 3 , and at least one of L 5 and L 6 is fluorine, -CF 3 or -OCF 3 . ;
X 1 and X 2 are independently hydrogen or fluorine. - 式(1-1-1-1)から式(1-1-1-7)で表される、請求項1から3、6、7、10、および12のいずれか1項に記載の化合物。
式(1-1-1-1)から(1-1-1-7)において、
R1およびR2は独立して、炭素数1から7のアルキル、炭素数1から6のアルコキシ、炭素数2から6のアルコキシアルキル、炭素数2から7のアルケニル、または炭素数2から7のアルケニルオキシである。
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルである。 The compound according to any one of claims 1 to 3, 6, 7, 10, and 12, represented by formulas (1-1-1-1) to (1-1-1-7).
In equations (1-1-1-1) to (1-1-1-7),
R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons. Alkoxyoxy.
Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms. - 式(1-14-1-1)、または式(1-14-1-2)で表される、請求項1、4、5、8、9、11、および13のいずれか1項に記載の化合物。
式(1-14-1-1)、または式(1-14-1-2)において、
R1およびR2は独立して、炭素数1から7のアルキル、炭素数1から6のアルコキシ、炭素数2から6のアルコキシアルキル、炭素数2から7のアルケニル、または炭素数2から7のアルケニルオキシである。
Raは、水素、炭素数1から4の直鎖アルキル、または炭素数3または4の分岐鎖アルキルである。 13. Compound.
In the formula (1-14-1-1) or the formula (1-14-1-2),
R 1 and R 2 are independently alkyl with 1 to 7 carbons, alkoxy with 1 to 6 carbons, alkoxyalkyl with 2 to 6 carbons, alkenyl with 2 to 7 carbons, or alkenyl with 2 to 7 carbons. Alkoxyoxy.
Ra is hydrogen, a linear alkyl having 1 to 4 carbon atoms, or a branched chain alkyl having 3 or 4 carbon atoms. - 請求項1から15のいずれか1項に記載の化合物の少なくとも1つを含有する液晶組成物。 A liquid crystal composition containing at least one of the compounds according to any one of claims 1 to 15.
- 式(2)から式(4)で表される化合物の群から選択された少なくとも1つの化合物を含有する、請求項16に記載の液晶組成物。
式(2)から式(4)において、
R11およびR12は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR11およびR12において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
環B1、環B2、環B3、および環B4は独立して、1,4-シクロヘキシレン、1,4-フェニレン、2-フルオロ-1,4-フェニレン、2,5-ジフルオロ-1,4-フェニレン、またはピリミジン-2,5-ジイルであり;
Z11、Z12、およびZ13は独立して、単結合、-COO-、-(CH2)2-、-CH=CH-、または-C≡C-である。 The liquid crystal composition according to claim 16, which contains at least one compound selected from the group of compounds represented by formulas (2) to (4).
In equations (2) to (4),
R 11 and R 12 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 11 and R 12, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
Ring B 1 , Ring B 2 , Ring B 3 and Ring B 4 are independent, 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro- 1,4-phenylene, or pyrimidine-2,5-diyl;
Z 11 , Z 12 , and Z 13 are independently single-bonded, -COO-,-(CH 2 ) 2- , -CH = CH-, or -C≡C-. - 式(5)から式(13)で表される化合物の群から選択された少なくとも1つの化合物をさらに含有する、請求項16または17に記載の液晶組成物。
式(5)から式(13)において、
R13およびR14は独立して、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR13およびR14において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
R15は、水素、フッ素、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR15において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
環C1、環C2、環C3、および環C4は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
環C5および環C6は独立して、1,4-シクロヘキシレン、1,4-シクロヘキセニレン、1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、またはデカヒドロナフタレン-2,6-ジイルであり;
Z14、Z15、Z16、およびZ17は独立して、単結合、-COO-、-CH2O-、-OCF2-、-(CH2)2-、または-OCF2-(CH2)2-であり;
L11およびL12は独立して、フッ素または塩素であり;
S11は、水素またはメチルであり;
Xは、-CHF-または-CF2-であり;
j、k、m、n、p、q、r、およびsは独立して、0または1であり、k、m、n、およびpの和は、1または2であり、q、r、およびsの和は、0、1、2、または3であり、tは、1、2、または3である。 The liquid crystal composition according to claim 16 or 17, further comprising at least one compound selected from the group of compounds represented by formulas (5) to (13).
In equations (5) to (13),
R 13 and R 14 are independently alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in the R 13 and R 14, at least one -CH 2 - is replaced by -O- At least one hydrogen may be replaced with fluorine;
R 15 is hydrogen, fluorine, alkenyl alkyl carbon atoms or 2 to 10 from 10 1 carbon atoms, in the R 15, at least one -CH 2 - may be replaced by -O-, At least one hydrogen may be replaced by fluorine;
Ring C 1 , Ring C 2 , Ring C 3 , and Ring C 4 may independently replace 1,4-cyclohexylene, 1,4-cyclohexenylene, and at least one hydrogen with fluorine 1, 4-Phenylene, tetrahydropyran-2,5-diyl, or decahydronaphthalene-2,6-diyl;
Ring C 5 and ring C 6 are each independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, tetrahydropyran-2,5-diyl or decahydronaphthalene, 2,6 -Jeil;
Z 14, Z 15, Z 16 , and Z 17 are independently a single bond, -COO -, - CH 2 O -, - OCF 2 -, - (CH 2) 2 -, or -OCF 2 - (CH 2 ) 2- is;
L 11 and L 12 are independently fluorine or chlorine;
S 11 is hydrogen or methyl;
X is -CHF- or -CF 2- ;
j, k, m, n, p, q, r, and s are independently 0 or 1, and the sum of k, m, n, and p is 1 or 2, q, r, and The sum of s is 0, 1, 2, or 3, and t is 1, 2, or 3. - 式(21)から式(23)で表される化合物の群から選択された少なくとも1つの化合物をさらに含有する、請求項16から18のいずれか1項に記載の液晶組成物。
式(21)から(23)において、
R16は、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR16において、少なくとも1つの-CH2-は-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
X11は、フッ素、塩素、-CF3、-CHF2、-CH2F、-OCF3、-OCHF2、-OCF2CHF2、または-OCF2CHFCF3であり;
環D1、環D2、および環D3は独立して、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
Z18、Z19、およびZ20は独立して、単結合、-COO-、-CH2O-、-CF2O-、-OCF2-、-(CH2)2-、-CH=CH-、-C≡C-、または-(CH2)4-であり;
L13およびL14は独立して、水素またはフッ素である。 The liquid crystal composition according to any one of claims 16 to 18, further comprising at least one compound selected from the group of compounds represented by formulas (21) to (23).
In equations (21) to (23),
R 16 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 16, at least one -CH 2 - may be replaced by -O-, at least one hydrogen , May be replaced with fluorine;
X 11 is fluorine, chlorine, -CF 3 , -CHF 2 , -CH 2 F, -OCF 3 , -OCHF 2 , -OCF 2 CHF 2 , or -OCF 2 CHFCF 3 ;
Ring D 1 , Ring D 2 , and Ring D 3 are independently 1,4-cyclohexylene, 1,4-phenylene, where at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl. , 1,3-dioxane-2,5-diyl, or pyrimidine-2,5-diyl;
Z 18 , Z 19 and Z 20 are independently single-bonded, -COO-, -CH 2 O-, -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , -CH = CH. -, - C≡C-, or - (CH 2) 4 - a and;
L 13 and L 14 are independently hydrogen or fluorine. - 式(24)で表される化合物の群から選択された少なくとも1つの化合物をさらに含有する、請求項16から19のいずれか1項に記載の液晶組成物。
式(24)において、
R17は、炭素数1から10のアルキルまたは炭素数2から10のアルケニルであり、このR17において、少なくとも1つの-CH2-は、-O-で置き換えられてもよく、少なくとも1つの水素は、フッ素で置き換えられてもよく;
X12は-C≡Nまたは-C≡C-C≡Nであり;
環E1は、1,4-シクロヘキシレン、少なくとも1つの水素がフッ素で置き換えられてもよい1,4-フェニレン、テトラヒドロピラン-2,5-ジイル、1,3-ジオキサン-2,5-ジイル、またはピリミジン-2,5-ジイルであり;
Z21は、単結合、-COO-、-CH2O-、-CF2O-、-OCF2-、-(CH2)2-、または-C≡C-であり;
L15およびL16は独立して、水素またはフッ素であり;
iは、1、2、3、または4である。 The liquid crystal composition according to any one of claims 16 to 19, further containing at least one compound selected from the group of compounds represented by the formula (24).
In equation (24)
R 17 is an alkenyl alkyl carbon atoms or 2 to 10 1 to 10 carbons, and in this R 17, at least one -CH 2 - may be replaced by -O-, at least one hydrogen May be replaced with fluorine;
X 12 is -C≡N or -C≡C-C≡N;
Ring E 1 is 1,4-cyclohexylene, 1,4-phenylene in which at least one hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl. , Or pyrimidine-2,5-dioxane;
Z 21 is a single bond, -COO-, -CH 2 O-, -CF 2 O-, -OCF 2 -,-(CH 2 ) 2- , or -C ≡ C-;
L 15 and L 16 are independently hydrogen or fluorine;
i is 1, 2, 3, or 4. - 請求項16から20のいずれか1項に記載の液晶組成物を含む液晶表示素子。
A liquid crystal display device containing the liquid crystal composition according to any one of claims 16 to 20.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180007071.2A CN114787130A (en) | 2020-03-25 | 2021-03-24 | Compound, liquid crystal composition and liquid crystal display element |
JP2022510597A JPWO2021193708A1 (en) | 2020-03-25 | 2021-03-24 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-054507 | 2020-03-25 | ||
JP2020054507 | 2020-03-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021193708A1 true WO2021193708A1 (en) | 2021-09-30 |
Family
ID=77890459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/012218 WO2021193708A1 (en) | 2020-03-25 | 2021-03-24 | Compound, liquid crystal composition, and liquid crystal display element |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2021193708A1 (en) |
CN (1) | CN114787130A (en) |
WO (1) | WO2021193708A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4943973A (en) * | 1972-07-24 | 1974-04-25 | ||
WO2008096791A1 (en) * | 2007-02-07 | 2008-08-14 | Astellas Pharma Inc. | Acylguanidine derivative |
WO2010133278A1 (en) * | 2009-05-22 | 2010-11-25 | Merck Patent Gmbh | Liquid crystal display |
WO2017084231A1 (en) * | 2015-11-17 | 2017-05-26 | 江苏师范大学 | Series of fluorine-containing carbazole compounds, preparation method and use thereof |
WO2018031410A2 (en) * | 2016-08-04 | 2018-02-15 | Nitto Denko Corporation | Heterocyclic liquid crystal composition, reverse-mode polymer dispersed liquid crystal element, and associated selectively dimmable device |
WO2018088386A1 (en) * | 2016-11-10 | 2018-05-17 | Dic株式会社 | Liquid crystal display element |
-
2021
- 2021-03-24 JP JP2022510597A patent/JPWO2021193708A1/ja active Pending
- 2021-03-24 CN CN202180007071.2A patent/CN114787130A/en active Pending
- 2021-03-24 WO PCT/JP2021/012218 patent/WO2021193708A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4943973A (en) * | 1972-07-24 | 1974-04-25 | ||
WO2008096791A1 (en) * | 2007-02-07 | 2008-08-14 | Astellas Pharma Inc. | Acylguanidine derivative |
WO2010133278A1 (en) * | 2009-05-22 | 2010-11-25 | Merck Patent Gmbh | Liquid crystal display |
WO2017084231A1 (en) * | 2015-11-17 | 2017-05-26 | 江苏师范大学 | Series of fluorine-containing carbazole compounds, preparation method and use thereof |
WO2018031410A2 (en) * | 2016-08-04 | 2018-02-15 | Nitto Denko Corporation | Heterocyclic liquid crystal composition, reverse-mode polymer dispersed liquid crystal element, and associated selectively dimmable device |
WO2018088386A1 (en) * | 2016-11-10 | 2018-05-17 | Dic株式会社 | Liquid crystal display element |
Non-Patent Citations (2)
Title |
---|
KUETHE, J. T ET AL.: "Suzuki-Miyaura cross- coupling of 2-nitroarenediazonrnm tetrafluoroborates: synthesis of unsymmetrical 2- nitrobiphenyls and highly functionalized carbazoles", ADVANCED SYNTHESIS & CATALYSIS, vol. 350, no. 10, 2008, pages 1577 - 1586, XP002542896, DOI: 10.1002/adsc.200800162 * |
RIDDELL NICOLE, JIN UN-HO, SAFE STEPHEN, CHENG YATING, CHITTIM BROCK, KONSTANTINOV ALEX, PARETTE ROBERT, PENA-ABAURREA MIREN, REIN: "Characterization and Biological Potency of Mono-to Tetra-Halogenated Carbazoles", ENVIRONMENTAL SCIENCE & TECHNOLOGY, vol. 49, no. 17, 2015, pages 10658 - 10666, XP055861215, DOI: 10.1021/acs.est.5b02751 * |
Also Published As
Publication number | Publication date |
---|---|
TW202142678A (en) | 2021-11-16 |
JPWO2021193708A1 (en) | 2021-09-30 |
CN114787130A (en) | 2022-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7078030B2 (en) | Compounds with dibenzofuran rings, liquid crystal compositions and liquid crystal display devices | |
WO2019107394A1 (en) | Compounds having dibenzothiophene ring, liquid crystal composition, and liquid crystal display element | |
JP6627515B2 (en) | Liquid crystal compound having negative dielectric anisotropy having 3,6-dihydro-2H-pyran, liquid crystal composition, and liquid crystal display device | |
JP7127295B2 (en) | Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display element | |
JP6850410B2 (en) | Liquid crystal compounds, liquid crystal compositions and liquid crystal display devices with benzothiophene | |
JP6784069B2 (en) | Liquid crystal compounds, liquid crystal compositions and liquid crystal display devices | |
JP6623567B2 (en) | Dihydropyran compound, liquid crystal composition and liquid crystal display device | |
JP2020158503A (en) | Liquid crystalline compound having dibenzothiophene ring, liquid crystal composition and liquid crystal display element | |
JP6939241B2 (en) | Compounds with dibenzothiophene rings, liquid crystal compositions, and liquid crystal display devices | |
JPWO2019116979A1 (en) | Polymerizable compounds with methoxymethylacrylic groups, liquid crystal compositions, and liquid crystal display devices | |
JP2020066580A (en) | Mesomorphism compound having methyl group, liquid crystal composition, and liquid crystal display element | |
WO2020184142A1 (en) | Compounds, liquid crystal composition, and liquid crystal display element | |
JP6435923B2 (en) | Dihydropyran compound, liquid crystal composition, and liquid crystal display device | |
JP6511975B2 (en) | Liquid crystal composition and liquid crystal display device containing dihydropyran compound | |
JP6555144B2 (en) | Liquid crystal compound, liquid crystal composition, and liquid crystal display device | |
JPWO2020080120A1 (en) | Compounds, liquid crystal compositions, and liquid crystal display devices | |
JP6919394B2 (en) | Liquid crystal compounds having fluorene and CF2O, liquid crystal compositions and liquid crystal display devices | |
JP6766556B2 (en) | Liquid crystal compounds, liquid crystal compositions and liquid crystal display devices | |
TWI787521B (en) | O-bonded liquid crystal compound, liquid crystal composition and liquid crystal display element | |
JP7052597B2 (en) | Polymerizable polar compounds, liquid crystal compositions, and liquid crystal display devices | |
JP6738046B2 (en) | Liquid crystalline compound having biphenylene, liquid crystal composition and liquid crystal display device | |
JP6790741B2 (en) | Piperidine derivatives, liquid crystal compositions and liquid crystal display devices | |
WO2020116380A1 (en) | Compound, liquid crystal composition and liquid crystal display element | |
TWI856246B (en) | Compound, liquid crystal composition and liquid crystal display element | |
JP7234728B2 (en) | Liquid crystalline compound, liquid crystal composition and liquid crystal display element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21777185 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022510597 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21777185 Country of ref document: EP Kind code of ref document: A1 |